2016 Surveys Catalog PDF

Ensuring the accuracy that todays environment demands
Maximize confidence in your test results with the most extensive selection of scientifically developed
programs available. The CAP can help your laboratory:

Deliver the highest quality standards that your laboratory and patients can depend on
Ensure performance through peer comparisons with programs used by more than
20,000 laboratories worldwide
Enhance staff skills through technical and professional guidance included in all
participant summaries
2016
Surveys
and Anatomic
Pathology
Education Programs
Choose from a comprehensive offering to cover your testing needs:

Histocompatibility
Anatomic Pathology
Immunology and Flow Cytometry
Blood Gas, Critical Care, and Oximetry
Instrumentation Validation Tools
Coagulation
Microbiology
Continuing Education
Point-of-Care Programs
Endocrinology
Quality Management Tools
Forensic Sciences
Reproductive Medicine
General Chemistry and Therapeutic Drug Monitoring
Toxicology
Genetics and Molecular Pathology
Transfusion Medicine, Viral Markers, and

Parentage Testing
Hematology and Clinical Microscopy
2016 Surveys and Anatomic Pathology Education Programs
Accuracy-Based Programs
325 Waukegan Road

Northfield, IL 60093-2750
800-323-4040
847-832-7000 (Country code: 001)
2015 College of American Pathologists. All rights reserved.

23873.0715.1937
cap.org
Together,
we move forward
to achieve better
patient care.
Welcome to the 2016 Surveys Catalog

As I write this letter to introduce the College of American Pathologists
(CAP) 2016 Surveys Program, I am humbled to think of all the laboratory
professionals before us who dedicated themselves to advancing the practice
of laboratory medicine, a dedication that continues to reap value for us and
the patients we serve today.
In the pages that follow, you will read quotes from your laboratory peers
on why they choose CAP programs and the value they receive from them
whether its the full range of proficiency testing (PT) to validate and ensure
quality test results, the high-quality challenges and materials to help identify
potential problems before patients are impacted, or the ability to meet and
exceed regulatory requirements.
Through its laboratory
improvement programs,
the College of American
Pathologists provides an
unmatched level of peer
connectivity, including
the largest peer groups
for proficiency testing
and a vast network of
laboratory professionals
interacting with each other
through accreditation.
The CAP helps you meet
regulatory requirements
and mitigate risk through
such programs, while
maintaining high levels
of quality and employing
cutting-edge laboratory
practices, all for the
benefit of your patients.
The CAPs decades-long partnership with laboratories in PT and accreditation,

along with many other quality management and educational programs, has
resulted in the most rigorous and comprehensive laboratory improvement
programs in the world, bringing value to your laboratory and helping you
provide excellent service to other health care professionals and patients.
Your commitment to CAP laboratory improvement programs is crucial to
improving patient outcomes, from the management of technical areas to the
effectiveness of your daily work with colleagues throughout your organization.
Together with the CAP, you can help ensure better patient care through
ensuring the quality of your laboratory practices.
I applaud you for partnering with the CAP to connect you with the largest
network of peers, leading scientific experts, and industry leaders. Together,
we are all dedicated to providing the best patient care through the delivery of
consistent, accurate patient results.
Sincerely,
R. Bruce Williams, MD, FCAP

Chair, CAP Council on Scientific Affairs
Table of Contents

1 New Developments ....................................... 36
2 Continuing Education .................................. 720
Continuing Education Programs .................... 8
Competency Assessment Program.............. 15
QMEd TM Online Educational Courses ........... 18
3 Quality Management Tools ...................... 2140
Q-PROBESTM ...................................................... 24
Q-TRACKS ....................................................... 29
Q-MONITORS ................................................. 39
4 Point-of-Care Programs ............................ 4148
Point-of-Care Programs ................................. 42
EXCEL to Surveys Crosswalk ......................... 44
5 General Chemistry and Therapeutic
Drug Monitoring .......................................... 4974
General Chemistry and Therapeutic
Drug Monitoring .......................................... 50
Urine Chemistry ............................................... 63
Special Chemistry........................................... 66
6 Endocrinology............................................. 7582
7 Blood Gas, Critical Care,
and Oximetry .............................................. 8386
8 Toxicology ................................................. 87100
9 Accuracy-Based Programs .................. 101108
10 Instrumentation Validation Tools ......... 109128
Calibration Verification/Linearity................ 110
Instrumentation Quality
Management Programs........................... 124
11 Hematology and
Clinical Microscopy............................... 129144
Hematology .................................................. 130
Clinical Microscopy...................................... 139
12 Reproductive Medicine ........................ 145148
Andrology and Embryology ........................ 146
13 Coagulation ............................................ 149156
14 Microbiology ........................................... 157186

Bacteriology .................................................. 158
Mycobacteriology........................................ 170
Mycology....................................................... 171
Parasitology................................................... 174
Virology.......................................................... 178
Molecular Microbiology............................... 180
Infectious Disease Serology......................... 186
15 Immunology and Flow Cytometry ...... 187198

Immunology .................................................. 188
Flow Cytometry............................................. 196
16 Transfusion Medicine, Viral Markers,

and Parentage Testing .......................... 199212
Transfusion Medicine.................................... 200
Viral Markers .................................................. 209
Parentage Testing ........................................ 212
17 Histocompatibility .................................. 213218

18 Genetics and Molecular Pathology ..... 219234
Cytogenetics................................................. 220
Biochemical and Molecular Genetics....... 223
Next-Generation Sequencing..................... 229
Molecular OncologySolid Tumors ........... 231
Molecular OncologyHematologic ......... 234
19 Anatomic Pathology .............................. 235256

Surgical Pathology ....................................... 236
General Immunohistochemistry.................. 245
Predictive Markers ........................................ 247
Specialty Anatomic Pathology................... 248
Cytopathology ............................................. 250
20 Forensic Sciences .................................. 257260

21 Analyte/Procedure Index ..................... 261308
22 Program Code Page Index .................. 309312
You get more

from this box
Five more reasons to participate in the
CAPs proficiency testing (PT) programs:
1. Earn more than 100 CE credits per laboratory
employee
2. Gain collective knowledge and insight through
staff competency and learning
3. Increase your confidence in delivering accurate
patient results and meeting regulatory
requirements
4. Save time and money (operational efficiency,
fiscal responsibility, and fewer processing costs)
5. Realize better patient outcomes
1 | New Developments
1
NEW
Its about building the trust of the clinical staff in the

quality of our laboratory results. CAP proficiency
testing is more than what is in the box, its being on
the cutting edge of laboratory practices.
New Developments
New Developments
NEW

Subsection
Name
Program Code
Page(s)
Q-PROBES
Technical Staffing Ratios
QP161
25
Q-PROBES
Impact of Transit Times on Detection of

Bacterial Pathogens from Blood Cultures
QP162
26
Q-PROBES
Hospital Nursing Satisfaction

with Clinical Laboratory Services
QP163
27
Q-PROBES
Technical Competency Assessment on

Peripheral Blood Smear Review
QP164
28

Subsection
Name
Program Code
Page(s)

Drug Monitoring
Limited Chemistry
C4
50

Drug Monitoring
Waived Combination
HCC2
61

Drug Monitoring
Whole Blood Creatinine
WBCR
61
Name
Program Code
Page(s)
Ligand Assay, Limited
K2
76
Endocrinology
Section
Endocrinology
Toxicology
Subsection
Name
Program Code
Page(s)
Toxicology
Drug-Facilitated Crime
DFC
99
4 College of American Pathologists
2016 Surveys & Anatomic Pathology Education Programs
New Developments

Subsection
1
Program Code
Page(s)
Calibration Verification/Linearity
C-Reactive Protein, Extended Calibration

Verification/Linearity
LN12E
116
Lamellar Body Count Calibration Verification/Linearity
LN43
123
Fibrinogen Calibration Verification/Linearity
LN44
123
NEW
Name

Subsection
Name
Program Code
Page(s)
Hematology
Blood Cell Identification, Limited
BCP2
130
Hematology
Hematology Automated Differential Series
FH13, FH13P
131
Hematology
Centrifugal Hematology
FH15
132
Hematology
Waived Combination
HCC2
136
Clinical Microscopy
Urinalysis, Basic
CMP2
139
Clinical Microscopy
Urinalysis with Clinical Microscopy
CMP3
139
Clinical Microscopy
Urine, hCG
UHCG
144
Coagulation
Subsection
Name
Program Code
Page(s)
Coagulation
Basic Coagulation
CGB
150
Coagulation
ADAMTS-13
CGS7
151
800-323-4040 | 847-832-7000 Option 1 | cap.org
New Developments
NEW
Microbiology
Subsection
Name
Program Code
Page(s)
Bacteriology
Microbiology Combination with GC
MC1
161
Bacteriology
Microbiology Combination
MC2
161
Bacteriology
Urine Colony Count
MC3
161
Bacteriology
Urine Colony Count Combination
MC4
161
Bacteriology
Throat Culture/Rapid Strep
MC5
161
Bacteriology
Bordetella pertussis/parapertussis, Molecular
BOR
164
Bacteriology
C. difficile Detection, 2 challenges
CDF2
165
Bacteriology
CDF5
165
Parasitology
Trichomonas vaginalis, Molecular
TVAG
176
Influenza A, Influenza B, RSV by NAA
ID3
183
Molecular Microbiology

Subsection
Name
Program Code
Page(s)
Immunology
Celiac Serology, Additional Volume
CESX
192
Rare Flow Antigen Validation, CD103
RFAV2
198
Flow Cytometry
Transfusion Medicine, Viral Markers, and Parentage Testing

Subsection
Name
Program Code
Page(s)
ABO Subgroup Typing
ABOSG
203
Name
Program Code
Page(s)
CAP/ACMG BRCA1/2 Sequencing
BRCA
224
Next-Generation Sequencing
Next-Generation Sequencing, Solid Tumor
NGSST
229
Next-Generation Sequencing, Hematologic Malignancies
NGSHM
229
Next-Generation Sequencing Bioinformatics

for Illumina Platforms
NGSB1
230

for Ion Torrent Platforms
NGSB2
230
DNA Purification from FFPET
MHO5
231
Transfusion Medicine

Subsection
Biochemical and Molecular Genetics
Molecular OncologySolid Tumors
2 | Continuing Education
2
results and review them with the staff, especially

if you have had issuestrue issues. When each
CAP Survey comes back, we go over it with the
whole staff for their continuing education. We
see if, and where, we went wrong or if we have
more to learn. The educational part is when you
get the results backCAP encourages people to
be current on their education and knowledge.
Continuing Education Programs ...........................................................................................................8
Competency Assessment Program ......................................................................................................15
QMEd Online Educational Courses ................................................................................................18
The educational part comes when you get the
Continuing Education Programs
Your laboratory demonstrates its commitment to quality by choosing

CAP Surveys programs. Youll find the same level of quality in the CAP
Continuing Education Programs.
Legend
This activity is eligible for continuing medical education (CME) credit.
This activity is eligible for continuing education (CE) credit.
This activity is eligible for continuing medical education (CME) credit or continuing education (CE) credit.
Information for Courses Bearing the CME Icon

Accreditation
The College of American Pathologists (CAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME)
to provide continuing medical education for physicians.
CME Category 1
The College of American Pathologists designates these enduring materials educational activities for a maximum of the stated
number of AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their
participation in the activity.
Note to CME participants of enduring* materials courses:
An AMA requirement mandates that all physicians wishing to claim CME credits must pass a scored assessment. All CAP
enduring materials CME courses require participants to pass a scored assessment prior to claiming credit.
* Enduring courses are those courses that endure over time such as print or Internet courses.
CE (Continuing Education for Nonphysicians) for Courses Bearing the CE Icon

The College of American Pathologists designates these educational activities for a maximum of the stated number of credits of
continuing education. Participants should claim only the credit commensurate with the extent of their participation in the activity.
The American Society for Clinical Pathology (ASCP) Board of Certification (BOC) Certification Maintenance Program (CMP)
accepts this activity to meet its continuing education requirements. The states of California and Florida also approve these activities
for continuing education credit.
Cytotechnologists may apply the credits from the PAP Education (PAPCE/PAPJE/PAPKE/PAPLE/PAPME), NGC, FNAG, FNA, and
TICP programs toward the required educational activities for the American Society of Cytopathology (ASC) Continuing Education
Credit Program (CECC) and the International Academy of Cytology (IAC).
Surveys Continuing Education Activities

When your laboratory participates in CAP Surveys, every member of your team can enroll in education activities and earn
continuing education (CE) credit at no additional charge. Simply follow these steps:
2
1. Establish a free Web account.

2. Complete a reading provided in the Participant Summary or Final Critique.
3. Answer online learning assessment questions.
Each member of your staff can access the Surveys education activities for a maximum of 12 months.
Surveys Education Activities

Program Code
Source
Catalog
Page(s)
C1, C3/C3X,
C4, CZ/CZX/CZ2X
Participant Summary
5052
ZE, ZT, ZZT
Participant Summary
54
CS
Participant Summary
53
Mycophenolic Acid
MPA
Participant Summary
54
Serum Drug Screening
SDS
Participant Summary
93
IG/IGX, ANA, S2, S4, S5
Participant Summary
188, 189
CES
Participant Summary
192
SE
Participant Summary
193
ASC
Participant Summary
191
HE, HEP
Participant Summary
130
BCP, BCP2
Participant Summary
130
Program Name
General Chemistry and Therapeutic Drugs

Therapeutic Drug Monitoring, Extended and Special
CAP/AACC Immunosuppressive Drugs
Immunology
Celiac Serology
Diagnostic Allergy
Anti-Saccharomyces cerevisiae Antibody
Basic Hematology
Blood Cell Identification
Hematology Automated Differentials FH Series
FH1FH15, FH1PFH13P
Participant Summary
131, 132
Bone Marrow Cell Differential
BMD
Participant Summary
134
Virtual Peripheral Blood Smear
VPBS
Participant Summary
136
CGL, CGDF, CGB
Participant Summary
150
Final Critique
158
D1, D2, D3, D4, D6, D7, D9,

MC1, MC2, MC3, MC4, MC5
Participant Summary
160163
Final Critique
171
P, P3, P4, P5
Participant Summary
174
Coagulation, Limited
Bacteriology
Limited Bacteriology
Mycology
Parasitology
Blood Parasite
BP
Participant Summary
175
Transfusion Medicine, Comprehensive, Limited
J, J1
Participant Summary
200
Transfusion Medicine, Educational Challenges
JE1, JATE1
Participant Summary
200, 201
Transfusion Medicine, Electronic Crossmatch
EXM, EXM2
Participant Summary
203
JAT
Participant Summary
200
HQIP
Final Critique
242
SC, SC1, PV, SM, SV, ASA
Participant Summary
146
SMCD, SM1CD, SM2CD
Participant Summary
146
Transfusion Medicine, Automated Testing

CAP/NSH HistoQIP
Semen Analysis
Sperm Motility, Morphology, and Viability
Whole Blood Glucose
Rapid Anti-HIV
Clinical Microscopy
WBG, WB2
Participant Summary
61
AHIV, AHIVW
Participant Summary
210
CMP, CMP1, CMP2, CMP3
Participant Summary
139
800-323-4040 | 847-832-7000 Option 1 | cap.org
Surveys Self-Reported Training Opportunities

When your laboratory participates in CAP Surveys, every member of your team can receive self-reported training opportunities.
Self-Reported Training Opportunities*

Program Code
Source
Catalog
Page(s)
Technical Staffing Ratios
QP161
Final Critique
25
Impact of Transit Times on Detection of Bacterial

Pathogens from Blood Cultures
QP162
Final Critique
26
Hospital Nursing Satisfaction with Clinical

Laboratory Services
QP163
Final Critique
27
Technical Competency Assessment on Peripheral

Blood Smear Review
QP164
Final Critique
28
Blood Cell Identification
BCP
Participant Summary
130
Bone Marrow Cell Differential
BMD
Participant Summary
134
FH1FH13, FH1PFH13P
Participant Summary
131
Basic Hematology
HE, HEP
Participant Summary
130
Hemoglobinopathy
HG
Participant Summary
134
VPBS
Participant Summary
136
CMP, CMMP , CMP1,

CMP2, CMP3
Participant Summary
139
BP
Participant Summary
175
DEX
Participant Summary/Final Critique
159
Mycobacteriology
170
Yeast
F1
171
Parasitology
174
Ticks, Mites, and Other Arthropods
TMO
Participant Summary
176
Worm Identification
WID
Participant Summary
176
CAP/ACMG Cytogenetics
CY
Participant Summary
220
CAP/ACMG FISH for Constitutional/Hematologic

Disorders
CYF
Participant Summary
220
CAP/ACMG FISH for Paraffin-Embedded Tissue
CYJ, CYK, CYL
Participant Summary
221
CAP/ACMG Cytogenomic Microarray Analysis
CYCGH
Participant Summary
221
Program Name
Hematology Automated Differentials FH Series
Virtual Peripheral Blood Smear

Clinical Microscopy
Microbiology
Blood Parasite
Expanded Bacteriology
*Notes:
C
AP Self-Reported Training opportunities do not offer CE credit, but can be used towards fulfilling requirements for certification
maintenance by agencies such as the American Society for Clinical Pathology (ASCP). Please verify with your certifying agency to
determine your education requirements.
These opportunities are subject to change. Refer to the Participant Summary/Final Critique for availability.
Maintenance of Certification (MOC)

Maintenance of Certification (MOC) is the board certification program that involves continuous professional development and
ensures that an American Board of Pathology (ABP) board-certified pathologist is committed to lifelong learning and competency
in a specialty and/or subspecialty.
2
There are six competency categories defined by the American Board of Medical Specialties (ABMS) and endorsed by the ABP to
fulfill specific MOC requirements. They are listed below with their descriptions.
All CAP education activities providing CME credits meet the MOC Part II: Lifelong Learning requirements. Some programs will
meet the requirements for Self-Assessment Module (SAM) and/or MOC Part IV at the laboratory or the individual levels. Programs
that meet Part IV are identified within the description of the program. Visit the CAP website for the current list of programs that
meet the requirements for MOC Part II and Part IV.
Interpersonal and Communication Skills
Demonstrate interpersonal and communication skills that result in effective information exchange and teaming with patients,
patients families, and professional associates.
Medical Knowledge
Demonstrate knowledge of established and evolving biomedical, clinical, and cognate sciences and the application of this
knowledge to pathology.
Practice-Based Learning and Improvement
Demonstrate ability to investigate and evaluate diagnostic and laboratory practices in your own lab, appraise and assimilate
scientific evidence, and improve laboratory practices and patient care.
Patient Care
Demonstrate a satisfactory level of diagnostic competence and provide appropriate and effective consultation in the context of
pathology services.
Professionalism
Demonstrate a commitment to carrying out professional responsibilities, adherence to ethical principles, and sensitivity to diverse
patient population.
Systems-Based Practice
Demonstrate understanding of and contribution to local, regional, and national health care systems, and support health care in
systems-based practice definition.
This activity fulfills the SAM credit requirements for MOC and is therefore eligible for SAM credit. Participants who
successfully complete an online assessment may apply their earned credit(s) to the ABPs SAM requirements.
Note to CME/CE participants: The AMA mandates that all education providers (such as the CAP) require participants
pass assessment questions in an enduring* program in order to earn and claim CME credits. All participants in
any activity granting CME/CE will be required to complete and pass assessment questions before claiming their
credits.
For CME/SAM activities ONLY: Participants will have three attempts to pass the assessment, with feedback
provided after each attempt. Participants may not claim CME/SAM if they do not pass on the third attempt.
*Enduring programs are those courses that endure over time such as print or online courses.
800-323-4040 | 847-832-7000 Option 1 | cap.org
11
Education Programs
Program Name
Program Code
Maximum AMA PRA

CME Category 1
Credits Annually
Maximum
CE Credits
Annually
Format
Catalog
Page
Autopsy Pathology
AUCD/AUCD1
12
NA
CD-ROM
248
CPIP/CPIP1
15
NA
Online
14
Online Digital Slide Program

in Dermatopathology*
DPATH/DPATH1
14****
NA
Online (DigitalScope)
239
Online Digital Slide Program

in Fine-Needle Aspiration*
FNA/FNA1
10
10
255
FNAG/FNAG1
10
10
Glass Slides
256
FR/FR1
12
12
CD-ROM
259
HPATH/HPATH1
NGC/NGC1
25
25
Glass Slides
With Online Cases
(DigitalScope)
254
NP/NP1
10****
NA
CD-ROM with Online
249
PAPCE/APAPCE
PAPJE/APAPJE
PAPKE/APAPKE
PAPLE/APAPLE
PAPME/APAPME
Series 1 or 2
Glass Slides
251
PAPCPT/APAPCPT
PAPJPT/APAPJPT
PAPKPT/APAPKPT
PAPLPT/APAPLPT
PAPMPT/APAPMPT
Glass Slides
250
PCSP/PCSP1
5****
NA
241
Clinical Pathology Improvement

Program*
Fine-Needle Aspiration
Glass Slide
Forensic Pathology
Hematopathology Online
Education
Nongynecologic
Cytopathology Education**
Neuropathology Program
Gynecologic Cytopathology
PAP Education Program***
Glass Slide Cytopathology PAP

PT Program (with Glass Slide
PAP Education)***
Cancer Staging Improvement
Program
Online (DigitalScope) 138, 240
*Program is available for purchase online. Go to cap.org and choose the Learning tab.
**NGC provides up to 20 CME/CE credits for the glass slides and 5 CME/CE credits for the online slide portion of the program.
*** PAP provides up to 8 CME/CE credits for glass slides.
**** SAM credits are included in CME totals for the appropriate programs.
Education Programs
Maximum AMA PRA
CME Category 1
Credits Annually
Maximum
CE Credits
Annually
Format
Catalog
Page
PIP/PIP1
40
NA
Glass Slides
236
PIPW/PIPW1
40
NA
237
Nongynecologic Cytopathology
Intraoperative Touch Imprint/
Crush Preparation Program*
TICP/TICP1
10****
10
253
Online Virtual Biopsy Program*
VBP/VBP1
23****
NA
238
Performance Improvement
Program in Surgical Pathology
Online Performance
Improvement Program in
Surgical Pathology*
2
Program Code
Program Name
*Program is available for purchase online. Go to cap.org and choose the Learning tab.
**** SAM credits are included in CME totals for the appropriate programs.
System Requirements
Many of our education programs utilize online whole slide images that simulate the use of a microscope. This allows you to scan
and use multiple magnifications to view the image.
To best view these programs, we recommend the following:
Both indows and Macintosh systems must have Microsoft (MS) Silverlight installed to properly view these slides. If your
system does not have MS Silverlight you should be prompted to download this software when viewing the slides for the first
time. You may also manually download MS Silverlight (microsoft.com/getsilverlight).
Browser Version Internet Explorer 7 or higher. In IE 10 and 11, open in Compatibility View. Go to windows.microsoft.com
for more information.
Note: Browsers that do not allow the use of MS Silverlight as a plug-in, such as Chrome version 42 or later, will not display
the CAP DigitalScope whole slide images.
Pop-up bloc ers must be turned off to access the activity. Also, cap.org must be added as a trusted website.
Note: Go to cap.org and select CONTACT & SUPPORT for the most up-to-date information on system requirements.
The download speed and the appearance of the activity will vary depending on the type and speed of your Internet connection,
computers power, and browser.
800-323-4040 | 847-832-7000 Option 1 | cap.org
13
Clinical Pathology Improvement Program (CPIP)

The Clinical Pathology Improvement Program (CPIP) delivers 12 online clinical laboratory cases to studyone per monthand an
opportunity to earn up to 15 CME/SAM credits annually. Assess and improve clinical pathology skills and fulfill Maintenance of
Certification (MOC) requirements.
CPIP cases feature real-life case scenarios, including images and clinical background. Participants work through sequentiallyrevealed information and a series of prompts to arrive at a resolutionjust as in the laboratory.
Cases include thought-provoking questions with feedback and a multiple-choice post-test. Participants who earn passing scores on
post-tests may apply their earned credits to the ABPs MOC SAM requirements.
Clinical Pathology Improvement Program

CPIP/CPIP1
Program Name
Program Code
Cases/Year
CPIP/CPIP1
Online cases in clinical pathology
12
Additional Information
Pathologists and residents can use CPIP online to assess and improve their skills in
clinical pathology.
Case topics may originate from the ABP s general listing suggested for MOC
including laboratory administration and operations, transfusion medicine,
chemistry, coagulation, hematology, immunology, microbiology, and molecular
genetic pathology.
Cases may include patient history, case-related static images, and whole
slide images.
Monthly individual CPIP cases can also be purchased online. Go to cap.org and
choose the Learning tab. To purchase both CPIP and CPIP1, please call
800-323-4040 or 847-832-7000 option 1.
Program Information
One online clinical laboratory
case per month
CPIP1 - Additional
pathologist (within the
same institution) reporting
option with CME/SAM credit;
must order in conjunction
with CPIP
Earn a maximum of 15
CME/SAM credits (AMA PRA
Category 1 Credits) per year
This activity meets the
ABP MOC Part IV Practice
Performance Assessment
requirements
Twelve cases per year; your
CAP shipping contact will be
notified via email when the
activity is available
Competency Assessment Program

2
Competency Assessment Program includes:
Competency assessment courses with customized training and CE credit

Two levels of assessment courses for Blood Ban /Transfusion Medicine and Microbiology modules one for generalists and
one for specialists
Reassessment courses
A library of educational training courses (Pro Courses) with CE credit
Instrument-specific observation chec lists for competency and training
Course-building and modifying tools
Management trac ing and reporting
Individual transcripts
Competency Profiles. This new functionality will allow administrators to create profiles to document the six areas of
competency as defined by CLIA and the CAP Laboratory Accreditation Program. Learn more about Competency Profile at
cap.org.
Safety & Compliance Courses for the Laboratory
The package includes all seven courses, which are appropriate for annual laboratory compliance training and for clinical
laboratory science students prior to clinical rotations. Access Safety & Compliance courses throughout the subscription period;
the CAP updates these courses when necessary to reflect changes in regulations or best practices.
OSHA Bloodborne Pathogens

OSHA Chemical Hygiene
OSHA Electrical Safety
OSHA Fire Safety
OSHA Formaldehyde
Tuberculosis Awareness
Medical Errors and Patient Safety
Note: You must purchase the Safety & Compliance course package in conjunction with the Competency Assessment Program
subscription; it is not available for purchase separately.
The Safety & Compliance courses listed above do not offer CE credit.
Please see next pages for all course descriptions. For more information, visit cap.org and choose the Learning tab.
800-323-4040 | 847-832-7000 Option 1 | cap.org
15
Assessment Course Schedule
Discipline
January 2016 Release
July 2016 Release
Blood componentsstorage,
handling, and selection
Compatibility testing and quality control
Cardiac biomarkers
Therapeutic drug monitoring
Erythrocyte inclusions
White blood cells
Quality management in histology
Immunohistochemistry, part 1
Immunology
Hepatitis testing
Serology kit tests
Microbiology
Blood cultures
Microbiology of the gastrointestinal tract
Phlebotomy/Specimen Processing
Common pitfalls in specimen processing
General specimen handling and

transportation requirements
Point-of-Care Testing
Point-of-care whole blood glucose testing
Point-of-care blood gases
Investigating occurrences
Development and implementation

of a quality management program
Bloodborne pathogens
General laboratory safety
Physical and chemical urinalysis
Microscopic urinalysis, part 1
Blood Banking/Transfusion Medicine

Chemistry
Hematology and Coagulation
Histology
Quality Programs/Management
Safety
Urinalysis/Body Fluids
Pro Course Schedule

Discipline
Blood Banking/Transfusion Medicine

Chemistry
Hematology and Coagulation
Histology
January 2016 Release
July 2016 Release
Antibody screen and identification
Transfusion reactions
Liver and renal testing
Chemistry quality control, calibration,

and reportable range
Common coagulation tests
Platelet testing, morphology, and disorders
Safety issues in the histology laboratory
Special stains
Immunology
Qualitative HIV testing
Molecular amplification methods for

detection of infectious diseases
Microbiology
Gram stain: organism detection and

differentiation
Urine and body fluid cultures
Phlebotomy/Specimen Processing
Challenges of phlebotomy: pediatric

blood collection, alternate sites,
and difficult draws
Specimen collection for workplace urine

drug testing programs and forensic drug
and alcohol testing
Point-of-Care Testing
Point-of-care whole blood prothrombin

time and INR (PT/INR) testing
Point-of-care cardiac biomarkers
Quality Programs/Management
Monitoring the quality control program
Competency evaluation
Fire and electrical safety
Ergonomics
Cerebrospinal fluid analysis
Semen analysis
Safety
Urinalysis/Body Fluids
Safety & Compliance Courses

OSHA Bloodborne Pathogens Addresses the OSHA Bloodborne Pathogens standard as it applies to clinical and medical
laboratories. Covers major bloodborne pathogens, including hepatitis B and HIV. Focuses on proper handling of sharps, personal
protective equipment (PPE), engineering controls such as microbiological safety cabinets, and proper work practices like handwashing.
2
OSHA Chemical Hygiene Describes the OSHA Chemical Hygiene Standard and helps satisfy OSHA requirements for annual
training. Explains Haz-Com, the National Fire Protection Agency diamond, the Safety Data Sheet, and common-sense laboratory
safety rules applied to clinical laboratory practice.
OSHA Electrical Safety Addresses electrical safety and electrical hazards commonly found in the clinical laboratory. Covers
prevention and safety measures, fighting electrical fires, and treatment of electrical injuries.
OSHA Fire Safety Teaches the basics of fire safety in the clinical laboratory, including classes of fire and key acronyms such as
PASS and RACE. Addresses fire prevention, drills, and firefighting techniques.
OSHA Formaldehyde Covers essentials for any laboratory that uses formaldehyde or formalin. Shares facts about
formaldehyde, safety risks, proper handling procedure, monitoring, spill clean-up, and personal protective equipment.
Tuberculosis Awareness Provides background information about spread of TB, PPD testing procedures, CDC guidelines, and
methods of control.
Medical Errors and Patient Safety Includes potential causes of medical errors in the clinical laboratory, important legislation
and definitions, and steps laboratory professionals can take to reduce the impact of medical errors in their workplace. Serves
as an ideal part of an effective medical error reduction program and is appropriate for both experienced and newer laboratory
personnel.
Note: The Safety & Compliance courses are not available for purchase separately. The courses listed above do not offer CE credit.
800-323-4040 | 847-832-7000 Option 1 | cap.org
17
QMEd Online Educational Courses
Learn quality tools and techniques with case examples from

medical laboratories.
Program information
CAP uality Management Educational Resources ( MEd) courses help you improve your processes and eliminate waste.
CAP MEd courses help you build a quality management systemone piece at a timethat sustains your continuous
improvement and Lean efforts.
CAP MEd courses are delivered online via a highly interactive user interface that allows you to learn at your own pace.
All CAP MEd courses are licensed for one year, allow sharing of logins, and include continuing education (CE) credit.
CAP online interactive QMEd courses will help you:
nderstand the concept of a uality management system

Self-assess your current MS against international uality standards
Plan and resource for the development of your MS
Interpret ISO 15189 re uirements
Improve your document control system
Perform internal audits using tracer audit and process audit methods
Implement and refine occurrence management with root cause analysis
rite an effective uality manual
Measure, analyze, and set goals with senior management
About the Courses

15189 Walkthrough
Order ISOEDWT
Designed for lab quality managers (along with your medical and administrative decision makers) considering implementation of
an ISO 15189 program. Summarizes each section of the standard, while clarifying its intent and key requirements. Hear directly
from the CAPs ISO 15189 assessors who offer context and examples of how technical problems relate to more fundamental
deficiencies in the quality management system.
2 CE credits available
QMS Implementation Roadmap
Order ISOEDRM
Outlines the practical steps necessary to build, implement, and maintain a quality management system that meets the
ISO 15189 standard. Gain perspective on practices (and pitfalls) straight from the CAPs ISO 15189 assessors, as well as
ISO 15189-accredited labs. Designed for lab quality managers, plus your implementation team members.
Root Cause Analysis
Order ISOEDRC
Learn real-world methodology to conduct a root cause analysis, along with the tools necessary to implement it. Learn from actual
examples of complete root cause analysis based on projects in labs like yours. You will even perform key steps based on a
participant case study. The course is designed for laboratory quality managers and implementation team members.
Internal Auditing
Order ISOEDIA
Increase your capabilities for internal auditing with a proven methodology for process audits, tracer audits, and laser audits. Learn
from the CAPs ISO 15189 assessors how to prepare for interviews, communicate findings to your quality management team, and
use audits to drive process improvements.
2
Document Control
Order ISOEDDC
This how-to course on document control systems details how to control documents in a way that meets ISO 15189 re uirements,
how to accomplish document control even with minimal resources (such as spreadsheets), and how document control contributes
to cost containment. All this from the CAPs ISO 15189 assessors who give examples and commentary on common pitfalls and
issues.
Quality Manual Development
Order ISOEDQM
This course provides guidance on how to go beyond a quality plan to develop a manual that organizes and communicates your
laboratorys quality management system. You will see an example of an effectively structured and written manual so you can
organize and create your own. Plus, the CAPs ISO 15189 assessors show you approaches to link your quality policy to quality
objectives and metrics.
Management Review
Order ISOEDMR
This course interprets the ISO 15189 requirements for management review. The CAPs ISO 15189 assessors discuss how to
structure the review meeting, communicate results of quality assessments, and prompt strategic decisions from managementall in
the context of the overall health of your organization.
Make sure your laboratory team is ready to meet the challenges ahead. Sign up now for this comprehensive set of learning tools.
For more information, visit cap.org and choose the Laboratory Improvement Programs tab or call 800-323-4040
or 847-832-7000 option 1.
800-323-4040 | 847-832-7000 Option 1 | cap.org
19
Let us give you

a hand
Meeting all six elements of competency assessment
is resource intensive. CAP records indicate that
22.2% of CAP-accredited laboratories fail one or
more Laboratory General Checklist requirements for
competency assessment documentation.*
Now with the new Competency Profile feature,
CAP Competency Assessment Program is even
better than before! This new feature:
Keeps you inspection ready with the
documentation to support compliance with the
six elements of competency.
Acts like your personal administrator, notifying
users when their six-month and annual
assessments are due.
Fuels your productivity with real-time
management reports just a few clicks away.
Join more than 1,200 laboratories who have
discovered the one competency assessment
program that helps you make more time for what
matters mostdelivering better patient results.
See for yourselfaccess a free trial

program today!
Email us at competency@cap.org.
3 | Quality Management Tools

3
it is an organization with a great reputation for
helping laboratories improve.

Q-PROBES ...................................................................................................................................24
Q-TRACKS .....................................................................................................................................29
Clinical Pathology Monitors ...........................................................................................................31
Anatomic Pathology Monitors ........................................................................................................37
Q-MONITORS ...............................................................................................................................39
New Programs
New
Technical Staffing Ratios (QP161)......................................................................................................25

Impact of Transit Times on Detection of Bacterial Pathogens from Blood Cultures (QP162) .......................26
Hospital Nursing Satisfaction with Clinical Laboratory Services (QP163)................................................27
Technical Competency Assessment on Peripheral Blood Smear Review (QP164) .....................................28
Discontinued Programs
Blood Bank Safety Practices (QP151)
Clinical Test Utiization: Unnecessary Testing (QP152)
Physician Satisfaction with Anatomic Pathology Services (QP153)
Identification Errors (QP154)
I like being associated with the CAP because
Quality Management
Tools
Use the CAPs Quality Management Tools (QMT) to improve the Total Testing Process by
identifying quality improvement opportunities of selected key processes in the clinical and anatomic
pathology laboratories, examining preanalytical, analytical and postanalytical phases:
Establish realistic goals by comparing performance against similar institutions with
comparable demographics
Monitor progress through unique and robust quality indicators on a periodical basis
Make effective quality management decisions based on practical and in-depth
individual reports provided to participants
Improve efficiencies to allow time for more patient-centric activities
Easily integrate quality management into your daily work processes with
predesigned monitoring tools developed by laboratory professionals and scientists
Q-PROBES A One-Time Opportunity to Perform In-Depth Quality Assessment
Q-TRACKS A Program for Continuous Quality Monitoring
Q-MONITORS Customized Quality Monitors Program
Q-PROBES, Q-TRACKS, and Q-MONITORS activities meet the American Board of Pathology MOC Part IV Practice
Performance Assessment requirements.
Q-PROBES, Q-TRACKS, and

Q-MONITORS
Customer
Satisfaction
Transfusion
Medicine
Chemistry/
Hematology
Microbiology
Patient Safety
Clinical
Pathology
z
Turnaround Time
Anatomic
Pathology
Postanalytic
Analytic
3
Select Q-PROBES, Q-TRACKS, and

Q-MONITORS studies to support
your quality improvement initiatives.
Preanalytic
offer a comprehensive collection of tools to

complement your quality management program needs.*
Q-PROBES
Technical Staffing Ratios (QP161)

Impact of Transit Times on Detection of
Bacterial Pathogens from Blood Cultures (QP162)
Hospital Nursing Satisfaction with

Clinical Laboratory Services (QP163)

Peripheral Blood Smear Review (QP164)
z
z
z
z
z
z
z
Q-TRACKS
Patient Identification Accuracy (QT1)
Blood Culture Contamination (QT2)
Laboratory Specimen Acceptability (QT3)
In-Date Blood Product Wastage (QT4)
Gynecologic Cytology Outcomes:

Biopsy Correlation Performance (QT5)
Satisfaction With Outpatient Specimen Collection (QT7)
Stat Test Turnaround Time Outliers (QT8)
z
z
z
z
Outpatient Order Entry Errors (QT17)

z
z
z
Corrected Results (QT16)

Mislabeled Cases, Specimens, Blocks, and Slides in
Surgical Pathology (QT19)
Critical Values Reporting (QT10)

Turnaround Time of Troponin (QT15)
Q-MONITORS
Monitoring of Troponin Metrics for Suspected MI (QM1)
*The CAP requires accredited laboratories to have a quality management plan that covers all areas of the laboratory and includes
benchmarking key measures of laboratory performance (GEN.13806, GEN.20316, COM.04000). The Joint Commission requires
accredited hospitals to regularly collect and analyze performance data (PI.01.01.01, PI.02.01.01). CLIA requires laboratories to monitor,
assess, and correct problems identified in preanalytic, analytic, and postanalytic systems (493.1249, 493.1289, 493.1299).
800-323-4040 | 847-832-7000 Option 1 | cap.org
23
Q-PROBES
Q-PROBES
A One-Time Opportunity to Perform In-Depth Quality

Assessment
Pilot quality monitoringUse Q-PROBES short-term comprehensive quality studies1 to learn
how to start monitoring and measuring key processes that you may not have followed in the past
or that are not commonly monitored in most laboratories. Q-PROBES studies analyze hot topics
and industry trends to keep the laboratory current.
Gain experience in data collection and analysisParticipants will collect data during
predetermined dates. Based on submitted data, the CAP provides personalized reports with the
individual participants performance compared against other participants.
Strengthen your quality assessment expertiseCAPs pathologist experts provide
in-depth discussion and identify best practices for laboratories to strive for. In addition,
consolidated results of the studies are carefully reviewed and analyzed to be published in
the form of scientific articles. Such articles give participants an extra layer of information
to be utilized for further analysis.
Q-PROBESTM 2015: QP151 - Blood Bank Safety Practices
Quality Management Report: Individual Report of Results
Participants in the Q-PROBES program receive:
ser guide
Templates and instructions for data collection

Individual report, how to interpret the results
guide, overall aggregated data
Data Analysis and Criti ue that includes data
distributions and analysis of laboratory practices
and commentaries from pathologist experts on
improvement opportunities
Performance Indicator
Your
Result
ABO mislabeled specimen rate (per 1000

specimens) (n=30)
3.68
All Institutions Percentiles

10th
50th
90th
(left edge
of box)
(vertical line)
(right edge
of box)
0.00
4.04
Performance Distribution
18.19
0
10
15
20
Performance note: The bar graph ranges from the 10th to 90th percentile. The thick vertical line represents the median value.
Lower percentiles (shaded area and lower) represent better relative performance.
ABO typing result discrepancy rate (per 1000

specimens) (n=29)
Estimated annual rate of ABO typing result
discrepancies (per 1000 specimens) (n=30)
Mislabeled ABO specimen rejection rate (%) (n=15)
Your
Result
All Institutions Percentiles

10th
50th
90th
0.00
1.82
2.17
0.00
0.23
0.00
0.00
0.41
100.0
88.9
100.0
100.0
Access to the scientific articles that are published with the results of the studies
For your institution's use
Reviewed by:
Q-PROBES activities meet the American Board of Pathology MOC Part IV

Practice Performance Assessment requirements.
Date:
Comments/Actions:
Data summarized in this Individual Report of Results includes data returned by 03/27/2015.
Kit ID Number:
5HSRUW Date: 03/27/2015
CAP Number:
/DE1DPH
Q-PROBES studies are available only one time annually and may not be repeated in the future.
Q-PROBES
Technical Staffing Ratios QP161
New
Staff accounts for two-thirds of direct clinical laboratory costs, making management of staffing levels central to managing
overall laboratory expenses. In this study, key staffing ratios are calculated for four different laboratory testing sections:
anatomic pathology, chemistry/hematology/immunology, microbiology, and transfusion medicine. Your laboratorys results
will be benchmarked against staffing levels from all participating institutions.
3
Objectives
Measure staffing in different areas of the laboratory, calculate key staffing ratios, and compare key staffing ratios with
other institutions.
Data Collection
Participants will use their laboratorys or institutions revenue and usage reports to obtain billable test counts and staffing
figures for the most recently completed fiscal year for five key laboratory testing sections.
Performance Indicators
Anatomic Pathology:
o Histology blocks/histology nonmanagement FTE
o Cytology accessions/cytology nonmanagement FTE
o Nonmanagement FTE/management FTE
Chemistry/Hematology/Immunology:
o Total billable tests/nonmanagement FTE
Microbiology:
Transfusion Medicine:
o Crossmatches or type & screens/nonmanagement FTE
o Transfused units/nonmanagement FTE
Molecular Pathology:
This is a one-time study conducted in the first quarter.
800-323-4040 | 847-832-7000 Option 1 | cap.org
25
Q-PROBES
Impact of Transit Times on Detection of Bacterial Pathogens

from Blood Cultures QP162
New
Delays in delivering blood culture specimens to the laboratory have the potential to prolong the time to detection of bacterial
pathogens. Proper blood collection volumes improve the sensitivity of blood cultures and may also affect the time to pathogen
detection. Prolonged time to detection may delay appropriate antibiotic therapy and adversely impact patient care.
Participation in this Q-PROBE will help laboratories meet Checklist Statement MIC.22640, Blood Culture Volume.
Objective
Examine the effects of specimen transportation time to placement on the instrument, and volume on detection of bacterial
pathogens from blood cultures.
Data Collection
Over a twelve-week period, participants will collect data on positive blood cultures yielding a primary pathogen. While this
study is primarily focused on Staphylococcus aureus and Escherichia coli, data on all noncontaminated blood cultures will be
collected. Data will include the time of collection, the lab arrival time, the time the blood culture is loaded on the instrument, the
instrument time to detection of bacterial pathogens, and the adequacy of blood culture volumes.
Time from specimen collection to delivery to the laboratory
Time from specimen delivery to the laboratory to being loaded onto blood culture instrument
Time from when blood culture specimens are loaded onto the instrument to the time the cultures are flagged positive
Total time from specimen collection to time culture flagged as positive
Percent of blood culture bottles that are ade uately filled
This is a one-time study conducted in the second quarter.
Q-PROBES
Hospital Nursing Satisfaction with

Clinical Laboratory Services QP163
New
Assessment of customer satisfaction is a component of the quality improvement program for most laboratories. In the hospital
setting, an important customer of laboratory services is the nursing service. Nursing personnel spend a significant amount of
time and effort interacting with laboratory personnel to initiate laboratory testing and follow-up of results. Developing a method
for constructive feedback from the nursing service provides a useful way to identify improvement opportunities. Enrollment
in QP163 can help meet College of American Pathologist (Laboratory General Checklist Statement GEN.20316) and Joint
Commission requirements for laboratory accreditation.
3
Objectives
Evaluate nursing satisfaction with clinical laboratory services and determine laboratory characteristics that correlate with a high
level of satisfaction by the nursing staff.
Data Collection
Management and nonmanagement nursing staff will be asked to complete a standardized questionnaire regarding their
perception of the clinical laboratory services. Nursing staff will be asked to rate overall satisfaction with the clinical laboratory
as well as services such as response to problems, turnaround time of stat results, and availability of reports.
The questionnaires will be available by two modes of access: electronic distribution with direct return to the CAP, or by use of
hard copy response forms. Data from the first 50 returned questionnaires will be submitted for analysis for hard copy users
while the number of questionnaires for electronic users is unlimited.
Overall mean satisfaction score with clinical laboratory services
Mean satisfaction scores for the specific service categories
This is a one-time study conducted in the third quarter.
800-323-4040 | 847-832-7000 Option 1 | cap.org
27
Q-PROBES

Peripheral Blood Smear Review QP164
New
The widespread use of automated white blood cell (WBC) differential counts and computer generated whole slide imaging has
decreased the time that the technical staff dedicates to morphological assessment of blood cells. However, technologists must
maintain their morphological skills and laboratories are required to provide education and assess competency in this area on a
regular basis.
Participation in this Q-PROBE helps laboratories meet CLIA personnel requirements (Subpart M, 42 CFR 493.1), CAP
Laboratory Accreditation Program Checklist Statement requirement (GEN.55500 Competency Assessment of Testing Personnel)
and Joint Commission HR.01.06.01 for competency assessment of nonwaived testing personnel.
Objectives
Assess the effectiveness of educational and practical experience policies and procedures dedicated to the laboratorys efforts
in maintaining technologist skills in the performance of accurate WBC differential counts and other peripheral blood smear
morphological assessment. The individual competency assessment will be performed using whole slide images that were
evaluated by hematology experts.
Data Collection
Information will be collected from each site regarding minimum qualification and experience requirements of their technologists,
their ongoing educational programs and requirements, as well as relevant procedures and policies. A series of validated virtual
whole slide image peripheral blood smears will be available online to each participating institution to assess technologists
performance on WBC differential counts and morphology assessment. Each program ordered provides input forms for use by
up to 10 technologists. Laboratories that need forms for more than 10 individuals should order additional programs (available
in multiples of 10).
Participants will also provide information about their competency assessment programs, continuing education, and
professional background.
Individual technologist score based on a standardized competency assessment method for WBC differential counts using
whole slide image blood smears
Technologist performance in their ability to identify various WBC types, red blood cell morphology, and platelet morphology
in normal and abnormal cases
Overall laboratory score based on the facilitys individual technologist performance(s)
A summary of responses to the general questions will be provided to participants.
This is a one-time study conducted in the fourth quarter.
Q-TRACKS
Q-TRACKS
A Program for Continuous Quality Monitoring
Identify and monitor opportunities for quality improvement over time
Use established Q-TRACKS programs to identify opportunities to quantitate your quality improvement measures.
3
Evaluate quality improvements

Measure the effectiveness and impact of implemented changes in key processes. The individual reports include performance of
quality indicators over time, benchmarking information, trends, and suggested areas for improvement.
Step 1:
Establish realistic benchmarks by comparing your

laboratory to others like yours.
Q-TRACKS: QT3 - Laboratory Specimen Acceptability
External Comparison Report: January-March
Step 2:
Identify improvement opportunities.
(most like you)
Q-TRACKS: QT3 - Laboratory Specimen Acceptability

Trend Analysis Report: January-March
Step 3:
Monitor improvement over time to

ensure accurate results, patient safety,
and quality patient care.
800-323-4040 | 847-832-7000 Option 1 | cap.org
29
Q-TRACKS
Participants in the Q-TRACKS program receive:
ser Guide
Templates and instructions for data collection

uarterly reports that include fingerprint clusters, customer-defined groups, and all institution
comparisons
Peer directory
Q-TRACKS activities meet the American Board of Pathology MOC Part IV Practice Performance
Assessment requirements.
Quality Management Resources from CAP Experts

Laboratory Administration for Pathologists
Elizabeth A. Wagar, MD, FCAP
Also available as ebooks!
Richard E. Horowitz, MD, FCAP, and
Visit ebooks.cap.org
Gene P. Siegal, MD, PhD, FCAP, editors
Item number: PUB312
Hardcover; 300 pages; 100+ figures, tables, and photographs; 2011
Quality Management in Anatomic Pathology: Promoting Patient
Safety through Systems Improvement and Error Reduction
Raouf E. Nakhleh, MD, FCAP, and
Patrick L. Fitzgibbons, MD, FCAP, editors
Item number: PUB118
Softcover; 198 pages; 70+ exhibits and tables; 2005
Quality Management in Clinical Laboratories: Promoting Patient
Safety through Risk Reduction and Continuous Improvement
Paul Valenstein, MD, FCAP, editor
Item number: PUB214
Softcover; 265 pages; 80+ exhibits and tables; 2005
To order
PRESS
Visit cap.org and choose the Shop tab or call the CAP Customer
Contact Center at 800-323-4040 or 847-832-7000 option 1.
Q-TRACKS
Q-TRACKS Clinical Pathology Monitors

Patient Identification Accuracy QT1
3
In order to report accurate laboratory results and meet The Joint Commission National Patient Safety Goal #1: Identify patients
correctly, institutions must properly identify patients. Since most laboratories perform testing away from the patient, patient
identification, and labeling of specimens and coordination with test requisitions must be performed accurately and completely.
By continuously monitoring for wristband errors, participants can promptly identify and correct problems that may interfere with
patient care services.
Objectives
Assess the incidence of wristband errors within individual institutions, compare performance between participating institutions,
and identify improvement opportunities.
Data Collection
On six predetermined days per month, participants will monitor patient wristband identification for all phlebotomies performed
at their institution. Phlebotomists will tally the total number of wristbands checked, the number of errors found, and the types
of wristband error. This monitor includes all routinely wristbanded patients. Include emergency department patients only if the
emergency department routinely applies wristbands to these patients.
ristband error rate ( )
Performance Breakdown
Brea down of wristband error types ( )
Blood Culture Contamination QT2

Despite advances in blood culture practices and technology, false-positive blood culture results due to contaminants continue to
be a critical problem. Blood culture contamination rate, the primary indicator of preanalytic performance in microbiology, is
associated with increased length of hospital stay, additional expense, and the administration of unnecessary antibiotics. The
CAP and other accrediting organizations require you to monitor and evaluate key indicators of quality for improvement
opportunities. Use this monitor to help meet this requirement.
Objective
Determine the rate of blood culture contamination using standardized criteria for classifying contaminants.
Data Collection
On a monthly basis, participants will tabulate the total number of blood cultures processed and the total number of contaminated
blood cultures. Blood cultures from neonatal patients are tabulated separately. For the purposes of this study, participants
will consider a blood culture to be contaminated if they find one or more of the following organisms in only one of a series
of blood culture specimens: Coagulase-negative Staphylococcus; Micrococcus; Alpha-hemolytic viridans group streptococci;
Propionibacterium acnes; Corynebacterium sp. (diptheroids); or Bacillus sp. Participants have the option to monitor institutionspecific subgroups, for example, a specific department or patient population.
Neonatal contamination rate ( )
Other contamination rate ( )
Overall contamination rate ( )
Look for your input forms approximately three weeks prior to the quarter.
800-323-4040 | 847-832-7000 Option 1 | cap.org
31
Q-TRACKS
Laboratory Specimen Acceptability QT3
A substantial amount of rework, diagnostic and therapeutic delay, and patient inconvenience can result from specimen
rejection. Patient redraws may result from unlabeled, mislabeled, and incompletely labeled specimens; clotted and/or
hemolyzed specimens; or insufficient specimen quantity. By continuously monitoring specimen acceptability, collection, and
transport, laboratories can promptly identify and correct problems.
Objective
Identify and characterize unacceptable blood specimens that are submitted to the chemistry and hematology/coagulation
sections of the clinical laboratory for testing.
Data Collection
This monitor includes all blood specimens submitted for testing to the chemistry and hematology departments of the clinical
laboratory. On a weekly basis, participants will record the total number of specimens received, the number of rejected
specimens, and the primary reason each specimen was rejected.
Specimen rejection rate ( )
Brea down of reasons for rejection ( )
In-Date Blood Product Wastage QT4

Blood for transfusion is a precious resource. At a minimum, wastage of blood that is not out-of-date represents a financial loss
to the health care system. More ominously, systemic wastage of blood may reflect an environment of care that is out of control
and could pose risks to patient safety.
Objective
Compare the rates of blood product wastage (ie, units discarded in-date) in participating hospitals and track rates of
improvement over time.
Data Collection
On a monthly basis, participants will use blood bank records to obtain information on the total number of units transfused
for each type of blood component. Participants will track the number and type of blood units that are wasted in-date and the
circumstances of wastage. This monitor includes the following types of blood components: red blood cells (allogeneic), frozen
plasma, platelet concentrates, single donor platelets, and cryoprecipitate.
Overall blood wastage rate ( )
astage rates by blood component type ( )
Brea down of circumstances of wastage ( )
Q-TRACKS
Satisfaction With Outpatient Specimen Collection QT7

Specimen collection is one of the few areas of laboratory medicine that involves direct outpatient contact. As a result, patient
satisfaction with this service is a vital indicator of quality laboratory performance. The CAPs Laboratory Accreditation
Program requires measurement of patient satisfaction with laboratory services (GEN.20335). Use this monitor to help meet this
requirement.
3
Objective
Assess patient satisfaction with outpatient phlebotomy services by measuring patients assessment of waiting time, discomfort
level, courteous treatment, and overall satisfaction.
Data Collection
On a monthly basis, participants will provide copies of a standardized questionnaire to a minimum of 25 outpatients (maximum
of 99 outpatients) using predetermined data collection criteria. This monitor includes any outpatient undergoing venipuncture.
This monitor excludes patients seen in the emergency department, ambulatory surgery area, urgent care facility, chest pain
center, 23-hour short-stay facility, employee health department, outpatient health screening fair/promotion, dialysis center,
nursing home, or extended care facility.
Overall patient satisfaction score
Patients more than satisfied ( )
Stat Test Turnaround Time Outliers QT8

The stat test turnaround time (TAT) outlier rate, expressed as a percentage of tests missing target reporting times, is a measure
of outcomes that evaluates how well the laboratory meets patient and clinician needs. This monitor helps meet CAP Checklist
requirement GEN.20316, The QM program includes monitoring key indicators of quality in the preanalytic, analytic, and
postanalytic phases.
Objective
Monitor the frequency that stat test TAT intervals exceed institutional stat test TAT expectations.
Data Collection
Before beginning data collection, participants will establish a specimen receipt-to-report deadline for emergency department
(ED) stat potassium tests. On six predetermined days per month, participants will monitor the TAT of up to 10 randomly
selected ED stat potassium tests on each of three, eight-hour shifts (up to 180 tests per month) and track the number of ED stat
potassium results reported later than the established reporting deadline. This monitor includes stat potassium tests
ordered as part of a panel and excludes stat potassium levels that are requested on body fluids other than blood, as part of
timed or protocol studies, or after the specimen arrives in the laboratory.
Stat test TAT outlier rate ( )

Performance Breakdowns
Brea down of outliers by shift ( )
Brea down of outliers by day of wee ( )
800-323-4040 | 847-832-7000 Option 1 | cap.org
33
Q-TRACKS
Critical Values Reporting QT10
Laboratories commonly refer to critical values as results requiring immediate notification to the physician or caregiver for
necessary patient evaluation or treatment. Regulations from agencies and accreditors such as the CMS, The Joint
Commission, and the CAP (GEN.20316, COM.30000) mandate that laboratories develop and implement an alert system
for critical values. Use this monitor to document compliance with your laboratorys alert plan.
Objective
Evaluate the documentation of successful critical values reporting in the general laboratory for inpatients and outpatients.
Data Collection
On a monthly basis, participants will evaluate 120 inpatient and 120 outpatient critical values. Data collection will include
general chemistry, hematology, and coagulation analytes on the critical values list. Retrospectively, participants will record the
total number of critical values monitored and the number with documentation of successful notification. In addition, participants
will provide the number of critical values that were not communicated within three hours, the number of failed notifications due
to laboratory oversight, and the number of successful notifications to licensed caregivers. This monitor will exclude critical values
for cardiac markers, drugs of abuse, therapeutic drug levels, urinalysis, blood gases, point-of-care tests, and tests performed at
reference laboratories.
Total critical values reporting rate ( )
Inpatient critical values reporting rate ( )
Outpatient critical values reporting rate ( )
Failed notification (< hours) rate ( )
Q-TRACKS
Turnaround Time of Troponin QT15

The swiftness with which physicians establish diagnoses of acute myocardial infarction (AMI) in patients presenting to the
emergency department (ED) with chest pain may determine the type and predict the outcome of therapy those patients will
receive. Included in the total time consumed in establishing diagnoses of AMI are the component intervals required to measure
biochemical markers of myocardial injury. One of the most critical biochemical markers is troponin. Use this monitor to help
meet CAP Checklist requirement GEN.20316 QM Indicators of Quality.
3
Objective
Determine the median order-to-report turnaround time (TAT) of troponin (I or T) ordered to rule out myocardial infarction and
the percent of troponin results reported by each institutions established deadline.
Data Collection
On six predetermined days per month, participants will record TATs (in minutes) for three randomly selected troponin
specimens obtained from ED patients on each of three traditional shifts, a total of nine measurements. Participants will measure
TATs from the time of test order to the time results are available to ED personnel.
Median troponin order-to-report TAT (minutes)
Troponin TAT compliance rate ( )
Corrected Results QT16

The CAP developed this Q-TRACKS monitor in recognition of the importance of timely detection and correction of erroneous
laboratory results. Accuracy in laboratory results is critical to the effectiveness of a physicians plan of care for a patient. An
erroneous result can delay or alter patient treatment; therefore, detection of erroneous results should be a priority in every
laboratory and should be monitored as a key quality indicator. Help measure your compliance with CLIA 493.1299,
Postanalytic Systems Quality Assessment, with this monitor.
Objective
Monitor the number of corrected test results within individual institutions and compare performance with that of all institutions
and those institutions similar to yours.
Data Collection
On a monthly basis, participants will monitor the number of corrected test results and the total number of billable tests for that
month. Include test results for all patients in all care settings with the following exclusions: anatomic pathology tests, narrative
physician-interpreted tests (eg, bone marrow biopsies and peripheral smear reports), and point-of-care tests.
Test result correction rate (per 10,000 billable tests)
800-323-4040 | 847-832-7000 Option 1 | cap.org
35
Q-TRACKS
Outpatient Order Entry Errors QT17
Order accuracy bears an obvious relationship to the quality of laboratory testing. When the laboratory fails to complete a
requested test, it delays the diagnostic evaluation, potentially extending a patients hospital stay and prolonging therapy.
When the laboratory completes a test that was not requested, the cost of care increases, patients may be subjected to
unnecessary phlebotomy, and laboratory efficiency declines.
Objective
Measure the incidence of incorrectly interpreted and entered outpatient physician test orders into the laboratory information
system, compare performance across institutions, and track performance over time.
Data Collection
On six preselected weekdays per month, participants will compare eight outpatient requisitions or order sheets to the orders
entered into the laboratorys information system to determine if any order entry errors occurred.
This monitor includes test order review from ambulatory outpatients seen in offices and clinics operated by your laboratory
services, private physician offices, nursing homes, extended care facilities, and free-standing phlebotomy areas. Also included
are send-out tests, chemistry, hematology, microbiology, immunology, toxicology, and urinalysis tests on outpatients. Order
entry error categories include requesting physician errors; incorrect, missing, and extra test errors; test priority errors; and copy
or fax result errors.
This monitor excludes tests performed in transfusion medicine or anatomic pathology and also excludes tests from the following
patient care settings: inpatient, emergency department, ambulatory surgery, urgent care, chest pain center, 23-hour short-stay
facility, employee health department, outpatient screening fair/promotion, and dialysis center.
Overall outpatient order entry error rate ( )
Order entry error rates by type ( )
Brea down of error types ( )
Q-TRACKS
Q-TRACKS Anatomic Pathology Monitors

Gynecologic Cytology Outcomes: Biopsy Correlation Performance QT5
3
The correlation of cervicovaginal cytology (Pap test) findings with cervical biopsy results is a significant part of the
cytopathology laboratorys quality assurance program. By monitoring this correlation, the laboratory can identify and address
potential problems requiring improvement, thereby ensuring better patient results.
Objective
Quantify the correlation between the findings of cervicovaginal cytology and corresponding histologic material.
Data Collection
On a monthly basis, participants will record the number of true-positive, false-positive, and false-negative cytology-biopsy
correlations. The false-negative correlations will be classified into four error categories: screening errors, interpretive errors,
screening and interpretive errors, and adequacy determination errors. Participants will also record the biopsy diagnoses for
Pap tests with an interpretation of atypical squamous cells (ASC-US and ASC-H) or atypical glandular cells (AGC). This monitor
includes cervical biopsy specimens submitted to the laboratory that have a corresponding satisfactory or satisfactory but limited
Pap test within three months of the biopsy.
Predictive value of positive cytology ( )
Sensitivity ( )
Screening/interpretation sensitivity ( )
Sampling sensitivity ( )
Percent positive for ASC- S interpretations
Percent positive for ASC-H interpretations
Percent positive for AGC interpretations
800-323-4040 | 847-832-7000 Option 1 | cap.org
37
Q-TRACKS
Mislabeled Cases, Specimens, Blocks, and Slides

in Surgical Pathology QT19
Mislabeling of surgical pathology specimens has potential catastrophic consequences for patient care. By continuously
monitoring the rate of mislabeled specimens, participants will be able to identify problems and variables associated with
mislabeled specimens, blocks, and slides. This Q-TRACKS monitor will also help participating laboratories fulfill The Joint
Commission National Patient Safety Goal #1: Identify patients correctly in the discipline of surgical pathology.
Objectives
Determine the rates of mislabeled cases, specimens, blocks, and slides and the rate at which mislabeling errors led to a
corrected report and compare performance to other institutions.
Data Collection
Prospectively track each time a specimen container, block or slide is relabeled or renumbered due to an identification error;
and if, as a result, a corrected report is issued. Participants will also report the number of cases processed each month and the
number of blocks and slides (including special stains) that are processed during the same time period. Data will be collected
monthly.
This Q-TRACKS monitor is limited to routine histology processing.
Rate of mislabeled events (mislabeled cases, specimens, bloc s, and slides) per case
Percent of errors that resulted in a corrected report
Rate of mislabeled cases
Rate of mislabeled specimens
Rate of mislabeled bloc s
Rate of mislabeled slides
Q-MONITORS
Q-MONITORS
A Program for a Customized Comprehensive Assessment
Evaluate quality improvements in your laboratory
3
With todays focus on reducing medical errors, achieving and maintaining excellence is key to
success. Using continuous monitoring, Q-MONITORS provide a comprehensive assessment of key
processes in your institution.
Structure your data collection and analysis for success
Use Q-MONITORS to help build and improve data collection and analyze processes that
contribute to quality of care, patient safety, and outcomes. Observe performance trends over
time to identify and monitor opportunities for quality improvement through quantitative quality
measures.
Establish realistic laboratory benchmarks and performance goals
Q-MONITORS is a customized program that addresses process-, outcome-, and structure-oriented
quality assurance issues. Establish benchmarks through external database comparisons and
compare your performance to establish goals for performance improvement.
800-323-4040 | 847-832-7000 Option 1 | cap.org
39
Q-MONITORS
Q-MONITORS Customized Quality Monitoring Program

Monitoring of Troponin Metrics for Suspected MI QM1
Patients presenting to the emergency department (ED) with chest pain must be evaluated quickly. Rapid serum troponin
measurement is an important part of ED practice that can provide decisive information for patient management. Reducing
delays in troponin testing has been reported to result in shorter length of stay in the ED and more rapid initiation of anti-ischemic
treatment. Emergency departments and chest pain centers should, therefore, have effective procedures for ensuring optimal
turnaround time (TAT) for troponin and a process for ongoing monitoring to ensure that performance meets expectations.
Objective
Determine and monitor troponin TATs for patient arrival to result availability and/or up to six time intervals within the total
testing process for patients presenting to the ED with chest pain.
Data Collection
Six days per month, collect data from nine patients presenting to the ED with chest pain and tested for troponin level. Data
includes time of patient arrival, troponin test order, specimen collection, laboratory receipt, and result availability. It is not
necessary to provide data from each TAT component. Participants select which TAT metrics to monitor, with the option to
monitor all metrics.
Participants will also complete a questionnaire about clinical and laboratory practices related to troponin testing.
Metrics
Depending on the data submitted, the following metrics will be provided. In addition, TAT benchmarking, as compared to all
institutions, will be provided for both point-of-care and clinical laboratory testing for patient arrival to result availability and
specimen collection to result availability.
Patient arrival to result availability
Specimen collection to result availability
Test order to result availability
Patient arrival to test order
Test order to specimen collection
Specimen collection to laboratory receipt
Laboratory receipt to result availability
Performance indicators
Median TAT for troponin testing intervals (monthly)
Test order to result availability compliance rate (if applicable)
Specimen collection to result availability compliance rate (if applicable)
4 | Point-of-Care Programs
4
associated with an organization that is so interested

in high quality patient care. The CAP is not just
a proficiency testing providerthe CAP is so
much more.
Point-of-Care Programs .....................................................................................................................42
EXCEL to Surveys Crosswalk.............................................................................................................44
POC PT/NR, i-STAT Competancy (POC5)
I think the CAP is fantastic and Im proud to be
POC Competency Challenges are designed to improve waived test results. These programs evaluate
instrument and method performance, troubleshoot, assess staff competency, and provide information to
train staff. Expected results will be provided. These programs are not proficiency testing programs and
participants will not return results to the CAP.
POC Competency Challenges may have limited availability and stability.

Program Information
POC1 - One positive 10.0-mL
liquid urine specimen
POC Competency Challenges

POC1, POC2, POC3, POC4
Program Name
Challenges/
Shipment
Program Code
POC1
POC hCG Competency
POC2
POC3
POC4
10
POC Glucose Competency
10
POC Urine Dipstick Competency
10
POC Strep Screen Competency
10
POC2 - One abnormal

2.5-mL whole blood specimen
POC - One abnormal
10.0-mL li uid urine
specimen
POC - One 1.0-mL positive
liquid specimen
Each program provides
material to test up to 10 staff
Shipments available upon
request

POC6, POC7, POC8, POC9
Program Name
POC6
POC PT/INR, CoaguChek XS Plus and

XS Pro Competency
POC Waived Chemistry, Glucose and
HgB Competency
POC Influenza A/B Antigen Detect
Competency
POC Fecal Occult Blood Competency
Challenges/
Shipment
Program Code
POC7
POC8
POC9
10
10
10
z
z
10
Program Information
POC6 - Five abnormal 0. -mL
lyophilized plasma specimens
and five corresponding
diluents
POC7 - One abnormal 1.0-mL
whole blood specimen
compatible with the
HemoCue B, HemoCue 201,
and Stanbio HemoPoint H2
instruments
POC8 - One 1.5-mL vial
positive for influenza A; one
1.5-mL vial positive for
influenza B
POC9 - One positive 2.0-mL
fecal specimen
Each program provides
material to test up to 10 staff
request

POC10, POC11, POC12
Program Name
Challenges/
Shipment
Program Code
POC10
POC Blood Gases Competency
POC11
POC12
10
POC Blood Gases, i-STAT

Competency
10
z
z
10
POC11 - Ten abnormal

2.5-mL a ueous specimens
for blood gas and
hematocrit/hemoglobin
testing
4
POC Plasma Cardiac Markers

Competency
Program Information
POC10 - Ten abnormal
2.5-mL a ueous blood gas
specimens and ten 2.5-mL
hematocrit/hemoglobin
specimens
POC12 - Two 1.5-mL plasma

specimens; compatible with
plasma based tests, such
as Alere Triage and i-STAT
instruments
request

POC14, POC15, POC16
Program Name
POC14
POC Medtronic ACT/ACT,

i-STAT Competency
POC Hemochron r IL GEM PCL
ACT-LR Competency
POC Hemochron r Signature IL
GEM PCL ACT Competency
Challenges/
Shipment
Program Code
POC15
POC16
z
z
Program Information
POC1 - Five abnormal
1.7-mL lyophilized whole
blood specimens with five
corresponding diluents
and one calcium chloride
diluent vial; compatible with
Medtronic HemoTect ACT/
ACTII/ACT Plus, Medtronic
Hepcon HMS/HMS Plus, and
i-STAT Celine and aolin ACT
0.5-mL unitized specimens;
compatible with IL GEM
PCL Plus ACT-LR and ITC
Hemochron Jr./Signature
ACT-LR
0.5-mL unitized specimens;
compatible with IL GEM PCL
Plus ACT and ITC Hemochron
Jr./Signature ACT+
request
800-323-4040 | 847-832-7000 Option 1 | cap.org
43
EXCEL to Surveys Crosswalk

New for 2016, the E CEL program offerings have been integrated into the CAP Surveys programs to better serve CAP
laboratories and allow for easier and more convenient ordering. If you previously ordered E CEL modules, your order has been
automatically converted to the most appropriate CAP Surveys program. The table below provides details by test menu needs and
displays the conversion of each E CEL program to the appropriate CAP Surveys program.
In many instances, the integration of E CEL modules into the CAP Surveys programs will provide larger peer groups than were
previously available in E CEL. Larger peer groups and peer comparisons will help to more precisely measure analytic accuracy
and foster continuous improvement while ensuring accurate patient diagnoses.
Clinical Chemistry
Former EXCEL
Program Code
Description
Converted to
Surveys Program
CH
General Chemistry, Comprehensive
C1
General Chemistry
50
CH
General Chemistry, Basic
General Chemistry
50
CH9
Hematology/Oncology
Ligand Assay, Limited
76
L11
Neonatal Bilirubin, 2 challenges
NB2
59
L1
NB
59
Limited Chemistry,
59
L17
aived Cholesterol/Lipids
L20
hole Blood Glucose,

challenges
L21
hole Blood Glucose, 5

challenges
L22
Hemoglobin A1c
L27
Reproductive Endocrinology
L 0
Plasma Cardiac Markers
L 1
LC
Description
avied
Page(s)
hole Blood Glucose,

challenges
61
WBG
hole Blood Glucose, 5

challenges
61
GH2
Hemoglobin A1c
57
Ligand Assay, Special
77
PCARM
Plasma Cardiac Markers
60
WBCR
61
B2
Toxicology
Former EXCEL
Program Code
Description
Converted to
Surveys Program
Description
Page(s)
L2
Serum Alcohol
AL2
CAP/AACC Alcohol/Ethylene
Glycol/Volatiles
L26
Urine Drug Screen
DS6
CAP/AACC Urine Drug Testing,

Screening
90
Coagulation
Former EXCEL
Program Code
Converted to
Surveys Program
Description
Description
Page(s)
Coagulation - reporting PT, APTT,

INR, and Fibrinogen
CGL
Coagulation, Limited
150
XC
Coagulation - reporting PT, APTT,

and INR
CGB
Coagulation, Basic
150
XC1
Coagulation - PT and INR
CGB
Coagulation, Basic
150
Whole Blood Coagulation
P6
15
C19
15
C20
hole Blood D-Dimer
WBDD
hole Blood D-Dimer
4
XC
155
Hematology
Former EXCEL
Program Code
XH1
Description
Converted to
Surveys Program
Description
Page(s)
Routine Hematology
HE
Basic Hematology
1 0
Routine Hematology - with

photographs and online images
(XHP)
HEP
Basic Hematology
1 0
Comprehensive Hematology With

Differential
FH1
Hematology Automated Differential

Series
1 1
H and HP
Comprehensive Hematology - with

(XHP)
FH1P

Series
1 1
Comprehensive Hematology With

Differential
FH2

Series
1 1
H and HP
Comprehensive Hematology - with

(XHP)
FH2P

Series
1 1
H6
FH15
1 2
H7
FH15
1 2
H8
Erythrocyte Sedimentation Rate
1 1
H9
Reticulocyte Count
Reticulocyte
1 5
Blood Cell Identification, Limited
1 0
XH1 and XHP
XHP
Routine Hematology, Blood Cell

Identification
ESR
RT
BCP2
800-323-4040 | 847-832-7000 Option 1 | cap.org
45
Clinical Microscopy
Former EXCEL
Program Code
Description
Converted to
Surveys Program
XU
rinalysis, Comprehensive without an additional photograph

product ( 2P,
P,
5P,
7P,
and/or
8P)
CMP2
Urinalysis, Basic and Clinical

Microscopy
1 9
XU and
photograph
rinalysis, Comprehensive - with

an additional photograph product
product ( 2P,
P,
5P,
7P,
and/or
8P)
CMP
1 9
XU1
rinalysis, Basic - without an

additional photograph product
( 2P,
P,
5P,
7P, and/or
8P)
CMP2
Urinalysis, Basic and Clinical

Microscopy
1 9
XU1 and
photograph
rinalysis, Basic - with an

additional photograph product
( 2P,
P,
5P,
7P and/or
8P)
CMP
1 9
2P
Urine Sediment (without XU, XU1,

or L5)
CMMP
Clinical Microscopy Miscellaneous
1 9
Clinical Microscopy (without XU,

1, or L5)
CMMP
1 9
Urine hCG
UHCG
Urine hCG and Clincal Microscopy
5P
Provider-Performed Microscopy
(without
,
1, or L5)
CMMP
1 9
7P
Urine Sediment (without XU, XU1,

or L5)
CMMP
1 9
8P
Clinical Microscopy (without XU,

1, or L5)
CMMP
1 9
Occult Blood
OCB
Occult Blood
SC
Sperm Count
1 6
Urine Albumin (Microalbumin)/

Creatinine
Amniotic Fluid Lea age
1 0
Rupture of Fetal Membranes Testing
XU10
Sperm Count and Presence/

Absence
XUX11
Urine Albumin (Microalbumin)

Creatinine
12
Amniotic Fluid Lea age
Rupture of Fetal Membranes Testing
UMC
AFL
ROM1
Description
Page(s)
Immunology
Former EXCEL
Program Code
Converted to
Surveys Program
Description
Description
Page(s)
Anti-HIV-1 and Anti-HIV-1/2,

Waived
AHIVW
Anti-HIV-1 and Anti-HIV-1/2,

Waived
210
XS1
Infectious Mononucleosis and

Rheumatoid Factor
IM and RF
Infectious Mononucleosis and

Rheumatoid Factor
188
Infectious Mononucleosis
Infectious Mononucleosis
188
C-Reactive Protein
CRP
IM
C-Reactive Protein
188
Serum hCG
HCG
hCG, Serum
188
S5
Rheumatoid Factor
RF
Rheumatoid Factor
188
S7
Helicobactor pylori, Antigen

Detection
S5
Helicobactor pylori IgG Antibody
189
S9
Infectious Mononucleosis, Waived
IMW
Infectious Mononucleosis, Waived
189
4
S2
Microbiology
Former EXCEL
Program Code
Description
Converted to
Surveys Program
Description
Page(s)
M1
Throat Culture
D1
Throat Culture
160
M6
Rapid Group A Strep Antigen

Detection, 5 challenges
D6
Rapid Strep A Antigen Detection
162
M8
Gram Stain
D5
Gram Stain
162
M9
Urine Colony Count
MC
Urine Colony Count
161
M10
Throat and Urine Culture/Rapid

Strep A Antigen Detection
MC5
Throat Culture/Rapid Strep
161
M1
Rapid Group A Strep Antigen

Detection, 2 challenges
D9
Rapid Strep A Antigen Detection,

Waived
16
M17
Urine Colony Count/Urine Culture

Identification
MC
Urine Colony Count Combination
161
M18
C. difficile Toxin Antigen Detection
CDF2
165
M20
Microbiology Combination, Basic
MC2
Microbiology Combination
161
MM
Microbiology Combination,
Comprehensive
MC1
Microbiology Combination with

GC
161
M21
Viral Antigen Detection
VR
Virology Antigen Detection

(Non-DFA)
179
800-323-4040 | 847-832-7000 Option 1 | cap.org
47
Multidiscipline Combination Series

Former EXCEL
Program Code
Description
Converted to
Surveys Program
Description
Page(s)
L5
Waived Test Combination Series
HCC2
Waived Combination
61
L6
Waived Test Combination Series
HCC
Waived Combination
61
Guide your point-of-care testing with confidence

Point-of-Care Testing (POCT) Toolkit
POCT implementation requires a systematic approach that involves all stakeholders.
This toolkit serves as a resource for any member of the POCT team who wants to learn
about POCT or who has responsibility to guide or direct POCT. Pathologists may also use
the toolkit to guide other members of their POCT teams, including POCT coordinators
and medical technologists who are involved in POCT.
The toolkit covers:
POCT advantages and disadvantages

Current and projected technology
Pathologist, laboratory director, and
POC coordinator roles in POCT
Selection of appropriate test methods

Validation and verification protocols
Quality control and data management
Patient safety
POCT training and competency
Purchase the ebook at ebooks.cap.org.
General Chemistry and

Therapeutic Drug Monitoring
5
is everything to us. The last thing I want
is for a clinician to doubt my results.

General Chemistry and Therapeutic Drug Monitoring...........................................................................50
Urine Chemistry ...............................................................................................................................63
Special Chemistry ............................................................................................................................66
New Programs
New
Limited Chemistry (C4)......................................................................................................................50

Waived Combination (HCC2) ...........................................................................................................61
Whole Blood Creatinine (WBCR).......................................................................................................61
New Analyte/Drug Additions

Lipoprotein-Associated Phospholipase A2 (PLA) Activity.........................................................................69
Accuracy-Based Lipids (ABL)..............................................................................................................55
Non-HDL cholesterol
Testosterone and Estradiol Accuracy Survey (ABS) ...............................................................................71
Sex hormone-binding globulin (SHGB)
Testosterone, bioavailable
Testosterone, free
The CAPs proficiency testing quality

Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Program Information
C1, C3, C4, CZ, Z - Five
5.0-mL liquid serum specimens

C1, C3/C3X, C4, CZ/CZX/CZ2X, Z
Analyte
Challenges/
Shipment
Program Code
C1 C3/C3X
C4
CZ/CZX/
CZ2X
CZ2X - Five 5.0-mL liquid

serum specimens in triplicate
Alanine aminotransferase
(ALT/SGPT)
Albumin
Alkaline phosphatase
Amylase
Aspartate aminotransferase
(AST/SGOT)
Bilirubin, direct
Bilirubin, total*
Calcium
Chloride
Cholesterol, total
Cortisol
Creatine kinase (CK)
Creatinine
Glucose
HDL cholesterol
Human chorionic gonadotropin

(hCG), quantitative
Iron
Lactate dehydrogenase (LD)
LDL cholesterol
Lipoprotein (a)
Magnesium
Pancreatic amylase
Potassium
Protein, total
Sodium
T3, free (triiodothyronine, free)
T3, total (triiodothyronine, total)
z
z
C3X, CZX - Five 5.0-mL liquid

serum specimens in duplicate
Conventional and International

System of Units (SI) reporting
offered
Three shipments per year
For second instrument
reporting options, see
the Quality Cross Check
program, CZQ on page 53
Continued on the next page

*General Chemistry and Therapeutic Drugs Surveys do not fulfill the CAP accreditation
requirements for neonatal bilirubin proficiency testing. See Surveys NB, NB2 on page 59.
Program Information

C1, C3/C3X, C4, CZ/CZX/CZ2X, Z continued
Analyte
Challenges/
Shipment
Program Code
C1 C3/C3X
C4
CZ/CZX/
CZ2X

T3, uptake and related tests
T4, free (thyroxine, free)
T4, total (thyroxine, total)

offered
Thyroid-stimulating
hormone (TSH)
Triglycerides
Urea nitrogen (BUN)
Uric acid
Ammonia
Apolipoprotein A1
Apolipoprotein B
Calcium, ionized
Carbon dioxide (CO2)
Ferritin
Gamma glutamyl transferase (GGT)
Iron binding capacity,

total (measured)
Iron binding capacity,

unsaturated (measured)
Iron saturation (%)
Lactate
Lipase
Osmolality
Phosphorus (inorganic)
Prealbumin
Transferrin
Acetaminophen
Amikacin
Caffeine
Carbamazepine
Carbamazepine, free
Lithium

Acid phosphatase
Continued on the next page
800-323-4040 | 847-832-7000 Option 1 | cap.org
51
Program Information

C1, C3/C3X, C4, CZ/CZX/CZ2X, Z continued
Analyte
Digoxin
Digoxin, free
Disopyramide

offered
Ethosuximide
Gentamicin
Lidocaine
Methotrexate
N-acetylprocainamide (NAPA)

Phenobarbital
Phenytoin
Phenytoin, free
Primidone
Procainamide
Quinidine
Salicylate
Theophylline
Tobramycin
Valproic acid
Valproic acid, free
Vancomycin
C4

Download My PT Shipping Calendar to access your customized

shipping schedule
.
. .
. . .
. .
. .
-LAB
S TM
N
O
*CAP distributor customerscontact your distributor for your PT shipping schedule
Access your customized shipping calendar* through e-LAB Solutions Suite.

Not enrolled in e-LAB Solutions Suite? Go to cap.org to get started.

CZ/CZX/
CZ2X
C1 C3/C3X
Challenges/
Shipment
Program Code
. . . .
.
Program Information
Three 5.0-mL li uid serum
specimens in duplicate
Quality Cross CheckGeneral

Chemistry and Therapeutic
Drug Monitoring CZQ
Analyte
Program Code
Report up to three instruments
Challenges/Shipment
CZQ
See Survey C analytes on

pages 50 52
Conventional and
International System of nits
(SI) reporting offered
Two shipments per year
This program does not meet regulatory requirements for proficiency testing. See Survey CZ
on pages 5052.
The CAP uality Cross Chec program
Complements CAP Survey programs by offering more opportunities to monitor and
proactively identify instrument problems before they impact patient test results.
Helps improve uality processes and provides additional opportunities for fulfilling
staff competency re uirements.
CAP/AACC Immunosuppressive Drugs CS

Analyte
Program Code
Challenges/Shipment
CS
Cyclosporine
Sirolimus (rapamycin)
Tacrolimus
Program Information
Three 5.0-mL whole blood
specimens
For laboratories monitoring
cyclosporine, sirolimus, and
tacrolimus in transplant
patients
AACC
Everolimus EV
Analyte
Program Code
Challenges/Shipment
EV
Everolimus
Program Information
Three .0-mL whole blood
specimens
800-323-4040 | 847-832-7000 Option 1 | cap.org
53
Mycophenolic Acid MPA

Analyte
Program Code
Challenges/Shipment
MPA
Mycophenolic acid

3
Program Information
Three 5.0-mL serum specimens
Therapeutic Drug Monitoring,

Extended ZE
5
Analyte
Program Code
Program Information
Three 5.0-mL lyophilized
serum specimens
Challenges/Shipment
ZE
Clozapine
Gabapentin
Lamotrigine
Levetiracetam
Oxcarbazepine metabolite
Teriflunomide
onisamide
Therapeutic Drug Monitoring, Special ZT, ZZT

Analyte
Program Code
Challenges/Shipment
ZT, ZZT
Amitriptyline
Desipramine
Imipramine
Nortriptyline
Tricyclics, total ( ualitative/ uantitative)
Program Information
T - Three 5.0-mL lyophilized
serum specimens
T - Six 5.0-mL lyophilized
serum specimens
Accuracy-Based Lipids ABL

Analyte
Program Code
Challenges/Shipment
ABL
Program Information
Three 1.0-mL human serum
specimens
Apolipoprotein B*
Cholesterol*
HDL cholesterol*
Non-HDL cholesterol
LDL cholesterol
Lipoprotein (a)
Triglycerides*
5
Apolipoprotein A1*
*This analyte will be evaluated against the reference method.
B-Type Natriuretic Peptides BNP, BNP5

Analyte
Challenges/Shipment
Program Code
BNP
BNP5
BNP
NT-pro BNP
The College of American Pathologists Accreditation Program re uires all accredited
laboratories performing non-waived testing for BNP and NT-pro BNP to complete
15 PT challenges per year.
For second instrument reporting options, see the uality Cross Chec program,
BNP on page 56.
Program Information
BNP - Two 1.0-mL li uid
plasma specimens
Conventional and
International System of
nits (SI) reporting offered;
two shipments per year
BNP5 - Five 1.0-mL li uid
plasma specimens
Conventional and
nits (SI) reporting offered;
three shipments per year
Check on your PT shipment with CAPTRAKerSM

Our CAPTRAKer electronic shipment tracking program* gives your lab
the ability to locate your PT kit in an instant!
erts ou that our
o s ou to track our ship ent through a ink
esu ts in ess
P P kits ha e been shipped
SM
orries
To begin receiving CAPTRAKer emails, send your name, CAP account number, and email address
to contactcenter@cap.org.
*CAP distributor customerscontact your distributor for your PT shipping information
800-323-4040 | 847-832-7000 Option 1 | cap.org
55
Program Information
Three 1.5-mL li uid specimens
in duplicate
Quality Cross CheckB-Type

Natriuretic Peptides BNPQ
Analyte
Program Code
Challenges/Shipment
BNPQ
BNP
NT-pro BNP

Conventional and
nits (SI) reporting offered
This program does not meet regulatory requirements for proficiency testing. See Surveys BNP
or BNP5 on page 55.
Complements CAP Surveys programs by offering more opportunities to monitor and
Harmonized Thyroid ABTH

Analyte
Program Code
Challenges/Shipment
ABTH
Program Information
Three 1.0-mL frozen human
specimens
T , free (thyroxine, free)
T , total (thyroxine, total)
Thyroid-stimulating hormone (TSH)
PRICE (USD)
Analytes will be evaluated using harmonization.
Specimens are collected by a modified application of Clinical Laboratory and
Standards Institute Guideline CLSI C 7-A, Preparation and Validation of
Commutable Frozen Human Serum Pools as Secondary Reference Materials for
Cholesterol Measurement Procedures; Approved Guideline.
Cardiac Markers CRT, CRTI, TNT, TNT5

Analyte
Challenges/
Shipment
Program Code
TNT5
CRTI - Ten 2.0-mL li uid

serum specimens
CRT
CRTI
CK isoenzymes (C -BB, CK-MB,

C -MM), electrophoretic
TNT - Two 2.0-mL li uid

serum specimens
LD1, LD2, LD , LD , LD5,

electrophoretic
TNT5 - Five 2.0-mL li uid

serum specimens
LD1/LD2 ratio, calculation

and interpretation
CK-MB, immunochemical
TNT
Program Information
CRT - Five 2.0-mL li uid
serum specimens
Troponin I
Troponin T, two challenges
Myoglobin
Troponin T, five challenges
The College of American Pathologists Accreditation Program requires all accredited

laboratories performing non-waived testing for Troponin I and Troponin T to complete
Hemoglobin A1c GH2, GH5

Analyte
Challenges/Shipment
Program Code
Hemoglobin A1c
GH2
GH5
These Surveys will be evaluated against the National Glycohemoglobin
Standardization Program (NGSP) reference method.
Hemoglobin A1c GH5I

Analyte
Program Code
Challenges/Shipment
GH5I
Hemoglobin A1c
This program meets the CAP s Accreditation Program re uirements for
proficency testing.
This Survey will not be evaluated against the National Glycohemoglobin
Standardization Program (NGSP) reference method. See Survey GH5 to be
evaluated against the NGSP reference method.
Program Information
GH2 - Three 0.8-mL
li uid human whole blood
specimens; two shipments
per year
GH5 - Five 0.8-mL li uid
human whole blood
specimens; three shipments
per year
Program Information
Five 0.5-mL lyophilized
specimens with a .0-mL
dropper-tipped vial of diluent
Designed for international
laboratories that have
experienced significant
shipping and receiving
issues and re uire longer
specimen stability
800-323-4040 | 847-832-7000 Option 1 | cap.org
57
Glycated Serum Albumin GSA

Analyte
Program Code
Challenges/Shipment
GSA
Glycated serum albumin

3
Program Information
Three 0.5-mL li uid
serum specimens
High-Sensitivity/Cardiac
C-Reactive Protein HSCRP
5
Analyte
Program Code
Program Information
specimens
Challenges/Shipment
HSCRP
High-sensitivity/Cardiac
C-reactive protein
Homocysteine HMS
Analyte
Program Code
Challenges/Shipment
HMS
Homocysteine

3
Ketones KET
Analyte
Program Code
Program Information
Three 1.0-mL serum
specimens
Challenges/Shipment
KET
Beta-hydroxybutyrate
Total etones
Program Information
Two 2.0-mL serum specimens
For use with Acetest and
other ualitative/semiuantitative methods using
the nitroprusside reaction for
total etones testing
Limited Chemistry, Waived LCW

Analyte
Program Code
Challenges/Shipment
LCW
Cholesterol
Glucose
HDL cholesterol
LDL cholesterol
Triglycerides
Program Information
specimens
For use with waived methods
such as the Cholestech LD
and Roche ACC -CHE
Instant Plus
The glucose specimens
are not appropriate for
use on other whole blood
glucose meters
Analyte
Program Information
NB - Five 1.0-mL human
serum specimens; three
shipments per year
Neonatal Bilirubin NB, NB2

Challenges/Shipment
Program Code
NB
NB2
Bilirubin, direct
Bilirubin, total
One human-based serum specimen will offer the value assigned using the reference
method procedure (Clin Chem. 1985;31:1779-1789).
NB2 - Two 1.0-mL human

serum specimens; must
order in conjunction with a
five-challenge total bilirubin
proficiency testing program to
meet regulatory re uirements
Conventional and
Simplify your CVL needs with the CAPs comprehensive program

NEW
na tica easure ent anges

ha e been
enhanced to better meet instrument ranges.
Testing KitEverything you need to test and accurately
report your CVL results, including CAP-prepared samples.
Customized Reports Package
eports ana sis e a uations and other

resources to provide the insights into your instrument performance.
User GuideInterpret and troubleshoot information

with suggested actions.
Technical SupportAccess CVL resources, reports, and more online.

See Section 10 of this catalog, Instrumentation Validation Tools, to determine
programs that best fit your laboratorys CVL needs.
800-323-4040 | 847-832-7000 Option 1 | cap.org
59
Plasma Cardiac Markers PCARM, PCARMX

Analyte
Program Code
Challenges/Shipment
PCARM
PCARMX
BNP
CK-MB
D-dimer
Myoglobin
Troponin I
Program Information
PCARM - Five 1.5-mL li uid
EDTA plasma specimens
PCARM - All Survey PCARM
For Point-of-Care instruments
such as Alere Triage
and i-STAT
The College of American Pathologists Accreditation Program requires all accredited laboratories
performing non-waived testing for BNP and Troponin I to complete 15 PT challenges per year.
Whole Blood Chemistry Compatible Matrix

Whole Blood Analyzer/Method
Analyte
Compatible
Survey Programs
Page
Hemocue
Glucose
HCC
61
Roche Reflotron
Cholesterol
Glucose
Cholestech LD
C1, C
Total cholesterol
LC
Triglycerides
Glucose
hole blood glucose meters
Nova StatSensor /
E- -EM E Chem
Cholesterol
Glucose
Creatinine
50
59
HDL cholesterol
hole blood cholesterol meters
50
59
59
59
C1, C , LC
B2,
50, 59
BG, HCC2
61
BCR
61
Waived Test Combination HCC, HCC2

Analyte
Program Code
HCC
HCC2
Hematocrit
Hemoglobin
rinalysis/ rine hCG

hole blood glucose
Challenges/Shipment
2 (HCC)/ (HCC2)
Program Information
HCC - Two 1.0-mL whole
blood specimens; two
shipments per year
HCC2 - Hematocrit,
hemoglobin, and urinalysis/
urine hCG testing - Two
.0-mL whole blood
specimens and two
10.0-mL urine specimens;
5
hole blood glucose

testing - Three 2.5-mL
whole blood specimens;
To verify instrument
compatibility, refer to
the instrument matrix
on page 60
New
Whole Blood Creatinine WBCR

Program Code
Challenges/Shipment
WBCR
Creatinine
For use with the Nova

StatSensor/E- -EM E
Chem
Program Information
Five .0-mL whole
blood specimens
Program Information
BG - Five 2.5-mL
Whole Blood Glucose WBG, WB2

Analyte
Challenges/Shipment
Program Code
Glucose
WBG
WB2
B2 - Three 2.5-mL
Conventional and
Report up to 20 different
ancillary testing sites or
instruments
800-323-4040 | 847-832-7000 Option 1 | cap.org
61
Improve the reliability of your patient results with CAP Survey

Validated Materials
se the same material that is sent in the Surveys program to
Identify and troubleshoot instrument/method problems

Correlate results with other laboratories or instruments
Document correction of problems identified in Surveys
tilize material with confirmed results as an alternative external uality control
Identify potential proficiency testing failures
Each laboratory receives a Survey Participant Summary, which includes readily

available results.
General Chemistry and TDM, Validated Material

Validated Material
Program Code
Chemistry/TDM VM
C VM
Corresponding Survey
Pages
5052
Program Information
Five 5.0-mL li uid serum
specimens
Now there is a performance monitoring program for all your instruments

CAP Quality Cross Check is a quality assurance program
that complements your existing CAP prociency testing (PT).
Designed by experts, this program serves as a periodic review
for monitoring all of your instruments on a more routine basis.
The CAP Quality Cross Check program enhances
your quality assurance efforts by:
Delivering confidence in patient resultsregardless of which

instrument your laboratory chooses.
Providing a comprehensive tool for proactive monitoring of your

laboratory instruments performance to ensure accurate results.
Augmenting your instrument comparability efforts with additional

resources, saving you valuable staff time.
Youll find CAP Quality Cross Check programs in the General

Chemistry and Therapeutic Drugs; Hematology; and Blood Gas,
Critical Care, and Oximetry sections of this catalog.
Urine Chemistry
Urine Chemistry
Urine Chemistry, General U

Analyte
Program Code
Challenges/Shipment
Program Information
Six 15.0-mL urine specimens
One mailing per year
will include an additional
educational specimen for
uric acid testing for a total
of seven challenges per year
Calcium
Chloride
Creatinine
Glucose
Conventional and
Magnesium
Nitrogen, total
Osmolality
Phosphorus
Potassium
Protein, total
Sodium
rea nitrogen
ric acid
rine albumin ( uantitative)
rine albumin creatinine ratio
Accuracy-Based Urine ABU

Analyte
Program Code
Challenges/Shipment
ABU
5
Amylase
Program Information
Three 5.0-mL human urine
specimens
Calcium
Creatinine
Target values for albumin are obtained by LC-MS/MS after trypsin digestion, performed by the
Renal Testing Laboratory, Mayo Clinic, Rochester, MN, using calibration materials prepared from
human serum albumin (>99% pure).
Other analytes will be compared by peer group for harmonization purposes.
800-323-4040 | 847-832-7000 Option 1 | cap.org
63
Urine Chemistry
Kidney Stone Risk Assessment KSA

Analyte
Program Code
Challenges/Shipment
KSA
Program Information
Three 1 .5-mL li uid urine
specimens
Citrate
Cystine
Oxalate
Sulfate
5
Urine Chemistry, Special N, NX
Analyte
Program Code
Challenges/Shipment
N, NX
-methoxytyramines
5-hydroxyindoleacetic acid
17-hydroxycorticosteroids
17- etosteroids
Aldosterone
Coproporphyrins
Cortisol, urinary free
Dopamine
Epinephrine
Homovanillic acid
Metanephrine
Norepinephrine
Normetanephrine
roporphyrin
Vanillylmandelic acid
Myoglobin, Urine MYG

Analyte
Program Code
Challenges/Shipment
MYG
Myoglobin, urine ( ualitative and

uantitative)
Program Information
N - Six 10.0-mL lyophilized
urine specimens and three
specimens
N - All lyophilized Survey N
specimens in duplicate and
three 10.0-mL li uid urine
specimens
Program Information
Two 1.0-mL urine specimens
Urine Chemistry
Porphobilinogen, Urine UPBG

Analyte
Program Code
Challenges/Shipment
Program Information
Three 5-mL urine specimens
UPBG
Porphobilinogen
For use with ualitative and

uantitative methods
Improve the reliability of your patient results with CAP Survey Validated Materials

Each laboratory receives a Survey Participant Summary, which includes readily available results.
Urine Chemistry, Validated Materials

Validated Material
rine Chemistry (Special) VM

rine Chemistry (General) VM
Program Code
NVM
VM
Corresponding Survey Page
N, N
6
6
Program Information
NVM - Six 10.0-mL lyophilized
and three 10.0-mL li uid
urine specimens
VM - Six 15.0-mL urine

specimens
We rely on the CAPs high-quality

proficiency testing materials to help
our laboratory technologists identify
potential problems with a testing
method before it reaches our patients.
Rakesh Mandal, MD, MBBS
University of Wisconsin Hospital and Clinics
Madison, Wisconsin
800-323-4040 | 847-832-7000 Option 1 | cap.org
65
Special Chemistry
Special Chemistry
1,5-Anhydroglucitol AG
Analyte
Program Code
Challenges/Shipment
AG
1,5-anhydroglucitol
Program Information
specimens
5
Aldolase ADL
Analyte
Program Code
Challenges/Shipment
ADL
Aldolase

2
Angiotensin-Converting Enzyme ACE

Analyte
Program Code
Challenges/Shipment
ACE
Angiotensin-converting enzyme
( uantitative)
Program Information
Two .0-mL li uid serum
specimens
Program Information
Two 2.0-mL lyophilized serum
specimens
Special Chemistry
Body Fluid Chemistry FLD

Analyte
Program Code
Challenges/Shipment
FLD
Program Information
Three .0-mL simulated li uid
body fluid specimens
Albumin
Amylase
Conventional and
CA19-9
CEA
Cholesterol
Creatinine
Glucose
Lactate
pH
Protein, total
Triglycerides
1 per year
Body Fluid Chemistry 2 FLD2

Analyte
Program Code
Challenges/Shipment
FLD2
Program Information
Three .0-mL li uid body fluid
specimens
Al aline phosphatase
Bilirubin
Conventional and
Calcium
Chloride
Lipase
Potassium
Sodium
ric acid
rea nitrogen
800-323-4040 | 847-832-7000 Option 1 | cap.org
67
Special Chemistry
Cadmium CD
Analyte
Program Code
Challenges/Shipment
CD
Beta-2-microglobulin, urine
Cadmium, urine
Cadmium, whole blood
Creatinine, urine
Program Information
specimens and three 11.0-mL
urine specimens
System of nits (SI)
reporting offered
Six shipments per year
This Survey meets the Occupational Safety and Health Administration (OSHA) guidelines for
proficiency testing (OSHA standard-29 CFR 1910.1027AppF).
Program Information
M - Three 5.0-mL simulated
li uid spinal fluid specimens
Cerebrospinal Fluid Chemistry and

Oligoclonal Bands M, OLI
Analyte
Program Code
Challenges/Shipment
OLI
Albumin, uantitative
Electrophoresis (albumin
and gamma globulin)
Glucose
IgG, uantitative
Lactate
Protein, total
Oligoclonal bands
Cystatin C CYS
Analyte
Program Code
Challenges/Shipment
CYS
Cystatin C
OLI - Three 5.0-mL simulated

li uid spinal fluid specimens
and three paired serum
specimens
Program Information
Two 1.0-mL li uid serum
specimens
Special Chemistry
Fecal Fat FCFS

Analyte
Program Code
Challenges/Shipment
FCFS
Fecal fat, ualitative
Program Information
Two 10.0-g simulated fecal
fat specimens
For microscopic detection
of neutral fats (triglycerides)
and/or split fats (total free
fatty acids)
Fructosamine FT
Program Code
Challenges/Shipment
FT
Fructosamine

2
Glucose-6-Phosphate Dehydrogenase G6PDS

Analyte
Program Code
Challenges/Shipment
G6PDS
G6PD ( ualitative and uantitative)
Program Code
Program Information
Two 0.5-mL lyophilized
hemolysate samples
Lipoprotein-Associated Phospholipase A2 PLA

Analyte
Analyte
Program Information
Two 1.0-mL li uid serum
specimens
Challenges/Shipment
PLA
Lipoprotein-associated phospholipase
(Lp-PLA2) concentration
Lipoprotein-associated
phospholipase (Lp-PLA2) activity
Program Information
Two 1.0-mL li uid specimens
800-323-4040 | 847-832-7000 Option 1 | cap.org
69
Special Chemistry
Lipoprotein and Protein Electrophoresis

LPE, SPE, UBJP
Analyte
Program Code
LPE
SPE
UBJP
IgA, uantitation
IgG, uantitation
IgM, uantitation
M-protein (Paraprotein) identification
Protein, total
Lipoprotein electrophoresis
Challenges/Shipment
Protein electrophoresis
Protein electrophoresis pattern

interpretation
rine Bence ones proteins
Program Code
Challenges/Shipment
LBC
Lamellar body count
SPE - Two 1.0-mL lyophilized

serum specimens; two
educational protein
electrophoresis dry
challenges per year
B P - Two 10.0-mL urine

specimens
Lamellar Body Count LBC

Procedure
Program Information
LPE - Two 1.0-mL li uid serum
specimens
Program Information
Three 2.0-mL simulated li uid
amniotic fluid specimens
For use with LBC methods
performed on all hematology
analyzers
Lung Maturity LM, LM1

Analyte/Procedure
Program Code
LM
Challenges/Shipment
LM1
Program Information
LM - Three 5.0-mL simulated
li uid aminotic fluid
specimens
Lecithin sphingomyelin (L S) ratio
LM1 - Four 5.0-mL simulated

li uid amniotic fluid specimens
Phosphatidylglycerol (PG)
Bilirubin (OD 50)
Plasma Hemoglobin PHG

Analyte
Program Code
Challenges/Shipment
PHG
Plasma hemoglobin
Program Information
Special Chemistry
Procalcitonin PCT
Analyte
Program Code
Challenges/Shipment
PCT
Procalcitonin

3
Pseudocholinesterase C7
Analyte
Program Code
Challenges/Shipment
C7
Salivary Cortisol SALC

Analyte
Program Code
Challenges/Shipment
SALC
Salivary cortisol
Program Code
Calcium
Cortisol
Estradiol
Sex hormone-binding globulin

(SHGB)
Testosterone
Testosterone, free
Program Information
Three 1.0-mL synthetic oral
fluid specimens
Challenges/Shipment
ABS
Albumin
Testosterone and Estradiol Accuracy Survey ABS

Analyte
Program Information
One 2.0-mL lyophilized
serum specimen
Pseudocholinesterase
Program Information
serum specimens
Program Information
Four 1.0-mL human serum
specimens
One shipment per year
The Centers for Disease Control and Prevention (CDC) will set target values for
testosterone and estradiol using the established reference methods.
800-323-4040 | 847-832-7000 Option 1 | cap.org
71
Special Chemistry
Total Bile Acids TBLA

Analyte
Program Code
Challenges/Shipment
TBLA
Total bile acids

3
Trace Metals R
Analyte
Program Code
Challenges/Shipment
Program Information
specimens
Program Information
specimens
Aluminum
Chromium
Conventional and
Copper
Manganese
Selenium
inc
Trace Metals, Urine TMU

Analyte
Program Code
Challenges/Shipment
TMU
Aluminum
Arsenic
Chromium
Cobalt
Copper
Lead
Manganese
Mercury
Selenium
Thallium
inc
Program Information
Two 25.0-mL urine
specimens
Conventional and
For laboratories that monitor
trace metals at normal and
toxic levels
Special Chemistry
Sweat Analysis Series SW1, SW2, SW3, SW4

Analyte
Program Code
Challenges/Shipment
SW1, SW2, SW3, SW4
Program Information
human sweat specimens
Chloride
Conductivity
Osmolality
Sodium
For method compatibility, see chart below.
Method/Procedure
Program Code
SW1
Orion direct electrode
SW2
SW3
Materials Included
SW4
Precut 2-cm diameter

hatman filter papers
escor Macroduct &

Nanoduct Systems
CF Indicator System
22-gauge blunt-tipped
needles
Polystyrene boats and

chloride-free sponges
All other methodologies
No additional
materials provided
Viscosity V
Analyte
Program Code
Challenges/Shipment
Viscosity
Soluble Transferrin Receptor STFR

Program Code
Challenges/Shipment
STFR
Soluble transferrin receptor (sTfR)
Program Information
Two 10.0-mL serum
specimens
Analyte
Compatibility Matrix for Sweat Analysis Series
Program Information
Three 2.5-mL li uid human
serum specimens
800-323-4040 | 847-832-7000 Option 1 | cap.org
73
Special Chemistry

Validated Materials

Each laboratory receives a Survey Participant Summary, which includes

readily available results.
Special Chemistry, Validated Materials

Validated Material
Cerebrospinal Fluid VM
Program Code Corresponding Survey
MVM
Page
68
Program Information
spinal fluid specimens
Less is MORE
With the CAPs e-LAB Solutions Connect automated proficiency testing (PT) service,
youll spend less time doing clerical work, giving you more time to focus
on what matters most, accurate patient results.
MORE
LESS
Clerical errors
i e or patient centric acti ities
Time spent inputting PT results
ost sa ings in sta ti e
Checking and double-checking data entry
ua it assurance
Delays between testing and releasing results
bi it to recei e re or at and resend data
Proficiency Testing Compliance Notices
i e or anagers to spend on
management responsibilities
Missed submission deadlines
Now you can run PT more like To learn more, visit cap.org and
a patient specimen. search e-LAB Solutions Connect.
Available in the US and Canada only at this point.
6 | Endocrinology
The CAP proficiency testing allows us as a laboratory

to look at how we compare with our peers and it
reporting good quality results.
New Programs
New
Ligand Assay, Limited (K2) ................................................................................................................76

Pharmacogenetics (PGX) ...................................................................................................................81
CYP3A4
CYP3A5
SLCO1B1
Program Changes
International System of Units (SI) reporting now available. See specific program for availability
Additional specimen for beta-2-microglobulin testing
Tumor Markers (TM,TMX) ..............................................................................................................82
Endocrinology
also builds the trust of the clinical staff that we are
Endocrinology
Endocrinology
Program Information
- Five 5.0-mL li uid serum
specimens; two 5.0-mL
lyophilized serum specimens
for PSA assays; three
shipments per year
- Five 5.0-mL li uid serum

specimens and two 5.0-mL
for PSA assays in duplicate;
2 - Three 5.0-mL li uid

serum specimens; two
shipments per year
Ligand Assay, General K, KK, K2

Analyte
K, KK
Endocrinology
Challenges/
Shipment
Program Code
K2
Alpha-fetoprotein (AFP)
CEA
Cortisol
Ferritin
Folate, serum
hCG, quantitative
IgE
Prostate-specific antigen (PSA)
Prostate-specific antigen,
complexed (cPSA)
Prostate-specific antigen, free
Prostatic acid phosphatase (PAP)
T3 uptake and related tests
Vitamin B12
2 (K,KK)/3 (K2)
B-Type Natriuretic Peptides BNP, BNP5

Analyte
Challenges/Shipment
Program Code
BNP
BNP5
BNP
NT-pro BNP
The College of American Pathologists Accreditation Program re uires all accredited
laboratories performing non-waived testing for BNP and NT-pro BNP to complete
BNP on page 77.
Program Information
BNP - Two 1.0-mL li uid
plasma specimens
Conventional and
Units (SI) reporting offered;
BNP5 - Five 1.0-mL li uid
plasma specimens
Conventional and
Units (SI) reporting offered;
Endocrinology
Program Information
in duplicate
Quality Cross CheckB-Type

Natriuretic Peptides BNPQ
Analyte
Program Code
Challenges/Shipment
BNPQ
BNP
NT-pro BNP

Conventional and
Units (SI) reporting offered
This program does not meet regulatory requirements for proficiency testing. See Surveys BNP
or BNP5 on page 76.
Analyte
Program Code
Y, YY
Challenges/Shipment
DY
Program Information
Y - Six 5.0-mL li uid serum
specimens (two duplicate sets)
YY - Nine 5.0-mL li uid
serum specimens (three
duplicate sets)
11-deoxycortisol
17-hydroxyprogesterone
Androstenedione
DHEA sulfate
Estradiol
Estriol, unconjugated (uE3)
Conventional and
Follicle-stimulating hormone (FSH)
Growth hormone (GH)
IGF-1 (somatomedin C)
Luteinizing hormone (LH)
Progesterone
Prolactin
Testosterone
Testosterone, free
Sex hormone-binding globulin (SHBG)
Endocrinology
Ligand Assay, Special Y, YY, DY
DY - Must order in conjunction

with Survey Y or YY
800-323-4040 | 847-832-7000 Option 1 | cap.org
77
Endocrinology
Antimllerian Hormone AMH

Analyte
Program Code
Challenges/Shipment
AMH
Antim llerian hormone (AMH)

3
25-OH Vitamin D VITD

Analyte
Endocrinology
Program Code
Challenges/Shipment
VITD
25-OH vitamin D, total
Program Information
serum specimens
Program Information
Three 1.0-mL serum
specimens
Conventional and
International System of Units
Bone and Growth BGS

Analyte
Program Code
Challenges/Shipment
BGS
Osteocalcin
Program Information
specimens
Conventional and
Accuracy-Based Vitamin D ABVD

Analyte
Program Code
Challenges/Shipment
ABVD
25-OH vitamin D (D2 and D )
The Centers for Disease Control and Prevention (CDC) will establish reference targets
using isotope-dilution LC-MS/MS method.
Standards Institute Guideline CLSI C 7-A, Preparation and Validation of
Commutable Frozen Human Serum Pools as Secondary Reference Materials
for Cholesterol Measurement Procedures; Approved Guideline.
Program Information
Three 1.0-mL human li uid
serum specimens
Serum is from multidonor
endogenous pools
Conventional and
Endocrinology
Bone and Mineral Metabolism, Urine BU

Analyte
Program Code
Challenges/Shipment
BU
Program Information
human urine specimens
C-telopeptide (CTx)
Creatinine
Conventional and
Deoxypyridinoline (DPD)
N-telopeptide (NTx)
Pyridinoline (PYD)
Analyte
BMV1
1,25 dihydroxy
vitamin D
Bone specific al aline
phosphatase
Vitamin A
Vitamin E
Challenges/
Shipment
Program Code
BMV2
BMV3
BMV4
BMV5
BMV6
Erythropoietin EPO
Program Code
Challenges/Shipment
EPO
Program Code
Challenges/Shipment
FF
Fetal fibronectin
Program Information
Fetal Fibronectin FF
Analyte
N-telopeptide (NTx)
Erythropoietin
BMV5 and BMV6 - Three

1.0-mL li uid serum specimens
for each program
C-telopeptide (CTx)
Analyte
Program Information
BMV1 through BMV Three 5.0-mL li uid serum
specimens for each program
Endocrinology
Bone Markers and Vitamins

BMV1, BMV2, BMV3, BMV4, BMV5, BMV6
Program Information
Two 1.2-mL specimens
800-323-4040 | 847-832-7000 Option 1 | cap.org
79
Endocrinology
C-Peptide, Gastrin, Insulin, and PTH Assays ING

Analyte
Program Code
Challenges/Shipment
ING
C-peptide
Gastrin
Conventional and
Insulin
Parathyroid hormone (PTH)
Maternal Screening FP, FPX
6
Analyte
Endocrinology
Program Information
serum specimens
Program Code
Challenges/Shipment
FP, FPX
Program Information
FP - Five 1.0-mL li uid serum
specimens; two 1.0-mL
simulated amniotic fluid
specimens
Alpha-fetoprotein (AFP), amniotic fluid
Alpha-fetoprotein (AFP), serum
Dimeric inhibin A (DIA)
Estriol, unconjugated (uE3)
FP - All Survey FP serum

specimens in duplicate; two
1.0-mL simulated amniotic
fluid specimens
Human chorionic gonadotropin (hCG),

quantitiative
The CAP designed this Survey for laboratories using AFP and hCG for prenatal screening
purposes only. For all other applications, see Survey K or KK on page 76.
Program Information
FP1T - Five 1.0-mL serum
specimens
First Trimester
Maternal Screening FP1T, FP1B
Analyte
Program Code
FP1T
Total hCG
PAPP-A
FP1B - Five 1.0-mL serum

specimens
FP1B
Free beta hCG
Challenges/Shipment
The CAP designed these Surveys for laboratories using hCG for prenatal screening purposes
only. For all other applications, see Survey K or KK on page 76.
Endocrinology
Pharmacogenetics PGX, PGX1, PGX2

Analyte/Procedure
Challenges/
Shipment
Program Code
PGX
PGX1
PGX2
Program Information
PG , PG 1, and PG 2 Three 25.0- g extracted DNA
specimens
CYP2C19
CYP2C9
Includes allele detection

(genotyping) and/or
interpretive challenges
CYP2D6
CYP3A4
CYP3A5
SLCO1B1
UGT1A1
VKORC1
3
3
HLA-B*5701
Endocrinology
IL28B (rs12979860)
UGT1A1 (PG Survey) tests the laboratory s ability to detect variants in the TATA
repeat se uence in the UGT1A1 promotor (eg, UGT1A1*28 with seven TA repeats).
The ability to detect variants in other regions of the UGT1A1 gene is not part of this
program.
Survey PG 2 is designed for laboratories that provide HLA-B*5701 testing to identify
ris of hypersensitivity to abacavir. The intended response is ualitative (presence/
absence of the allele). This Survey is not appropriate for laboratories that perform
molecular HLA typing. For HLA typing proficiency testing, please consult the HLA
Molecular Typing (ML, DML) Surveys.
RBC Folate FOL

Analyte
Program Code
Challenges/Shipment
FOL
RBC folate
Program Information
Two 2.0-mL lyophilized whole
blood specimens
Conventional and
Renin and Aldosterone RAP

Analyte
Program Code
Challenges/Shipment
RAP
Aldosterone
Renin
Program Information
plasma specimens
Conventional and
800-323-4040 | 847-832-7000 Option 1 | cap.org
81
Endocrinology
Tumor Markers TM, TMX

Analyte
Program Code
Challenges/Shipment
TM, TMX
Endocrinology
Adrenocorticotropic hormone (ACTH)
Beta-2-microglobulin
CA 15-3
CA 19-9
CA 27.29
CA 72-
CA 125
Calcitonin
Thyroglobulin
Program Information
TM - Three 2.0-mL li uid
serum specimens
TM - All Survey TM
One mailing per year
will include an additional
educational specimen for
beta-2-microglobulin and
thyroglobulin testing for
a total of seven challenges
per year

Validated Materials

Each laboratory receives a Survey Participant Summary, which includes readily

available results.
Endocrinology, Validated Materials

Validated Material
Ligands (General) VM
Ligands (Special) VM
Page
VM
76
YVM
77
Program Information
VM - Five 5.0-mL li uid
serum specimens; two 5.0-mL
for PSA assays; three
shipments per year
YVM - Six 5.0-mL li uid
serum specimens (two
duplicate sets); two shipments
per year
7 | Blood Gas, Critical Care, and Oximetry
If youre talking to a physician, and theyre

the tools you have to go to and say, Heres why we
feel were putting out good results, and heres the
data to back that up. Using the CAP Surveys gives
me the confidence to have that discussion.
Program Changes
International System of Units (SI) reporting now available. See specific program for availability
questioning things, CAP Surveys results are one of

Critical Care Aqueous Blood Gas

AQ, AQ2, AQ3, AQ4
Analyte
Challenges/
Shipment
Program Code
AQ
AQ2
AQ3
AQ4
Calcium, ionized
Chloride
Hematocrit
Hemoglobin, estimated
Lactate
Magnesium, ionized
PCO2
pH
PO2
Potassium
Sodium
tCO2
Creatinine
Glucose
Urea nitrogen (BUN)
Program Information
A , A 2 - Ten 2.5-mL
aqueous specimens (two
duplicate sets) and ten
2.5-mL specimens for
hematocrit testing (two
duplicate sets); appropriate
for all methods except i-STAT
A ,A
- Ten 2.5-mL
for i-STAT methods only
Conventional and
For second instrument reporting options, see the Quality Cross Check programs, AQQ, AQ2Q,
AQ3Q, and AQ4Q, on page 85.
Yes
Order Survey
AQ3 or AQ4
No
Order Survey
AQ or AQ2
Do you use
an i-STAT
instrument?
Quality Cross CheckCritical Care

Aqueous Blood Gas AQQ, AQ2Q, AQ3Q, AQ4Q
Analyte
Challenges/
Shipment
Program Code
Program Information
A
, A 2 - Nine 2.5-mL
specimens (three duplicate
sets) and nine 2.5-mL
specimens for hematocrit
testing (three duplicate sets);
appropriate for all methods
except i-STAT
AQQ
AQ2Q
AQ3Q
AQ4Q
Calcium, ionized
Chloride
Hematocrit
A
,A
- Nine 1.7-mL
specimens (three duplicate
sets) for i-STAT methods only
Lactate
Magnesium, ionized
PCO2
pH
Conventional and
PO2
Potassium
Sodium
tCO2
Glucose
rea nitrogen (B N)
Creatinine
These programs do not meet regulatory requirements for proficiency testing. See Surveys AQ,
AQ2, AQ3, or AQ4 on page 84.
800-323-4040 | 847-832-7000 Option 1 | cap.org
85
Blood Oximetry SO
Analyte
Program Code
Challenges/Shipment
SO
Carboxyhemoglobin
Hematocrit, estimated
Hemoglobin, total
Methemoglobin
Oxyhemoglobin
Program Information
Five 1.7-mL stabilized
human hemoglobin solution
specimens
Conventional and
This Survey is not compatible with Oxicom-2000, -2100, or - 000 whole
blood oximeters.
SO , below.
Quality Cross CheckBlood Oximetry

SOQ
Analyte/Procedure
Program Code
Challenges/Shipment
SOQ
Program Information
Nine li uid specimens (three
duplicate sets)
Carboxyhemoglobin
Hematocrit, estimated
Conventional and
Hemoglobin, total
Methemoglobin
Oxyhemoglobin
This program does not meet regulatory requirements for proficency testing. See Survey SO
above.
As a trusted partner, you can rely on the CAP to provide the insight, nowledge, and
peer-based educational coaching to protect your laboratory from regulatory sanctions.
The CAP uality Cross Chec program complements CAP PT by offering more
opportunities to monitor and proactively identify instrument problems before they
impact patient test results.
This new offering will help you improve uality processes, reduce stress, raise
competency of staff, and verify the performance of your instrument results.
8 | Toxicology
We use CAP Surveys for continuing education.
Why? Because not every staff member works on
every proficiency test and its a chance to get
everybody together to see if we have everything
right or wrongjust a chance to stop and take a
few minutes to go over what were doing.
8
Toxicology
New Programs
New
Drug-Facilitated Crime (DFC) .............................................................................................................99

Toxicology (T) and Urine Toxicology (UT)............................................................................................88
Oral Fluid for Drugs of Abuse (OFD) ..................................................................................................92
Forensic Toxicology, Criminalistics (FTC).............................................................................................96
Synthetic Cannabinoid/Designer Drugs (SCDD) ..................................................................................97
Program Changes
Trace Metals, Urine (TMU) ................................................................................................................95
Number of challenges per mailing has changed
Toxicology
Toxicology
Toxicology T
Analyte
Program Code
Challenges/Shipment
See drug listing on next page
Program Information
A total of five specimens
consisting of 20.0-mL
lyophilized serum and
specimens
For laboratories performing
ualitative and uantitative
drug analysis on serum and
ualitative analysis on urine
specimens
Toxicology
Urine Toxicology UT
Analyte
Program Code
Challenges/Shipment
UT
See drug listing on next page
Program Information
Five 50.0-mL li uid urine
specimens
ualitative drug analysis
with ualitative confirmatory
testing
Toxicology
T, UT Drug Listing
Challenges will include a mix of drugs from the list below.
6-acetylmorphine (6-AM)
Delta-9-THC (serum only)
Mephedrone
Opiate group
7-aminoclonazepam
Delta-9-THC-COOH
Meprobamate
Oxazepam
7-aminoflunitrazepam
Desal ylflurazepam
Methadone
Oxycodone
Acetaminophen
Desipramine
Oxymorphone
Alpha-hydroxyalprazolam
Desmethylclomipramine
Methadone
metabolite (EDDP)
Desmethylcyclobenzaprine
Methamphetamine
Phencyclidine
Amitriptyline
Desmethylsertraline
Phenethylamine
Amphetamine
Dextromethorphan
Methylenedioxy-
amphetamine (MDA)
Amphetamine group
Diazepam
Atenolol
Dihydrocodeine
Atropine
Diltiazem
Barbiturate group
Alprazolam
Methylenedioxymethamphetamine
(MDMA)
Paroxetine
Pheniramine
Phenobarbital
Phentermine
Phenylephrine
Diphenhydramine
Methylenedioxypyrovalerone (MDPV)
Benzodiazepine
group
Doxepin
Methylphenidate
Phenytoin
Doxylamine
Metoprolol
Propoxyphene
Benzoylecgonine
Duloxetine
Mirtazapine
Propranolol
Brompheniramine
Ecgonine ethyl ester
Morphine
Pseudoephedrine
Buprenorphine
Ecgonine methyl ester
N-desmethyltramadol
Quetiapine
Bupropion
Ephedrine
Naproxen
Quinidine
Butalbital
Fentanyl
Nicotine
Quinine
Flunitrazepam
Norbuprenorphine
Ranitidine
Fluoxetine
Norchlordiazepoxide
Salicylates
Flurazepam
Norcodeine
Sertraline
Hydrocodone
Norcyclobenzaprine
Strychnine
Hydromorphone
Nordiazepam
Temazepam
Hydroxyzine
Nordoxepin
Tramadol
Ibuprofen
Norfentanyl
Trazodone
Imipramine
Norfluoxetine
Tricyclic group
etamine
Nor etamine
Trimipramine
Lamotrigine
Normeperidine
Valproic acid
Levetiracetam
Norpropoxyphene
Venlafaxine
Lidocaine
Norsertraline
Verapamil
Lorazepam
Nortrimipramine
Codeine
Lysergic acid diethylamide

(LSD)
Nortriptyline
Cotinine
Maprotiline
Cyclobenzaprine
O-desmethyltramadol
Meperidine
Olanzapine
Carbamazepine
Carbamazepine-10,
11-epoxide
Carisoprodol
Chlordiazepoxide
Chlorpheniramine
Chlorpromazine
Citalopram
Clomipramine
Clonazepam
Clozapine
Cocaethylene
Cocaine
8
Toxicology
Cannabinoids
Phenylpropanolamine
olpidem
Norverapamil
800-323-4040 | 847-832-7000 Option 1 | cap.org
89
Toxicology
CAP/AACC Urine Drug Testing, Screening

UDS, UDS6
Analyte
Program Code
Challenges/Shipment
Toxicology
UDS
UDS6
Limited
Acetaminophen
Amphetamine
Amphetamine/methamphetamine group
Barbiturate group
Benzodiazepine group
Benzoylecgonine/cocaine metabolites
Buprenorphine
Delta-9-THC-COOH
Ethanol
Fentanyl
Lysergic acid diethylamide (LSD)
Methadone
Methadone metabolite (EDDP)
Methamphetamine
Metha ualone
Methylenedioxymethamphetamine (MDMA)
Opiate group
Oxycodone
Phencyclidine
Propoxyphene
Tricyclic group
Urine Drug Adulterant/Integrity Testing DAI

Analyte
Program Code
Challenges/
Shipment
DAI
Creatinine
Glutaraldehyde
Nitrite
Oxidants
pH
Specific gravity
Program Information
DS - Five 10.0-mL li uid
urine specimens; three
shipments per year
DS6 - Three 10.0-mL li uid

urine specimens; two
shipments per year

drugs of abuse testing on
urine specimens using
immunoassay or other
screening techni ues only
Participants will have access
to the AACC uarterly
newsletter, Clinical & Forensic
Toxicology News
AACC
Program Information
Three 25.0-mL urine
specimens
Toxicology
CAP/AACC Forensic Urine Drug Testing,

Confirmatory UDC
Analyte
Program Code
Challenges/Shipment
UDC
10
10
Amphetamine
10
Benzoylecgonine
10
Buprenorphine
10
Butalbital
10
Codeine
10
Delta-9-THC-COOH
10
Hydrocodone
10
Hydromorphone
10
Lorazepam
10
Methadone
10
10
Methamphetamine
10
Metha ualone
10
Methylenedioxyamphetamine (MDA)
10
Methylenedioxyethylamphetamine
(MDEA)
10
10
Morphine
10
Norbuprenorphine
10
Nordiazepam
10
Norpropoxyphene
10
Oxazepam
10
Oxycodone
10
Oxymorphone
10
Phencyclidine
10
Phenobarbital
10
Propoxyphene
10
Secobarbital
10
Temazepam
10
Creatinine
10
pH
10
Specific gravity
10
For laboratories that

perform both screening
and confirmatory testing,
including uantitation, for
drugs of abuse in urine
specimens; laboratories are
as ed to report creatinine,
pH, and specific gravity for
each specimen to ensure
specimen adulteration has not
occurred
Participants will have access
to the AACC uarterly
newsletter, Clinical & Forensic
Toxicology News
Four shipments per year
AACC
Toxicology
Program Information
Ten 50.0-mL li uid urine
specimens
Adulterant/Integrity Indicator
800-323-4040 | 847-832-7000 Option 1 | cap.org
91
Toxicology
Oral Fluid for Drugs of Abuse OFD

Analyte
Program Code Challenges/Shipment

OFD
Amphetamine

drug screening, confirmation,
and uantitation
Methamphetamine
Methylenedioxyethylamphetamine
(MDEA)
Diazepam
Nordiazepam
Temazepam
Benzoylecgonine
Cocaine
Cannabinoids
Methadone
Opiate Group
Codeine
Hydrocodone
Hydromorphone
Morphine
Oxycodone
Oxymorphone
Phencyclidine (PCP)
Amphetamine Group
Benzodiazepine Group
Toxicology
Program Information
Five 2.0-mL oral fluid
specimens
Cocaine and/or metabolite
Delta-9-THC
Toxicology
Vitreous Fluid, Postmortem VF

Analyte
Program Code
Challenges/Shipment
VF
Acetone
Chloride
Creatinine
Ethanol
Glucose
Potassium
Sodium
Vitreous urea nitrogen
Serum Drug Screening SDS

Analyte
Program Code
Challenges/Shipment
Acetaminophen ( uantitative)
Acetone (semi uantitative and ualitative)
Barbiturate group ( ualitative)
Benzodiazepine group ( ualitative)
Salicylate ( uantitative)
Total tricyclic antidepressants ( ualitative)
CAP/AACC Alcohol/Ethylene Glycol/Volatiles

AL1*, AL2
Analyte
Program Code
Challenges/Shipment
AL1*
Whole Blood
AL2
Serum
Acetone ( uantitative)
Ethanol ( uantitative)
Ethylene glycol ( ualitative and

uantitative)
Isopropanol ( uantitative)
Methanol ( uantitative)
For forensic and other

toxicology laboratories that
perform uantitative analysis
of vitreous fluid
Program Information
Three 2.0-mL serum
specimens
8
Toxicology
SDS
Program Information
Three 5.0-mL synthetic
vitreous fluid specimens
For laboratories that perform

serum drug screening using
immunoassay or other
screening techni ues
Program Information
AL1 - Five 5.0-mL li uid
conventional reporting
AL2 - Five 2.0-mL li uid serum
specimens; conventional and
AACC
*The American Society of Crime Laboratory Directors/Laboratory Accreditation Board Proficiency

Review Committee (ASCLD/LAB PRC) has approved Survey AL1.
800-323-4040 | 847-832-7000 Option 1 | cap.org
93
Toxicology
Ethanol Biomarkers ETB

Analyte
Program Code
Challenges/Shipment
ETB
Ethyl glucuronide (EtG) ( ualitative

and uantitative)
Ethyl sulfate (EtS) ( uantitative)
CAP/AACC Blood Lead BL

Analyte
Program Code
Challenges/Shipment
BL
Lead
This Survey meets the Occupational Safety and Health Administration (OSHA) requirements for
proficiency testing [OSHA lead standards-29 CFR 1910.1025(j)(2)(iii)].
Toxicology
Cadmium CD
Analyte
Program Code
Program Information
Three 10.0-mL synthetic urine
specimens
Challenges/Shipment
CD
Beta-2-microglobulin, urine
Cadmium, urine
Creatinine, urine
Program Information
Five 6.0-mL li uid nonhuman
whole blood specimens
Conventional and
AACC
Program Information
specimens and three 11.0-mL
urine specimens
System of nits (SI)
reporting offered
Six shipments per year
This Survey meets the Occupational Safety and Health Administration (OSHA) guidelines for
proficiency testing (OSHA standard-29 CFR 1910.1027AppF).
Toxicology
Trace Metals, Urine TMU

Analyte
Program Code
Challenges/Shipment
TMU
Aluminum
Arsenic
Chromium
Cobalt
Copper
Lead
Manganese
Mercury
Selenium
Thallium
inc
Program Information
Two 25.0-mL urine
specimens
Conventional and
For laboratories that monitor
trace metals at normal and
toxic levels
8
Toxicology
Find a practical guide to toxicology laboratory operations

with this resource
Clinical Toxicology Testing:
A Guide for Laboratory Professionals
Also available as an ebook!

Complex issues face the laboratory director or pathologist who

offers toxicology services. This thorough reference book will guide
both experienced physicians and those in training through the
pharmacological principles, testing menus, and methodologies for
toxicology testing.
To order
PRESS
Visit cap.org and choose the Shop tab;

or call the CAP Customer Contact Center
at 800-323-4040 or 847-832-7000 option 1.
Item number: PUB220
ISBN: 978-0-9837068-1-6
Softcover; 304 pages; 2012
800-323-4040 | 847-832-7000 Option 1 | cap.org
95
Toxicology
Forensic Toxicology, Criminalistics FTC

Analyte
Program Code
Challenges/Shipment
FTC
See drug listing below
The American Society of Crime Laboratory Directors/Laboratory Accreditation Board Proficiency

Review Committee (ASCLD/LAB PRC) has approved Survey FTC.
Program Information
specimens and one 20.0-mL
synthetic urine specimen
For crime and hospital
forensic toxicology divisions
performing ualitative and
uantitative analysis of drugs
in whole blood specimens
along with a urine ualitative
challenge
FTC Drug Listing

Toxicology
Norfluoxetine
7-aminoclonazepam
Ephedrine
Nor etamine
Fentanyl*
Norpropoxyphene
Acetaminophen
Fluoxetine
Norsertraline
Flurazepam*
Nortriptyline
Alprazolam
Gamma-hydroxybutyrate (GHB)
Oxazepam
Amitriptyline
Hydrocodone
Oxycodone
Amphetamine
Hydromorphone
Oxymorphone
Benzoylecgonine
Imipramine
Paroxetine
Butalbital
etamine
Phencyclidine
Carisoprodol
Lorazepam
Phenethylamine
Chlorpheniramine
Phenobarbital
Clonazepam
Meperidine*
Phentermine
Cocaethylene
Meprobamate
Phenytoin
Cocaine
Methadone
Propoxyphene
Codeine
Pseudoephedrine
Cyclobenzaprine*
Methamphetamine
Secobarbital
Delta-9-THC
Sertraline
Delta-9-THC-COOH
(MDMA)
Temazepam
Morphine*
Trazodone
Desipramine
Diazepam
Diphenhydramine
Doxepin
N-desmethyltramadol
Tramadol*
olpidem
Nordiazepam
Nordoxepin
Norfentanyl
*and/or metabolite(s)
Toxicology
Synthetic Cannabinoid/Designer Drugs SCDD

Analyte
Program Code
Challenges/Shipment
SCDD
Synthetic Cannabinoid/Designer Drugs
PRICE (USD)
Synthetic cannabinoids and designer drug stimulants are widespread and constantly
changing in respect to the available chemical moieties. In order to stay contemporary,
the CAP has decided to modify the compounds in this program in accordance with the
appearance and prevalence of new compounds.
Program Information
Three 20.0-mL urine
specimens
For laboratories that perform
screening and confirmatory
testing for the compounds
found in this program
SCDD Drug Listing

For the most current list of drugs, please go to cap.org and select
Laboratory Improvement.
5F-PB-22 -carboxyindole metabolite
Ethylone
Toxicology
-methylethcathinone ( -MEC)
H-018 N-Pentanoic Acid
AB CHMINACA
MAM 2201 pentanoic acid metabolite
AB F BINACA
Mephedrone
AB-PINACA N-pentanoic acid metabolite
ADBICA N-pentanoic acid metabolite
Methylone
ADB-PINACA N-pentanoic acid metabolite
Naphyrone
A B- 8 N-pentanoic acid metabolite
PB-22 -carboxyindole metabolite
Alpha-PVP (-Pyrrolidinopentiophenone)
Pentylone
AM-2201 N-( -hydroxypentyl) metabolite
TH -2201
BB-22 -carboxyindole metabolite
R-1
Butylone
LR-11 -hydroxypentyl metabolite
N-pentanoic acid metabolite
800-323-4040 | 847-832-7000 Option 1 | cap.org
97
Toxicology
Drug Monitoring for Pain Management DMPM

Analyte
Program Code
Challenges/Shipment
DMPM
Program Information
Three 0.0-mL urine
specimens
For laboratories offering
ualitative, confirmatory
and/or uantitative urine
drug analysis for pain
management
Includes clinical cases and
uestions along with detailed
descriptions of how to
interpret test results
DMPM Drug Listing
Toxicology

Amphetamine Group
Codeine
Morphine
Delta-9-THC-COOH
N-desmethyltramadol
7-aminoclonazepam
Diazepam
Norbuprenorphine
Fentanyl
Nordiazepam
Alprazolam
Fentanyl and/or metabolites
Norfentanyl
Amphetamine
Hydrocodone
Normeperidine
Barbiturate Group
Hydromorphone
Noroxycodone
Benzodiazepine Group
Lorazepam
Noroxymorphone
Benzoylecgonine
Lorazepam glucuronide
Norpropoxyphene
Buprenorphine
Meperidine
Opiate Group
Buprenorphine and/or metabolites
Meperidine and/or metabolites
Oxazepam
Butalbital
Meprobamate
Oxycodone
Cannabinoids
Methadone
Oxymorphone
Carisoprodol
Propoxyphene
Carisoprodol and/or metabolites
Methamphetamine
Propoxyphene and/or metabolites
Clonazepam
Temazepam
Cocaine
(MDMA)
Tramadol
Cocaine and/or metabolites
Tramadol and/or metabolites
Toxicology
New
Drug-Facilitated Crime DFC

Analyte
Program Code
Challenges/Shipment
Program Information
Three 25.0-mL urine
specimens
DFC

ualitative urine drug analysis
with confirmation testing
Designed for laboratories

performing testing for
drugs associated with drugfacilitated crimes, which
target drugs at much lower
concentrations than in other
toxicology Surveys
DFC Drug Listing

Norsertraline
7-aminoclonazepam
Fluoxetine
Nortriptyline
7-aminoflunitazepam
Gamma hydroxybutyrate (GHB)
Oxazepam
alpha-hydroxyalprazolam
Hydrocodone
Oxycodone
Amitriptyline
Hydromorphone
Oxymorphone
Amobarbital
Imipramine
Paroxetine
Amphetamine
etamine
Toxicology
Fentanyl
-hydroxytriazolam
Pentobarbital
Benzoylecgonine
Lorazepam
Phencyclidine (PCP)
Brompheniramine
Meperidine
Phenobarbital
Butalbital
Meprobamate
Phenytoin
Carisoprodol
Methadone
Propoxyphene
Chlorpheniramine
Methadone Metabolite (EDDP)
Scopolamine
Citalopram/escitalopram
Methamphetamine
Secobarbital
Clonidine
Sertraline
Codeine
Temazepam
Cyclobenzaprine
(MDMA)
Delta-9-THC-COOH
Morphine
Tramadol
Desipramine
Nordoxepin
Valproic Acid
Dextromethorphan
Norfluoxetine
Zaleplon
Diphenhydramine
Nor etamine
Ziprasidone
Doxepin
Normeperidine
olpidem
Doxylamine
Norpropoxyphene
opiclone/Eszopiclone
Tetrahydrozoline
800-323-4040 | 847-832-7000 Option 1 | cap.org
99
Toxicology

Toxicology, Validated Materials

Validated Material
Serum Alcohol/Ethylene
Glycol/Volatiles VM
Blood Lead VM
rine Drug Testing (Screening) VM
Page
AL2M
AL2
BLM
BL
DSM
DS
90
Program Information
AL2M - Five 2.0-mL li uid
serum specimens
BLM - Five 6.0-mL li uid
nonhuman whole blood
specimens
DSM - Five 10.0-mL li uid

urine specimens
Toxicology
9 | Accuracy-Based Programs
What we do is so exact that we want to know

its correct. CAP proficiency testing validates our
laboratory process so we feel confident that we are
sending out the correct results.
Accuracy-Based Programs ...............................................................................................................102

Validated Materials........................................................................................................................106

Accuracy-Based Lipids (ABL)............................................................................................................102
Non-HDL cholesterol
Testosterone and Estradiol Accuracy Survey (ABS) .............................................................................103
Sex hormone-binding globulin (SHGB)
Testosterone, free
Accuracy-Based Lipids ABL

Analyte
Program Code
Challenges/Shipment
ABL
Program Information
Three 1.0-mL human serum
specimens
Apolipoprotein A1*
Apolipoprotein B*
Cholesterol*
HDL cholesterol*
Non-HDL cholesterol
LDL cholesterol
Lipoprotein (a)
Triglycerides*
*This analyte will be evaluated against the reference method.
9
Accuracy-Based Vitamin D ABVD
Analyte
Program Code
Challenges/Shipment
ABVD
25-OH vitamin D (D2 and D3)
The Centers for Disease Control and Prevention (CDC) will establish reference targets
using isotope-dilution LC-MS/MS method.
Standards Institute Guideline CLSI C37-A, Preparation and Validation of
Commutable Frozen Human Serum Pools as Secondary Reference Materials
for Cholesterol Measurement Procedures; Approved Guideline.
Program Information
Three 1.0-mL human li uid
serum specimens
Serum is from multidonor
endogenous pools
Conventional and
Testosterone and Estradiol Accuracy Survey ABS

Analyte
Program Code
Challenges/Shipment
ABS
Program Information
Four 1.0-mL human serum
specimens
Albumin
Calcium
Cortisol
Estradiol
Sex hormone-binding globulin

(SHGB)
Testosterone
Testosterone, free
The Centers for Disease Control and Prevention (CDC) will set target values for
testosterone and estradiol using the established reference methods.
Analyte
Program Code
Challenges/Shipment
ABU
Program Information
Three 5.0-mL human urine
specimens
Accuracy-Based Urine ABU
Calcium
Creatinine
Target values for albumin are obtained by LC-MS/MS after trypsin digestion, performed by the
Renal Testing Laboratory, Mayo Clinic, Rochester, MN, using calibration materials prepared from
human serum albumin (>99% pure).
Other analytes will be compared by peer group for harmonization purposes.
800-323-4040 | 847-832-7000 Option 1 | cap.org
103
Creatinine Accuracy
Calibration Verification/Linearity LN24
Analyte
Program Code
LN24
Creatinine
Estimated glomerular
filtration rate (eGFR)
Program Information
Six 1.0-mL human serum
specimens
LN24 Target Range
0.6
.0 mg/dL
LN Express service is available.
The College of American Pathologists (CAP) and the National idney Disease Education
Program (N DEP) have an initiative to harmonize clinically reported creatinine values.
This initiative is analogous to what the federal health agencies and the clinical laboratory
community did to improve the accuracy of cholesterol and glycohemoglobin testing.
Harmonized Thyroid ABTH
Analyte
Program Code
Challenges/Shipment
ABTH
Program Information
Three 1.0-mL frozen human
specimens
T , free (triiodothyronine, free)
T , free (thyroxine, free)
PRICE (USD)
Analytes will be evaluated using harmonization.
Standards Institute Guideline CLSI C37-A, Preparation and Validation of
Commutable Frozen Human Serum Pools as Secondary Reference Materials for
Cholesterol Measurement Procedures; Approved Guideline.
Hemoglobin A1c Accuracy

Analyte
Program Code
LN15
Hemoglobin A1c
Program Information
Six 0.8-mL li uid human
LN15 Target Range
12
CAP-assigned target values derived from Hemoglobin A1c measurements assayed by

National Glycohemoglobin Standardization Program (NGSP) secondary reference laboratories.
Hemoglobin A1c GH2, GH5

Analyte
Challenges/Shipment
Program Code
Hemoglobin A1c
GH2
GH5
These Surveys will be evaluated against the National Glycohemoglobin
Standardization Program (NGSP) reference method.
Program Information
GH2 - Three 0.8-mL
li uid human whole blood
per year
GH5 - Five 0.8-mL li uid
human whole blood
per year
9
800-323-4040 | 847-832-7000 Option 1 | cap.org
105
Validated Materials
Validated Materials

Chemistry, Validated Materials

Validated Material
Validated Material Code
Page
Chemistry/TDM VM
CZVM
CZ
50
Cerebrospinal Fluid VM
MVM
68
NVM
N, NX
rine Chemistry (Special) VM
rine Chemistry (General) VM
VM
Coagulation, Validated Material

Validated Material
Page
CGM
CGL
150
Page
Chemistry, Lipid, Enzyme Calibration Verification/Linearity VM
LN2VM
LN2
112
Chemistry, Lipid, Enzyme Calibration Verification/Linearity;

All Bec man (except A ) and Vitros VM
LN2VM1
LN2BV
112
LDM
LN3
113
LLM
LN5
114
L M
LN6
114
Coagulation (Limited) VM
Calibration Verification/Linearity, Validated Materials

Validated Material
TDM Calibration Verification/Linearity VM

Ligand Assay Calibration Verification/Linearity VM
rine Chemistry Calibration Verification/Linearity VM
Validated Materials
Cytogenetics, Validated Material

Validated Material
Cytogenetics VM
Page
CYM
CY
220
Page
Endocrinology, Validated Materials

Validated Material
Ligands (General) VM
VM
Ligands (Special) VM
YVM
76
Y
77
Page
AL2M
AL2
93
BLM
BL
94
DSM
DS
90
Toxicology, Validated Materials

Validated Material
Serum Alcohol/Ethylene Glycol/Volatiles VM

Blood Lead VM
800-323-4040 | 847-832-7000 Option 1 | cap.org
rine Drug Testing (Screening) VM
107
Fast identification
of cells, fungi, and
parasites at your
fingertips
These laminated guides are
a quick, easy reference for
confident identification.
Portable5 x 6.5 or 6.5 x 7
Durableheavy duty to
withstand years of benchtop use
Praticalfull color images for
easy reference
See sample pages and order at

cap.org under the Shop tab.
Also available in ebook format at
ebooks.cap.org.
10 | Instrumentation Validation Tools
The CAP has proficiency testing available for just

about every test we do and I really like using their
linearity and calibration verification programs.
Everything blends well together.
10
Calibration Verification/Linearity .....................................................................................................110

Instrumentation Quality Management Programs .................................................................................124
New Programs
New
C-Reactive Protein, Extended CVL (LN12E)........................................................................................116

Lamellar Body Count CVL (LN43).....................................................................................................123
Fibrinogen CVL (LN44) ...................................................................................................................123
Program Changes
Calibration Verification/Linearity programs now include International System of Units (SI) reporting options
New target ranges for enhanced analytical measuring range (AMR) coverage
C-Reactive Protein CVL (LN12) .....................................................................................................116
Ammonia CVL (LN32) .................................................................................................................121
D-Dimer CVL (LN42) ...................................................................................................................123
The CAP CVL program
Our program will help you meet CLIA regulations and CAP Laboratory Accreditation Program requirements for
calibration verification and analytical measurement range (AMR) verification under 42 CFR493.1255(b)(3) for most
analytes. In addition, you will receive a linearity assessment to help identify instrument/method performance issues
before they can affect your patient results.
With your enrollment in the CAP CVL program you will receive:
Testing Kit
o Kit instructionsContain important information to help you complete testing and accurately report your results
o Result form
o SpecimensThe majority of CAP CVL programs offer human-based materials to closely mimic your patient results
Customized Report Package
o Executive SummaryA quick overview of both your calibration verification and linearity results for all reported
analytes
o Calibration Verification evaluation
o Linearity evaluation
Receive your linearity evaluations through LN Express , our expedited delivery service, within two business
days for select CVL programs by logging in to e-LAB Solutions
o Linearity Troubleshooting Report
o Participant SummaryA summary of laboratory performance that includes peer group statistics and enhanced
diagnostic information for early insight into potential problems
SM
10
Additional Tools
o Calibration Verification/Linearity Program Users GuideGet assistance in interpreting your evaluations and
reports as well as helpful troubleshooting information with suggested actions. Also available online by logging in
to e-LAB Solutions
o Calibration Verification Troubleshooting GuideThe guide provides suggested actions if you receive a
calibration verification result of Different, or if your evaluation result is Verified over a range that does not
include all of your reported results
o Calibration Verification/Linearity Surveys Investigation Checklist for Problematic ResultsInterpretative checklists
are included to help with troubleshooting and documentation
Your Total Calibration Verification/Linearity (CVL) Solution

CVL Program
Page
No.
Corresponding
Proficiency Testing Survey
Page
No.
112
C1, C3/C3X,
CZ/CZX/CZ2X
50
113
CZ/CZX/CZ2X/Z
LN2 - Chemistry, Lipid, Enzyme CVL

LN2BV - Chemistry, Lipid, Enzyme all Beckman
(except AU), Vitros CVL
LN3 - TDM CVL
112
LN5 - Ligand Assay CVL

LN5S - Ligand Assay all Siemens ADVIA
(Centaur, CP, and XP) CVL
LN6 - Urine Chemistry CVL
114
114
Validated Page
Material
No.
127
LN2VM1
127
50
LDM
127
K/KK
76
LLM
127
114
63
LUM
127
LN7 - Immunology CVL
115
IG/IGX
188
LN8 - Reproductive Endocrinology CVL
115
Y/YY
77
LN9 - Hematology CVL
116
FH series, HE series
131, 130
LN11 - Serum Ethanol CVL
116
AL2
93
LN12 - C-Reactive Protein CVL
116
LN12E - C-Reactive Protein, Extended CVL
116
CRP
188
LN13, LN13C - Blood Gas/Critical Care CVL
117
AQ, AQ2, AQ3, AQ4
84
LN14 - Whole Blood Ethanol CVL
117
AL1
93
LN15 - Hemoglobin A1c Accuracy CVL
117
GH2
57
LN16 - Homocysteine CVL
118
HMS
58
LN17 - Whole Blood Glucose CVL
118
WBG, WB2
61
LN18, LN19 - Reticulocyte CVL
118
RT, RT2, RT3, RT4
135
LN20 - Urine Albumin CVL
119
63
LN21 - High-Sensitivity C-Reactive Protein CVL
119
HSCRP
58
LN22 - Flow Cytometry CVL
119
FL
196
LN23 - Prostate-Specific Antigen CVL
119
K/KK
76
LN24 - Creatinine Accuracy CVL
120
C1, C3/C3X, CZ/CZX/CZ2X
50
LN25, LN27 - Troponin I and T CVL
120
CRT, CRTI, TNT
57
LN30 - B-Type Natriuretic Peptides CVL
120
BNP
55
LN31 - Immunosuppressive Drugs CVL
121
CS
53
LN32 - Ammonia CVL
121
C1, C3/C3X, CZ/CZX/CZ2X
50
LN33 - Serum Myoglobin CVL
121
CRT, CRTI
57
LN34 - Tumor Markers CVL
121
TM/TMX
82
LN35 - Thrombophilia CVL
122
CGS2
151
LN36 - Heparin CVL
122
CGS4
151
LN37 - von Willebrand Factor Antigen CVL
122
CGS3
151
LN38 - CMV Viral Load CVL
122
VLS, VLS2
180
LN39 - HIV Viral Load CVL
122
HIV, HV2
180
LN40 - Vitamin D CVL
122
VITD
78
LN41 - Procalcitonin CVL
123
PCT
71
LN42 - D-Dimer CVL
123
CGL, CGDF
150
LN43 - Lamellar Body Count CVL
123
LBC
70
LN44 - Fibrinogen CVL
123
CGL
150
10
LN2VM
All CVL Surveys provide individual evaluation reports by analytes, an Executive Summary, and graphical plots for linearity and calibration verification.
800-323-4040 | 847-832-7000 Option 1 | cap.org
111
Chemistry, Lipid, Enzyme

Calibration Verification/Linearity LN2, LN2BV
Analyte
Program
Code
LN2,
LN2BV
10
LN2
LN2BV
(All
All Beckman
Instruments) (except AU)
Units
Vitros
g/dL
Program Information
Seven 5.0-mL li uid serum
specimens for basic chemistry,
six 3.0-mL liquid serum
specimens for direct and total
bilirubin, seven 2.0-mL liquid
serum specimens for lipids,
and seven 5.0-mL liquid
serum specimens for enzymes
Albumin
1.59.0
Calcium
4.018.0
mg/dL
Chloride
60180
mmol/L
CO2
740
mmol/L
Creatinine
0.332.0
mg/dL
Glucose
20780
mg/dL
LN2BV Appropriate for

Beckman (except AU) and
Vitros instruments only
Iron
10950
g/dL
Magnesium
0.310.0
mg/dL
Osmolality
200600
mOsm/kg H2O
Phosphorus
0.520.0
mg/dL
Potassium
1.513.0
mmol/L
Protein
1.510.0
g/dL
Sodium
90215
mmol/L
Urea nitrogen/Urea
3190
mg/dL
Uric acid
125
mg/dL
251,800
251,000
251,100
U/L
ALT (SGPT)
10900
10650
30700
U/L
Amylase
301,800
30900
30800
U/L
AST (SGOT)
10900
10500
10700
U/L
Creatine kinase
252,000
251,200
25700
U/L
CK-2 (MB) Mass
1250
1300
1200
ng/mL
Gamma glutamyl
transferase
101,400
10900
101,100
U/L
Lactate
dehydrogenase
501,800
50700
1853,000
U/L
Lipase
201,400
20190
1502,500
U/L
Bilirubin, direct
0.110.0
Bilirubin, total
0.225.0
mg/dL
Cholesterol
35625
mg/dL
HDL
7120
mg/dL
Triglycerides
20700
mg/dL
LN2 Appropriate for most

major instruments
mg/dL

Please note that the ranges listed are an estimate of the values recovered. Some instruments may recover lower or higher values
than the ranges listed.
Therapeutic Drug Monitoring

Analyte
Program Code
LN3
LN3 Target Ranges
Acetaminophen
20450 g/mL
Amikacin
245 g/mL
Carbamazepine
218 g/mL
0.54.4 g/mL
111 g/mL
Lidocaine
110 g/mL
Lithium
0.34.0 mmol/L
N-acetylprocainamide (NAPA)
225 g/mL
Phenobarbital
870 g/mL
Phenytoin
535 g/mL
Primidone
122 g/mL
Procainamide
218 g/mL
Quinidine
0.47.0 g/mL
Salicylate
790 mg/mL
Theophylline
535 g/mL
Tobramycin
112 g/mL
Valproic acid
15140 g/mL
Vancomycin
790 g/mL
A seventh .0-mL li uid serum

specimen for acetaminophen
and vancomycin
10
Digoxin
Gentamicin
Program Information
Six .0-mL li uid serum
specimens
800-323-4040 | 847-832-7000 Option 1 | cap.org
113
Ligand Calibration Verification/Linearity LN5, LN5S

Analyte
Program Code
LN5, LN5S*
Target Ranges
LN5 Target Ranges
LN5S Target Ranges
1.0900.0 ng/mL
AFP
CEA
Cortisol
165 g/dL
Ferritin
21,000 ng/mL
Folate
1.320 ng/mL
Human chorionic
gonadotropin (hCG)
514,000 mIU/mL
T3, total (triidothyronine)
0.57.0 ng/mL
T4, total (thyroxine)
124 ng/mL
Thyroid-stimulating
hormone (TSH)
0.01100 IU/mL
Vitamin B12
1002,200 pg/mL
0.5750.0 ng/mL
0.690.0 ng/mL
Program Information
LN5 - Eight .0-mL li uid
serum specimens; appropriate
for most major instruments
except Siemens ADVIA
Centaur, XP, and CP users
LN5S - Thirteen .0-mL li uid
for Siemens ADVIA Centaur,
XP, and CP users
*The LN5S CVL will allow Siemens ADVIA Centaur users to report other major instruments for
analytes other than CEA, if needed.
10
Urine Chemistry Calibration Verification/Linearity

LN6
Analyte
Program Code
Program Information
Eighteen .0-mL li uid urine
specimens
LN6
LN6 Target Ranges
Amylase
401,500 U/L
Calcium
530 mg/dL
Chloride
20330 mmol/L
Creatinine
20460 mg/dL
Glucose
25640 mg/dL
Osmolality
301,800 mOsm/kg H20
Phosphorus
15200 mg/dL
Potassium
7225 mmol/L
Protein, total
10235 mg/dL
Sodium
20340 mmol/L
Urea nitrogen/Urea
202,000 mg/dL
Uric acid
6150 mg/dL

Immunology Calibration Verification/Linearity

LN7
Analyte
Program Code
Program Information
Six 2.0-mL li uid serum
specimens
LN7
LN7 Target Ranges
Alpha-1-antitrypsin
25616 mg/dL
Complement C3
21420 mg/dL
Complement C4
5100 mg/dL
IgA
32650 mg/dL
IgG
1503,000 mg/dL
IgM
25450 mg/dL
Transferrin
38950 mg/dL
Reproductive Endocrinology
Analyte
Program Code
Program Information
Seven .0-mL li uid serum
specimens
LN8 Target Ranges
Estradiol
254,500 pg/mL
3190 mIU/mL
Human chorionic gonadotropin (hCG)
58,000 mIU/mL
2190 mIU/mL
Progesterone
150 ng/mL
Prolactin
3315 ng/mL
Testosterone
201,500 ng/dL
10
LN8
800-323-4040 | 847-832-7000 Option 1 | cap.org
115
Hematology Calibration Verification/Linearity

LN9
Analyte
Program Code
Program Information
Twenty .0-mL li uid
specimens
LN9
LN9 Target Ranges
Hemoglobin
1.524.0 g/dL
Platelet count
102,500 x 109/L
RBC count
0.58.00 x 1012/L
WBC count
0.5350.0 x 109/L
Serum Ethanol Calibration Verification/Linearity

LN11
Analyte
Program Code
Serum ethanol
10
Program Information
specimens
LN11
LN11 Target Range
15550 mg/dL
C-Reactive Protein; C-Reactive Protein, Extended

Calibration Verification/Linearity LN12, LN12E
Analyte
Program
Code
LN12
C-reactive protein
Program
Code
LN12E
Target Range
LN12
LN12E
Target Range
5110 mg/L
5320 mg/L
Program Information
LN12 - Five 1.0-mL li uid
for Beckman Immage,
Siemens Dimension, and
Vitros instruments
LN12E - Six 1.0-mL li uid
serum specimens: appropriate
for Abbott Architect, Beckman
(except Immage), Roche, and
Siemens (except Dimension)
instruments
Select program based on
appropriate target range for
assay used
Not appropriate for reporting
high-sensitivity C-reactive
protein (hsCRP)
Blood Gas/Critical Care

Calibration Verification/Linearity LN13, LN13C
Program
Code
Analyte
Program
Code
Single instrument reporting

only
LN13
LN13
Target Ranges
LN13C
LN13C
Target Ranges
PCO2
1291 mm Hg
1291 mm Hg
pH
6.837.82
6.837.82
PO2
18490 mm Hg
18490 mm Hg
Calcium, ionized
0.153.3 mmol/L
Chloride
62148 mmol/L
Glucose
10465 mg/dL
Lactate
0.218 mmol/L
Magnesium, ionized
0.12.4 mmol/L
Potassium
0.510.7 mmol/L
Sodium
83172 mmol/L
Whole Blood Ethanol

Program Code
Ethanol
Program Information
Six .0-mL li uid whole blood
specimens
10
Analyte
Program Information
Ten 2.5-mL ampules of
aqueous specimens
LN14
LN14 Target Range
15400 mg/dL
Hemoglobin A1c Accuracy

Program Information
Six 0.8-mL li uid human
Program Code
Analyte
Hemoglobin A1c
LN15
LN15 Target Range
5%12%
CAP-assigned target values derived from Hemoglobin A1c measurements assayed by

National Glycohemoglobin Standardization Program (NGSP) secondary reference laboratories.
800-323-4040 | 847-832-7000 Option 1 | cap.org
117
Homocysteine Calibration Verification/Linearity

LN16
Analyte
Program Code
Homocysteine
Program Information
specimens
LN16
LN16 Target Range
565 mol/L
Whole Blood Glucose

Program Information
Five 2.0-mL li uid whole
blood specimens
Program Code
Report up to 10 different
ancillary testing sites or
instruments
Analyte
Whole blood glucose
LN17
LN17 Target Range
50400 mg/dL
10
Reticulocyte Calibration Verification/Linearity

LN18, LN19
Instrument/Method
Program Code
LN18
Program Code
LN18 Target
Range
Coulter GenS ,
LH 500, LH 700 series,
and UniCel DxH
All other instruments
Pierceable caps
Program Information
LN18 - Five 2.5-mL li uid
whole blood specimens with
pierceable caps
LN19
LN19 Target
Range
LN19 - Five .0-mL li uid

whole blood cell specimens
with pierceable caps
0.3%27.0%
0.3%24.0%
z
Urine Albumin Calibration Verification/Linearity

LN20
Analyte
Program Code
LN20
LN20 Target Ranges
Urine albumin
10350 mg/L
Urine creatinine
20500 mg/dL
High-Sensitivity C-Reactive Protein

Program Code
Analyte
High-sensitivity C-reactive protein
LN21
LN21 Target Range
0.56.0 mg/L
Program Information
Six 5.0-mL urine specimens
Program Information
specimens
For high-sensitivity methods
only
Flow Cytometry Calibration Verification/Linearity

LN22
Program Code
LN22
LN22 Target Ranges
CD3+
50%70% positive
CD3+ T lymphocytes absolute
3504,000 cells/L
CD3+/CD4+
1%40% positive
CD3+/CD4+ T lymphocytes absolute
62,000 cells/L
CD3+/CD8+
25%40% positive
CD3+/CD8+ T lymphocytes absolute
2501,600 cells/L
Prostate-Specific Antigen
Analyte
Prostate-specific antigen
10
Analyte
Program Information
Seven 1.0-mL li uid whole
blood specimens
Program Code
Program Information
Twelve 1.0-mL li uid serum
specimens
LN23
LN23 Target Range
0.190.0 ng/mL
800-323-4040 | 847-832-7000 Option 1 | cap.org
119
Creatinine Accuracy
Program Information
Six 1.0-mL human serum
specimens
Program Code
Analyte
LN24
LN24 Target Range
Creatinine
0.64.0 mg/dL
The College of American Pathologists (CAP) and the National Kidney Disease Education
Program (NKDEP) have an initiative to harmonize clinically reported creatinine values.
This initiative is analogous to what the federal health agencies and the clinical laboratory
community did to improve the accuracy of cholesterol and glycohemoglobin testing.
Troponin Calibration Verification/Linearity

LN25, LN27
Analyte
10
Program Code
Troponin I
Program Code
LN25
LN25 Target Range
0.0560.00 ng/mL
Troponin T
LN27
LN27 Target Range
LN27 - Six 2.0-mL li uid

serum specimens
0.127.00 ng/mL
B-Type Natriuretic Peptides

Analyte
Program Information
LN25 - Seven 2.0-mL li uid
serum specimens
Program Code
LN30
LN30 Target Ranges
BNP
303,500 pg/mL
NT-pro BNP
5030,000 pg/mL
Program Information
Six 1.0-mL li uid plasma
specimens for BNP and
NT-pro BNP
A seventh 1.0-mL li uid
plasma specimen for NT-pro
BNP only
Immunosuppressive Drugs
Analyte
Program Code
LN31
LN31 Target Ranges
Cyclosporine
601,200 ng/mL
Tacrolimus
1.530.0 ng/mL
Ammonia Calibration Verification/Linearity LN32

Analyte
Ammonia
Program Information
Seven 2.0-mL li uid whole
blood hemolysate specimens
Program Code
LN32
LN32 Target Range
131500 mol/L
Program Information
specimens
Serum Myoglobin Calibration Verification/Linearity

LN33
Analyte
10
LN33
LN33 Target Range
25900 ng/mL
Myoglobin
Program Code
Program Information
specimens
Tumor Markers Calibration Verification/Linearity

LN34
Analyte
Program Code
Program Information
specimens
LN34
LN34 Target Ranges
CA 125
11,000 U/mL
CA 15-3
2190 U/mL
CA 19-9
10900 U/mL
800-323-4040 | 847-832-7000 Option 1 | cap.org
121
Coagulation Calibration Verification/Linearity

LN35, LN36, LN37
Analyte
Program Code
LN35
LN36
LN37
Target Ranges
Antithrombin activity
10%130%
Protein C activity
10%100%
Heparin, low molecular weight
0.12.0 U/mL
Heparin, unfractionated
0.11.3 U/mL
von Willebrand factor antigen
5%140%
Program Information
LN 5, LN 7 - Six 1.0-mL
frozen plasma specimens
per mailing
LN 6 - Twelve 1.0-mL
frozen plasma specimens per
mailing, which include six
for low molecular weight
heparin and six for
unfractionated heparin
Two shipments per year;
ships on dry ice
The LN35, LN36, and LN37 CVL programs meet the CAP Accreditation requirements
HEM.38009, 38010, and 38011.
Viral Load Calibration Verification/Linearity

LN38, LN39
Analyte
10
Program Code
LN38
CMV viral load
LN39
Target Ranges
Program Information
LN 8 - Six 1.5-mL frozen
plasma specimens
Two shipments per year; ships
on dry ice
0.3M1.0M IU/L
HIV viral load
010M copies/L

plasma specimens
Vitamin D Calibration Verification/Linearity

LN40
Analyte
25-OH vitamin D, total
Program Code
LN40
Target Range
4120 ng/mL
Program Information
Six 1.0-mL serum specimens
Program Information
Six 1.0-mL frozen plasma
specimens
Procalcitonin Calibration
Verification/Linearity LN41
Analyte
Program Code
Procalcitonin
LN41
Target Range
0.3200 ng/mL

on dry ice
Program Information
Six 1.0-mL plasma specimens
D-Dimer Calibration
Analyte
Program Code
D-dimer
LN42
Target Range
2205,500 ng/mL FEU

New
Lamellar Body Count Calibration

Lamellar body count
Program Code
LN43
Target Range
5200 particles x 109/L
New
Fibrinogen Calibration
Analyte
Fibrinogen
Program Code
LN44
Target Range
80900 mg/dL
10
Analyte
Program Information
Six 2.0-mL simulated li uid
performed on hematology
analyzers
Program Information
Six 2.0-mL frozen plasma
specimens
on dry ice
800-323-4040 | 847-832-7000 Option 1 | cap.org
123
Instrumentation Quality Management Programs

Instrumentation I
Challenges
Program Code
I
A Shipment
10
B Shipment
C Shipment
Program Information
Designed to assess
instruments not routinely
challenged during the
proficiency testing process
Adjustable micropipette
calibration verification/linearity
Analytical balance check
Gravimetric pipette calibration
Includes appropriate
materials to assess important
functional parameters,
including accuracy and
linearity
Microtiter plate linearity
Refractometer calibration
Spectrophotometer (stray light check)
Absorbance check UV wavelength
Fluorescent intensity check

fluorescent microscopes
Ocular micrometer calibration
Osmometer study
Peak absorbance measurement
pH meter check
Photometric calibration visible

wavelength
WARNING: The Instrumentation (I) Survey specimens may contain corrosive or toxic substances,
environmental hazards, or irritants.
Program Information
Eighteen 10.0-mL li uid
serum specimens
Interfering Substance Survey IFS

Analyte
Program Code
IFS
Designed for verifiying

manufacturing interference
specifications and
investigating discrepant
results caused by interfering
substances
Hemoglobin
Interferent
Lipid
Interferent
Alanine aminotransferase (ALT/SGPT)
Albumin
Amylase
Aspartate aminotransferase (AST/SGOT)
Submit results any time prior to

the material's expiration date
Calcium
Chloride
CK2 (MB) mass
Creatinine
Gamma glutamyl transferase (GGT)
Glucose
Iron
Lipase
Magnesium
Osmolality
Phosphorus
Potassium
Protein, total
Sodium
Urea nitrogen (BUN)
Uric acid
10
Bilirubin
Interferent
The material expires December 1, 2016.
800-323-4040 | 847-832-7000 Option 1 | cap.org
125
Serum Carryover SCO

Analyte
Program Code
SCO
Creatinine
hCG
Phenytoin
Program Information
One 10.0-mL li uid serum
specimen (low level) and one
5.0-mL liquid serum specimen
(high level)
Designed to screen for
instrument sample probe
carryover
The material expires May 1, 2017.
Urine Toxicology Carryover UTCO

Analyte
Program Code
UTCO
10
Program Information
Two 0.0-mL urine specimens
(low and high levels)
Benzoylecgonine
Delta-9-THC-COOH
Designed to screen for

instrument sample probe
carryover
Opiates
Propoxyphene
The material expires May 1, 2017.
Simplify your CVL needs with the CAPs comprehensive program

NEWAnalytical Measurement Ranges (AMR) have been
enhanced to better meet instrument ranges.
Testing KitEverything you need to test and accurately
report your CVL results, including CAP-prepared samples.
Customized Reports PackageReports, analysis, evaluations, and other

resources to provide the insights into your instrument performance.
User GuideInterpret and troubleshoot information

with suggested actions.
Technical SupportAccess CVL resources, reports, and more online.

See Section 10 of this catalog, Instrumentation Validation Tools, to determine
programs that best fit your laboratorys CVL needs.
Improve the reliability of your patient results with CAP CVL Validated Materials
Use the same material that is sent in the CVL program to:

Document corrective actions
Each laboratory receives a Participant Summary, which includes readily available results.
Calibration Verification/Linearity, Validated Materials

Validated Material
Page
LN2VM
LN2
112
Chemistry, Lipid,
Enzyme Calibration
Verification/Linearity;
All Beckman (except AU)
and Vitros VM
LN2VM1
LN2BV
112
TDM Calibration
Verification/Linearity VM
LDM
LN3
113
Ligand Assay Calibration

LLM
LN5
114
Urine Chemistry Calibration

LUM
LN6
114
LDM - Six .0-mL li uid

serum specimens
LLM - Eight .0-mL li uid
for most major instruments
except for Siemens ADVIA
Centaur
10
Program Code
Chemistry, Lipid,
Enzyme Calibration
Program Information
LN2VM, LN2VM1 - Seven
5.0-mL liquid serum
specimens for basic chemistry,
six 3.0-mL liquid serum
specimens for direct and total
bilirubin, seven 2.0-mL liquid
serum specimens for lipids,
and seven 5.0-mL liquid
serum specimens for enzymes
L M - Eighteen .0-mL li uid

urine specimens
800-323-4040 | 847-832-7000 Option 1 | cap.org
127
Now there is a performance monitoring program for all your instruments

CAP Quality Cross Check is a quality assurance program
that complements your existing CAP prociency testing (PT).
Designed by experts, this program serves as a periodic review
for monitoring all of your instruments on a more routine basis.
The CAP Quality Cross Check program enhances
your quality assurance efforts by:
Delivering confidence in patient resultsregardless of which

instrument your laboratory chooses.
Providing a comprehensive tool for proactive monitoring of your

laboratory instruments performance to ensure accurate results.
Augmenting your instrument comparability efforts with additional

resources, saving you valuable staff time.
Youll find CAP Quality Cross Check programs in the General

Chemistry and Therapeutic Drugs; Hematology; and Blood Gas,
Critical Care, and Oximetry sections of this catalog.
10
11
| Hematology and Clinical Microscopy

Hematology ..................................................................................................................................130
Clinical Microscopy .......................................................................................................................139
New Programs
New
Blood Cell Identification, Limited (BCP2) ...........................................................................................130

Hematology Automated Differential Series (FH13, FH13P)..................................................................131
Centrifugal Hematology (FH15) .......................................................................................................132
Waived Combination (HCC2) .........................................................................................................136
Urinalysis, Basic (CMP2).................................................................................................................139
Urinalysis with Clinical Microscopy (CMP3) ......................................................................................139
Urine, hCG (UHCG).......................................................................................................................144
MPV
Basic Hematology (HE/HEP) ........................................................................................................130
Hematology Automated Differential Series (FH1FH13, FH1PFH13P)..............................................131
Quality Cross CheckHematology Automated Differential Series (FH3Q, FH4Q, FH6Q, FH9Q) ........132
Urine Sediment
Clinical Microscopy Miscellaneous (CMMP) ..................................................................................139
Program Changes
CD-ROMs no longer offered
Basic Hematology (HE, HEP)........................................................................................................130
Hematology Automated Differential Series (FH1FH15, FH1PFH15P)...................................... 131132
Clinical Microscopy (CMP, CMP1, CMMP) ...................................................................................139
Wet sample no longer included; instead it consists of two photographs/mailing
Crystals (BCR) ............................................................................................................................141
Hematology Automated Differential Series (FH11, FH12, FH11P, FH12P)
11
Hematology
Hematology
Basic Hematology HE, HEP

Analyte/Procedure
Program Code
HE
Challenges/Shipment
HEP
Hematocrit
HEP - Ten images, each

available as photographs and
online images
Hemoglobin
MCV, MCH, and MCHC
MPV
Platelet count
RDW
Red blood cell count
White blood cell count
Blood cell identification
10
Blood Cell Identification/Limited BCP, BCP2

Procedure
11
Program Information
Five .0-mL whole blood
specimens
Program Code
BCP
Challenges/Shipment
BCP2
Educational challenge(s)
5 (BCP)/1 (BCP2)
Program Information
BCP - Ten images, each
online images
BCP2 - Six images, each
online images
Hematology
Program Information
ESR, ESR1 - Three 6.0-mL

ESR, ESR1, ESR2, ESR3
Procedure
Challenges/
Shipment
Program Code
ESR
All methods except the Sedimat 15 ,

Sedimat 15 Plus, Alifax,
and ALCOR
ESR1
ESR2
ESR3
ESR2 - Three .0-mL simulated

ESR - Three .5-mL whole
blood specimens
Sedimat 15, Sedimat 15 Plus
Alifax
ALCOR iSED

FH1FH13, FH1PFH13P
Analyte/Procedure
Challenges/
Shipment
Program Code
FH1FH10
FH1PFH10P
FH13
FH13P
10
Program Information
FH1-FH10 and FH1P-FH10P Five 2.5-mL whole blood
specimens with pierceable
caps
FH1 and FH1 P - Five
2.0-mL whole blood
caps
Hemoglobin
Immature granulocyte
parameter
5 (FH9 only)
Large unstained cell (L C)
5 (FH only)
MCV, MCH, and MCHC
For method compatibility,

see instrument matrix on
page 1
MPV
Nucleated red blood cell

count (nRBC)
Platelet count
RDW
WBC differential
FHP series - Ten images, each

online images
11
Hematocrit
5 (FH
and FH9)
For second instrument reporting options, see the Quality Cross Check programs, FH3Q, FH4Q,
FH6Q, and FH9Q on page 132.
800-323-4040 | 847-832-7000 Option 1 | cap.org
131
Hematology
New
Centrifugal Hematology FH15

Analyte/Procedure
Program Code
Challenges/Shipment
FH15
Hematocrit
Hemoglobin
For use with BC instruments;

not intented for spun
hematocrit methods
Platelet count
WBC count
WBC differential (2-part)
Program Information
caps
Quality Cross Check

FH3Q, FH4Q, FH6Q, FH9Q
Analyte/Procedure
11
Program Information
Five 0.6-mL whole blood
specimens
Challenges/
Shipment
Program Code
FH3Q
FH4Q
FH6Q
FH9Q
Hematocrit
For method compatibility,

see instrument matrix on
page 1
Hemoglobin
Immature granulocyte parameter
(FH9
only)
Large unstained cells (L C)
(FH9
only)
MCV, MCH, MCHC
MPV
Nucleated red blood cell count

(nRBC)
Platelet count
RDW
hite blood cell count
BC differential
(FH
and
FH9 only)
These programs do not meet regulatory requirements for proficiency testing. See the FH series
on page 131.
Hematology
Hematology Automated Differential Series, Instrument Matrix

Instrument
FH and FHQ Series

FH1
Horiba ABX 9000+, 9018+, 9020+
Sysmex K-series, KCP-1, KX-21/21N, poc

H-100i, XP-series
Abbott Cell-Dyn 1200, 1600, 1700, 1800,

Emerald
FH2
Horiba ABX Micros
Siemens ADVIA 60
Coulter AcT, MD, ONYX, S880, S-plus

V, ST, STKR, T-series
Drew Scientific DC-18, I-1800, Excell

10/16/18 DREW3
CDS/Medonic M-Series
Mindray BC - 2800, 3000/3200 series
FH3/ FH4/
FH3Q FH4Q
FH6
FH6Q
FH9/
FH10 FH13
FH9Q
FH15
Abbott Cell-Dyn 3000, 3200, 3500, 3700,

4000, Sapphire, Ruby
Drew Scientific Excell 22, 2280
Siemens ADVIA 120, 120 w/SP1, 2120
Coulter Gen-S, HmX, LH500, MAXM,

MAXM A/L, STKS, VCS
11
Sysmex XE-2100, XE-2100D, XE-2100L, XE2100C, XE-2100DC, XE-5000, XN-Series,

XT-1800i, XT-2000i, XS-800i, XS-1000i,
XS-1000iC, XS-1000iAL, XT-4000i
Horiba ABX Pentra 60, 80, 120
Coulter AcT 5 diff (AL, CP, OV)
Coulter LH750, LH755, LH780, LH785,

Unicel DxH
QBC
Program Code
Challenges/Shipment
BP
Thin/thick blood film sets*
z
z
Blood Parasite BP
Procedure
*This Survey will include corresponding thick films when available.
Program Information
Five Giemsa-stained blood
film sets, photographs,
and/or online images
A variety of blood parasites,
including Plasmodium,
Babesia, Trypanosoma, and
filarial worms
800-323-4040 | 847-832-7000 Option 1 | cap.org
133
Hematology
Bone Marrow Cell Differential BMD

Procedure
Program Code
Challenges/Shipment
BMD
Bone marrow differential, including

myeloid erythroid ratio
Bone marrow cell identification
Bone marrow interpretive uestions
Examine a whole slide image that includes a 500 bone marrow differential count and
annotated cells for identification.
DigitalScope technology simulates the use of a microscope by enabling the user to
scan and adjust magnification of the whole slide image.
Evaluate cell morphology and identify specific cells in bone marrow.
See system re uirements on page 1 .
Fetal Red Cell Detection HBF

Procedure
Program Code
Challenges/Shipment
HBF
leihauer-Bet e, flow cytometry
11
Rosette fetal screen
Two online whole slide images
Program Code
Challenges/Shipment
z
z
Hemoglobin A2 uantitation
Hemoglobin F uantitation
Sic ling test, ualitative
Program Information
Two 1.2-mL li uid whole
blood specimens
Not designed for F cell
uantitation
HG
Dry lab educational challenges
Two online activities per year;

your CAP shipping contact
will be notified via email
when the activity is available
Hemoglobinopathy HG
Hemoglobin identification and

uantification
Powered by DigitalScope
technology
DigitalScope technology simulates the use of a microscope by enabling the user to scan
and adjust magnification of the whole slide image.
Procedure
Program Information
One online bone marrow
aspirate whole slide image
that includes five annotated
cells for identification
2
1
technology
Program Information
Four 0.5-mL stabilized red
blood cell specimens
Two dry lab educational
challenges (case histories,
electrophoresis patterns, and
clinical interpretation
uestions)
Hematology
Reticulocyte RT, RT2, RT3, RT4

Instrument/Method
Program Code
RT
Abbott Cell-Dyn 200, 500, 700,

Ruby
RT2
RT3
RT4
RT , RT - Three 2.0-mL
stabilized red blood cell
specimens
Coulter ST S, MA M, GenS, Hm ,
LH500, LH700 series, nicel DxH
Sysmex E-2100, E-2100C, E-5000,

N Series, T-2000i, T- 000i
Abbott Cell-Dyn Sapphire, Siemens
ADVIA 120/2120 and all other
automated and manual methods
Challenges/Shipment
Includes percentage and

absolute result reporting
Pierceable caps
Sickle Cell Screening SCS

Procedure
Program Code
Challenges/Shipment
SCS
Sic ling test, ualitative
Program Information
RT, RT2 - Three 1.0-mL
stabilized red blood cell
specimens
Program Information
Three 1.0-mL stabilized
human erythrocyte specimens
11
Procedure
Program Code
Two 1.0-mL vials leu ocytereduced platelet material
Two 1.0-mL vials leu ocytereduced red blood cells
TRC
Platelet count (platelet-rich plasma)
WBC count
Dry challenge
Challenges/Shipment
Program Information
Five 1.2-mL suspensions of
platelet-rich plasma
Transfusion-Related Cell Count TRC

WBC counts must be performed using a Nageotte chamber, fluorescence microscopy or by
flow cytometry.
800-323-4040 | 847-832-7000 Option 1 | cap.org
135
Hematology
Waived Test Combination HCC, HCC2

Analyte
Program Code
HCC
HCC2
Hematocrit
Hemoglobin
rinalysis/ rine hCG

hole blood glucose
Challenges/Shipment
2 (HCC)/ (HCC2)
Program Information
HCC - Two 1.0-mL whole
blood specimens; two
shipments per year
HCC2 - Hematocrit,
hemoglobin, and urinalysis/
urine hCG testing - Two
.0-mL whole blood
specimens and two
10.0-mL urine specimens;
hole blood glucose

testing - Three 2.5-mL
To verify instrument
compatibility, refer to
the instrument matrix
on page 60
Rapid Total White Blood Cell Count RWBC

Procedure
11
Program Code
Challenges/Shipment
RWBC
Rapid total white blood cell count
Program Information
specimens
For use with the HemoCue
BC instrument
Virtual Peripheral Blood Smear VPBS

Procedure
Program Code
Challenges/Shipment
VPBS
BC differential
Platelet estimate
RBC morphology
technology
15
Examine whole slide images that include a 100 BC differential count and annotated
cells for identification.
Evaluate and identify red blood cell (RBC) morphology and identify specific white
blood cells ( BC) in peripheral blood.
Program Information
Three online whole slide
images that include
15 annotated cells for
identification

Hematology
Expanded Virtual
Peripheral Blood Smear EHE1
Procedure
Program Code
Challenges/Shipment
EHE1
BC differential
Platelet estimate
RBC morphology
10
Interpretive uestions
1-2
BC morphology
Program Information
Two online whole slide images
that include 10 annotated
cells for identification
technology
More challenging and/or complex testing.
Examine whole slide images that include a 100 BC/differential count and
annotated cells for identification.
Comprehensive case studies.
Ability to recognize and integrate problem-solving s ills through the use of
interpretive uestions.
Evaluate and identifiy red blood cell (RBC) morphology and identify specific white
blood cells ( BC) in peripheral blood.
11
Hematology Benchtop Reference Guide (HBRG)

More than 50 different cell identifications, including
common and rare cells

Detailed descriptions for each cell morphology

Six tabbed sections for easy reference
o
Erythrocytes
Erythrocyte Inclusions
Granulocytic (Myeloid) and Monocytic Cells
Lymphocytic Cells
Platelets and Megakaryocytic Cells
Microorganisms and Artifacts
A durable and water-resistant format5" x 6" and

spiral bound to withstand years of benchtop use
Add code HBRG to your Surveys order form.
800-323-4040 | 847-832-7000 Option 1 | cap.org
137
Hematology
Hematopathology Online Education

HPATH/HPATH1
Program
Program Code
Challenges/Shipment
HPATH/HPATH1
Hematopathology online case review
HPATH educates pathologists, hematolopathologists, and hematologists with an interest
in hematopathology to assess and improve their diagnostic s ills in hematopathology.
Clinical history and relevant laboratory data.
At least one whole slide image of peripheral blood, bone marrow,
spleen, lymph node, or other tissue.
Results of ancillary studies such as immunohistochemistry, flow cytometry,
FISH, aryotyping, and molecular studies, where appropriate.
Case discussion and discussion of differential diagnoses.
Five SAM uestions per case.
DigitalScope technology simulates the use of a microscope by enabling
the user to scan and adjust magnification of the whole slide image.
11
Program Information
HPATH - Five diagnostic
challenges/whole slide
images with clinical
history; for each additional
pathologist/hematologist,
purchase HPATH1
HPATH1 - Reporting option
with CME/SAM credit for
each additional pathologist
and hematologist (within
the same institution); must
order in conjunction with
Survey HPATH
CME/SAM credits (AMA
PRA Category 1 Credits)
per pathologist and a
maximum of 12 CE credits
per hematologist for
completion of an entire year
re uirements
technology

Clinical Microscopy
Clinical Microscopy
Urinalysis and Clinical Microscopy

CMP, CMP1, CMP2, CMP3
Program Code
Analyte/Procedure
CMP CMP1 CMP2
Challenges/
Shipment
CMP3
Program Information
CMP - Three 10.0-mL li uid
urine specimens; for use
with all instruments except
iCHEM; ten images, each
online images
Bilirubin
Blood or hemoglobin
Body fluid photographs
Glucose
hCG urine ( ualitative)
Leu ocyte esterase
Nitrite
Osmolality
pH
Protein ( ualitative)
Reducing substances
CMP - Three 10.0-mL li uid

urine specimens; for use with
all instruments except iCHEM
instruments; ten images each
online images
Specific gravity
robilinogen
rine sediment photographs
Clinical microscopy
etones
CMP2 - Three 10.0-mL li uid

urine specimens for use with
all instruments except iCHEM
Challenges/Shipment
Nasal smear
Pinworm preparation
Stool for leu ocytes
Vaginal wet preparation

(for spermatozoa, trichomonas,
clue cells, and epithelial cells)
OH preparation (s in or vaginal)
rine sediment
Program Code
CMMP
Fern test (vaginal)
11
Clinical Microscopy Miscellaneous CMMP

Procedure
CMP1 - Three 12.0-mL

li uid urine specimens; for
use with iCHEM instruments;
ten images each available
as photographs and online
images
Program Information
Ten images, each available
images
800-323-4040 | 847-832-7000 Option 1 | cap.org
139
Clinical Microscopy
Virtual Body Fluid VBF

Procedure
Program Code
Challenges/Shipment
VBF
Total nucleated cells differential
Body fluid cell identification
10
technology
Examine whole slide images that include a differential count and annotated
cells for identification.
Evaluate cell morphology and identify specific cells in a body fluid.
See system requirements on page 13.
Amniotic Fluid Leakage AFL

Procedure
Program Code
Challenges/Shipment
AFL
pH interpretation

Program Information
Three 2.0-mL liquid
specimens
For use with nitrazine paper
and the Amniotest
Program Information
Two online whole slide body
fluid images that inlcude
10 annotated cells for
identification
11
Automated Body Fluid ABF1, ABF2, ABF3

Procedure
Program Code
Challenges/Shipment
ABF1
ABF2
ABF3
Program Information
Two 3.0-mL simulated body
fluid specimens
For method compatibility, see instrument matrix below.
Automated Body Fluid, Instrument Matrix

Instrument
ABF Series
ABF1
Siemens ADVIA 120/2120 series
ABF2
Coulter LH 700 Series,

Unicel DxH
Sysmex XE-2100, XE-5000,

XN-series, XT-1800i, XT-2000i,
XT-4000i
IRIS iQ 200
ABF3
Clinical Microscopy
Automated Urinalysis UAA, UAA1

Analyte
Program Code
Challenges/Shipment
UAA
UAA1
Casts, semi uantitative
Crystals, semi uantitative
hite blood cells, uantitative
Crystals BFC, URC, BCR

Procedure
Program Code
BFC
Body fluid crystal identification

rine crystal identification
Epithelial cells, semi uantitative

Red blood cells, uantitative
Program Information
AA Two 10.0-mL li uid
IRIS and Roche instruments
URC
Challenges/Shipment
BCR
Bile crystal identification
Program Information
BFC - Two 1.5-mL simulated
body fluid specimens (eg,
synovial fluid)
RC - Two 1.5-mL urine

specimens
BCR - Two photographs
AA1 - Two 12.0-mL li uid

Sysmex instruments
Dipstick Confirmatory DSC

Program Code
Challenges/Shipment
DSC
Bilirubin
Sulfosalicylic acid (SSA)
11
Analyte/Procedure
Program Information
Two 12.0-mL li uid urine
specimens
For use with methods to
confirm positive bilirubin and
protein dipstic results
Fecal Fat FCFS

Analyte
Program Code
Challenges/Shipment
FCFS
Fecal fat, ualitative
Program Information
Two 10.0-g simulated fecal
fat specimens
For microscopic detection
of neutral fats (triglycerides)
and/or split fats (total free
fatty acids)
800-323-4040 | 847-832-7000 Option 1 | cap.org
141
Clinical Microscopy
Fetal Hemoglobin APT

Analyte
Program Code
Challenges/Shipment
APT
Fetal hemoglobin

2
Gastric Occult Blood GOCB

Analyte
Program Code
Challenges/Shipment
GOCB
Gastric occult blood
Gastric pH
Program Code
Challenges/Shipment
G6PDS
G6PD ( ualitative and uantitative)
Program Information
Three 2.0-mL simulated
gastric specimens
Glucose-6-Phosphate Dehydrogenase G6PDS

Analyte
Program Information
Two 1.2-mL simulated gastric
fluid specimens
Program Information
hemolysate samples
11
Hemocytometer Fluid Count HFC
Procedure
Program Code
HFC
Cytopreparation differential
Red blood cell fluid count
hite blood cell fluid count
Challenges/Shipment
Program Information
Three 1.0-mL simulated body
fluid specimens
Clinical Microscopy
Hemocytometer Fluid Count HFCI

Procedure
Program Code
Challenges/Shipment
HFCi
Red blood cell fluid count
hite blood cell fluid count

Differential
This program meets the CAPs Accreditation Program requirements.
Program Information
Three 2.0-mL simulated body
fluid specimens; two whole
slide images for 2- and 5-part
differential
Designed for international
experienced significant
shipping and receiving
issues and need longer
program stability
Lamellar Body Count LBC

Procedure
Program Code
Challenges/Shipment
LBC
Lamellar body count
Program Information
performed on all hematology
analyzers
11
Analyte
Program Code
Challenges/Shipment
OCB
Occult blood
Rupture of Fetal Membranes Testing ROM1

Procedure
Program Code
ROM1
Rupture of fetal membranes
Program Information
Three 2.0-mL simulated fecal
specimens
Occult Blood OCB
Challenges/Shipment
Program Information
Three 0.5-mL, simulated
vaginal specimens for
methods such as Amnisure
and Clinical Innovations
800-323-4040 | 847-832-7000 Option 1 | cap.org
143
Clinical Microscopy
Special Clinical Microscopy SCM1, SCM2

Analyte/Procedure
Program Code
SCM1
rine hemosiderin, Prussian blue

rine eosinophils,
Challenges/Shipment
SCM2
right stain
Ticks, Mites, and Other Arthropods TMO

Procedure
Program Code
Challenges/Shipment
TMO
Tic , mite, and arthropod identification
Program Code
Challenges/Shipment
UMC
11
Program Information
Three images, each available
images
Urine Albumin (Microalbumin)/Creatinine UMC

Analyte/Procedure
Program Information
images
Creatinine
rine albumin (microalbumin)

creatinine ratio
rine albumin (microalbumin),

semi uantitative
Program Information
Two .0-mL li uid urine
specimens
For use with dipstic and
semi uantitative methods only
For quantitative reporting, refer to Survey U, page 63.

New
Urine hCG UHCG

Procedure
Program Code
Challenges/Shipment
UHCG
rine hCG, ualitative
Program Code
WID
orm identification
Worm Identification WID

Procedure
Program Information
Five 1.0-mL urine specimens
Challenges/Shipment
Program Information
images
12 | Reproductive Medicine
The CAP covers everything and their Surveys are

thorough. They are at the cutting edge and give
good comparative data which we use for our
performance improvement. I will continue to use
CAP PT for our entire test menuI feel that it is just
another good measure to ensure that were turning
out quality results for our patients.
12
Andrology and Embryology ............................................................................................................146
Andrology and Embryology

Semen Analysis SC, SC1, PV, SM, SV, ASA

Procedure
Challenges/
Shipment
Program Code
SC
Sperm count & presence/absence

(manual methods and CASA systems)
SC1
PV
SM
SV
ASA
Sperm count & presence/absence

(automated methods)
Postvasectomy sperm count &

presence/absence
Sperm morphology
Sperm viability
Antisperm antibody IgG
PV - Two 0. -mL stabilized

human sperm specimens
with counts appropriate for
postvasectomy testing
SM - Two prepared slides
for staining
SV - Two eosin-nigrosinstained slides
SC1- Two 1.0-mL stabilized

Program Information
SC - Two 0. -mL stabilized
ASA - Two 0. -mL serum

specimens
12
Sperm Motility, Morphology, and Viability

SMCD, SM1CD, SM2CD
Procedure
Program Code
SMCD
SM1CD
Challenges/Shipment
SM2CD
Sperm count
Sperm motility/forward
progression
Sperm morphology
Sperm viability
z
z
scan and adjust the magnification of the whole slide image.
Program Information
SMCD - One CD-ROM with
video clips
SM1CD - Two challenges,
each available as images
on CD-ROM and online
whole slide images powered
by DigitalScope technology
SM2CD - Two challenges,
each available as images
on CD-ROM and online
whole slide images powered
by DigitalScope technology
Embryology EMB
Procedure
Program Code
Challenges/Shipment
EMB
Embryo transfer and quality assessment

(three- and five-day-old embryos)

4
Ligand Assay, Special Y, YY, DY

Analyte
Program Code
Y, YY
11-deoxycortisol
Androstenedione
DHEA sulfate
Estradiol
Estriol, unconjugated (uE )
Growth hormone (GH)
Progesterone
Prolactin
Testosterone
Challenges/Shipment
DY
YY - Nine 5.0-mL li uid

serum specimens (three
duplicate sets)
Conventional and
12
Testosterone, free
Sex hormone-binding globulin (SHBG)
Antimllerian Hormone AMH

Program Code
AMH
Challenges/Shipment
Antim llerian hormone (AMH)
Program Information
Y - Six 5.0-mL li uid serum
DY - Must order in conjunction

with Survey Y or YY
Analyte
Program Information
One CD-ROM with video
clips
Program Information
serum specimens
800-323-4040 | 847-832-7000 Option 1 | cap.org
147
Are you ready for your

CAP inspection?
The CAP Accreditation Readiness Assessment
(CARA) is an on-site evaluation and education
program for laboratories just beginning their pursuit
of CAP accreditation. CARA focuses on:
Facilitating an in-depth understanding of
CAP requirements as they apply to your laboratory
Helping you manage the time and resources
necessary for compliance with CAP accreditation

requirements and preparation for your initial inspection
Delivering on-site education when youre ready for it

CARA provides a unique educational coaching
experience that leverages the expertise of the worlds
most respected pathology organization.
The Readiness Assessment [CARA] helped our lab
immediately spot potential problems before our inspection.

Our CAP inspection went like clockwork!
Laboratory Director
More control. Zero risk. Give your laboratory its best opportunity
to be prepared and be successful.
Email us at readiness-assessment@cap.org to accelerate your quality journey.
13 | Coagulation
As an executive director, its important to me to

keep proficiency testing with the CAP to standardize
PT throughout all my laboratoriesthat way I can
see and understand when there are problems in
particular laboratories.
13
New
Basic Coagulation (CGB) ................................................................................................................150

ADAMTS-13 (CGS7) ......................................................................................................................151
Coagulation
New Programs
Coagulation
Coagulation
Coagulation, Limited CGB, CGL, CGDF

Analyte
Challenges/
Shipment
Program Code
CGB
Activated partial thromboplastin time
CGL
CGDF
International normalized ratio (INR)*
Prothrombin time
Fibrinogen
D-dimer
2 per year
Fibrin(ogen) degradation products,

plasma
2 per year
Fibrin(ogen) degradation products,

serum
2 per year
Program Information
CGB - Five 1.0-mL lyophilized
plasma specimens; three
shipments per year
CGL - Five 1.0-mL lyophilized
shipments per year; one
1.0-mL plasma specimen and
one 1.0-mL serum specimen;
CGDF - One 1.0-mL serum
specimen; one 1.0-mL
lyophilized plasma specimen;
*Participants reporting INR results will receive a special evaluation to assess the INR calculation.
Coagulation, Extended CGE, CGEX

Analyte
Challenges/
Shipment
Program Code
CGE, CGEX
See analyte listing below
Coagulation
13
Program Information
CGE - Six 1.0-mL
(three duplicate vials for each
challenge)
CGE - Ten 1.0-mL
(five duplicate vials for each
challenge)
Analyte Listing
50:50 mixing study, PT and APTT
Factor VIII assay
Protein S
Activated partial thromboplastin time
Fibrin monomer
Prothrombin fragment 1.2
Activated protein C resistance
Fibrinogen activity
Prothrombin time
Alpha-2-antiplasmin
Fibrinogen antigen
Reptilase time
Anti-beta-2-glycoprotein (IgG and IgM)
Heparin-induced thrombocytopenia (HIT)
Thrombin-antithrombin
Antiphospholipid antibody
(IgG, IgM, and IgA)
High molecular weight kininogen
Thrombin time
Kaolin-activated APTT
Tissue plasminogen activator
Antithrombin activity/antigen
Kaolin clotting time
Dilute prothrombin time
Lupus anticoagulant
Dilute Russells viper venom time
Plasminogen activator inhibitor
Euglobulin test
Plasminogen activity/antigen
von Willebrand factor activity:

- Collagen binding
- Glycoprotein Ib binding
- Ristocetin cofactor
Factors II, V, VII, VIII, IX, X, XI,

XII, and XIII
Prekallikrein
Protein C

von Willebrand multimer analysis
Coagulation
Coagulation Special Testing Series

CGS1, CGS2, CGS3, CGS4, CGS5, CGS6, CGS7
Module/Analyte
Challenges/Shipment
Program Information
CGS1, CGS2, CGS - A total
of two 2.0-mL lyophilized
plasma specimens
CGS - Three 1.0-mL
Program Code
CGS1 CGS2 CGS3 CGS4 CGS5 CGS6 CGS7
CGS5 - Two 60.0- L serum

specimens
CGS6 - Three 00.0- L

frozen serum specimens
CGS7 - Four 1.0-mL

plasma specimens
Activated partial
thromboplastin time*
International normalized
ratio (INR)
Prothrombin time*
Lupus Anticoagulant and Mixing Studies Module

Dilute Russells viper venom time
Lupus anticoagulant
(confirmation and screen)
50:50 mixing studies,

PT and APTT
Thrombophilia Module
Activated protein C resistance
Antithrombin (activity, antigen)
Protein C (activity, antigen)
Protein S (activity, free

antigen, total antigen)
von Willebrand Factor Antigen Module

Factor VIII assay
von Willebrand factor

(antigen, activity, multimers)
13
Heparin Module
3
Thrombin time
Coagulation
Heparin activities using

methodologies including Anti Xa
(unfractionated low molecular
weight, and hybrid curve)
Heparin-Induced Thrombocytopenia Module
Appropriate with methods such
as Gen-Probe Lifecodes PF4 IgG
and Gen-Probe Lifecodes PF4
Enhanced assays
Appropriate with the Akers
Biosciences, Inc. PIFA Heparin/
Platelet Factor 4 Rapid Assay
ADAMTS-13 Module
ADAMTS-13 (activity, inhibitor
screen, and titer)
*Not appropriate for meeting regulatory requirements, see page 150.
800-323-4040 | 847-832-7000 Option 1 | cap.org
151
Coagulation
Dabigatran, Fondaparinux,
Rivaroxaban Anticoagulant Monitoring
DBGN, FNPX, RVBN
Analyte
Program Code
Challenges/Shipment
DBGN
FNPX
RVBN
Activated partial thromboplastin time*
Prothrombin time*
Thrombin time
Dabigatran
Fondaparinux
Program Information
specimens
Rivaroxaban
*Not appropriate for meeting regulatory requirements, see page 150.
Program Information
CT - Three .0-mL lyophilized
Activated Clotting Time Series

CT, CT1, CT2, CT3, CT5
Instrument/Cartridge
Program Code
Challenges/Shipment
CT CT1 CT2 CT3 CT5
Helena Actalyke
Helena Cascade POC
IL Gem PCL ACT
IL Gem PCL ACT-LR
Coagulation
ITC Hemochron CA510/FTCA510
ITC Hemochron FTK-ACT
ITC Hemochron Jr. Signature/

ACT-LR
3
3
i-STAT Celite and Kaolin ACT
Medtronic HemoTec
ACT/ACTII/ACT Plus HR-ACT
Medtronic HemoTec
ACT/ACTII/ACT Plus LR-ACT
Medtronic HemoTec
ACT/ACTII/ACT Plus R-ACT
Sienco Sonoclot
CT5 - Three 1.7-mL lyophilized

3
z
Medtronic Hepcon HMS, HMS Plus
CT2, CT - Three 0.5-mL

lyophilized whole blood
specimens
ITC Hemochron Jr. Signature/ACT+
IL GEM PCL Plus ACT-LR
ITC Hemochron P214/P215
IL GEM PCL Plus ACT
13
CT1 - Three 1.7-mL lyophilized

Coagulation
Platelet Function* PF, PF1

Instrument/Method
Program Code
PF
Platelet aggregation
Challenges/Shipment
PF1
PFA-100
Helena Plateletworks
Program Information
PF - Four .2 sodium citrate
vacuum tubes; two 10.0-mL
plastic tubes; two vials of
specified agonists
PF1 - Four .2 sodium
citrate vacuum tubes; two
10.0-mL plastic tubes
Second instrument/method
reporting requires the
purchase of an additional kit
*This Survey requires the draw of a normal donor sample.
Thromboelastogram TEG
Instrument/Method
Program Code
Challenges/Shipment
TEG
Thromboelastogram
Program Information
Two 1.0-mL lyophilized whole
blood specimens
For use with the Haemonetics
Thromboelastograph and
ROTEM delta hemostasis
analyzers
Coagulation Calibration Verification/Linearity

LN35, LN36, LN37
Analyte
Program Code
LN35
LN36
LN37
Target Ranges
10%130%
Protein C activity
10%100%
Heparin, low molecular weight
0.12.0 U/mL
0.11.3 U/mL
z
5%140%
LN 6 - Twelve 1.0-mL
frozen plasma specimens per
mailing, which include six
for low molecular weight
heparin and six for
unfractionated heparin
13
Coagulation
Antithrombin activity
Program Information
LN 5, LN 7 - Six 1.0-mL
frozen plasma specimens
per mailing

ships on dry ice
The LN35, LN36, and LN37 CVL programs meet the CAP Accreditation requirements
HEM.38009, 38010, and 38011.
800-323-4040 | 847-832-7000 Option 1 | cap.org
153
Coagulation
Program Information
Six 1.0-mL plasma specimens
D-Dimer Calibration
Analyte
Program Code
D-dimer
LN42
Target Ranges
220-5,500 ng/mL FEU
Program Information
P - Five 1.0-mL lyophilized
plasma specimens

WP3, WP4, WP6, WP9, WP10
Analyte
Challenges/Shipment
P , P6 - Five 0.5-mL
lyophilized whole blood
specimens
P9 - Five 0. -mL lyophilized

plasma specimens
Program Code
WP3
WP4
WP6
WP9
WP10
International normalized ratio (INR)
Prothrombin time
For method compatibility, see instrument matrix below.
Coagulation
13

P10 - Three 0. -mL
lyophilized plasma specimens;
Whole Blood Coagulation, Instrument Matrix

Instrument
Program Code
WP3 WP4 WP6 WP9 WP10
Abbott CoaguSense
Helena Cascade POC Citrated
Helena Cascade POC Noncitrated
IL GEM PCL, PCL Plus Citrated
IL GEM PCL, PCL Plus Noncitrated
ITC Hemochron Jr. Signature/Signature +, Signature

Elite and Jr. II Citrated cuvette
ITC Hemochron Jr. Signature/Signature +, Signature

Elite and Jr. II Noncitrated cuvette
i-STAT
z
z
Coagulation
Roche CoaguChek XS Plus and XS Pro
Roche CoaguChek XS System
For use with the SimpliRED

and Clearview Simplify
D-dimer methods
Whole Blood D-Dimer WBDD

Analyte
Program Code
Program Information
Two 0.5-mL whole blood
specimens
Challenges/Shipment
WBDD
D-dimer, qualitative
Program Information
Three lyophilized specimens
with diluents
Drug-Specific Platelet Aggregation PIA

Procedure
Program Code
Challenges/Shipment
PIA
Aspirin assay
PRU test
llb/llla assay
For use with the Accumetrics

VerifyNow System
it includes sufficient material

to perform one assay; multiple
assay reporting requires the
purchase of additional kits
Program Information
urine specimens
For use with Aspirin
11-Dehydrothromboxane B2 TBX
Analyte
Program Code
or s
Challenges/Shipment
13
TBX
Platelet Mapping* PLTM

Analyte
Program Code
Challenges/Shipment
Program Information
One .2 sodium citrate and
two heparin vacuum tubes;
two 3.5-mL plastic tubes;
one vial of 0.2M CaCl2
Coagulation
11-dehydrothromboxane B2
For use with the Haemonetics

Platelet Mapping assay
PLTM
AA % aggregation/inhibition
ADP % aggregation/inhibition
*This Survey requires the draw of a normal donor sample.
800-323-4040 | 847-832-7000 Option 1 | cap.org
155
Coagulation
Use the same material that is sent in the Surveys program to:

Coagulation, Validated Material

Validated Material
Coagulation VM
CGM
CGL
Page
150
Program Information
Five 1.0-mL lyophilized
shipments per year; one
1.0-mL lyophilized plasma
specimen and one 1.0-mL
serum specimen; two
shipments per year
Im a cancer survivor.
I always try to remember
the person I am assisting
is crucial to getting
accurate patient results.
It is that simple.
Coagulation
13
Patrick
CAP Customer Contact Center representatives

understand the importance of what you do.
14 | Microbiology
In my state, especially, were very regulated and have
all these regulatory agencies coming in. The CAP is the
recognized laboratory standard and its great to be
compared with a large peer group. Ive been a manager
in a laboratory without the CAP and with the CAP, and
I will tell you that it is better to be with the CAP!
Microbiology
Bacteriology ..................................................................................................................................158
Mycobacteriology ..........................................................................................................................170
Mycology......................................................................................................................................171
Parasitology ..................................................................................................................................174
Virology........................................................................................................................................178
Molecular Microbiology..................................................................................................................180
Infectious Disease Serology .............................................................................................................186
New Programs
New
Hepatitis C Viral Load (HCVN)
See Survey HCV2.......................................................................................................................180
Microbiology
Microbiology Combination with GC (MC1) ......................................................................................161

Microbiology Combination (MC2) ...................................................................................................161
Urine Colony Count (MC3) .............................................................................................................161
Urine Colony Count Combination (MC4) ..........................................................................................161
Throat Culture/Rapid Strep (MC5) ...................................................................................................161
Bordetella pertussis/parapertussis, Molecular (BOR)...........................................................................164
C. difficile Detection, 2 challenges (CDF2)........................................................................................165
C. difficile Detection, 5 challenges (CDF5)........................................................................................165
Trichomonas vaginalis, Molecular (TVAG) ........................................................................................176
Influenza A, Influenza B, RSV by NAA (ID3) .....................................................................................183
14
Bacteriology
Bacteriology
Guide for Ordering Appropriate Bacteriology Surveys

Procedure
Program Code
D
D4
MC1
MC2
MC5
D2
D7
D3
MC4
D1
Bacterial identification
Gram stain
Antimicrobial susceptibility testing
Bacterial antigen detection
Participants must report five specimens for each mailing to meet CLIA requirements
for the subspecialty of bacteriology. See the following pages for more detailed
information about each Survey.
Bacteriology D
Procedure
Program Code
Challenges/Shipment
1 graded, 1 ungraded
Gram stain
Antigen detection challenges will be included in the following shipments:
Two specimens for bacterial

antigen detection from the
following:
One swab for Group A
Streptococcus
specimen for spinal fluid
meningitis testing
specimen for Clostridium
difficile, for use with rapid
or molecular testing methods
Microbiology
14
Shipment A C. difficile antigen/toxin and spinal fluid meningitis panel

Shipment B Spinal fluid meningitis panel and Group A Streptococcus
Shipment C C. difficile antigen/toxin and Group A Streptococcus
Program Information
Five swabs (in duplicate) with
diluents for culture
Refer to the Ordering Information provided for information regarding additional dangerous goods and related fees.
Bacteriology
Expanded Bacteriology DEX

Analyte
Program Code
Challenges/Shipment
DEX
Live organisms
Program Information
Two swabs (in duplicate)
with diluents to perform
bacterial identification and
susceptibility (when directed)
Expanded Bacteriology (DE ) is an educational opportunity that provides
Culture and susceptibility testing challenges for microbiology laboratories
that perform complete identification and susceptibility of bacterial isolates
including less common or problematic bacteria
More exposure to emerging bacterial pathogens and novel resistance mechanisms
Ability to recognize and identify organisms that exhibit multiple
drug-resistance patterns
Recovery and identification of mixed pathogens such as yeast, aerobic,
and anaerobic bacteria in cultures containing multiple organisms
Microbiology Bench Tools

Competency MBT
Procedure
Program Code
Challenges/Shipment
MBT
Program Information
Six swab specimens with
diluents for bacterial
identification and susceptibility
Results will be provided with
the kit to assess personnel
competency
Microbiology Bench Tools for Competency (MBT) is a supplemental module for
competency assessment and an educational resource for microbiology laboratories.
The module
14
Microbiology
Provides organisms that challenge the basic elements of testing at the

microbiology bench, including direct observation, monitoring, recording,
and reporting of test results
Can be used for both competency and educational purposes, including teaching
and training pathology residents, new employees, medical, and MT/MLT students
Provides identification and susceptibility results for supervisor use
This is not a proficiency testing program and participants will not return results to the CAP.
800-323-4040 | 847-832-7000 Option 1 | cap.org
159
Bacteriology
GC, Throat, and Urine Cultures D1, D2, D3, D7

Procedure
D1
D2
Antimicrobial
susceptibility
testing
D7
Throat
Urine
Cervical
Throat/ rine
Gram stain
Microbiologic
level:
D3
Bacterial
identification
Culture source:
Challenges/
Shipment
Program Code
Procedure
Program Code
Challenges/Shipment
D4
Microbiology
Throat swabs compatible

with molecular and
culture-based methods
Presence or Organisms Presence or Combination

absence of identified to absence of of two throat
Group A
the extent
Neisseria
and three
Streptococcus
of your
gonorrhoeae urine culture
determination laboratorys determination specimens
protocol
Limited Bacteriology D4
14
Program Information
Five loop/swab specimens
(in duplicate) with diluents
Antimicrobial susceptibility
testing
Gram stain
Program Information
Five loop/swab specimens
(in duplicate) with diluents
and one swab specimen
Two throat culture specimens,
two urine culture specimens,
one susceptibility specimen,
one GC culture specimen,
and one bacterial antigen
detection specimen for
Group A Streptococcus
Culture source:
Microbiologic level
GC culture
Presence or absence of
Neisseria gonorrhoeae
determination
Throat swabs compatible

with molecular and
culture-based methods
Presence or absence of
determination
Throat culture
Urine culture
Organisms identified to the

extent of your laboratorys
protocol
Bacteriology
New
Microbiology Combination MC1, MC2

Procedure
Challenges/Shipment
Program Code
Program Information
MC1 - Ten loop/swab
one swab for antigen detection
MC1
MC2
GC culture
MC2 - Eight loop/swab

one swab for antigen detection
Gram stain
Rapid group A Streptococcus antigen detection
rine cultures will only have

one susceptibility challenge
Throat culture
Urine culture
New
Urine Colony Count; Urine Colony

Count Combination MC3, MC4
Procedure
Challenges/Shipment
Program Code
MC3
MC4
Urine colony count/

urine culture identification
Rapid group A Streptococcus antigen detection
Throat culture
Throat Culture/Rapid Strep Combination

MC5
MC - Five urine specimens,

three swab specimens in
duplicate and three swabs
for antigen detection
New
Challenges/Shipment
Program Information
Six loop/swab specimens in
duplicate and two swabs for
antigen detection
14
Microbiology
Procedure
Program
Code
Program Information
MC - Two 2.0-mL urine
specimens
MC5
Gram stain
Rapid group A Streptococcus antigen detection*
Throat culture
Urine culture
*If you are using a waived method for Streptococcus testing, these results will not count
toward the required five challenges for the subspecialty of microbiology.
800-323-4040 | 847-832-7000 Option 1 | cap.org
161
Bacteriology
Gram Stain D5
Procedure
Program Code
Challenges/Shipment
D5
Gram stain

5
Virtual Gram Stain VGS1, VGS2

Procedure
Program Code
VGS1
Virtual Gram stain basic
Challenges/Shipment
VGS2
Virtual Gram stain advanced
Virtual Gram Stain Basic Competency (VGS1) is for general and new laboratory
technologists/technicians. Participants will assess the quality of specimens and
stains and will report artifacts and detailed gram-positive and gram-negative
morphology. Challenges will include specimens such as CSF, body fluids, and
positive blood cultures.
Virtual Gram Stain Advanced Competency (VGS2) is for experienced laboratory
technologists/technicians and microbiologists. Participants will receive challenging
images of sputum, body fluids, and other specimens to assess the quality, quantity,
and typical morphology of both gram-positive and gram-negative organisms
appropriate for the site.
Microbiology
14
Rapid Strep A Antigen Detection D6

Procedure
Program Code
Challenges/Shipment
D6
Group A Streptococcus antigen detection
Program Information
Five air-dried, methanol-fixed
unstained glass slides
Program Information
images
Results included in the it to
assess personnel competency
technology
Program Information
Five swab specimens
Bacteriology
Rapid Strep A Antigen Detection, Waived D9

Procedure
Program Code
Challenges/Shipment
D9
Group A Streptococcus antigen

detection
Program Code
Challenges/Shipment
D8
Group B Streptococcus detection
Group B Strep Detection D8

Procedure
Program Information
Two swab specimens
Program Information
Five swab specimens with
diluents
Compatible with culture and
molecular methods
Bacterial Antigen Detection LBAS, SBAS

Procedure
Program Code
LBAS
Legionella pneumophila
antigen detection
Challenges/Shipment
SBAS

2
Streptococcus pneumoniae
antigen detection
Program Code
Challenges/Shipment
BCS
Blood culture bacterial detection
Program Information
Two specimens with diluents
for inoculation of blood
culture bottles
14
Microbiology
Blood Culture BCS

Procedure
Program Information
Two 0.5-mL li uid simulated
clinical specimens
800-323-4040 | 847-832-7000 Option 1 | cap.org
163
Bacteriology
Blood Culture, Staphylococcus aureus BCS1

Analyte
Program Code
Challenges/Shipment
BCS1
Staphylococcus aureus/MRSA/MSSA
Compatible with methods for

rapid detection of S. aureus/
MRSA/MSSA from positive
blood culture bottles
Program Information
Three specimens with diluents
culture bottles
PNA FISH PNA1, PNA2, PNA3, PNA4

Analyte
Program Code
Challenges/Shipment
PNA1 PNA2 PNA3 PNA4
Staphylococcus
Yeast
Enterococcus
Gram-negative rods
New
Bordetella pertussis/parapertussis,
Molecular BOR
Analyte
Program Code
Challenges/Shipment
BOR
Program Information
Three specimens
Designed for molecular
techniques
Bordetella pertussis
Bordetella parapertussis
Microbiology
14
Program Information
Three specimens with diluents
culture bottles
Bacteriology
Campylobacter CAMP
Analyte
Program Code
Challenges/Shipment
CAMP
Campylobacter
Program Information
Two swabs with diluents
For use with rapid antigen,
culture-based testing, and
molecular methods
New
C. difficile Detection CDF2

Procedure
Program Code
Challenges/Shipment
CDF2
Clostridium difficile toxin
Procedure
Program Code
New
C. difficile Detection CDF5
Challenges/Shipment
CDF5
Clostridium difficile toxin
Chlamydia trachomatis HC1, HC3

Procedure
Program Code
HC1
Antigen detection (DFA)
z
z
Program Information
CDF5 - Five 0.5-mL
lyophilized specimens,
for use with rapid or
molecular testing methods
Program Information
HC1 - Five 5-well slide
specimens; for the detection
of chlamydial elementary
bodies by DFA
14
HC - Five 2.0-mL li uid

specimens
Microbiology
Antigen detection (EIA)
Challenges/Shipment
HC3
Program Information
CDF2 - Two 0.5-mL
lyophilized specimens,
for use with rapid or
molecular testing methods
800-323-4040 | 847-832-7000 Option 1 | cap.org
165
Bacteriology
Fecal Lactoferrin FLAC

Analyte
Program Code
Challenges/Shipment
FLAC
Fecal lactoferrin
For use with rapid methods

3
Helicobacter pylori Antigen, Stool HPS

Procedure
Program Code
Challenges/Shipment
HPS
Helicobacter pylori antigen detection
Program Code
Challenges/Shipment
LPX
Live organisms
Program Information
Two 0.5-mL fecal suspensions
The Laboratory Preparedness Exercise (LP ) was developed as a collaborative effort between
the College of American Pathologists, the Centers for Disease Control and Prevention
(CDC), and the Association of Public Health Laboratories (APHL). Laboratories will be sent
live organisms that either exhibit characteristics of bioterrorism agents or demonstrate
epidemiologic importance and will be expected to respond following Laboratory Response
Networ Sentinel Laboratory Guidelines if a bioterrorism agent is suspected. All agents
provided are excluded from the CDC s select agent list. These may include strains of
Bacillus anthracis, Yersinia pestis, Francisella tularensis, and Brucella abortus that have been
modified and are safe for testing in a laboratory that contains a certified Class II Biological
Safety Cabinet and is capable of handling Category A and B agents.
Program Information
Three swab specimens with
diluents
Not available to international
customers due to United
States export law restrictions
Microbiology
14
Laboratory Preparedness Exercise LPX

Analyte
Program Information
Three simulated stool
specimens
Bacteriology
Methicillin-Resistant Staphylococcus aureus

Screen MRS
Procedure
Program Code
Challenges/Shipment
MRS
MRSA/MSSA detection
Methicillin-Resistant Staphylococcus aureus

Screen MRS5
Procedure
Program Code
Challenges/Shipment
MRS5
MRSA/MSSA detection
Rapid Urease RUR

Analyte
Program Code
Challenges/Shipment
RUR
Urease
Program Information
Two swab specimens with
diluents
For use with molecular methods
and culture-based testing
Program Information
Five swab specimens with
diluents
For use with molecular methods
and culture-based testing
Program Information
Three simulated gastric
biopsy specimens
For use with methods
such as CLOTEST
14
Microbiology
800-323-4040 | 847-832-7000 Option 1 | cap.org
167
Bacteriology
Stool Pathogen SP, SPN, SP1

Analyte/Procedure
Program Code
Challenges/Shipment
SP
SPN
SP1
Adenovirus 0/ 1
C. difficile
Rotavirus
Shiga toxin
Norovirus
Program Information
SP - Two 1.0-mL li uid
specimens; for use with rapid
or molecular testing methods;
not available to international
SPN - Two 1.0-mL li uid
specimens; for use with rapid
or molecular testing methods;
intended for international
laboratories
SP1 - One 1.0-mL li uid
specimen
Shiga Toxin ST
Analyte
Program Code
Challenges/Shipment
ST
Shiga toxin
Program Information
For use with direct shiga toxin
testing only; not compatible
with culture methods,
cytotoxicity assays, or PCR
Microbiology
14
Bacterial Vaginosis BV
Procedure
Program Code
Challenges/Shipment
BV
Bacterial vaginosis detection
Program Information
For OSOM BVBlue users
Bacteriology
Vaginitis Screen VS, VS1

Analyte
Program Code
VS
Challenges/Shipment
VS1
Candida sp.
Gardnerella vaginalis
Trichomonas vaginalis
Program Information
VS - Five swabs for DNA
probe technology; BD Affirm
VP III probe detection method;
5
VS1 - Five swabs for DNA
probe technology; Sekisui
OSOM Trichomonas Rapid
Test Trichomonas vaginalis
methods; two shipments
per year
Vaginitis Screen, Virtual Gram Stain VS2

Procedure
Program Code
Challenges/Shipment
VS2
Interpretation of Gram-stained vaginal

smears
Vancomycin-Resistant Enterococcus VRE

Procedure
Program Code
Challenges/Shipment
Vancomycin-resistant Enterococcus
(VRE) detection
technology
Two activities per year; your
CAP shipping contact will be
Program Information
Two swabs with diluents
14
For use with molecular

methods and culture-based
testing
Microbiology
VRE
Program Information
images
800-323-4040 | 847-832-7000 Option 1 | cap.org
169
Mycobacteriology
Mycobacteriology
Mycobacteriology E
Procedure
Program Code
Challenges/Shipment
Acid-fast smear
Antimycobacterial susceptibility testing
1 graded, 1 ungraded
Mycobacterial identification*
Limited Mycobacteriology E1
Program Code
Challenges/Shipment
E1
14
Acid-fast smear
Mycobacterial culture
Molecular MTB Detection and Resistance MTBR

Procedure
Program Code
Challenges/Shipment
MTBR
Microbiology
Identification may be
performed by culture or
molecular methods
*This procedure requires identification of Mycobacterium tuberculosis.
Procedure
Program Information
Five simulated clinical
isolates with diluents and one
specimen for performing an
acid-fast bacillus smear
Program Information
Five simulated specimens
for acid-fast smears and/or
for the determination of the
presence or absence of
acid-fast bacillus by culture
Program Information
sputum specimens for use
with molecular methods
Mycobacterium tuberculosis detection
Not suitable for culture
Rifampin resistance
Mycology
Mycology
Mycology F
Procedure
Program Code
Challenges/Shipment
Antifungal susceptibility testing
Cryptococcal antigen detection
2 per year
Mold and yeast identification
Program Information
Five loops for culture (in
duplicate) with diluents
and one 1.0-mL simulated
cerebrospinal fluid specimen
(A and B shipments only)
Identification of yeast and
mold may be performed by
culture or molecular methods
Yeast F1
Procedure
Program Code
Challenges/Shipment
F1
Antifungal susceptibility testing
Cryptococcal antigen detection
2 per year
Yeast identification
Program Information
and one 1.0-mL simulated
cerebrospinal fluid specimen
(A and B shipments only)
Identification of yeast may
be performed by culture or
molecular methods
14
Microbiology
800-323-4040 | 847-832-7000 Option 1 | cap.org
171
Mycology
Candida Culture F3
Procedure
Program Code
Challenges/Shipment
F3
Program Information
Contains Candida species
Identification of Candida
species may be performed by
culture, molecular, and rapid
methods
Galactomannan FGAL
Analyte
Program Code
Challenges/Shipment
FGAL
Galactomannan - Aspergillus
Fungal Serology FSER

Procedure
Program Code
Challenges/Shipment
FSER
Serological detection of specific

fungal antibodies
Microbiology
14
Program Information
Three li uid specimens
For use with methods such as
Bio-Rad Platelia
Program Information
Three serum specimens
For use with immunodiffusion
methods
Designed for the detection
of antibodies to Aspergillus,
Blastomyces, Coccidiodes,
and Histoplasma
Fungal Smear FSM

Procedure
Program Code
Challenges/Shipment
FSM
OH preparation/calcofluor white
Program Information
Three slides
Mycology
India Ink IND

Procedure
Program Code
Challenges/Shipment
IND
India Ink
Pneumocystis jirovecii
PCP1, PCP2, PCP3, PCP4
Program Code
PCP1
PCP Calcofluor white stain

PCP
DFA stain
PCP
Giemsa stain
PCP
GMS stain
PCP2
PCP3
Procedure
Program Information
Two li uid specimens
Challenges/Shipment
Program Information
images
PCP4
z
z
Put fast identification of fungi at your fingertips

Mycology Benchtop Reference Guide (MBRG)
More than 70 fungal identifications of yeast and molds

commonly encountered in the clinical laboratory
Detailed descriptions of the most significant morphologic

elements, ecology, and clinical significance

Color images of macroscopic and
14
microscopic morphologies
o
Yeast and Yeast-Like Fungi
Molds With Narrow, Hyaline Hyphae
Dimorphic Fungi
Dermatophytes
Zygomycetes
Dematiaceous Molds
Microbiology
A durable and water-resistant format 6" x 7" and

Add code MBRG to your Surveys order form.
800-323-4040 | 847-832-7000 Option 1 | cap.org
173
Parasitology
Parasitology
Parasitology P, P3, P4, P5

Procedure
Program Code
P
P3
P4
Fecal suspension (wet mount)
Fecal suspension (Giardia and/or

Cryptosporidium immunoassay and
modified acid-fast stain)
Giemsa-stained blood smear
Preserved slide (for permanent stain)
P5
The proficiency testing materials used for the Parasitology Surveys contain formalin
as a preservative.
Modified acid-fast stain results do not meet CLIA re uirements for parasite identification.
Microbiology
14
Program Information
P - Five specimens consisting
of thin and thick films for
blood and tissue parasite
identification; preserved slides
for permanent stain; 0.75-mL
fecal suspensions for direct
wet mount examination,
photographs, and/or online
images; two 0.75-mL fecal
suspensions for Giardia
and/or Cryptosporidium
immunoassay testing and
modified acid-fast stain
P - Five 0.75-mL fecal
suspensions for direct
wet mount examination,
images; one 0.75-mL fecal
suspension for Giardia
P - Five specimens consisting
of 0.75-mL fecal suspensions
for direct wet mount
examination, preserved
slides for permanent stain,
images; one 0.75-mL fecal
suspension for Giardia
P5 - Five 0.75-mL fecal
suspensions for Giardia
Parasitology
Blood Parasite BP
Procedure
Program Code
Challenges/Shipment
BP
Thin/thick blood film sets*
*This Survey will include corresponding thick films when available.
Program Information
Five Giemsa-stained blood
film sets, photographs,
and/or online images
A variety of blood parasites,
including Plasmodium,
Babesia, Trypanosoma, and
filarial worms
Rapid Malaria RMAL

Procedure
Program Code
Challenges/Shipment
RMAL
Rapid malaria detection
Program Information
Three antigen specimens
*May not be compatible with methods that use enzyme detection for mixed malaria infections.
Put fast identification of parasites at your fingertips

Parasitology Benchtop Reference Guide (PBRG)
More than 70 identifications for parasites commonly

encountered in the clinical laboratory
Detailed descriptions of the parasite morphology,

ecology, and clinical significance
Color images of microscopic morphologies using
14
routine parasitology stains and preparations
Microbiology
Color images of macroscopic worms routinely

submitted to the clinical laboratory
Five tabbed sections for easy reference

o
Blood Parasites
Intestinal Protozoa
Intestinal Helminths
Miscellaneous Specimens
Macroscopic Worms
A durable and water-resistant format6" by 7" and

spiral bound to withstand years of benchtop use.
Add code PBRG to your Surveys order form.
800-323-4040 | 847-832-7000 Option 1 | cap.org
175
Parasitology
Ticks, Mites, and Other Arthropods TMO

Procedure
Program Code
Challenges/Shipment
TMO
Tic , mite, and arthropod identification
New
Trichomonas vaginalis, Molecular TVAG

Analyte
Program Code
Challenges/Shipment
TVAG
Worm Identification WID

Procedure
Program Code
Challenges/Shipment
WID
Worm identification
Program Information
images
Program Information
Three li uid specimens
techniques
Program Information
images
Microbiology
14
Virology and Molecular Microbiology Testing
Virology and Molecular Microbiology Testing

se this flowchart as a guide for ordering the appropriate Virology and Molecular Microbiology Surveys for your laboratory s
testing menu. For the subspecialty of virology, you must test five specimens per mailing. If you have any uestions, please call
the Customer Contact Center at 800- 2 - 0 0 or 8 7-8 2-7000 option 1.
Virology
Do you perform any of the following

virology testing?
n virology culture
n virology antigen testing
n virology antibody testing
Do you
perform
molecular
testing on
Chlamydia
or GC only?
Yes
Yes
For Comprehensive Virology
Culture Testing
For Virology Antigen
Testing by Immunofluorescence
For Viral Serology Testing
For Virology Antigen by EIA or

Latex Agglutination
For Herpes Simplex Virus

Culture Testing
Select
VR1
Select
VR2
Select
VR3/
VR3M
Select
Select from
the
following
Surveys:
n
HC6,
HC6X,
HC7
Chlamydia/
GC
Nucleic Acid
Amplification
Select from
the
following
Surveys:
n
HC2
Nucleic Acid
Amplification
n
BOR
Bordetella
pertussis/
parapertussis
n
CDF5
C. difficile
detection
n
Select from
the
following
Surveys:
n
HIV,
HV2
Yes
Select from
the
following
Surveys:
n
HCV2,
HBVL,
HBVL5
VLS,
VLS2
IDR
Infectious
Disease
Respiratory
Panel
Hepatitis
Viral Load
n
ID3
Influenza A,
Influenza B,
RSV by NAA
HIV Viral Load
BSTE,
BSTN,
BSTS
Bacterial
Strain Typing
Select
HC4
IDO, ID1,
ID1T,
ID2, IDN
Do you
perform
molecular
multiplexing?
Yes
Yes
VR4
Select
Do you
perform
viral load
testing
only?
Viral Load
14
Microbiology
For Herpes Simplex Virus

Antigen Detection by DFA
Do you
perform
nucleic acid
amplification
other than
GC?
GIP
Gastrointestinal
Panel
n
GNBC,
GPBC
Blood Culture
Panels
TVAG
Trichomonas
vaginalis
800-323-4040 | 847-832-7000 Option 1 | cap.org
177
Virology
Virology
Virology Culture VR1

Procedure
Program Code
Challenges/Shipment
VR1
Chlamydia trachomatis culture
Viral isolation/identification
Educational challenge
1 per year
Virology Antigen Detection (DFA) VR2

Analyte/Procedure
Program Code
Challenges/Shipment
VR2
Adenovirus antigen
Cytomegalovirus antigen
Herpes simplex virus (HSV) antigen
Influenza A antigen
Influenza B antigen
Parainfluenza antigen
Respiratory syncytial virus (RSV)

antigen
Varicella-zoster antigen
1
1
Program Information
Five 0.5-mL specimens for
viral culture and one 0.5-mL
specimen for Chlamydia
trachomatis culture
Program Information
Five 5-well slide specimens
1
1
Microbiology
14
Virology
Virology Antigen Detection (Non-DFA) VR4

Analyte
Program Code
Challenges/Shipment
Program Information
Five 1.5-mL specimens
Adenovirus (Not 40/41) antigen
For use with enzyme

immunoassay and/or latex
agglutination methods
Influenza A antigen
Influenza B antigen

antigen
Rotavirus antigen
VR4
Herpes Simplex Virus HC2, HC4

Procedure
Program Code
HC2
Antigen detection (DFA)
Challenges/Shipment
HC4*
HC - Five 2.0-mL specimens

5
Culture
Program Information
HC2 - Five 5-well slide
specimens
*The biohazard warning applies to Survey HC4.
14
Microbiology
Check on your PT shipment with CAPTRAKerSM

Our CAPTRAKer electronic shipment tracking program* gives your lab
the ability to locate your PT kit in an instant!
erts ou that our
o s ou to track our ship ent through a ink
esu ts in ess
P P kits ha e been shipped
SM
orries
To begin receiving CAPTRAKer emails, send your name, CAP account number, and email address
to contactcenter@cap.org.
*CAP distributor customerscontact your distributor for your PT shipping information
800-323-4040 | 847-832-7000 Option 1 | cap.org
179
Program Information
HCV2 - Five 1.5-mL li uid
plasma specimens
Hepatitis Viral Load HCV2, HBVL, HBVL5

Analyte/Procedure
Challenges/Shipment
Program Code
HCV2
HBVL
HBVL5
HBVL - Two 1.25-mL plasma

specimens
HCV genotyping
HCV, ualitative
HBVL5 - Five 2.0-mL plasma

specimens
HCV viral load
HBV viral load
Challenges/Shipment
Program Information
HIV - Five 0.5-mL plasma
specimens
HV2 - Five 2.5-mL plasma

specimens
HIV Viral Load HIV, HV2, HIVG

Procedure
Program Code
HIV, HV2
HIV-RNA viral load
HIVG
HIV genotyping
HIVG - One 1.0-mL plasma

specimen
Viral Load VLS, VLS2

Analyte/Procedure
Microbiology
14
Program Code
Challenges/Shipment
VLS
VLS2
B viral load
CMV viral load
EBV viral load
Adenovirus viral load
HHV6 viral load
Program Information
VLS - Six 1.0-mL EDTA
plasma specimens; two
shipments per year
VLS2 - Ten 2.0-mL EDTA
plasma specimens;
Viral Load Calibration Verification/Linearity

LN38, LN39
Analyte
Program Code
LN38
CMV viral load
LN39

on dry ice
0. M 1.0M I /L
HIV viral load
Target Ranges
Program Information
plasma specimens
0 10M copies/L
plasma specimens
C. trachomatis and N. gonorrhoeae

HC6, HC6X, HC7
Procedure
Nucleic acid amplification (NAA)
Program Code
HC6, HC6X
HC7
Challenges/Shipment
Program Information
HC6 - Three swab specimens
and two 1.0-mL simulated
urine specimens
HC6 - Three swab
specimens; two simulated
urine specimens (in duplicate)
For Surveys HC6 and HC6 ,
use each swab to perform
both C. trachomatis and N.
gonorrhoeae testing
HC7 - Five simulated body

fluid specimens; designed for
Cepheid users
14
Microbiology
800-323-4040 | 847-832-7000 Option 1 | cap.org
181
Human Papillomavirus HPV

Analyte
Program Code
Challenges/Shipment
HPV
Human papillomavirus
For laboratories using Digene, SurePath, and/or ThinPrep collection media, see page 252.
Bacterial Strain Typing BSTE, BSTN, BSTS

Analyte
Program Code
BSTE
Enterococcus
BSTN
Challenges/Shipment
BSTS
Program Information
Two simulated cervical
specimens contained in
Digene transport media
For Digene Hybrid Capture
only
Program Information
Two sets of loops with diluents
Gram-negative organisms*
Staphylococcus
*Gram-negative organisms include Klebsiella sp. and Pseudomonas aeruginosa.
Nucleic Acid Amplification, Organisms IDO, IDN

Analyte/Procedure
Microbiology
14
Program Code
Challenges/Shipment
IDO
IDN
Bordetella pertussis/parapertussis*
Legionella pneumophila/
Chlamydophila pneumoniae*
Methicillin-resistant
Staphylococcus aureus
Molecular typing (bacterial isolates)
Mycobacterium tuberculosis
Mycoplasma pneumoniae
Vancomycin-resistant Enterococcus
Program Information
IDO - Seven li uid or swab
simulated clinical isolate
specimens and two diluents
IDN - Six li uid or swab
simulated clinical isolate
specimens and two diluents;
designed for international
laboratories that cannot
receive MTB
*Bordetella pertussis/parapertussis and Legionella pneumophila/Chlamydophila

pneumoniae will be included in the following shipments:
Shipment A Bordetella pertussis and Chlamydophila pneumoniae
Shipment B Bordetella parapertussis and Legionella pneumophila
Challenges/Shipment
Program Information
ID1- Eight 1.0-mL li uid
specimens
Nucleic Acid Amplification, Viruses ID1, ID1T

Analyte
Program Code
ID1
ID1T
Cytomegalovirus
ID1T - Two 1.0-mL li uid

specimens
Enterovirus
Epstein-Barr virus
Herpes simplex virus
Human herpesvirus 6
Human herpesvirus 8
Parvovirus B19
Varicella-zoster virus
B virus
JC virus
Nucleic Acid Amplification, Respiratory ID2

Analyte
Program Code
Challenges/Shipment
ID2
Adenovirus
Coronavirus/Rhinovirus*
Human metapneumovirus
Influenza virus*
Parainfluenza virus
Program Information
Six 1.0-mL li uid specimens
14
*Coronavirus/Rhinovirus and Influenza virus will be included in the following shipments
New
Influenza A, Influenza B, and RSV

by NAA ID3
Analyte
Program Code
Challenges/Shipment
ID3
Microbiology
Shipment A Coronavirus and Influenza A

Shipment B Rhinovirus and Influenza B
Program Information
Five 1.0-mL li uid specimens
multiplex panel users
Influenza A
Influenza B
800-323-4040 | 847-832-7000 Option 1 | cap.org
183
Program Information
Six 1.0-mL li uid specimens
Infectious Disease Respiratory Panel

for Molecular Multiplex Testing IDR
Analyte
Program Code
Challenges/Shipment
IDR
Adenovirus
Human metapneumovirus
Influenza A
Influenza B
Parainfluenza
Rhinovirus/Enterovirus
Educational challenge (Bocavirus,

Coronavirus, or Parainfluenza )
Program Information
stool specimens
Gastrointestinal Panel for Molecular

Multiplex Testing GIP
Analyte
Program Code
Challenges/Shipment
GIP
Microbiology
14
Campylobacter
Clostridium difficile, toxin A/B
Cryptosporidium
Enterotoxigenic E. coli (ETEC) LT/ST
Entamoeba histolytica
Escherichia coli 0157
Giardia
Norovirus GI/GII
Rotavirus A
Salmonella
Shiga-like toxin producing

E. coli (STEC) stx1/stx2
Shigella


Blood Culture Panels for Molecular Multiplex Testing

GNBC, GPBC
Program Information
Three 1.0-mL li uid simulated
blood culture fluid specimens
Procedure
For laboratories using

molecular multiplex panels
Program Code
GNBC
Identification of gram-negative
organisms such as Acinetobacter,
Citrobacter, Enterobacter, Proteus,
Haemophilus, Klebsiella, Neisseria,
Pseudomonas, Serratia, E. coli, and
common resistance mechanisms isolated
from positive blood culture bottles
Challenges/Shipment
GPBC
Identification of gram-positive organisms

such as Staphylococcus, Streptococcus,
Enterococcus, Listeria, and common
resistance mechanisms isolated from
positive blood culture bottles
These Surveys are not for the inoculation of blood culture bottles.
Put fast identification of arthropods at your fingertips

Arthropod Benchtop Reference Guide (ABRG)
14
Numerous identifications of ectoparasites commonly
Microbiology
encountered in the clinical laboratory
Detailed descriptions of the most significant
morphologic elements, ecology, and clinical significance
Eight tabbed sections for easy reference
o Bed bugs
Introduction
o Ticks
o Kissing Bugs
o Mites
o Fleas
o Lice
o Myiasis-causing fly larvae
A durable and water-resistant format6" x 7" and spiral
bound to withstand years of benchtop use
o
Add code ABRG to your Surveys order form.
800-323-4040 | 847-832-7000 Option 1 | cap.org
185
Infectious Disease Serology
Infectious Disease Serology

Infectious Disease Serology VR3, VR3M

Analyte
Program Code
VR3
Cytomegalovirus (CMV)
total antibodies
IgG, IgM, and
Challenges/Shipment
VR3M
Epstein-Barr virus (EBV) VCA IgG, IgM

EBNA IgG, IgM, and total antibodies
EA IgG
Helicobacter pylori IgG, IgA, and

total antibodies
Herpes simplex virus (HSV) IgG antibody
Mycoplasma pneumoniae
total antibodies
IgG, IgM, and
Mumps IgG
z
Toxoplasma gondii IgG, IgM, and

total antibodies
Varicella-zoster virus IgG and

total antibodies
Tick-Transmitted Diseases TTD
Microbiology
14
Program Code
Challenges/Shipment
TTD
Antibodies to tick-transmitted disease

organisms
VR M - One 0.5-mL
lyophilized plasma specimen
Rubeola virus (English measles) IgG

antibody
Analyte
Program Information
VR - Eight 0.5-mL
Program Information
Three 0. -mL li uid specimens
Designed for the detection
of antibodies to Borrelia
burgdorferi, Babesia
microti, and Anaplasma
phagocytophilum
15
| Immunology and Flow Cytometry
The data we receive from CAP often drives changes

that are necessary to improve our performance.

Immunology...................................................................................................................................188
Flow Cytometry..............................................................................................................................196
New Programs
New
Celiac Serology, Additional Volume (CESX) ......................................................................................192

Rare Flow Antigen Validation, CD103 (RFAV2).................................................................................198
Flow CytometryImmunophenotypic Characterization of Leukemia/Lymphoma CD (FL3CD)
15
Immunology
Immunology
Immunology
ANA, ASO, CRP, HCG, IM, RF/RFX, RUB/RUBX, IL
Analyte
ANA ASO CRP HCG IM
Antinuclear antibody
(ANA)*
RF/ RUB/
IL
RFX RUBX
Antistreptolysin O (ASO)*
C-reactive protein
(qualitative/quantitative)
hCG, serum (qualitative/
quantitative)
z
z
z
Infectious mononucleosis
Rheumatoid factor*
Challenges/
Shipment
Program Code
Rubella (IgG)*
*Antinuclear antibody, Antistreptolysin O, Rheumatoid factor, and Rubella are regulated

analytes and are graded for both qualitative and quantitative methods. Semiquantitative
and/or titer results for these analytes are ungraded/educational in this Survey and do not
meet regulatory requirements.
Immunology, General IG/IGX

Analyte
Program Code
Challenges/Shipment
IG/IGX
15
Program Information
ANA and R B - Five 0.5-mL
liquid serum specimens
ASO, HCG, and RF - Five
1.0-mL li uid serum
specimens
CRP - Two 0.5-mL li uid
serum specimens; not
appropriate for highsensitivity CRP (hsCRP)
methods
IM - Five 0.6-mL li uid serum
specimens
RF - All Survey RF specimens
in duplicate
R B - All Survey R B
IL - All immunology specimens
except RF and R B
Program Information
IG - Ten 1.0-mL li uid serum
specimens
Alpha1-antitrypsin
IG - All Survey IG specimens

in duplicate
Complement C3
Complement C4
Haptoglobin
IgA
IgE
IgG
IgM
Total kappa/lambda ratio
Immunology
Immunology, Special; Immunology Special, Limited;

and H. pylori IgG Antibody S2, S4, S5
Analyte
Program Code
S2
Anticentromere antibody
Anti-DNA antibody (ds)
Antiglomerular basement membrane

(GBM), IgG antibody
Antimitochondrial antibody
Antineutrophil cytoplasmic antibody

(ANCA, anti-MPO, anti-PR )
S4
S5
Challenges/Shipment
A
1
1
1
1
Anti-RNP antibody
Anti-Sm antibody
Anti-Sm/RNP antibody
Antismooth muscle antibody
Anti-SSA antibody
Anti-SSB antibody
Anti-SSA/SSB antibody
Antithyroglobulin antibody
Antithyroid microsomal antibody
Antithyroid peroxidase antibody
Ceruloplasmin
Haptoglobin
Helicobacter pylori, IgG antibody
1
2
1
2
IgD
IgG
IgG subclass proteins
Prealbumin (transthyretin)
Total kappa/lambda ratio
Transferrin
S - A minimum of three
(0.5- to 1.0-mL/vial) serum
specimens
S2 and S - Three shipments
per year
S5 - Two 1.0-mL serum
per year
Program Information
S2 - A minimum of seven
(0.5- to 1.0-mL/vial) li uid
serum specimens
15
Survey S2 is not appropriate for antimitochondrial antibody assays that are specific for the M2
antibody. Refer to Survey H on page 190.
Infectious Mononucleosis, Waived IMW

Analyte
Program Code
IMW
Infectious mononucleosis, waived
Challenges/Shipment
Program Information
Three 0.6-mL serum
specimens
800-323-4040 | 847-832-7000 Option 1 | cap.org
189
Immunology
Antichromatin Antibody ACA

Analyte
Program Code
Challenges/Shipment
ACA
Antichromatin antibody
Program Information
Three 0.5-mL serum
specimens
Antifilamentous Actin IgG Antibody

FCN
Analyte
Program Information
Three 0.5-mL serum
specimens
Program Code
Challenges/Shipment
FCN
Antifilamentous actin (f-actin)

IgG antibody
Antihistone Antibody AHT

Analyte
Program Code
Challenges/Shipment
AHT
Antihistone antibody
Antimitochondrial M2 Antibody H
Analyte
Program Code
Challenges/Shipment
15
Antimitochondrial M2
antibody (AMA-M2)
Program Code
Challenges/Shipment
APC
Antiparietal cell antibody
Program Information
Antiparietal Cell Antibody APC

Analyte
Program Information
Three 0.5-mL serum
specimens
Program Information
Immunology
Antiphospholipid Antibody ACL

Analyte
Program Code
Challenges/Shipment
ACL
Anticardiolipin antibody
(polyclonal, lgG, lgM, and lgA)
Beta-2-glycoprotein I
(polyclonal, lgG, lgM, and lgA)
Antiphosphatidylserine Antibody APS

Analyte
Program Code
Challenges/Shipment
APS
Antiphosphatidylserine antibody
(IgG, IgM, and IgA)
Beta-2-glycoprotein I (polyclonal,
IgG, IgM, and IgA)
Antiribosomal-P Antibody ARP

Analyte
Program Code
Challenges/Shipment
ARP
Antiribosomal-P antibody
Program Code
Challenges/Shipment
ASC
Anti-Saccharomyces cerevisiae antibody,

lgG and lgA
Program Information
Three 0.5-mL serum
specimens
Anti-Saccharomyces cerevisiae Antibody ASC

Analyte
Program Information
serum specimens
Anticardiolipin antibody (polyclonal,

IgG, IgM, and IgA)
Program Information
serum specimens
Program Information
15
800-323-4040 | 847-832-7000 Option 1 | cap.org
191
Immunology
Celiac Serology CES, CESX

Analyte
Program Code
CES
Challenges/
Shipment
CESX
Antiendomysial antibody, IgA and IgG
Antiendomysial antibody screen, IgA and IgG
Antigliadin antibody, IgA and IgG
Antideamidated gliadin peptide (DGP)

antibody, IgA and IgG
Anti-DGP antibody screen, IgA and IgG
Antitissue transglutaminase (tTG) antibody,

IgA and IgG
Anti-DGP and anti-tTG antibody screen,

IgA and IgG
Program Code
CES - All Survey CES

specimens in triplicate
Cyclic-Citrullinated Peptide
Antibody (Anti-CCP) CCP
Analyte
Program Information
CES - Three 0. -mL specimens
Program Information
Challenges/Shipment
CCP
Anti-CCP
Cytokines CTKN
Analyte
Program Code
CTKN
15
Interferon (IFN)-gamma
Interleu in (IL)-1 beta
IL-2
IL-6
IL-8
IL-10
Tumor necrosis factor (TNF)-alpha
Vascular endothelial growth factor (VEGF)
Challenges/Shipment
Program Information
Nine 2.0- to .0-mL
Immunology
Diagnostic Allergy SE
Analyte/Procedure
Program Code
Challenges/Shipment
Program Information
Five 2.0-mL serum specimens
IgE, multiallergen screen ( ualitative)
IgE, total
Includes common allergens

from North America as well
as less frequently tested
allergens
Specific allergens
25
Educational challenges
2 per year
SE
Program Information
Three 1.0-mL serum
specimens
Heavy Chain/Light Chain

Analysis HCA
Analyte
Program Code
Challenges/Shipment
HCA
IgA lambda
IgA appa/lambda ratio and ratio

interpretation
IgG appa
IgG lambda
IgG appa/lambda ratio and ratio

interpretation
IgM appa
IgM lambda
IgM appa/lambda ratio and ratio

interpretation
IgA appa
This program will target uni ue junctional epitopes between the constant regions of
immunoglobulin heavy and light chains and will allow laboratories to identify the different
light chain types of each immunoglobulin class.
Program Information
Three 0.5-mL li uid
serum specimens
High-Sensitivity/Cardiac
C-Reactive Protein HSCRP
Analyte
Program Code
15
Challenges/Shipment
HSCRP
High-sensitivity/Cardiac C-reactive protein
800-323-4040 | 847-832-7000 Option 1 | cap.org
193
Immunology
Liver-Kidney Microsomal Antibody (Anti-LKM) LKM

Analyte
Program Code
Challenges/Shipment
LKM
Anti-L M
M. tuberculosis-Stimulated Infection Detection QF

Program Code
Challenges/Shipment
QF
M. tuberculosis
Analyte
Program Information
Program Information
specimens and one
lyophilized mitogen control
For use with the
uantiFERON-TB method
only
Rheumatic Disease Special Serologies RDS

Analyte
Program Code
Challenges/Shipment
RDS
Anti- o-1 (antihistidyl t-RNA synthetase)
Anti-Scl-70 (anti-DNA topoisomerase)
Syphilis Serology G
Analyte
Program Code
Challenges/Shipment
15
Syphilis
Program Information
Program Information
Five 1.5-mL serum specimens
Use with VDRL, RPR, MHA-TP/TP-PA/PK-TP, EIA, CMIA, multiplex flow immunoassay, TP-LIA IgG,
FTA-ABS, and USR methods. Laboratories performing syphilis serology on CSF specimens
may also use this Survey.
Total Hemolytic Complement CH50

Analyte
Program Code
Challenges/Shipment
CH50
Total hemolytic complement, 50 lysis
Total hemolytic complement, 100 lysis
Program Information
serum specimens
Immunology
Viscosity V
Analyte
Program Code
Challenges/Shipment
Viscosity

2
Serum Free Light Chains SFLC

Analyte
Program Code
Challenges/Shipment
SFLC
appa serum free light chain
Lambda serum free light chain
appa/lambda serum free light

chain ratio and ratio interpretation
Program Information
Two 10.0-mL serum
specimens
Program Information
Three 1.0-mL serum
specimens
Rely on this reference for a rapidly growing field

Flow Cytometry in Evaluation of Hematopoietic Neoplasms: A CaseBased Approach is a practical, case-based guide to flow cytometric
analysis in the workup of hematopoietic neoplasms presenting in
the peripheral blood, marrow, lymphoid tissue, and extranodal sites.
Using multicolor techniques pioneered by Brent Wood, the text
demonstrates a unique approach to diagnosis of hematopoietic
malignancies as well as identification of small abnormal populations
in the posttherapy setting (minimal residual disease testing).

15
This text provides pathologists, residents, laboratory technologists,

and hematologists with both a study guide and an atlas for
regular consultation in the clinical flow cytometry laboratory.
To order
PRESS
Visit cap.org and choose the Shop tab

or call the CAP Customer Contact Center
at 800-323-4040 or 847-832-7000 option 1.
Item number: PUB221

ISBN: 978-0-9837068-2-3
Hardcover; 176 pages; 2012
800-323-4040 | 847-832-7000 Option 1 | cap.org
195
Flow Cytometry
Flow Cytometry
Flow Cytometry FL, FL1, FL2

Procedure
Program Code
FL
DNA content and cell cycle analysis
Lymphocyte immunophenotyping
FL1
Challenges/Shipment
FL2
z
z
This Survey is not appropriate for hematology analyzers with monoclonal antibody analysis.
Program Information
FL1 - Three 1.5-mL whole
blood specimens
FL2 - Three 1.1-mL
specimens; two fixed cell line
specimens and one
calibrator for DNA content
and cell cycle analysis
FL - All Survey FL1 and FL2
specimens
Flow CytometryImmunophenotypic
Characterization of Leukemia/Lymphoma FL3
Procedure
Program Code
Challenges/Shipment
FL3
Leu emia/lymphoma
Survey FL features DigitalScope technology that simulates the use of a microscope by
enabling the user to scan and adjust magnification of the whole slide image.
15
Flow Cytometry, CD34+ FL4

Analyte
Program Code
Challenges/Shipment
FL4
CD
Program Information
Two .5-mL whole
blood specimens and/or cell
lines simulating leukemia/
lymphoma; images of tissue
sections, bone marrow, and/
or peripheral blood smears
with clinical histories
Online whole slide images
powered by DigitalScope
technology
Program Information
Two 1.5-mL stabilized human
CD
specimens
Flow Cytometry
Flow Cytometry, Interpretation Only FL5

Procedure
Program Code
Challenges/Shipment
FL5
Flow cytometry, interpretation only
Survey FL5 is for laboratories that receive ow cytometry analyses from referring laboratories to
perform the interpretation of patient results.
Survey FL5 features DigitalScope technology that simulates the use of a microscope by
enabling the user to scan and adjust magnification of the whole slide image.
Analyte/Procedure
Program Code
Challenges/Shipment

technology
Dot plots are available online
Program Information
specimens for RBC and
BC analysis
Flow CytometryImmunophenotypic
Characterization of Paroxysmal Nocturnal
Hemoglobinuria PNH
Program Information
Two cases consisting of gated
dot plots, clinical histories,
and pertinent laboratory data,
as well as images of tissue
sections, bone marrow, and/
or peripheral blood smears
PNH
PNH RBC analysis
PNH
BC analysis
The PNH Survey complies with the recommendations from the Guidelines for the
Diagnosis and Monitoring of Paroxysmal Nocturnal Hemoglobinuria and Related
Disorders by Flow Cytometry for RBC and BC analysis. Due to the uni ue nature
of these human, donor-based materials, the shipping dates are subject to change.
If this should occur, the CAP will provide notification prior to the originally scheduled
shipping date.
800-323-4040 | 847-832-7000 Option 1 | cap.org
15
197
Flow Cytometry

Procedure
Program Code
Challenges/Shipment
HBF

Rare Flow Antigen Validation RFAV1, RFAV2

Analyte
Program Code
RFAV1
CD1a
Challenges/Shipment
RFAV2
CD10
Program Information
blood specimens
quantitation
Two online whole slide
images
technology
Program Information
CD1a - One .5-mL cell line
specimen
CD10 - One 1.0-mL

stabilized cells
Surveys RFAV1 and RFAV2 do not meet the regulatory requirements for proficiency testing.
These Surveys meet the CAP Accreditation Chec list item FLO.2 7 7, which re uires
semiannual testing of antigens.
ZAP-70 Analysis by Flow Cytometry ZAP70

Analyte
Program Code
Challenges/Shipment
ZAP70
15
eta chain-associated protein inase 70
Program Information
Three .5-mL cell line
specimens
This Survey tests for intracellular AP-70 staining of cell lines co-stained with pan
T- and B-cell mar ers. It allows for assessment of the laboratory s staining techni ues and
the antibody clone used for AP-70 detection.
16
Transfusion Medicine, Viral Markers,

and Parentage Testing
have all these regulatory agencies coming in. The

CAP is the recognized laboratory standard and
its great that you are compared to a large peer
group. Ive been a manager in a laboratory without
the CAP and with the CAP, and I will tell you that
it is better to be with the CAP!

Transfusion Medicine......................................................................................................................200
Viral Markers ................................................................................................................................209
Parentage Testing ..........................................................................................................................212
New Programs
New
ABO Subgroup Typing (ABOSG) .....................................................................................................203

Viral MarkersSeries 1 (VM1)
Anti-HBs (quantitative) .................................................................................................................209
In my state especially, were very regulated, and
16
Transfusion Medicine, Comprehensive/Limited J, J1
Procedure
Program Code
Challenges/Shipment
J1
ABO grouping
Rh typing
Antibody detection
Antibody identification
Compatibility testing
1 - Five 2.0-mL
red
blood cell suspensions; five
.0-mL corresponding serum
specimens
Red blood cell antigen typing
Transfusion Medicine Automated Testing JAT

Procedure
Program Code
Challenges/Shipment
JAT
ABO grouping
Antibody detection
Rh typing
Transfusion Medicine Automated,

Educational Challenges JATE1
16
Program Information
- Five 2.0-mL
red blood
cell suspensions; five .0-mL
corresponding serum
specimens; one 2.0-mL donor
red blood cell suspension
Analyte/Program
Program Code
Challenges/Shipment
JATE1
Eduational challenge
Program Information
Five bar-coded .0-mL
blood specimens and one
.0-mL blood specimen for
compatibility testing
Program Information
One educational challenge,
which may consist of a
paper challenge and/or wet
specimen for ABO grouping,
Rh typing, antibody detection,
antibody identification,
and/or compatibility testing
Must purchase in conjunction
with Survey AT
Transfusion Medicine Educational Challenges JE1

Analyte/Program
Program Code
Challenges/Shipment
JE1
Program Information
One educational challenge,
which may consist of a
paper challenge and/or wet
specimen for ABO grouping,
Rh typing, antibody detection,
antibody identification,
compatibility testing, antigen
typing, and/or direct
antiglobulin testing
with Survey
Expanded Transfusion
Medicine Exercises ETME1
Procedure
Program Code
Challenges/Shipment
ETME1
Expanded challenges
Program Information
ETME1 - One paper
challenge and one wet
challenge consisting of a
serum specimen(s) and/or
red blood cell suspensions
Survey ETME1 is an educational opportunity that offers
More challenging and/or complex antibody identification
Comprehensive case studies in transfusion medicine
Simulated collaboration with other professionals, including those within or outside
your institution
A method for determining the laboratory s ability to recognize and integrate problem
solving s ills in transfusion medicine
The wet challenge may consist of specimens for ABO grouping, Rh typing, antibody
detection, antibody identification, compatibility testing, antigen typing, direct antiglobulin
testing, antibody titer, and/or antibody elution.
800-323-4040 | 847-832-7000 Option 1 | cap.org
16
201
Transfusion Medicine Competency Assessment

Comprehensive Transfusion Medicine TMCA
Procedure
Program Code
Challenges/Shipment
Two .0-mL corresponding

serum specimens
One 2.0-mL donor
red
blood cell suspension
TMCA
Program Information
Two 2.0-mL
red blood cell
suspensions
ABO grouping
Antibody detection
Rh typing
Three shipments per year;

order shipments individually
or for an entire year
Survey TMCA does not meet the regulatory requirements for proficiency testing.

Direct Antiglobulin Test TMCAD
Procedure
Program Code
Challenges/Shipment
TMCAD
Direct antiglobulin testing
Program Information
Two 2.0-mL
red
blood cell suspensions
Survey TMCAD does not meet the regulatory requirements for proficiency testing.
Program Information
Two 2.0-mL 50 red blood
cell suspensions
Transfusion Medicine Competency

AssessmentEluate Test TMCAE
Procedure
Program Code
Challenges/Shipment
TMCAE
Antibody elution

Survey TMCAE does not meet the regulatory requirements for proficiency testing.
16

Fetal Red Cell Quantitation TMCAF
Procedure
Program Code
Challenges/Shipment
TMCAF

Program Information
specimens
Survey TMCAF does not meet the regulatory requirements for proficiency testing.
Transfusion Medicine, Electronic Crossmatch EXM

Procedure
Program Code
Challenges/Shipment
EXM
Electronic crossmatch
Must order in conjunction with

Survey
Survey E M assists laboratories in monitoring the performance of their electronic

crossmatching system.
Program Code
Challenges/Shipment
EXM2
Program Information
Three simulated, ISBT-128
labeled donor unit challenges
and three corresponding red
with Survey AT
Survey E M2 assists laboratories in monitoring the performance of their electronic

crossmatching system.
New
ABO subgroup typing
Program Information
Three 1.0-mL
red blood
cell suspensions; three
1.0-mL corresponding
serum specimens
Rh typing
ABO Subgroup Typing ABOSG

Procedure
Program Code
ABOSG
Transfusion Medicine Automated,

Electronic Crossmatch EXM2
Procedure
Program Information
Three simulated, ISBT-128
labeled donor unit challenges
and three corresponding red
Challenges/Shipment
16
800-323-4040 | 847-832-7000 Option 1 | cap.org
203
Antibody Titer ABT, ABT1, ABT2, ABT3

Analyte/Procedure
Anti-A titer
Program Code
ABT
ABT1
ABT2
ABT3
Anti-B titer
Anti-D titer
Challenges/Shipment
z
z
1
1
Program Information
ABT - One 2.0-mL plasma
specimen for anti-A titer
with one corresponding titer
cell (
to
red blood
cell suspension); one 2.0-mL
plasma specimen for anti-D
titer with one corresponding
titer cell (
to
red blood
cell suspension)
ABT1- One 2.0-mL plasma

specimen for anti-A titer with
one corresponding titer cell
( to
red blood cell
suspension)
ABT2 One 2.0-mL plasma
specimen for anti-D titer with
(
to
red blood cell
suspension)
specimen for anti-B titer with
(
to
red blood cell
suspension)
16
Bacterial Detection in Platelets BDP, BDP5

Procedure
Challenges/Shipment
Program Code
Bacterial culture and detection systems
BDP
BDP5
Program Information
BDP - Two lyophilized pellet
specimens with diluents; two
shipments per year
BDP5 - Five lyophilized pellet
specimens with diluents; three
shipments per year
Bacterial Detection in Platelets, Rapid

BDPV, BDPV5
Procedure
Challenges/Shipment
Program Code
Rapid immunoassay
BDPV
BDPV5
The Centers for Medicare and Medicaid Services (CMS) re uires proficiency testing
for bacterial detection in platelets.
Survey BDP is designed for donor centers/laboratories that are associated with
a CMS-certified microbiology laboratory with the same CLIA number and are
participating in an approved proficiency testing program for bacterial detection.
Survey BDP5 is designed for donor centers/laboratories that are performing bacterial
detection for the purposes of platelet unit screening and are not associated with a
CMS-certified microbiology laboratory with the same CLIA number.
See International Shipping information section in the Ordering Information
Supplement regarding additional dangerous goods shipping fees.
Program Information
BDPV - Two frozen
per year
BDPV5 - Five frozen
per year
For use with methods such as
Verax Biomedical
The Centers for Medicare and Medicaid Services (CMS) re uires proficiency testing
for bacterial detection in platelets.
Survey BDPV is designed for donor centers/laboratories that are associated with
a CMS-certified microbiology laboratory with the same CLIA number and are
participating in an approved proficiency testing program for bacterial detection.
Survey BDPV5 is designed for donor centers/laboratories that are performing
bacterial detection for the purposes of platelet unit screening and are not associated
with a CMS-certified microbiology laboratory with the same CLIA number.
16
800-323-4040 | 847-832-7000 Option 1 | cap.org
205
Cord Blood and Stem Cell Processing CBT, SCP

Procedure
Program Code
CBT
Absolute CD
Absolute CD
Absolute CD 5
Bacterial culture
CD
SCP
2
2
CD
CD 5
BF -E
CF -E
CF -GEMM
CF -GM
Total CFC
Fungal culture
Hematocrit
Hemoglobin
Mononuclear cell count
Nucleated red cells
Number of CD
positive events
Number of CD 5 positive events
Total nucleated cells
Viability
BC count
16
Challenges/Shipment
Program Information
CBT - Two 2.5-mL cord blood
specimens; designed for
assays re uired for the
production of umbilical cord
blood stem cell programs
SCP - Two .0-mL peripheral
blood specimens; designed
for laboratories that process
and assess the suitability of
stem cells
Because these materials are human donor-based, the ship date is subject to change.
If this should occur, notification will be provided prior to the scheduled date. In some
instances, the program may ship in two installments.
Due to material stability, no replacements will be available.
Direct Antiglobulin Testing DAT

Procedure
Program Code
Challenges/Shipment
DAT
Direct antiglobulin testing
For use with manual method
Eluate Survey ELU

Procedure
Program Code
Challenges/Shipment

2

Procedure
Program Code
Challenges/Shipment
HBF
leihauer-Bet e and flow cytometry

Platelet Serology PS
Procedure
Program Code
Challenges/Shipment
PS
Antibody detection
Platelet crossmatch
Platelet antibody identification
Program Information
Two 2.0-mL 50 red blood
cell suspensions
ELU
Antibody elution
Program Information
Three 2.0-mL
red blood
cell suspensions
Program Information
blood specimens
uantitation
Two online whole slide
images
technology
Program Information
Three .0-mL plasma
specimens
For use with solid-phase
red cell adherence, flow
cytometry, and EIA/ELISA
methods
16
A low concentration of sodium azide may be present in the specimens and may affect
lymphocytotoxicity methods.
800-323-4040 | 847-832-7000 Option 1 | cap.org
207
Program Information
specimens
Red Blood Cell Antigen

Genotyping RAG
Procedure
Program Code
Challenges/Shipment
RAG
Red cell antigen genotype with

predictive phenotype
Red Blood Cell Antigen Typing RBCAT

Procedure
Program Code
Challenges/Shipment
RBCAT
Red blood cell antigen typing
Program Information
Two 2.0-mL
red blood cell
suspensions
Survey RBCAT is for donor centers and transfusion laboratories performing
non-automated/manual red cell phenotyping for the management of patients with
complex serology (ie, alloimmunization, sic le cell disease, warm autoimmune hemolytic
anemia). Challenges will include antigens such as Rh, ell, MNSs, Duffy, and idd blood
group system.
Transfusion-Related Cell Count TRC

Procedure
Program Code
Challenges/Shipment
TRC
Platelet count (platelet-rich plasma)
BC count
Dry challenge
Program Information
Five 1.2-mL suspensions of
platelet-rich plasma
Two 1.0-mL vials leu ocytereduced platelet material
Two 1.0-mL vials leu ocytereduced red blood cells

WBC counts must be performed using a Nageotte chamber, fluorescence microscopy or by

flow cytometry.
16
Viral Markers
Viral Markers
Viral MarkersSeries 1 VM1

Analyte
Program Code
Challenges/Shipment
VM1
Anti-HAV (IgG)
Anti-HBc (total: IgM and IgG)
Anti-HBs
Anti-HBs ( uantitative)
Anti-HCV
Anti-HIV-1
Anti-HIV-1/2
Anti-HIV-2
HBsAg
Anti-HAV (total IgM and IgG)
Program Information
Five .5-mL plasma specimens
Do not use Survey VM1 with rapid anti-HCV, anti-HIV-1, or anti-HIV-1/2 kits. See page 211 for
Surveys appropriate for rapid methods.

Analyte
Program Code
Challenges/Shipment
VM2
Anti-HBe
HBeAg

Analyte
Program Code
VM3
Anti-CMV
Anti-HTLV-I/II
HIV-1 p2 antigen
Challenges/Shipment
Program In formation
Five .5-mL plasma specimens
Program Information
Three .5-mL plasma
specimens
800-323-4040 | 847-832-7000 Option 1 | cap.org
16
209
Viral Markers

Analyte
Program Code
Challenges/Shipment
VM4
Anti-Trypanosoma cruzi (Chagas disease)

2

Analyte
Program Code
Challenges/Shipment
VM5
Anti-HBc (IgM)

Program Code
Challenges/Shipment
VM6
Anti-HIV-1/2, HIV-1 p2 antigen
Program Information
Five 1.5-mL plasma
specimens
Anti-HAV (IgM)
Analyte
Program Information
Two 1.0-mL plasma
specimens
Program Information
Five 0.5-mL plasma specimens
For use with methods such
as the Abbott ARCHITECT
HIV Combo, Bio-Rad GS HIV
Combo, and Alere Determine
HIV Combo assays
Rapid Anti-HIV; Rapid Anti-HIV, Waived

AHIV, AHIVW
Analyte/Procedure
Program Code
AHIV
Anti-HIV-1, Anti-HIV-2, Anti-HIV-1/2
16
Anti-HIV-1, Anti-HIV-1/2,
waived methods only
Challenges/Shipment
AHIVW
z
z
Program Information
AHIV - Five 0.5-mL plasma
specimens; second method
reporting available; three
shipments per year
AHIV - Two 0.5-mL plasma
specimens; report up to five
different locations within your
institution; two shipments
per year
Viral Markers
Anti-HCV, Rapid Methods, Waived RHCVW

Analyte/Procedure
Program Code
Challenges/Shipment
RHCVW
Anti-HCV, waived methods only
Nucleic Acid Testing NAT

Analyte
Program Information
Three 0.5-mL plasma
specimens
Program Code
Challenges/Shipment
Designed for blood donor

centers performing nucleic
acid testing on donor units
HBV
HCV
HIV
Compatible with HIV, HCV,

and HBV multiplex assays
est Nile virus
NAT
Program Information
Five 6.0-mL plasma specimens
16
800-323-4040 | 847-832-7000 Option 1 | cap.org
211
Parentage Testing
Parentage Testing
Parentage/Relationship Testing PARF
Analyte/Procedure
Program Code
Challenges/Shipment
PARF
Calculation challenge (paper challenge)
DNA testing (PCR)
Program Information
Three blood-stained filter
paper paternity trio
specimens; two buccal swabs
for a second alleged father
challenge
Reporting for short tandem
repeats (STRs), Y-STRs, as well
as the conclusions provided
Let them know youve earned the mark
16
The CAP certification mark recognizes organizations worldwide

for achieving CAP accreditation. Today, this honor is shared
with more than 7,600 laboratories. The mark is a way to display
to peers, patients, and the public that youve attained CAP
accreditation through the most respected and recognized
laboratory accreditation program in the world.
The CAP certification mark may be displayed on your website, advertisements, laboratory reports,
and in patient areas to communicate your CAP accreditation status.
To access and download your CAP certification mark, please log in to your
e-LAB Solutions Suite account, or contact the CAP Customer Contact Center
at contactcenter@cap.org.
17
| Histocompatibility
We really like the range of programs the CAP offers.

Within each area we can see how we can become
more efficient. Its always reassuring to the physicians
to say we have never failed a proficiency testing
challenge from the CAP.
Histocompatibility
17
Histocompatibility
Histocompatibility
HLA Crossmatching, Antibody Screen, and Antibody

Identification (Class I) MX1B, MX1C, MX1E
Procedure
Program Code
Challenges/Shipment
MX1B MX1C MX1E
Crossmatching
Antibody screen
Program Information
M 1B - Four 0.25-mL
(approximately 1.0 x 106
cells) purified peripheral
blood lymphocyte specimens
M 1C - Four 0.50-mL
(approximately .0 x 106
M 1E - Four 0. 0-mL plasma
specimens; must be ordered
in conjunction with Survey
M 1B or M 1C
Multiple method reporting
provided

Identification (Class II) MX2B, MX2C, MX2E
Procedure
Program Code
Histocompatibility
MX2B
Challenges/Shipment
MX2C MX2E
Crossmatching
Antibody screen
Program Information
M 2B - Two 0.25-mL
M 2C - Two 0.50-mL
M 2E - Two 0. 0-mL plasma
specimens; must be ordered
M 2B or M 2C
17
Multiple method reporting

provided
For laboratories conducting BOTH Class I and Class II HLA testing, see next page.
Histocompatibility

Identification (Class I/II) Combinations MXB, MXC
Procedure
Program Code
MXB
MXC
Crossmatching, antibody screen, and

antibody identification, Class I
M 1B*

antibody identification, Class II
M 2B*

antibody identification, Class I
M 1C*

antibody identification, Class II
M 2C*
*See page 214 for specimen and analyte information.
Program Information
M B - Class I four 0.25-mL
plasma specimens, two
purified peripheral blood
lymphocyte specimens; Class
II two 0.25-mL plasma
specimens, two purified
peripheral blood lymphocyte
specimens
M C - Class I four 0.50-mL
plasma specimens, two
purified peripheral blood
lymphocyte specimens; Class
II two 0.50-mL plasma
specimens, two purified
peripheral blood lymphocyte
specimens
HLA Molecular Typing ML, DL, DML

Procedure
Program Code
ML
Molecular HLA-A, -B, and -C typing (Class I)
DL
Molecular HLA-DR, -D , and -DP typing

(Class II)
Challenges/
Shipment
DML
Program Information
DL, ML - Five approximately
1.0-mL whole blood
specimens in CPD-A
DML - Ten approximately
1.0-mL whole blood
specimens in CPD-A
Serologic e uivalents and
MICA reporting available
Procedure
Program Code
ABO
ABO grouping (includes A subtyping)

HLA serologic typing (Class I and Class II)
HLA serologic typing (Class I only)
Challenges/
Shipment
HLAS HLAS1
z
z
z
Program Information
ABO - Five 2.0-mL
red
blood cell suspensions and
five .0-mL corresponding
serum specimens; must be
ordered in conjunction with
Survey HLAS or HLAS1
HLAS - Three .0-mL
suspensions of purified
peripheral blood lymphocytes
Histocompatibility
HLA Serologic Typing (Class I/II)

ABO, HLAS, HLAS1
17
HLAS1 - Three 1.0-mL

suspensions of purified
peripheral blood lymphocytes
800-323-4040 | 847-832-7000 Option 1 | cap.org
215
Histocompatibility
HLA-B27 Typing B27

Procedure
Program Code
Challenges/Shipment
B27
HLA-B27 typing

5
Antibody Titer ABT, ABT1, ABT2, ABT3

Analyte/Procedure
Program Code
ABT
ABT1
Anti-A titer
ABT2
Challenges/Shipment
ABT3
Anti-B titer
Anti-D titer
Program Information
specimens in CPD-A
Program Information
specimen for anti-A titer
with one corresponding titer
cell (
to
red blood
cell suspension); one 2.0-mL
plasma specimen for anti-D
titer with one corresponding
titer cell (
to
red blood
cell suspension)
ABT1- One 2.0-mL plasma
specimen for anti-A titer with
( to
red blood cell
suspension)
ABT2 One 2.0-mL plasma
specimen for anti-D titer with
(
to
red blood cell
suspension)
Histocompatibility

specimen for anti-B titer with
(
to
red blood cell
suspension)
Monitoring Engraftment ME
17
Procedure
Program Code
ME
Stem cell monitoring engraftment
Challenges/Shipment
Program Information
specimens
Designed for laboratories
supporting stem cell transplant
and laboratories monitoring
chimerism after organ
transplantation
Histocompatibility
HLA Disease Association, Drug Risk

DADR1, DADR2
Analyte
Program Code
DADR1
HLA-A* 1 01
HLA-B*1 01
HLA-B*15 02
HLA-B*57 01
HLA-B*58 01
Challenges/Shipment
DADR2
HLA-A*29 02
HLA-D A1*0 01
HLA-D A1*05 01
HLA-D B1*0 02
HLA-D B1*06 02
HLA-DRB1*0 01
HLA-DRB1*0 02
HLA-DRB1*0 02
HLA-DRB1*0 0
HLA-DRB1*0 06
HLA-DRB1*08 02
HLA-DRB1*08 0
HLA-DRB1*1 0
HLA-DRB1*1 05
HLA-DRB1*1 08
HLA-DRB1*15 01
HLA-DRB1*15 02
D A1*0 /D B1*0 02
D A1*05/D B1*02
Histocompatibility
HLA-A*29 01
Program Information
Three 0.1-mL specimens, each
containing 200 g/mL of
human DNA in media
PRICE (USD)
These Surveys will challenge the laboratory to accurately identify the presence or absence
of alleles associated with a variety of disease states (listed below) and/or the adverse
reactions to specific drugs.
DADR1
o Carbamezepine induced Stevensohnson syndrome (CS )
o Allopurinol Stevens- ohnson
syndrome (AS )
o Hypersensitivity to abacavir (HA)
o Dapsone hypersensitivity (DH)
DADR2
o Celiac disease (CD)
17
o Narcolepsy (N)
o Pemphigus vulgaris (PV)
o Psoriasis (P)
o Antiglomerular basement membrane
disease (ABM)
o Birdshot retinochoroidopathy (BR)
o Idiopathic myopathy (IM)
800-323-4040 | 847-832-7000 Option 1 | cap.org
217
Your Choice.
Gain the expertise of your peers using
the convenience of your mobile device.
Customize your reading experience
with font control, brightness, margins,
and quick navigation.
Enhance your learning by adding notes,
highlights, and bookmarks.
See for yourself at ebooks.cap.org.
Available nowyour favorite CAP Press books
in ebook format!
18 | Genetics and Molecular Pathology

Cytogenetics..................................................................................................................................220
Biochemical and Molecular Genetics................................................................................................223
Next-Generation Sequencing...........................................................................................................229
Molecular OncologySolid Tumors .................................................................................................231
Molecular OncologyHematologic .................................................................................................234
New Programs
New

Pharmacogenetics (PGX) .................................................................................................................227
CYP3A4
CYP3A5
SLCO1B1
CAP/ACMG Rett Syndrome (MECP2) (RETT) .....................................................................................227
MECP2 duplication/deletion analysis
Microsatellite Instability Testing (MSI) ...............................................................................................231
MLH1 promoter methylation analysis
Program Changes
CAP/ACMG Fluorescence In Situ Hybridization (CYF) .......................................................................220
Each mailing will include 2 wet challenges and 4 graded paper challenges
Pharmacogenetics (PGX) .................................................................................................................227
Each mailing will include 3 challenges per shipment
CAP/ACMG BRCA1/2 Sequencing (BRCA) ......................................................................................224

Next-Generation Sequencing, Solid Tumors (NGSST) .........................................................................229
Next-Generation Sequencing, Hematologic Malignancies (NGSHM) ...................................................229
Next-Generation Sequencing Bioinformatics for Illumina Platforms (NGSB1) .........................................230
Next-Generation Sequencing Bioinformatics for Ion Torrent Platforms (NGSB2) .....................................230
DNA Purification from FFPET (MHO5) ..............................................................................................231
18
Cytogenetics
Cytogenetics
CAP/ACMG Cytogenetics CY, CYBK

Analyte/Procedure
Program Code
Challenges/Shipment
CY
CYBK
Chromosome abnormality
Karyotype nomenclature
Educational challenge, ungraded
1 per year
Program Information
CY - Online images of
metaphase cells; delivered
two times a year; your CAP
shipping contact will be
CYB - Prints of metaphase
cells; two shipments per year
Each challenge includes a case history and images of metaphase cells that are
representative of each case. Each mailing will include three constitutional and three
neoplastic challenges.
CAP/ACMG Fluorescence In Situ Hybridization

CYF, CYI
Disease/Procedure
Program Code
CYF
CYI
Challenges/Shipment
A
Constitutional and Hematologic

Disorders
FISH for neoplastic disorder - slides
FISH for neoplastic disorder - graded,

paper challenge
FISH for constitutional disorder - slides
FISH for constitutional disorder graded, paper challenge
Program Information
CYF - Four slides and four
paper challenges
CYI - Two 250- L cell samples
suspended in ethanol from
two different specimens;
participants use FISH to detect
chromosome abnormalities
Urothelial Carcinoma
FISH for urothelial carcinoma
18
CYF 2016-A
Hematologic disorder - BCR/ABL1 rearrangement (two slides)
Hematologic disorder - (two graded paper challenges)
Constitutional disorder - Prader- illi/Angelman syndrome critical region (two slides)
Constitutional disorder - (two graded paper challenges)
CYF 2016-B
Hematologic disorder - t(11;14) in mantle-cell lymphoma (two slides)
Hematologic disorder - (two graded paper challenges)
Constitutional disorder - Miller-Dieker syndrome critical region (two slides)
Constitutional disorder - (two graded paper challenges)
CYF is prepared from cell suspension samples. For FISH in paraffin-embedded tissues,
see page 221.
Cytogenetics
CAP/ACMG Fluorescence In Situ Hybridization

for Paraffin-Embedded Tissue CYH, CYJ, CYK, CYL
Analyte/Procedure
Challenges/
Shipment
Program Code
CYH CYJ CYK CYL
10
10
Breast Cancer
HER2 gene amplification
Brain/Glioma Tissue
1p/19q
Solid Tumor
SS18 rearrangement
EWSR1 rearrangement
1
1
Lymphoma Tissue
MYC rearrangement
CCND1 (Cyclin D1) rearrangement
1
1
CAP/ACMG Cytogenomic Microarray Analysis

CYCGH
Program Code
Challenges/Shipment
CYJ - Four unstained slides;

one H&E stained slide
CYK, CYL - Two unstained
slides; one H&E stained slide
All specimens will be
4.0-micron tissue sections
mounted on positively
charged glass slides
Program Information
Two 3.0-g DNA specimens;
one educational paper
challenge
Procedure
Program Information
CYH - Two unstained, fivecore tissue microarray slides
equivalent to 10 paraffinembedded breast tissue
specimens; a duplicate set of
H&E stained tissue microarray
slides will also be provided
CYCGH
Cytogenomic microarray analysis

for constitutional abnormality
Educational paper challenge

for constitutional or neoplastic
abnormality
Participants will identify and characterize gains or losses and the cytogenetic location of
any abnormalities detected.
18
800-323-4040 | 847-832-7000 Option 1 | cap.org
221
Cytogenetics

Each laboratory receives a Participant Summary, which includes readily available results.
Cytogenetics, Validated Material

Validated Material
Cytogenetics VM
CYM
CY
Page
Program Information
Prints of metaphase cells
220
Hematology Benchtop Reference Guide (HBRG)

More than 50 different cell identifications, including
common and rare cells

Detailed descriptions for each cell morphology

18
Erythrocytes
Erythrocyte Inclusions
Granulocytic (Myeloid) and Monocytic Cells
Lymphocytic Cells
Platelets and Megakaryocytic Cells
Microorganisms and Artifacts
A durable and water-resistant format5" x 6" and

Add code HBRG to your Surveys order form.

CAP/ACMG Biochemical Genetics BGL, BGL1

Analyte/Procedure
Program Code
BGL
Challenges/Shipment
BGL1
Acylcarnitines, ualitative and

quantitative
Amino acids, ualitative and

quantitative
Carnitine, qualitative and quantitative
Program Information
BGL Acylcarnitines One 0.1-mL
plasma specimen
Amino acids One 1.0-mL
plasma or 2.0-mL urine
specimen
Glycosaminoglycans
(mucopolysaccharides)
One 2.0-mL urine specimen
Organic acids One 7.5-mL
urine specimen
Glycosaminoglycans
(mucopolysaccharides), qualitative
and quantitative
Organic acids, ualitative and

quantitative
ill
consist of any one of the
BGL analytes
BGL1 - Three 0. -mL serum
specimens
Analyte/Procedure
Program Code
Program Information
Three 10.0- g extracted
DNA specimens
CAP/ACMG Alpha-1 Antitrypsin

(SERPINA1) Genotyping AAT
Challenges/Shipment
AAT
Alpha-1 antitrypsin genotyping

This Survey will test for the M, S, and
alleles.
Program Information
DNA specimens
CAP/ACMG Apolipoprotein E
Genotyping APOE
Analyte/Procedure
Program Code
Challenges/Shipment
18
APOE
Apolipoprotein E (APOE) genotyping
This Survey is designed for laboratories utilizing APOE testing for cardiovascular and
Alzheimer diseases and will test for various variants (APOE e2, APOE e3, and APOE e4).
800-323-4040 | 847-832-7000 Option 1 | cap.org
223
New
CAP/ACMG BRCA1/2
Sequencing BRCA
Analyte/Procedure
Program Code
Challenges/Shipment
Program Information
Three 10- g extracted DNA
specimens
BRCA
BRCA1/2 DNA se uencing and variant

interpretation
Test your s ill at reporting and interpreting DNA se uence variants for BRCA1/2
using standard nomenclature.
Receive a summary and discussion of responses, including comments on the variant
nomenclature and nown or expected outcomes from identified variants.
Primers are not included; laboratories are expected to utilize the primers used in
routine clinical testing.
Program Information
DNA specimens
CAP/ACMG Hemoglobinopathies
Genotyping HGM
Analyte/Procedure
Program Code
Challenges/Shipment
HGM
Alpha-thalassemia
Beta-thalassemia
Hemoglobin S/C
18
Program Code
Program Information
MGL1, MGL2, MGL ,
MGL - Three 50.0- g
extracted DNA specimens
MGL5 - Two 50.0- g

CAP/ACMG Molecular Genetics

MGL1, MGL2, MGL3, MGL4, MGL5
Disease/Gene
Challenges/
MGL1 MGL2 MGL3 MGL4 MGL5 Shipment
Bloom syndrome
BRCA1/2
3
3
Canavan
Connexin 26
z
DMD/Bec er
Factor V Leiden
Cystic fibrosis
/2(MGL5)
3
3
Familial dysautonomia
Fanconi anemia complementation

group C
Fragile X
Friedreich ataxia
Gaucher
Glycogen storage disease type IA
Hemochromatosis
Hemoglobin S/C
Huntington
3
3
Mucolipidosis IV
Multiple endocrine neoplasia

type 2 (MEN2)
Niemann-Pic disease type A/B
3
3
Myotonic dystrophy
Plasminogen activator inhibitor (PAI)-1
Prader-
illi/Angelman syndrome
Prothrombin
RhD
Spinal muscular atrophy
Spinocerebellar ataxia
Tay-Sachs
Methylene tetrahydrofolate reductase

(MTHFR) c.665C T (677C T) and
c.1286A C (1298A C)
18
The BRCA1/2 program (module MGL ) is designed for laboratories testing for the
three Ash enazi ewish founder mutations.
Module MGL is designed for laboratories testing for diseases/disorders related to
Ash enazi ewish ancestry.
800-323-4040 | 847-832-7000 Option 1 | cap.org
225
CAP/ACMG Inherited Metabolic

Diseases IMD1, IMD2, IMD3
Analyte/Procedure
Program Code
Challenges/Shipment
IMD1 IMD2 IMD3
Mitochondrial DNA deletion syndromes
MCAD
Mitochondrial cytopathies*
Program Information
IMD1 - Three 50.0- L
DNA specimens (50.0-ng/
L DNA PCR product that
encompasses the entire
mitochondrial genome)
IMD2, IMD - Three 50.0- g
*Includes disorders/diseases such as Leber hereditary optic neuropathy and myoclonus epilepsy
with ragged red fibers (MERRF).
CAP/ACMG Molecular Genetics Sequencing

SEC, SEC1
Procedure
Program Code
SEC
DNA se uencing interpretation challenge

DNA se uencing
Challenges/Shipment
SEC1
z
z
Test your s ill at interpreting and reporting DNA se uence variants for inherited
diseases using standard nomenclature.
Receive a summary and discussion of responses, including comments on
nomenclature, nown or expected outcomes from identified variants, and teaching
points about genes/disorders represented.
Program Information
SEC - One CD-ROM
containing DNA se uence
electropherogram files with
a range of variants, suitable
for base-calling and analysis
using a range of commercial
or public domain software
programs; also includes
control sequences, normal
DNA reference se uences,
and nomenclature/variant
references
SEC1 - Three 10.0- g
extracted DNA specimens;
forward and reverse
lyophilized primers are
provided
18
Pharmacogenetics PGX, PGX1, PGX2

Analyte/Procedure
Challenges/
Shipment
Program Code
PGX
PGX1
PGX2
Program Information
PG , PG 1, and PG 2 Three 25.0- g extracted DNA
specimens
CYP2C19
CYP2C9
Includes allele detection

(genotyping) and/or
interpretive challenges
CYP2D6
CYP3A4
CYP3A5
SLCO1B1
UGT1A1
VKORC1
IL28B (rs12979860)
HLA-B*5701
CAP/ACMG Rett Syndrome (MECP2)

Analyte/Procedure
Program Code
RETT
Challenges/Shipment
RETT
UGT1A1 (PG Survey) tests the laboratory s ability to detect variants in the TATA
repeat sequence in the UGT1A1 promotor (eg, UGT1A1*28 with seven TA repeats).
The ability to detect variants in other regions of the UGT1A1 gene is not part of this
program.
Survey PG 2 is designed for laboratories that provide HLA-B*5701 testing to identify
ris of hypersensitivity to abacavir. The intended response is ualitative (presence/
absence of the allele). This Survey is not appropriate for laboratories that perform
molecular HLA typing. For HLA typing proficiency testing, please consult the HLA
Molecular Typing (ML, DML) Surveys.
Program Information
Three 10.0- g extracted DNA
specimens
MECP2 genotyping
MECP2 duplication/deletion analysis
18
800-323-4040 | 847-832-7000 Option 1 | cap.org
227
Program Information
Three 250- L synthetic whole
blood specimens
CAP/ACMG Thrombophilia
Mutations TPM
Analyte/Procedure
Program Code
Challenges/Shipment
TPM
Factor II
Factor V
This Survey is designed for the Cepheid Gene pert factor II and factor V assays. DNA
extraction for other assays/methods is NOT recommended.
Program Information
specimens
Red Blood Cell Antigen

Genotyping RAG
Procedure
Program Code
Challenges/Shipment
RAG
Red cell antigen genotype with

predictive phenotype
18
Next-Generation Sequencing NGS

Procedure
Program Code
Challenges/Shipment
NGS
Next-generation se uencing
Laboratories will have the ability to test up to 200 chromosomal positions. For a full list of
genes in this program, please go to cap.org. nder the Laboratory Improvement tab, clic
on Catalog and Ordering Information. The list is located under the PT Order Supplements
header.
New
Next-Generation SequencingSolid Tumors

NGSST
Analyte/Procedure
Program Code
Challenges/Shipment
Program Information
One 10.0- g extracted DNA
specimen
Methods-based challenge
for germline variants for
laboratories using gene
panels, exome, and whole
genome sequencing
Program Information
Three 1.0- g DNA (50 ng/ L)
specimens
NGSST
New
Next-Generation SequencingHematologic
Malignancies NGSHM
Analyte/Procedure
Program Code
Challenges/Shipment
This is a methods-based proficiency challenge for laboratories performing targeted nextgeneration se uencing of cancer genes or mutation hotspots in solid tumors. Laboratories
will be asked to identify somatic single nucleotide variants and small insertions or
deletions in the following genes AKT1, ALK, APC, ATM, BRAF, CDH1, CTNNB1,
EGFR, ERBB2, FBXW7, FGFR2, GNAQ, GNAS, HRAS, IDH1, KIT, KRAS, MET, NRAS,
PDGFRA, PIK3CA, PTEN, SMAD4, SMARCB1, SMO, SRC, STK11, TP53.
Program Information
Three 1.0- g DNA (50 ng/ L)
specimens
NGSHM
This is a methods-based proficiency challenge for laboratories performing targeted
next-generation se uencing of genes or mutation hotspots in hematologic malignancies.
Laboratories will be as ed to identify somatic single nucleotide variants and small
insertions or deletions in the following genes ASXL1, ATM, BRAF, CALR, CEBPA,
CREBBP, CSF3R, DNMT3A, EZH2, FLT3, IDH1, IDH2, JAK2, KIT, KMT2D, MPL,
MYD88, NOTCH1, NPM1, SF3B1, SRSF2, TET2, TP53, U2AF1.
800-323-4040 | 847-832-7000 Option 1 | cap.org
18
229
New

NGSB1, NGSB2
Analyte/Procedure
Program Code
NGSB1
Illumina TruSe Amplicon Cancer Panel

Ion Torrent AmpliSe Cancer Hotspot v2
Challenges/Shipment
NGSB2
Additional Information:
This in silico program augments wet bench NGS proficency testing programs by
testing a greater number of variants, at a greater range of variant frequencies.
The BAM and/or FAST files are platform-specific and cannot be used with other
instruments/software.
For a full list of genes in this program, please go to cap.org. nder the Laboratory
Improvement tab, clic on Catalog and Ordering Information. The list is located under
the PT Order Supplements header.
Program Information
Somatic gene-based
sequencing files to be
downloaded into your
laboratory bioinformatics
pipeline; file sizes range from
100MB to 1GB
NGSB1 - FAST file format
for the Illumina TruSe
Amplicon Cancer Panel
NGSB2 - BAM and FAST
file formats for the Ion Torrent
AmpliSe Cancer Hotspot v2
Panel
Give the CAPs complimentary Sample Exchange Registry service a try!

Sign up for this unique and complimentary service for those rare analytes for which
proficiency testing is not yet available. This service now includes all clinical
laboratory disciplines.
The CAP connects labs performing testing for which no formal

proficiency testing is available.
18
There is no charge for this service.

Participate at any time, no contract required.
A minimum of three labs performing the same analyte must participate
before the CAP can facilitate the sample exchange.
Each individual laboratory will receive its own results along with an anonymized summary
report for all participants.
Register today! Visit cap.org and search Sample Exchange Registry.

Defective DNA Mismatch Repair/Hereditary

Nonpolyposis Colorectal Cancer (HNPCC)
MSI
Procedure
Challenges/
Shipment
Program Code
MSI
Microsatellite instability testing

(DNA amplification)
MLH1 promoter methylation analysis
Program Information
Two 10.0-micron unstained
paraffin section slides
and one H&E slide; two
photograph challenges
molecular testing using PCR
Laboratories performing DNA mismatch repair assessment by immunohistochemistry methods

should see Survey MMR on page 2 5.
In Situ Hybridization ISH, ISH2

Analyte/Procedure
Program Code
ISH
Challenges/Shipment
ISH2
Human papillomavirus (HPV)
appa/Lambda (IG /IGL)
HER2 (ERBB2) gene amplification

(brightfield)
appa/Lambda Four -core

tissue microarray slides and
one H&E slide
ISH2 - Two sets of 5-core
tissue microarray slides
10
Epstein-Barr virus (EBV)
Program Information
ISH - EBV, HPV Three -core
tissue microarray slides and
one H&E slide (each)
Laboratories performing FISH for interphase chromosomal targets in paraffin sections refer to the
Cytogenetics Surveys, page 221.
New
DNA Purification from FFPET MHO5

Analyte/Procedure
Program Code
Challenges/Shipment
MHO5
DNA purification
Program Information
Three 10.0-micron paraffin
sections
Methods-based proficiency challenge to examine DNA purification from formalin-fixed,
paraffin-embedded tissues (FFPET). Laboratories will be able to purify DNA from FFPET
sections and amplify control targets using laboratory-provided reagents.
800-323-4040 | 847-832-7000 Option 1 | cap.org
18
231
Program Information
Forty Regions of Interests
(ROIs) using whole slide
images
Neoplastic Cellularity NEO

Procedure
Program Code
Challenges/Shipment
NEO
Online assessment of percent

neoplastic cellularity
A method-based preanalytic
Survey to assess competency
for determining percent
neoplastic cellularity
technology
Program Information
Snap-frozen cell pellet from
which approximately 5.0- g
of RNA can be extracted
Sarcoma Translocation SARC

Gene
Program Code
Challenges/Shipment
SARC
Sarcoma translocation* (RT-PCR)
*See translocation listing below.

Laboratories performing FISH for sarcoma translocation refer to the Cytogenetics Surveys,
page 221.
Sarcoma Translocation Listing

COL1A1/PDGFB, t(17;22)
EWSR1/WT1, t(11;22)
PAX3/FOXO1 or PAX7/FOXO1
EWSR1/ATF1, t(12;22)
FUS/DDIT3, t(12;16)
SS18/SSX1, t(X;18)
EWSR1/ERG, t(21;22)
PAX3/FOXO1, t(2;13)
SS18/SSX2, t(X;18)
EWSR1/FLI1, t(11;22)
PAX7/FOXO1, t(1;13)
SS18/SSX1 or SS18/SSX2
EWSR1/FLI1 or EWSR1/ERG
18
Solid TumorOther BRAF, EGFR, KRAS, KIT

Analyte
Program Code
BRAF EGFR KRAS
BRAF
Challenges/Shipment
KIT
EGFR
KRAS
KIT
PDGFRA
Program Information
BRAF, EGFR, RAS Paraffin-embedded
sections or shavings
IT/PDGFRA - Four
10.0-micron unstained
paraffin section slides and
one H&E slide
Multigene Tumor Panel MTP

Analyte
Program Code
Challenges/Shipment
MTP
BRAF
EGFR
KRAS
NRAS
PIK3CA
Program Information
Three 2.0- g gDNA
(50 ng/ L) specimens for
laboratories performing
molecular testing on multiple
targets
Glioma GLI
Analyte
Program Code
Challenges/Shipment
GLI
Survey MTP is now designed for laboratories performing both non-NGS multiplex testing
as well as non-multiplexed platforms (eg, Sanger se uencing).
Program Information
Four 10.0-micron unstained
paraffin section slides and
one H&E slide
MGMT
IDH1, IDH2

10 (PTEN) deletion
18
800-323-4040 | 847-832-7000 Option 1 | cap.org
233
Molecular OncologyHematologic
Molecular OncologyHematologic
Molecular Hematologic Oncology

MHO, MHO1, MHO2, MHO3, MHO5
Procedure/Gene
Challenges/
Shipment
Program Code
MHO, MHO1 MHO2, MHO3
MHO5
Lymphoid malignancy genotyping

IGH
IGH/BCL2 major
IGH/BCL2 minor
IGH/CCND1
IGK
TRB
TRG
Myeloid malignancy genotyping

CBFB/MYH11
FLT3 ITD
FLT3 TKD
JAK2 c.18 9G T(p.V617F)
NPM1
PML/RARA
RUNX1/RUNX1T1
DNA extraction and

amplification from formalinfixed, paraffin-embedded
(FFPE) tissue
Minimal Residual Disease MRD, MRD1, MRD2
18
BCR/ABL1 p190
BCR/ABL1 p210
PML/RARA
Challenges/
Shipment
Program Code
MRD
MRD1
MRD2
z
z
MHO1 - MHO specimens in

duplicate for additional DNA
testing
MHO2 - Two sample vials;
one with purified DNA
containing 200 g/mL and
one with purified RNA,
containing 00 g/mL
MHO - MHO2 specimen in
duplicate for additional DNA
and RNA testing
MHO5 - Three 10.0-micron
paraffin sections; extraction
and amplification from FFPE
tissue will be assessed by a
method-based challenge
ships on dry ice (dry ice
does not apply to MHO5 or
international shipments)
Analyte
Program Information
MHO - One sample vial
containing purified DNA
(200 g/mL per vial) for each
specimen
Program Information
MRD, MRD1, MRD2 - Three
RNA specimens in distilled
water
For laboratories diagnosing
and monitoring leukemia
tumor burden by measuring
the quantity of BCR/ABL1 or
PML/RARA fusion transcripts
ships on dry ice
19
| Anatomic Pathology
The CAP is good about being the leader, doing
research, and taking a role in developing these
programs.
Anatomic Pathology
Surgical Pathology .........................................................................................................................236
General Immunohistochemistry ........................................................................................................245
Predictive Markers .........................................................................................................................247
Specialty Anatomic Pathology .........................................................................................................248
Cytopathology...............................................................................................................................250
Hematopathology Online Education (HPATH/HPATH1) ......................................................................240

Number of mailings has changed
HER2 Immunohistochemistry (HER2) .................................................................................................247
Number of challenges per mailing has changed
Neuropathology Program (NP/NP1) ................................................................................................249
Online activity now offered with CD-ROM
Glass Slide Gynecologic Cytopathology PAP PT Program with Online Education (PTGD)
Online Gynecologic Cytopathology Education Program (PED)
Gynecologic CytopathologyFields of View (FOVK/FOVK1, FOVM/FOVM1)
Anatomic Pathology
Program Changes
19
Surgical Pathology
Surgical Pathology
Performance Improvement Program

in Surgical Pathology PIP/PIP1
Program
Program Code
Challenges/Shipment
PIP/PIP1
Surgical pathology case review
10
PIP educates pathologists in general surgical pathology. This program:
Provides a practical approach to continuing education
Gives pathologists a method to assess their diagnostic skills and compare their
performance with that of their peers
Features PIP case selections that include:
o A variety of neoplastic and nonneoplastic lesions
o Inflammatory and infectious disease
o Various sites, encompassing a variety of organ systems
Program Information
PIP - Ten diagnostic
challenges/H&E stained glass
slides with clinical history;
one individual response form
PIP1 - Reporting option
with CME credit for each
additional pathologist (within
Survey PIP
Earn a maximum of 40 CME
credits (AMA PRA Category
1 Credits) per pathologist for
requirements
Anatomic Pathology
19
Surgical Pathology
Online Performance Improvement Program

in Surgical Pathology PIPW/PIPW1
Program
Program Code
Challenges/Shipment
PIPW/PIPW1
Surgical pathology case review
10
PIP educates pathologists in general surgical pathology. Features of this online
educational program include:
Pathologists can assess their diagnostic s ills and compare their performance with
that of their peers.
Included PIP case selections feature
o A variety of neoplastic and nonneoplastic lesions
o Inflammatory and infectious disease
o Various sites, encompassing a variety of organ systems
See system re uirements on page 13.
Program Information
PIP - Ten diagnostic
H&E images with clinical
pathologist, purchase PIPW1
PIP 1 - Reporting option with
CME credit for each additional
pathologist (within the same
institution); must order in
conjunction with Survey PIPW
1 Credits) per pathologist for
requirements
technology
Four online activities per year;
Anatomic Pathology
19
800-323-4040 | 847-832-7000 Option 1 | cap.org
237
Surgical Pathology
Online Virtual Biopsy Program VBP/VBP1

Program
Program Code
Challenges/Shipment
VBP/VBP1
Online biopsy case review
VBP educates pathologists to assess and improve their diagnostic skills in surgical
pathology. Features of this online educational program include:
Cases may also include gross, radiographic, or endoscopic images.
Cases are from selected organ systems and may include a variety of
specimen types (eg, core biopsies, endoscopic biopsies, curettings, aspirate
smears). Activities with their corresponding topics are:
o 2016-A Upper Gastrointestinal Tract
o 2016-B Dermatopathology
o 2016-C Infectious Disease
o 2016-D Surgical Pathology Biopsy (various sites)
Program Information
VBP - Five diagnostic
images with clinical history;
for each additional
pathologist, purchase VBP1
VBP1 - Reporting option
Survey VBP
Earn a maximum of
23 CME/SAM credits
(AMA PRA Category 1
Credits) per pathologist for
requirements
technology
Four online activities per year;
Anatomic Pathology
19
Surgical Pathology
Online Digital Slide Program in Dermatopathology

DPATH/DPATH1
Program
Program Code
Challenges/Shipment
DPATH/DPATH1
Online dermatopathology case review
DPATH educates pathologists, dermatopathologists, and dermatologists to assess
and improve their diagnostic s ills in dermatopathology. Features of this online
educational program include:
Cases include static images.
Program Information
DPATH - Six diagnostic
pathologist, purchase DPATH1
DPATH1 - Reporting option
Survey DPATH
Earn a maximum of
1 CME/SAM credits
(AMA PRA Category 1
Credits) per pathologist for
requirements
technology
Anatomic Pathology
19
800-323-4040 | 847-832-7000 Option 1 | cap.org
239
Surgical Pathology
Hematopathology Online Education

HPATH/HPATH1
Program
Program Code
Challenges/Shipment
HPATH/HPATH1
Hematopathology online case review
HPATH educates pathologists, hematolopathologists, and hematologists with an interest
in hematopathology to assess and improve their diagnostic skills in hematopathology.
Clinical history and relevant laboratory data.
At least one whole slide image of peripheral blood, bone marrow,
spleen, lymph node, or other tissue.
Results of ancillary studies such as immunohistochemistry, flow cytometry,
FISH, karyotyping, and molecular studies, where appropriate.
Case discussion and discussion of differential diagnoses.
Five SAM questions per case.
Program Information
HPATH - Five diagnostic
pathologist/hematologist,
purchase HPATH1
HPATH1 - Reporting option
with CME/SAM credit for
each additional pathologist
and hematologist (within
Survey HPATH
per hematologist for
requirements
technology
Anatomic Pathology

19
Surgical Pathology
Cancer Staging Improvement Program

PCSP/PCSP1
Program
Program Code
Challenges/Shipment
PCSP/PCSP1
Online surgical pathology cancer

case review
PCSP educates pathologists in cancer case review and reporting.
Cases review challenges in interpretation, staging, and cancer reporting.
Cases represent the following
o Esophageal vs. Gastric Cancer Staging Tumors at or Near the Gastroesophageal
Junction
o Assessing Anaplasia in Wilms Tumor: What Is Big Enough?
o Endometrioid Carcinomas: Patterns and Measurement of Depth of Myoinvasion
o Extramural Venous Invasion in Colorectal Cancer Are e Missing It
Program Information
PCSP - One mailing
containing four diagnostic
H&E images with clinical
pathologist purchase PCSP1
PCSP1 - Reporting option with
CME credit for each additional
pathologist (within the same
conjunction with Survey PCSP
Earn a maximum of
5 CME/SAM credits (AMA
PRA Category 1 Credits ) per
pathologist for completion of
an entire year
technology
requirements
One online activity per year;
Anatomic Pathology
19
800-323-4040 | 847-832-7000 Option 1 | cap.org
241
Surgical Pathology
CAP/NSH HistoQIP HQIP

Stain/Tissue
Program Code
Challenges/Shipment
B
Program Information
Participant laboratories may
submit up to five stained and
coverslipped glass slides (one
from each category) per
mailing
HQIP
H&E - Lymph node excision
H&E - Breast resection
IHC - CD3 (Lymph node excision)
IHC - PR (Breast resection)
Includes photographs and

online learning assessment
questions
Special Stain - Trichrome (Liver needle core

biopsy)
H&E - Placenta
H&E - Prostate resection
IHC - p63 (Prostate resection)
IHC - CD30 (Hodgkin lymphoma)
Special stain - Acid-fast bacteria (AFB),

control tissue, no culture material
Anatomic Pathology
HistoQIP improves the preparation of histologic slides in all anatomic pathology
laboratories. In this educational program, participants will receive an evaluation specific
to their laboratory, an education critique, and a Participant Summary that includes peer
comparison data, evaluators comments, and performance benchmarking data. An expert
panel of pathologists, histotechnologists, and histotechnicians will evaluate submitted
slides for histologic technique using uniform grading criteria.
19
Surgical Pathology
CAP/NSH HistoQIPIHC HQIHC

Stain/Tissue
Program Code
Challenges/Shipment
HQIHC
IHC - GATA (Bladder biopsy)
IHC - p16 (Cervical biopsy)
IHC - MITF (S in, punch biopsy)
IHC - H. pylori (Stomach biopsy)
IHC - CDX2 (Colon biopsy)
IHC - PAX8 (Endometrium biopsy)
IHC - CD 1 (S in, exisional biopsy)
IHC - Prostate specific antigen (Prostate

biopsy)
Program Information
Participants may submit
up to four IHC stained and
coverslipped glass slides
(one from each category) per
mailing
HistoQIP - IHC improves the preparation of immunohistochemistry slides in all anatomic
laboratories involved in the handling of gastrointestinal, dermatologic, and urological
tract biopsies. Participants will receive an evaluation specific to their laboratory and
a Participant Summary. An expert panel of pathologists, histotechnologists, and
histotechnicians will evaluate submitted slides for histologic technique using uniform
grading criteria.
CAP/NSH HistoQIP Biopsy Series HQIPBX

Stain/Tissue
Program Code
Challenges/Shipment
HQIPBX
H&E Bladder biopsy
H&E Cervical biopsy
H E
H&E Stomach biopsy
H&E Colon biopsy
H&E Endometrial biopsy
H&E Prostate needle biopsy
H E
S in punch biopsy
The HistoQIP Biopsy Series is an additional program to improve the preparation of
histologic slides in all anatomic pathology laboratories. Participants will receive an
evaluation specific to their laboratory and a Participant Summary. An expert panel of
pathologists, histotechnologists, and histotechnicians will evaluate submitted slides for
histologic technique using uniform grading criteria.
800-323-4040 | 847-832-7000 Option 1 | cap.org
Anatomic Pathology
S in excisional biopsy (large excision)
Program Information
Participant laboratories may
submit up to four H&E stained
and coverslipped glass slides
(one from each category) per
mailing
19
243
Surgical Pathology
CAP/NSH HistoQIP Specialty Series

HQBX1, HQBX2, HQBX3
Stain/Tissue
Challenges/
Shipment
Program Code
HQBX1
HQBX2
HQBX3
Gastrointestinal Biopsy Module

H&E Colon biopsy
H&E Esophageal biopsy
H&E Small intestinal biopsy
H&E Stomach biopsy
Program Information
HQBX1, HQBX2, HQBX3 Participants may submit up
to four H&E stained and
coverslipped glass slides
(one from each category)
per mailing
Dermatologic Biopsy Module

H&E Alopecia
H&E Skin excisional biopsy

(large excision)
H&E Skin punch biopsy
H&E Skin shave biopsy
Urogenital Tract Biopsy Module

H&E Bladder biopsy (nonneoplastic)
H&E Bladder biopsy (with carcinoma)

(nonneoplastic)

(with carcinoma)
Anatomic Pathology
The HistoQIP Specialty Series includes modules to improve the preparation of histologic
slides in all anatomic pathology laboratories involved in the handling of gastrointestinal,
dermatologic, and urogenital tract biopsies. Participants will receive an evaluation
specific to their laboratory and a Participant Summary. An expert panel of pathologists,
histotechnologists, and histotechnicians will evaluate submitted slides for histologic
technique using uniform grading criteria.
19
General Immunohistochemistry
Immunohistochemistry MK
Procedure
Program Code
Challenges/Shipment
MK
Immunohistochemistry
16
The MK program allows laboratories to compare their assay methodology and results
with all participating laboratories.
DNA Mismatch Repair MMR

Procedure
Program Code
Challenges/Shipment
MMR
DNA mismatch repair by

immunohistochemistry
If your laboratory performs DNA mismatch repair by molecular methods,

see the MSI program on page 231.
Program Code
PM1
CD117
Challenges/Shipment
Program Information
Four .0-micron unstained
paraffin section slides
and one H&E slide for the
immunohistochemical analysis
of DNA mismatch repair
proteins MLH1, MSH2, MSH6,
and PMS2
Program Information
One 10-core tissue
microarray slide per
predictive mar er
PM3
10
CD20
CD117, CD20 Immunohistochemistry

Tissue Microarray PM1, PM3
Analyte
Program Information
Glass slides with unstained
tissue sections from four
separate cases; additional
slides provided for an H&E
stain and negative control
10
Anatomic Pathology
For ER/PgR testing, see the PM2 program on page 2 7.
19
800-323-4040 | 847-832-7000 Option 1 | cap.org
245
Immunohistochemistry Tissue
Microarray Series PM5
Analyte
Program Code
Challenges/Shipment
Program Information
Two 10-core tissue microarray
slides, one for p16 and one
for SOX10
PM5
p16
10
SOX10
10
Anatomic Pathology
Each year, the PM5 program will feature two different markers for immunohistochemistry
laboratories to evaluate assay performance on a variety of tissue and/or tumor types.
Let the CAP connect you to the IHC samples you need
19
Sign up for this complimentary service to access

those hard-to-obtain specimens.
New for 2015CAP Immunohistochemistry (IHC) Validation Program
The CAP will facilitate the exchange of tissue samples once a sufficient
number of laboratories performing the same marker are identified.
Samples will be exchanged twice a year based on availability.

Each laboratory will receive its own individual results along with
an anonymized summary report for all participants.
To get started, visit cap.org and search Sample Exchange Registry to learn
more and download a Contact Information Form.
Predictive Markers
Predictive Markers
HER2 Immunohistochemistry HER2

Analyte
Program Code
Challenges/Shipment
HER2
HER2
Program Information
Two 10-core tissue microarray
slides
20
The HER2 program fulfills the proficiency testing requirement stated in the ASCO/CAP
HER2 Testing Guideline. Due to the uni ue nature of these human, donor-based
materials, the shipping date is subject to change. If this should occur, the CAP will
provide notification prior to the originally scheduled shipping date.
Gastric HER2 GHER2

Analyte
Program Code
Challenges/Shipment
GHER2
HER2
Program Information
One 10-core tissue
microarray slide
10
The interpretive criteria for HER2 immunohistochemistry performed on gastroesophageal
adenocarcinomas differs significantly from breast carcinoma. The GHER2 program will
help participating laboratories understand these differences.
Program Information
Four 10-core microarray slides,
two for ER and two for PgR
ER/PgR Immunohistochemistry
Tissue Microarray PM2
Analyte
Program Code
Challenges/Shipment
Estrogen receptor (ER)
20
Progesterone receptor (PgR)
20
The PM2 program fulfills the proficiency testing requirement stated in the
ASCO/CAP ER/PgR Testing Guideline. Due to the uni ue nature of these human,
donor-based materials, the shipping date is subject to change. If this should occur,
the CAP will provide notification prior to the originally scheduled shipping date.
800-323-4040 | 847-832-7000 Option 1 | cap.org
Anatomic Pathology
PM2
19
247
Specialty Anatomic Pathology

Autopsy Pathology AUCD/AUCD1

Procedure
Program Code
Challenges/Shipment
AUCD/AUCD1
Autopsy case analysis
Each CD-ROM includes case description, gross and/or microscopic images, and case
discussion with sample death certificate, key teaching points, and current references.
Program Information
One CD-ROM with six
autopsy cases; one individual
response form
AUCD1 - Reporting option
Survey AUCD
credits (AMA PRA Category 1
Credits) per pathologist
requirements
Autopsy & Forensic Anthology of Classic Pathology Images (AFA)
Anatomic Pathology
This CD-ROM offering contains more than 2,000 classic

images from the CAPs 19922010 Autopsy Pathology (AUCD)
and the 19902010 Forensic Pathology (FR) programs.
View images in three different modes:
19
ListCases listed by program, year, patient age, and diagnosis
BrowseImages filtered by category (eg, cardiovascular,

CNS, external exam) and/or image type (eg, gross, H&E, scene)
SearchAccess images based on matching key

words or word fragments
Customize the anthology by adding your own images and categories

Use only a standard Web browserit runs on any operating
systemwith no software to install
Add this valuable tool to your laboratorys teaching library.

Add code AFA to your Surveys order form.
Challenges/Shipment
Program Information
Online activity providing eight
cases and a mini-symposium
Includes CD-ROM and option

to download program content
Neuropathology Program NP/NP1

Program
Program Code
NP/NP1
Neuropathology online case review
NP1 - Reporting option with

CME credit for each
Survey NP
The Neuropathology program helps anatomic pathologists, neuropathologists, and
trainees assess and improve their diagnostic s ills and learn about new developments
in neuropathology. Each shipment of this educational program includes eight cases
that cover the spectrum of neoplastic and nonneoplastic disorders affecting the central
and peripheral nervous systems, including infectious, degenerative, developmental,
demyelinating, traumatic, toxic-metabolic, vascular, and neuromuscular diseases. In
addition, each mailing will include a mini-symposium that focuses on a specific problem
area in neuropathology, which relates to four of the eight cases.
per pathologist
requirements
Prepare to meet the future needs

of personalized medicine

Anatomic Pathology
New from CAP Press, Developing and Organizing an

Institutional Biospecimen Repository provides you with
valuable information on establishing and maintaining
a biospecimen repository and discusses issues critical
to specimen collection, processing, storage,
and distribution.
Developing and Organizing an Institutional
Biospecimen
Repository
Donna E. Hansel
Scott D. Jewell
PRESS
View sample pages and order online:

Printed books at cap.org under the
Shop tab
Ebooks at ebooks.cap.org
Item number: PUB314

ISBN: 9780983706854
Softcover; 115 pages; 2014
800-323-4040 | 847-832-7000 Option 1 | cap.org
19
249
Cytopathology
Cytopathology
Glass Slide Gynecologic Cytopathology PT

Program with Glass Slide PAP Education PAP PT
Slide Type
Program Code
PAPCPT
Conventional
PAPKPT
PAPMPT
PAPLPT
SurePath
PAPJPT
Proficiency
Testing
Education
10
10
z
z
ThinPrep
Individual
Participant
Response Form
Challenges Per Year

1 CreditsTM) per pathologist
and a maximum of 8 CE
credits per cytotechnologist
for completing all challenges
requirements
APAPCPT APAPKPT APAPMPT APAPLPT APAPJPT
Ordering Information
You will receive one shipment for proficiency testing (10 slides) and two additional
shipments for your education (5 slides each).
Follow these steps to order your PAP Proficiency Testing and PAP Education:
1. Choose the following:

a. Slide Type program code (refer to table above)
b. PAP Education series shipment dates (choose one)
Series 1
o A mailing ships February
o B mailing ships August
Series 2
o A mailing ships May
o B mailing ships November
Add the PAP Education series number after the Slide Type program code
(eg, PAPCPT1).
2. Order one Individual Participant Response Form code for each participating
pathologist/cytotechnologist. Also include the PAP Education Series number after the
program code (eg, APAPCPT1).
3. Select primary testing session option with two alternative date options using the
Gynecologic Cytology Proficiency Testing Order Details Form.
4. Order PPTENR only if you are a laboratory possessing a CLIA license to perform
gynecologic cytology where all personnel are performing proficiency testing at
another CLIA location.
Anatomic Pathology
Program Information
Ten glass slides for proficiency
testing and ten glass slides for
education
Three shipments per year;

one shipment for proficiency
testing (10 slides) and two
shipments for education (5
slides each)
19
Participants can receive laboratory reference interpretations and performance for the
PAP Education slides within 20 minutes by fax.
The PAP Education component meets the CAP Laboratory Accreditation Program
requirement for participation in a peer educational program.
Cytopathology
Cytopathology Glass Slide Education Program

PAPCE, PAPJE, PAPKE, PAPLE, PAPME Series 1 or 2
Slide Type
Program Code
PAPCE
Conventional
PAPKE
PAPME
Challenges Per Year
PAPLE
SurePath
APAPCE
PAPJE
ThinPrep
Individual
Participant
Response
Form
Education
APAPKE
APAPME
APAPLE
APAPJE
10
Program Information
Ten glass slides for education
1 CreditsTM) per pathologist
and a maximum of 8 CE
credits per cytotechnologist
for completing all challenges
requirements
Two shipments (five slides
each)
Ordering Information
Follow these steps to order your PAP Education:
1. Choose the following:

a. Slide Type program code (refer to table above)
b. PAP Education series shipment dates (choose one)

Series 1
o A mailing ships February
o B mailing ships August

Series 2
o A mailing ships May
o B mailing ships November
Add the PAP Education series number after the Slide Type program code
(eg, PAPCE1).
2. Order one Individual Participant Response Form code for each participating
pathologist/cytotechnologist. Also include the PAP Education series number after the
program code (eg, APAPCE1).
Anatomic Pathology
Participants can receive laboratory reference interpretations and performance for the
PAP Education slides within 20 minutes by fax.
The PAP Education component meets the CAP Laboratory Accreditation Program
requirement for participation in a peer educational program.
19
800-323-4040 | 847-832-7000 Option 1 | cap.org
251
Cytopathology
Human Papillomavirus (High Risk) for Cytology

CHPVD, CHPVM, CHPVK, CHPVJ
Analyte/Procedure
Program Code
Program Information
Five simulated cervical
specimens
Challenges/Shipment
CHPVD - Digene Specimen

Transport Medium (STM)
CHPVD CHPVM CHPVK CHPVJ
HPV
High-ris HPV
genotyping (optional)
z
z
CHPVM - ThinPrep
PreservCyt Transport
Medium
CHPV - SurePath
Preservative Fluid Transport
Medium and corresponding
vial of diluent
Each laboratory should choose the Survey that best reflects the transport media
received in its facility. For Survey CHPV , participants must provide results for all three
media types. If your laboratory receives two types of media, order the Survey that is
most appropriate for your specific laboratory (CHPVD, CHPVM, or CHPVK).
For laboratories that perform HPV genotyping using ThinPrep PreservCyt Transport
medium on site, Survey CHPVM and select samples of Survey CHPVJ provide an
opportunity to report specific HPV genotypes.
The CAP does not report genotyping responses to the CMS.
New from CAP Press
CHPV - Combination of
Digene, ThinPrep
PreservCyt, and SurePath
transport mediums

Atlas of Transplant Pathology serves as a handy resource
Anatomic Pathology
for practical interpretation of solid organ transplant biopsies

and other specimens by general pathologists as well
as subspecialists.
Includes over 600+ photomicrographs and tables.
19
PRESS
Available in print and ebook formats!

View sample pages and order online:
Printed books at cap.org under the
Shop tab
Ebooks at ebooks.cap.org
Item number: PUB124

ISBN: 978-098370686-1
254 pages; 600+
photomicrographs and
tables; 2015
Cytopathology
Nongynecologic CytopathologyIntraoperative
Touch Imprint/Crush
Preparation Program TICP/TICP1
Procedure
Program Code
Challenges/Shipment
TICP/TICP1
Online slide and image program in rapid

assessment case review
The TICP Program is designed to familiarize surgical pathologists, cytopathologists,
and cytotechnologists with the cytomorphologic features of pathologic processes
and tumors in touch-imprints and crush or scrape preparations. These specimens
are prepared either for intraoperative consultation (frozen section) or rapid on-site
evaluation (ROSE) of tissue biopsies for adequacy and/or interpretation. Participants
will learn to ma e an immediate ade uacy assessment, assign the process to
a general category, and triage the specimen to appropriate ancillary studies.
Participants will review digital whole-slides of the TICP preparations (hematoxylin
eosin, modified right-Giemsa, and/or Papanicolaou stains), static images of
the preparation and ancillary studies, and clinical history/radiographic findings to
reach a diagnosis. Each case has a complete description of entities in the differential
diagnosis along with a discussion of the correct interpretation.
Participants will receive immediate feedbac on interpretations, ancillary studies, and
case-related adequate assessment.
The 2016 cases will be comprised of specimens from the lung and an eclectic mix of
procedural touch preparations from core biopsies from various body sites.
Program Information
TICP - Five online
assessment challenges with
clinical history; for each
additional pathologist or
cytotechnologist, purchase
TICP1
TICP1 - Reporting option with
CME/SAM/CE credit for
each additional pathologist/
technologist (within the same
conjunction with Survey TICP
PRA Category 1 CreditsTM)
per cytotechnologist for
requirements
technology
Anatomic Pathology
19
800-323-4040 | 847-832-7000 Option 1 | cap.org
253
Cytopathology
Nongynecologic Cytopathology
Education Program NGC/NGC1
Procedure
Program Code
Challenges/Shipment
NGC/NGC1
Nongynecologic cytopathology
case review glass slides
Nongynecologic cytopathology
case review online
5 per year
The Nongynecologic Cytopathology Education (NGC) program is an interlaboratory
educational opportunity to assess participants screening and interpretive s ills.
The NGC program is unsuitable for proficiency testing as these cases are chosen for
their educational value. Cases may incorporate static online images that incorporate
radiology and multiple aspects of pathology to enhance the interpretation.
Participants can access laboratory reference interpretations and performance for the
glass slides within 20 minutes by fax, providing rapid educational feedbac , peer
comparison, and additional review time.
Additional online advanced education cases provide immediate feedbac on
interpretation selection, follow-up recommendations, and case-related educational
questions.
Program Information
NGC - Five glass slides; five
online advanced education
cases; one laboratory
response form and two
individual response forms
NGC1 - Reporting option
with CME/CE credit for
cytotechnologist (within the
same institution); must order
NGC
Earn a maximum of
25 CME credits (AMA PRA
Category 1 Credits)
per cytotechnologist for
completing the glass slides
and online cases
requirements
technology
Anatomic Pathology
19
Cytopathology
Online Digital Slide Program in

Fine-Needle Aspiration FNA/FNA1
Procedure
Program Code
Challenges/Shipment
FNA/FNA1
Online program in fine-needle

aspiration case review
This program focuses on FNA diagnostic dilemmas in practice. Online cases, which
consist of whole slide images and static images, provide immediate feedbac on
interpretation selection, ancillary studies selection, and case-related educational
questions.
Cases will focus on pancreatic and liver pathology.
Program Information
FNA - Five online diagnostic
challenges; for each
additional pathologist or
cytotechnologist, purchase
FNA1
FNA1 - Reporting option
same institution); must order
in conjuction with Survey
FNA
1 Credits) per pathologist and
a maximum of 10 CE credits
per cytotechnologist
This activity meets the ABP
MOC Part IV Practice
requirements
technology
Anatomic Pathology
19
800-323-4040 | 847-832-7000 Option 1 | cap.org
255
Cytopathology
Fine-Needle Aspiration Glass Slide

Education Program FNAG/FNAG1
Procedure
Program Code
Challenges/Shipment
FNAG/FNAG1
Fine-needle aspiration glass

slide case review
The Fine-Needle Aspiration Glass Slide Education program is an interlaboratory
educational opportunity to assess participants screening and interpretive s ills.
FNAG cases may include more than one slide of varying stains and/or
preparations used on fine-needle aspirations.
Cases may include static online images that incorporate radiology and multiple
aspects of pathology to support the interpretation.
Participants can access laboratory reference interpretations and performance for the
glass slides within 20 minutes by fax, providing rapid educational feedbac , peer
comparison, and additional review time.
Program Information
FNAG - Five cases consisting
of glass slides and selected
online images, representing a
variety of conditions; one
laboratory response form and
two individual response forms
FNAG1 - Reporting option
same institution); must order in
conjunction with Survey FNAG
1 Credits) per pathologist/
resident and a maximum of 10
CE credits per cytotechnologist
This activity meets the ABP
MOC Part IV Practice
requirements
Anatomic Pathology
Experience a new level of pathology education with CAP SAMs
19
Outcomes-based learning at the cutting edge of pathology science

Peer reviewed by at least two subject matter experts
Highly interactive formats with immediate feedback
Visit cap.org and choose the Learning tab, then search SAM Courses.
20 | Forensic Sciences
We use CAP proficiency testing to ensure the

accuracy of our results and the competency
of our staff.

Forensic Toxicology, Criminalistics (FTC)...........................................................................................260
Norfentanyl
Forensic Sciences
20
Forensic Sciences
Forensic Sciences
DNA Database DNA, DNAF

Procedure
Program Code
DNA
Database analysis (whole blood)
DNAF
Database analysis (filter paper)
Challenges/Shipment

Review Committee (ASCLD/LAB PRC) has approved Surveys DNA and DNAF.
Forensic IdentityNuclear and Mitochondrial

DNA Analysis FID, FIDM
Procedure
Program Code
FID
Forensic nuclear DNA analysis
FIDM
Forensic mitochondrial DNA analysis
Challenges/Shipment

Review Committee (ASCLD/LAB PRC) has approved Surveys FID and FIDM.
Program Information
DNA - Three 0.5-mL whole
blood specimens
DNAF - Three blood-stained
filter paper challenges
Short tandem repeats (Au-STR
and Y-STR)
Program Information
FID - Simulated forensic case
work includes reference
standards for all suspects and
victims along with evidentiary
material such as vaginal
swabs, semen stains, and
crime scene blood stains
FIDM - One reference
challenge (blood stain) and
one challenge for
mitochondrial DNA analysis
(hair or nails)
Forensic Sciences
Everyday, Im impressed
by our customers
commitment to quality
patient care.
Lynne
CAP Customer Contact Center representatives

understand the importance of what you do.
20
Forensic Sciences
Forensic Pathology FR/FR1

Procedure
Program Code
Challenges/Shipment
FR/FR1
Forensic pathology cases
Cases may include or reflect anthropologic materials, ballistics, dental identification,
DNA identification, environmental pathology, forensic evidence, injury pattern,
natural death, medicolegal issues, toxicology, and trace evidence.
FR/FR1 is for hospital-based pathologists, forensic pathologists, residents, fellows,
and medical examiners/coroners. This educational program is also designed for
investigators, analysts, and technicians/technologists.
Program Information
FR - One CD-ROM containing
six case studies illustrating
gross and/or microscopic
slides and questions related to
medicolegal decision making;
one individual response form
FR1 - Additional pathologist or
investigator (within the same
institution) reporting option with
CME or CE credit; must order
in conjunction with Survey FR
Pathologists can earn a
maximum of 12 CME credits
(AMA PRA Category 1 Credits)
for completion of an entire year
requirements
Members of the American
Board of Medicolegal Death
Investigators, analysts, and
technologists can earn a
maximum of 12 CE credits for
Vitreous Fluid, Postmortem VF

Analyte
Program Code
Challenges/Shipment
VF
Chloride
Creatinine
Ethanol
Glucose
Potassium
Sodium
Vitreous urea nitrogen
For forensic and other

toxicology laboratories that
perform quantitative analysis
of vitreous fluid
Forensic Sciences
Acetone
Program Information
Three 5.0-mL synthetic
vitreous fluid specimens
20
800-323-4040 | 847-832-7000 Option 1 | cap.org
259
Forensic Sciences
Forensic Toxicology, Criminalistics FTC

Analyte
Program Code
Challenges/Shipment
FTC

Review Committee (ASCLD/LAB PRC) has approved Survey FTC.
FTC Drug Listing

Forensic Sciences
For crime and hospital

forensic toxicology divisions
performing qualitative and
quantitative analysis of drugs
in whole blood specimens
along with a urine qualitative
challenge
Norfluoxetine
7-aminoclonazepam
Ephedrine
Norketamine
Fentanyl*
Norpropoxyphene
Acetaminophen
Fluoxetine
Norsertraline
Flurazepam*
Nortriptyline
Alprazolam
Gamma-hydroxybutyrate (GHB)
Oxazepam
Amitriptyline
Hydrocodone
Oxycodone
Amphetamine
Hydromorphone
Oxymorphone
Benzoylecgonine
Imipramine
Paroxetine
Butalbital
Ketamine
Phencyclidine
Carisoprodol
Lorazepam
Phenethylamine
Chlorpheniramine
Phenobarbital
Clonazepam
Meperidine*
Phentermine
Cocaethylene
Meprobamate
Phenytoin
Cocaine
Methadone
Propoxyphene
Codeine
Pseudoephedrine
Cyclobenzaprine*
Methamphetamine
Secobarbital
Delta-9-THC
Sertraline
Delta-9-THC-COOH
(MDMA)
Temazepam
Morphine*
Trazodone
N-desmethyltramadol
Zolpidem
Desipramine
Diazepam
Diphenhydramine
Doxepin
20
Program Information
specimens and one 20.0-mL
synthetic urine specimen
Tramadol*
Nordiazepam
Nordoxepin
Norfentanyl
*and/or metabolite(s)
Refer to Section 8, Toxicology, for a more comprehensive selection of toxicology offerings.
21 | Analyte/Procedure Index
21
comprehensiveso when you're looking at

new tests you can go to the index to see across
the spectrum and it helps you pick what you
might want.
Analyte/Procedure Index
The CAP's Surveys analyte listings are
The following Analyte/Procedure Index is a comprehensive listing of analytes and corresponding CAP program options.
Analytes/procedures in bold type whose corresponding program codes are bold are regulated for proficiency testing by the
Centers for Medicare & Medicaid Services (CMS).
Laboratories must perform five challenges three times per year (as noted by boldface) for analytes that are regulated by the CMS.
21
The X in the LAP ENR column denotes the CAP programs that can be used to fulfill the proficiency testing enrollment
requirements for CAP-accredited laboratories. Refer to the program description in this catalog to determine compatibility
with your specific methodologies.
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
AG
1,5-Anhydroglucitol
66
1,25 dihydroxy
Vitamin D
BMV1
Bone Markers and

Vitamins
79
3-methoxytyramines
N/NX
Urine Chemistry,
Special
64
4-hydroxytriazolam
DFC
99
4-methylethcathinone
(4-MEC)
SCDD
Synthetic Cannabinoid/
Designer Drugs
97
17-ketosteroids
5-hydroxyindoleacetic
acid, qualitative
N/NX
Urine Chemistry,
Special
64
25-OH vitamin D
N/NX
Urine Chemistry,
Special
64
Description
Pg
ENR Code
1,5-anhydroglucitol
5-hydroxyindoleacetic
acid, quantitative
LAP Program
11-dehydrothromboxane
B2
TBX
11-Dehydrothromboxane B2
155
11-deoxycortisol
Y/YY
77
17-hydroxycorticosteroids
N/NX
Urine Chemistry,
Special
64
Y/YY
77
N/NX
Urine Chemistry,
Special
64
ABVD
Accuracy-Based
Vitamin D
78
LN40
Vitamin D Cal Ver/Lin
122
VITD
25-OH Vitamin D
78
CGE/CGEX
Coagulation, Extended
150
CGS1
Coag Special, Series 1
151
CGE/CGEX
150
CGS1
151
5F-PB-22
3-carboxyindole
metabolite
SCDD
Designer Drugs
97
50:50 mixing study,

APTT
6-acetylmorphine
(6-AM)
DMPM
Drug Monitoring for

Pain Management
98
50:50 mixing study, PT
FTC
Forensic Toxicology,
Criminalistics
96
AB CHMINACA
SCDD
97
OFD
Oral Fluid for Drugs of

Abuse
92
Designer Drugs
AB FUBINACA
SCDD
97
Toxicology
88
Designer Drugs
UDC
Forensic Urine Drug

Testing, Confirmatory
91
SCDD
Designer Drugs
97
UT
Urine Toxicology
88
AB-PINACA
N-pentanoic acid
metabolite
DFC
99
ABO
HLA Serologic Typing
215
DMPM
Drug Monitoring for

Pain Management
98
J, J1
200
JAT
200
FTC
Criminalistics
96
Transfusion Medicine,
Automated
JATE1
Toxicology
88
200
Automated, Educational
UT
Urine Toxicology
88
TMCA
202
DFC
99
Competency
Assessment
FTC
Criminalistics
96
Toxicology
UT
GLI
7-aminoclonazepam
10q (PTEN) deletion
ABO grouping
ABO Subgroup typing
ABOSG
ABO Subgroup typing
203
Chemistry and TDM
88
CZ, CZ2X,
CZX, Z
50
52
Urine Toxicology
88
CZQ
233
Quality Cross Check,

Chemistry and TDM
53
Glioma
Acetaminophen
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Acetaminophen (cont.)
FTC
Acetone
TDM Cal Ver/Lin
113
Serum Drug Screen
93
Adenovirus
Toxicology
88
UDS, UDS6
Urine Drug Screen
90
UT
Urine Toxicology
88
AL1
Whole Blood Alcohol/

Ethylene Glycol/
Volatiles
93
AL2
Serum Alcohol/
Ethylene Glycol/
Volatiles
93
SDS
Serum Drug Screen
93
VF
Vitreous Fluid, Postmortem
X
X
Pg
Criminalistics
96
SCDD
Designer Drugs
97
ID2
Nucleic Acid Amp,

Respiratory
183
IDR
Infectious Disease
Respiratory Panel
184
VLS2
Viral Load
180
VR1
Virology Culture
178
VR2
Viral Antigen by DFA
178
VR4
Viral Antigen by EIA

and Latex
179
Adenovirus 40/41
SP, SPN
Stool Pathogen
168
Instrumentation
124
93
Adjustable micropipette
Cal V/L
Tumor Markers
82
170
Adrenocorticotropic
hormone (ACTH)
TM/TMX
Mycobacteriology
E1
Mycobacteriology, Ltd
170
SCDD
Chemistry and TDM
50
52
Designer Drugs
97
C3, C3X,
CZ, CZ2X,
CZX
CZQ

Chemistry and TDM
53
CT, CT1,
CT2, CT3,
CT5
ACT
152
POC14,
POC15,
POC16
Competency Activated
Clotting Time
43
CGB
Basic Coagulation
150
CGE/CGEX
150
CGL
Coagulation, Ltd
150
CGS1
151
CGS3
151
CGS4
151
DBGN
Anticoagulant
152
Monitoring, Dabigatran
FNPX
Anticoagulant
Monitoring,
Fondaparinux
152
RVBN
Anticoagulant
Monitoring,
Rivaroxaban
152
Activated protein C
resistance
CGE/CGEX
150
CGS2
151
Acylcarnitine
BGL
Biochemical Genetics
223
ADAMTS-13
CGS7
ADAMTS-13
151
ADBICA N-pentanoic
acid metabolite
SCDD
Designer Drugs
97
Acid-fast smear
Acid phosphatase
Activated clotting time
Activated partial
thromboplastin time
AKB-48 N-pentanoic
acid metabolite
Alanine aminotransferase (ALT/SGPT)
Albumin
Albumin, CSF
Albumin, urine
X
C1, C3, C3X, Chemistry and TDM

CZ, CZ2X,
CZX
50
52
CZQ

Chemistry and TDM
53
IFS
Interfering Substances
125
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
except AU, Vitros Cal
Ver/Lin
112

CZ, CZ2X,
CZX
50
52
CZQ

Chemistry and TDM
53
FLD
Body Fluid
67
IFS
125
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
SPE
Protein Electrophoresis
70
M, OLI
CSF Chemistry and

Oligoclonal Bands
68
ABU
Accuracy-Based Urine
103
LN20
Urine Albumin
119
Urine Chemistry,
General
63
800-323-4040 | 847-832-7000 Option 1 | cap.org
21
LN3
SDS
Description
ENR Code
ADB-PINACA
N-pentanoic acid
metabolite
LAP Program
263
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Albumin: creatinine ratio
21
Alcohol, serum
Alcohol, whole blood
103
LN20
Urine Albumin Cal

Ver/Lin
119
Urine Chemistry,
General
63
UMC
Urine Albumin
Creatinine
144
AL2
Serum Alcohol/
Ethylene Glycol/
Volatiles
93
Serum Ethanol Cal

Ver/Lin
116

Ethylene Glycol/
Volatiles
93
LN14
Whole Blood Ethanol

Cal Ver/Lin
Aldolase
AL1
Alphahydroxyalprazolam
DFC
99
DMPM
Drug Monitoring for

Pain Management
98
FTC
Criminalistics
96
Toxicology
88
UDC
Forensic Urine Drug

91
Alpha-thalassemia
HGM
Hemoglobinopathies,
Molecular Methods
224
Alprazolam
DMPM
Drug Monitoring for

Pain Management
98
FTC
Criminalistics
96
Toxicology
88
UT
Urine Toxicology
88
Trace Metals
72
TMU
Trace Metals, Urine
95
SCDD
Designer Drug
97
CZ, CZ2X,
CZX, Z
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
Aldosterone, urine
N/NX
Urine Chemistry,
Special
64
(ALP)

CZ, CZ2X,
CZX
50
52
CZQ
53
Aluminum
FLD2
Body Fluid Chemistry 2
67
IFS
125
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
AM-2201 N-(4hydroxypentyl)
metabolite
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
Amikacin
PGX, PGX1,
PGX2
Pharmacogenetics
227
SE
Diagnostic Allergy
193
IG/IGX
Immunology, General
188
LN7
Immunology Cal
Ver/Lin
115
AAT
Alpha-1 antitrypsin
genotyping
223
Alpha-1 globulin
SPE
70
Alpha-2 globulin
SPE
70
CGE/CGEX
150
Alpha-fetoprotein (AFP),
amniotic fluid
FP/FPX
Maternal Screen
80
serum
FP/FPX
Maternal Screen
80
K/KK
Ligand Assay, General
76
114
97
81
Alpha-2-antiplasmin
Ligand Assay, Siemens

Cal Ver/Lin
117
66
LN5S
88
Renin and Aldosterone
Alpha-1 antitrypsin
genotyping
114
Designer Drug
Aldolase
Ligand Assay Cal

Ver/Lin
Urine Toxicology
RAP
Alpha-1 antitrypsin
LN5
SCDD
ADL

Chemistry and TDM
serum (cont.)
UT
Allergens (specific)
Pg
Alpha-PVP (a-Pyrrolidinopentiophenone)
Aldosterone, serum
Allele detection
Description
ENR Code
ABU
LN11
LAP Program
LN3
TDM Cal Ver/Lin
113
BGL
223
Amino acids,
quantitative
BGL
223
Amitriptyline
DFC
99
FTC
Criminalistics
96
Toxicology
88
UT
Urine Toxicology
88
ZT, ZZT
TDM, Special
54
C3, C3X,
CZ, CZ2X,
CZX
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
LN32
Ammonia Cal Ver/Lin
121
Amino acids, qualitative
X
Ammonia
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Amniotic fluid leakage
(nitrazine)
AFL
Amniotic Fluid Leakage
140
ABT, ABT1
Antibody Titer
204
Anti-B titer
ABT3
Antibody Titer
204
99
Anti-beta-2-glycoprotein
99
Antibody detection
DMPM
Drug Monitoring for

Pain Management
98
FTC
Criminalistics
96
OFD

Abuse
92
Toxicology
88
UDC
Forensic Urine Drug

91
UDS, UDS6
Urine Drug Screen
90
UT
Urine Toxicology
88
DMPM
Drug Monitoring for

Pain Management
98
OFD

Abuse
92
Toxicology
88
UDS, UDS6
Urine Drug Screen
90
UT
Urine Toxicology
Amylase, pancreatic
CGE/CGEX
150
J, JAT
200
JATE1
200
PS
Platelet Serology
207
TMCA
Competency
Assessment
202
MX1B,
HLA Analysis, Class I
MX1C,
MX1E, MXB,
MXC
214
215
MX2B,
HLA Analysis, Class II
MX2C,
MX2E, MXB,
MXC
214
215
ETME1
Medicine Exercises
201
J, JAT
200
200
Competency
Assessment
202
MX1B,
MX1C,
MX1E, MXB,
MXC
214
215
MX2B,
MX2C,
MX2E, MXB,
MXC
214
215
Anticardiolipin IgA,
qualitative
ACL, APS
Antiphospholipid
Antibody
191
Anticardiolipin IgA,
quantitative
ACL, APS
Antiphospholipid
Antibody
191
ACL, APS
Antiphospholipid
Antibody
191
Antibody detection/
identification (HLA)
X
88
JATE1

CZ, CZ2X,
CZX
50
52
TMCA
CZQ
53

Chemistry and TDM
FLD
Body Fluid
67
IFS
125
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
Antibody screen (HLA)

CZ, CZ2X,
CZX
50
52
CZQ

Chemistry and TDM
53
Anticardiolipin IgG, IgM,

polyclonal; qualitative
LN6
Urine Chemistry Cal

Ver/Lin
114
Anticardiolipin IgG, IgM,

polyclonal; quantitative
ACL, APS
Antiphospholipid
Antibody
191
Urine Chemistry,
General
63
Anti-CCP
CCP
Cyclic Citrullinated
Peptide Antibody
192
Analytical balance
Instrumentation
124
Anticentromere antibody
S2
Immunology Special
189
Anaplasma
phagocytophilum
TTD
Antibody DetectionTick-Transmitted
Diseases
186
Antichromatin antibody
ACA
Antichromatin Antibody 190
Y/YY
77
ACE
Angiotensin Converting
Enzyme
66
Amylase, urine
X
Androstenedione
Angiotensin converting
enzyme
Anti-CMV, total
Anti-CMV, IgG, IgM

Anti-D titer
VM3
Viral Markers-Series 3
209
VR3
Infectious Disease
Serology
186
VR3
Infectious Disease
Serology
186
ABT, ABT2
Antibody Titer
204
800-323-4040 | 847-832-7000 Option 1 | cap.org
21
DFC
DFC
Pg
Anti-A titer
Amphetamine
Amylase
Description
ENR Code
Amobarbital
Amphetamine group
LAP Program
265
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
Description
Pg
CES, CESX
Celiac Serology
192
CES, CESX
Celiac Serology
192
Antideamidated gliadin
peptide antibody, IgA,
IgG, quant
CES, CESX
Celiac Serology
192
peptide antibody screen,
IgA, IgG
CES, CESX
Celiac Serology
192
Antideamidated
gliadin peptide/tissue
transglutaminase
antibody screen, IgA,
IgG
CES, CESX
Celiac Serology
192
Antifilamentous actin
IgG antibody
FCN
Antifilamentous Actin
Antibody
190
S2
Immunology, Special
189
S2
Immunology, Special
189
ENR Code
Anti-DNA (ds) antibody,
qualitative
21
ENR Code
S2, S4
Immunology, Special
189
Antigliadin antibody
IgA, IgG, quantitative
Anti-DNA (ds) antibody,

quantitative
S2, S4
Immunology, Special
189
Anti-DNA topoisomerase (Scl-70)
RDS
Rheumatic Disease
Special Serologies
194
peptide antibody, IgA,
IgG, qual
CES, CESX
Celiac Serology
192
Antiendomysial antibody
IgA, quantitative
CES, CESX
Celiac Serology
192
IgG, qualitative
CES, CESX
Celiac Serology
192
IgG, quantitative
CES, CESX
Celiac Serology
192
Mycology
171
F1
Yeast
171
CDF2
Clostridium difficile
detection
165
CDF5
detection
165
Bacteriology
158
D4
Bacteriology, Ltd
160
D6
Rapid Group A Strep
162
D8
Group B Strep
163
D9
Rapid Group A Strep,

Waived
163
IgA, qualitative
Antifungal susceptibility
testing
Antigen detection,
bacterial
HC1
C. trachomatis by DFA
165
HC3
C. trachomatis by EIA
165
LBAS
Legionella pneumophila 163
MC1
Microbiology
Combination
161
Antigen detection, viral
Antigliadin antibody
IgA, IgG, qualitative
Antiglomerular basement
membrane, qualitative
VM5
210
Anti-HAV, IgG
VM1
209
Anti-HAV, total
VM1
209
VM5
210
VM1
209
VM2
209
Anti-HBs
VM1
209
Anti-HCV
RHCVW
Anti-HCV, Rapid
Methods, Wavied
211
VM1
209
RDS
Rheumatic Disease
Special Serologies
194
Anti-HBc, IgM
Anti-HBc, total
Anti-HBe
MC2
Microbiology
Combination
161
MC4
Urine Colony Count

Combination
161
Antihistone antibody
MC5
Throat Culture/Rapid
Strep Combination
161
POC4
POC Strep Screen

Competency
42
SBAS
Streptococcus
pneumoniae
163
VS
Vaginitis Screen
169
HC2
HSV by DFA
179
VR2

by DFA
178
VR4

by EIA and Latex
179
Celiac Serology
192
Anti-HAV, IgM
CES, CESX
Antiglomerular basement
membrane, quantitative
Antihistidyl t-RNA
synthetase (Jo-1)
LAP Program
Anti-HIV-1
Anti-HIV-2
Anti-HIV-1/2
AHT
Antihistone Antibody
190
AHIV
Anti-HIV Rapid
Methods
210
AHIVW
Anti-HIV Rapid
Methods
210
VM1
209
VM1
209
AHIV
Anti-HIV Rapid
Methods
210
AHIV
Anti-HIV Rapid
Methods
210
AHIVW
Anti-HIV Rapid
Methods
210
VM1
209
Anti-HIV-1/2, HIV-1
p24 antigen
VM6
210
Anti-HTLV-I/II
VM3
209
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
LAP Program
Description
Pg
RDS
Rheumatic Disease
Special Serologies
194
S2
Immunology, Special
189
S2
Immunology, Special
189
S2
Immunology, Special
189
S2
Immunology, Special
189
S2
Immunology, Special
189
ENR Code
RDS
Rheumatic Disease
Special Serologies
194
Anti-Scl-70 (anti-DNA
topoisomerase)
Anti-LKM
LKM
Liver-Kidney
Microsomal Antibody
194
Anti-Sm antibody,
qualitative
Bacteriology
158
Anti-Sm antibody,
quantitative
D2
Urine Cultures
160
D4
Bacteriology, Ltd
160
Anti-Sm/RNP antibody,
qualitative
D7
Throat, Urine Cultures
160
MBT
Microbiology Bench
Tools Competency
159
MC1
Microbiology
Combination with GC
161
Antisperm antibody IgG
ASA
Semen Analysis
146
MC2
Microbiology
Combination
161
Anti-SSA antibody,
qualitative
S2
Immunology, Special
189
MC5
Strep
161
Anti-SSA antibody,
quantitative
S2
Immunology, Special
189
S2
Immunology, Special
189
Anti-SSB antibody,
qualitative
S2
Immunology, Special
189
antibody
Antibody
190
Anti-SSB antibody,
quantitative
S2
Immunology, Special
189
Anti-MPO
S2
Immunology, Special
189
Immunology, Special
189
AMH
Antimllerian Hormone
78
Anti-SSA/SSB antibody,
qualitative
S2
Antimllerian Hormone
Mycobacteriology
170
Anti-SSA/SSB antibody,
quantitative
S2
Immunology, Special
189
MTBR
Molecular MTB
Detection and
Resistance
170
Antistreptolysin O (ASO)
ASO, IL
Immunology
188
CGE/CGEX
150
CGS2
151
S2
Immunology, Special
189
LN35
Thrombophilia Cal
Ver/Lin
122
Immunology, Special
189
Immunology
188
Antithyroglobulin
antibody, qualitative
S2, S4
ANA, IL
Immunology, Special
189
APC
Antiparietal Cell
Antibody
190
Antithyroglobulin
antibody, quantitative
S2, S4
Antiparietal cell antibody
Immunology, Special
189
ACL
Antiphospholipid
Antibody
191
Antithyroid microsomal,
qualitative
S2, S4
Antiphospholipid
antibody
Immunology, Special
189
150
Antithyroid microsomal,
quantitative
S2, S4
CGE/CGEX
Antiphosphatidylserine
antibodies (IgG, IgM,
and IgA)
APS
Antiphosphatidylserine
Antibodies
191
S2, S4
Immunology, Special
189
S2, S4
Immunology, Special
189
Anti-PR3
S2
Immunology, Special
189
Antiribosomal P
antibody
ARP
Antiribosomal P
Antibody
191
CES, CESX
Celiac Serology
192
S2
Immunology, Special
189
Celiac Serology
192
S2
Immunology, Special
189
Antitissue transglutaminase antibody IgA,

quantitative
CES, CESX
Anti-RNP antibody,
quantitative
Anti-Saccharomyces
cerevisiae antibody
ASC
Anti-Saccharomyces
cerevisiae Antibody
191
Antitissue transglutaminase antibody IgG

qualitative
CES, CESX
Celiac Serology
192
Antimicrobial
susceptibility testing
Antimitochondrial
antibody, qualitative
Antimycobacterial
susceptibility testing
Antineutrophil
cytoplasmic antibody
(ANCA)
Antinuclear antibody
(ANA)
Anti-RNP antibody,
qualitative
Anti-Sm/RNP antibody,
quantitative
Antismooth muscle
antibody
Antithrombin (Activity, Ag)
Antithyroid peroxidase,
qualitative
Antithyroid peroxidase,
quantitative
Antitissue transglutaminase antibody IgA,
qualitative
800-323-4040 | 847-832-7000 Option 1 | cap.org
21
Anti-Jo-1(antihistidyl tRNA synthetase)
267
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
CES, CESX
Celiac Serology
192
Anti-Trypanosoma cruzi
VM4
210
ABL
Accuracy-Based Lipids
102
C3, C3X,
CZ, CZ2X,
CZX
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
ABL
102
C3, C3X,
CZ, CZ2X,
CZX
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
APOE
Apolipoprotein E
(APOE) genotyping
223
Arsenic, urine
TMU
Trace Metals, Urine
95
Arthropod identification
TMO
Ticks, Mites, and Other

Arthropods
176
21
Apolipoprotein B
Apolipoprotein E (APOE)
genotyping
Aspartate aminotransferase (AST/SGOT)
Atenolol
Atropine
Automated WBC
differential
Autopsy pathology
50
52
CZQ

Chemistry and TDM
53
IFS
125
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
Toxicology
88
UT
Urine Toxicology
88
Toxicology
88
UT
Urine Toxicology
Hematology, Auto Diff

FH1-FH4,
FH6, FH9,
FH10, FH13,
FH1P-FH4P,
FH6P, FH9P,
FH10P,
FH13P
Pg
BNP
B-Type Natriuretic
Peptides, 2 Chall
55
BNP5
B-Type Natriuretic
Peptides, 5 Chall
55
BNPQ

B-Type Natriuretic
Peptides
56
LN30
B-Type Natriuretic
Peptides Cal Ver/Lin
120
PCARM,
PCARMX
Plasma Cardiac
Markers
60
POC12
Competency Plasma
Cardiac Markers
43
Babesia microti
TTD
Antibody Detection
of Tick-Transmitted
Diseases
186
Bacterial antigen
detection
CDF2
detection
165
CDF5
detection
165
Bacteriology
158
D4
Bacteriology, Ltd
160
D6
Rapid Group A Strep
162
HC1
165
HC3
165
LBAS
Legionella pneumophila 163

Antigen Detection
MC1
Microbiology
Combination
161
MC2
Microbiology
Combination
161
MC4
Urine Colony Count

Combination
161
MC5
Strep Combination
161
POC4
POC Strep Screen

Competency
42
SBAS
S. pneumoniae Antigen 163

Detection
88
131
VS
Vaginitis Screen
169
BDP, BDPV
Bacterial detection,
platelets
205
BDP5,
BDPV5
Bacterial detection,
platelets
205
Bacteriology
158
D1, D2, D3,

D7
Throat, Urine, GC
Cultures
160
D4
Bacteriology, Ltd
160
D8
Group B Strep
163
DEX
Expanded Bacteriology
159
X
Bacterial detection in
platelets
FH3Q,
FH4Q,
FH6Q,
FH9Q

132
Automated Hematology
Series
AUCD/
AUCD1
Autopsy Pathology,
CD-ROM
B-type natriuretic
peptides

CZ, CZ2X,
CZX
Description
ENR Code
Antitissue transglutaminase antibody IgG

quantitative
Apolipoprotein A1
LAP Program
248
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
(cont.)
LAP Program
Description
Pg
ENR Code
HC6/HC6X
C. trachomatis/GC by
Nucleic Acid Amp
181
(cont)
UT
Urine Toxicology
88
HC7
C. trachomatis/GC
DNA by NAA
181
Benzoylecgonine
DFC
99
DMPM
Drug Monitoring for

Pain Management
98
FTC
Criminalistics
96
OFD

Abuse
92
MC1
Microbiology
Combination with GC
161
MC2
Microbiology
Combination
161
MC4
Urine Colony Count

Combination
161
T
Toxicology
88
MC5
Strep
161
UDC
Forensic Urine Drug

91
MBT
Microbiology Bench
Tools Competency
159
UDS, UDS6
Urine Drug Screen
90
MRS
Methicillin-Resistant
Screen
167
UT
Urine Toxicology
88
UTCO
Urine Toxicology
Carryover
126
MRS5
Screen
167
ACL, APS
Antiphospholipid
Antibody
191
TM/TMX
Tumor Markers
82
BSTE
Bacterial Strain TypingEnterococcus
182
CD
Cadmium
94
BSTN
Bacterial Strain TypingGram-negative
182
58
BSTS
Bacterial Strain TypingStaphylococcus
182
BV
Bacterial Vaginosis
168
Bacterial strain typing
Bacterial vaginosis
screen
Barbiturate group
BB-22 3-carboxyindole
metabolite
VS2
Vaginitis Screen, Virtual 169

Gram Stain
DMPM
Drug Monitoring for

Pain Management
98
SDS
Serum Drug Screen
93
Toxicology
88
UDS, UDS6
Urine Drug Screen
90
UT
Urine Toxicology
88
SCDD
Designer Drugs
97
BCR/ABL1 p190
MRD1
Minimal Residual
Disease
234
BCR/ABL1 p210
MRD
Minimal Residual
Disease
234
Beta-2-glycoprotein I
Beta-2-microglobulin,
serum
Beta-2-microglobulin,
urine
Beta-hydroxybutyrate
KET
Ketones
Beta globulin
SPE
Serum Electrophoresis
70
Beta-thalassemia
HGM
Hemoglobinopathies,
Molecular Methods
224
Bile crystal identification
BCR
Bile Crystals
141
Bilirubin, confirmatory
urine
DSC
Dipstick Confirmatory
141
C1, C3,
C3X, CZ,
CZ2X, CZX
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
NB, NB2
Neonatal Bilirubin
Chemistry and TDM

C1, C3,
C3X, C4, CZ,
CZ2X, CZX
50
52
53
Bilirubin, direct
Bilirubin, total
21
59
Bence Jones protein
UBJP
Urinary Bence Jones

Protein
70
DMPM
Drug Monitoring for

Pain Management
98
CZQ

Chemistry and TDM
OFD

Abuse
92
FLD2
67
SDS
Serum Drug Screen
93
IFS
125
Toxicology
88
LM1
Lung Maturity
70
UDS, UDS6
Urine Drug Screen
90
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
800-323-4040 | 847-832-7000 Option 1 | cap.org
269
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Bilirubin, total (cont.)
21
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
Neonatal Bilirubin
59
NB, NB2
CMP, CMP1, Clinical Microscopy

CMP2,
CMP3
139
DSC
141
HCC2
Waived Combination
61
POC3
POC Urine Dipstick

Competency
42
Bioavailable testosterone
DY
77
Biochemical genetics
BGL, BGL1
223
Bioterrorism agents
LPX
Laboratory
Preparedness Exercise
166
BK virus
ID1T
Nucleic Acid Amp, JC

and BK
183
VLS, VLS2
Viral Load
180
BCP, BCP2
Blood Cell Identification 130
EHE1
Expanded Virtual
137
Peripheral Blood Smear
Blood cell identificationbody fluid

Blood culture
Blood culture
Blood parasite
Bloom syndrome

FH1-FH4,
FH6, FH9,
FH10, FH13,
FH1P-FH4P,
FH6P, FH9P,
FH10P,
FH13P
131
HEP
Basic Hematology
130
VPBS
Virtual Peripheral Blood 136

Smear
VBF
Virtual Body Fluid
140
BCS
Blood Culture
163
GNBC
Gram-Negative Blood
Culture Panel
185
GPBC
Gram-Positive Blood
Culture Panel
185
BCS1
Blood Culture
164
BP
Blood Parasite
175
Parasitology
174
RMAL
Rapid Malaria
175
MGL4
Molecular Genetics
225
Bocavirus
IDR
Infectious Disease
Respiratory Panel
184
Body fluid (cell count)
ABF1, ABF2, Automated Body Fluid

ABF3
140
HFC, HFCI
142
143
Pg
Hemocytometer Fluid
Count
Body fluid (chemistry)
FLD, FLD2
Body Fluid
67
Body fluid (crystals)
BFC
Crystals
141
Body fluid photographs
CMP, CMP1
Clinical Microscopy
139
Bone marrow cell

differential
BMD
Bone Marrow Cell

Differential
134
Bone marrow cell

identification
BMD
Bone Marrow Cell

Differential
134
Bone specific alkaline

phosphatase
BMV2
Bone Markers and

Vitamins
79
Bordetella parapertussis
BOR
Bordetella pertussis/
parapertussis,
Molecular
164
IDN, IDO
Nucleic Acid Amp,

Organisms
182
BOR
Bordetella pertussis/
parapertussis,
Molecular
164
IDN, IDO
Nucleic Acid Amp,

Organisms
182
Borrelia burgdorferi
TTD
Antibody Detection
of Tick-Transmitted
Diseases
186
BRAF
BRAF
Mutation testing
233
MTP
Multigene Tumor Panel
233
225
Bordetella pertussis
BRCA1/2
Blood parasite, rapid
Description
ENR Code
X
Bilirubin, urine
LAP Program
MGL3
Molecular Genetics
BRCA1/2 Sequencing
BRCA
BRCA1/2 sequencing
224
Brain tissue by FISH
CYJ
Fluorescence In Situ
Hybrid, Brain/Glioma
Tissue
221
ISH2
In Situ Hybridization
231
DFC
99
Toxicology
88
UT
Urine Toxicology
88
DMPM
Drug Monitoring for

Pain Management
98
Toxicology
88
UDC
Forensic Urine Drug

91
UDS, UDS6
Urine Drug Screen
90
UT
Urine Toxicology
88
Bupropion
Toxicology
88
UT
Urine Toxicology
88
Butalbital
DFC
99
DMPM
Drug Monitoring for

Pain Management
98
FTC
Criminalistics
96
Toxicology
88
UDC
Forensic Urine Drug

91
Brightfield in situ
hybridization
Brompheniramine
Buprenorphine
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
UT
Urine Toxicology
88
Butylone
SCDD
Designer Drugs
97
C. difficile
CDF2
detection
165
CDF5
detection
165
Bacteriology-Antigen
Detection
158
GIP
Gastrointestinal Panel
184
SP, SPN
Stool Pathogens- Rapid

and Molecular
168
LN34
Tumor Markers Cal

Ver/Lin
121
82
TM/TMX
Tumor Markers
FLD
Body Fluid
67
LN34
Tumor Markers Cal

Ver/Lin
121
TM/TMX
Tumor Markers
82
CA 27.29
TM/TMX
Tumor Markers
82
CA 72-4
Calcium, urine (cont.)
Urine Chemistry,
General
63
Calcium, ionized
AQ, AQ2,
AQ3, AQ4
Aqueous Blood Gas
84
AQQ,
AQ2Q,
AQ3Q,
AQ4Q

Critical Care Aqueous
Blood Gas Series
85
C3, C3X,
CZ, CZ2X,
CZX
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
LN13C
Blood Gas Cal Ver/Lin
117
POC10,
POC11
POC Competency Blood 43

Gases
Calcofluor white
FSM
Fungal Smear
Campylobacter
CAMP
Campylobacter
165
GIP
184
MGL4
Molecular Genetics
225
Candida culture
F3
Candida culture
172
VS
Vaginitis Screen
169
See Delta-9-THCCOOH and Delta-9THC
9092,
126
CZ, CZ2X,
CZX, Z
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
LN3
TDM Cal Ver/Lin
113
Toxicology
88
UT
Urine Toxicology
88
Toxicology
88
TM/TMX
Tumor Markers
82
Tumor Markers Cal

Ver/Lin
121
Candida sp., DNA

probe
TM/TMX
Tumor Markers
82
Cannabinoids
Cadmium, urine
CD
Cadmium
94
CD
Cadmium
94
Caffeine
CZ2X, CZX,
CZ, Z
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
TM/TMX
Tumor Markers
82
ABS
Accuracy-Based
Testosterone and
Estradiol
103
Calcitonin
Calcium
Calcium, urine
Chemistry and TDM

C1, C3,
C3X, C4, CZ,
CZ2X, CZX
50
52
CZQ

Chemistry and TDM
53
FLD2
67
IFS
125
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
ABU
103
LN6
Urine Chemistry Cal

Ver/Lin
114
Carbamazepine
Carbamazepine-10, 11epoxide
Carbamazepine, free
Carboxyhemoglobin
Carisoprodol
Carnitine
21
172
Canavan
LN34
CA 125
Pg
CA 19-9
Description
ENR Code
Butalbital (cont.)
CA 15-3
LAP Program
UT
Urine Toxicology
88
CZ, CZ2X,
CZX, Z
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
SO
Blood Oximetry
86
SOQ

Blood Oximetry
86
DFC
99
DMPM
Drug Monitoring for

Pain Management
98
FTC
Criminalistics
96
Toxicology
88
UT
Urine Toxicology
88
BGL1
223
800-323-4040 | 847-832-7000 Option 1 | cap.org
271
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
UAA, UAA1 Automated Urinalysis
141
CD1a
RFAV1
Rare Flow Antigen

Validation CD1a
198
FL, FL1
Lymphocyte subset
immunophenotyping
196
LN22
Flow Cytometry Cal

Ver/Lin
119
SCP
Stem Cell Processing
206
FL, FL1
Lymphocyte subset
immunophenotyping
196
LN22
Flow Cytometry Cal

Ver/Lin
119
FL, FL1
Lymphocyte subset
immunophenotyping
196
LN22
Flow Cytometry Cal

Ver/Lin
119
21
CD4
CD8
CD20
PM3
245
CD34
CBT
Cord Blood Testing
206
FL4
Flow Cytometry CD34+ 196
SCP
206
CBT
Cord Blood Testing
206
FL, FL1
Lymphocyte subset
immunophenotyping
196
FL4
SCP
206
CD103
RFAV2
Rare Flow Antigen

Validation, CD103
198
CD117 (c-kit)
PM1
245
CEA
FLD
Body Fluid
67
K, KK, K2
76
LN5
Ligand Assay Cal

Ver/Lin
114
LN5S

Cal Ver/Lin
114
S2, S4
Immunology, Special
189
CFU-GM
SCP
206
CH50
CH50
Total Hemolytic
complement
194
CH100
CH50
CH100
194
HC1
165
HC3
165
HC6, HC6X
Nucleic Acid Amp
181
HC7
C. trachomatis/GC
DNA by NAA
181
VR1
Virology Culture
178
Chlamydiophila
pneumoniae
IDN, IDO
Nucleic Acid Amp,

Organisms
182
Chlordiazepoxide
Toxicology
88
UT
Urine Toxicology
88
X
CD45
X
Ceruloplasmin
Chlamydia trachomatis
Description
Pg
ENR Code
Casts, urine
CD3
LAP Program
Chloride
Chloride, sweat
Chloride, urine
X
Chloride, vitreous fluid
Chlorpheniramine
Chlorpromazine
Cholesterol
X
AQ, AQ2,
AQ3, AQ4
Aqueous Blood Gas
84
AQQ,
AQ2Q,
AQ3Q,
AQ4Q

Blood Gas Series
85
Chemistry and TDM

C1, C3,
C3X, C4, CZ,
CZ2X, CZX
50
52
CZQ

Chemistry and TDM
53
FLD2
67
IFS
125
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
LN13C
117
POC10,
POC11

Gases
SW1, SW2,
SW3, SW4
Sweat Analysis Series
73
LN6
Urine Chemistry Cal

Ver/Lin
114
Urine Chemistry,
General
63
VF
93
DFC
Drug Facilitated Crime
99
FTC
Criminalistics
96
Toxicology
88
UT
Urine Toxicology
88
Toxicology
88
UT
Urine Toxicology
88
ABL
102
Chemistry and TDM

C1, C3,
C3X, C4, CZ,
CZ2X, CZX
50
52
CZQ
53

Chemistry and TDM
FLD
Body Fluid
67
LCW
Ltd Chem, Waived
59
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Chromium
Chromium, urine
Chromosomal
abnormalities
Citalopram
Trace Metals
72
TMU
Trace Metals, Urine
95
CY, CYBK
Cytogenetics
220
DFC
99
Toxicology
88
UT
Urine Toxicology
88
Pg
CRTI
Cardiac Markers
57
CRT, CRTI
Cardiac Markers
57
IFS
125
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
PCARM,
PCARMX
Plasma Cardiac
Markers
60
Clozapine (cont.)
ZE
Therapeutic Drug
Monitoring, Extended
54
CMV
ID1
Nucleic Acid Amp,

Viruses
183
LN38
CMV Viral Load Cal

Ver/Lin
122
VLS, VLS2
Viral Load
180
VM3
209
VR1
Virology Culture
178
VR2

by DFA
178
VR3
Infectious Disease
Serology
186
C3, C3X,
C4, CZ,
CZ2X, CZX
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
IFS
125
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
CO2
POC12
Competency Plasma
Cardiac Markers
43
LN2
IFS
125
LN2BV
112
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
Cobalt
TMU
Trace Metals, Urine
95
Cocaethylene
FTC
Criminalistics
96
Toxicology
88
UT
Urine Toxicology
88
DMPM
Drug Monitoring for

Pain Management
98
Clinical Pathology
Improvement Program
CPIP/CPIP1
Quality Management
(Education)
14
Clomipramine
Toxicology
88
UT
Urine Toxicology
88
DMPM
Drug Monitoring for

Pain Management
98
FTC
Criminalistics
96
FTC
Criminalistics
96
OFD

Abuse
92
Toxicology
88
Toxicology
88
UT
Urine Toxicology
88
UDS, UDS6
Urine Drug Screen
90
Clonidine
DFC
99
UT
Urine Toxicology
88
CDF2
detection
165
CDF5
detection
165
Bacteriology-Antigen
Detection
158
GIP
184
SP, SPN
Stool Pathogens- Rapid

and Molecular
168
Toxicology
88
UT
Urine Toxicology
88
Clonazepam
Clozapine
Cocaine
Codeine
DFC
99
DMPM
Drug Monitoring for

Pain Management
98
FTC
Criminalistics
96
OFD

Abuse
92
Toxicology
88
UDC
Forensic Urine Drug

91
UT
Urine Toxicology
88
J, JAT
200
800-323-4040 | 847-832-7000 Option 1 | cap.org
21
CK-MB
(immunochemical)
CK2 (MB)
Description
ENR Code
CK isoenzymes
LAP Program
273
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
(cont.)
21
Complement C3
Complement C4
50
52
CZQ

Chemistry and TDM
53
188
IFS
125
115
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
Immunology, General
188
LN2BV
115
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
Immunology Cal
Ver/Lin
AQ2, AQ4
Aqueous Blood Gas
84
AQ2Q,
AQ4Q

Blood Gas Series
85
200
TMCA
Competency
Assessment
202
IG/IGX
Immunology, General
LN7
Immunology Cal
Ver/Lin
IG/IGX
LN7
K/KK
76
SW1, SW2,
SW3, SW4
73
Connexin 26
MGL3
Molecular Genetics
225
Copper
X
X
Coronavirus
Cortisol
Cortisol, salivary
Cortisol, urinary free
Cotinine
C-peptide
C-reactive protein (CRP)
C-reactive protein, highsensitivity (hsCRP)
Trace Metals
72
TMU
Trace Metals, Urine
95
N/NX
Urine Chemistry,
Special
64
ID2
Nucleic Acid Amp,

Respiratory
183
IDR
Infectious Disease,
Respiratory Panel
184
ABS
Accuracy-Based
Testosterone and
Estradiol
103

CZ, CZ2X,
CZX
50
52
CZQ

Chemistry and TDM
53
K/KK
76
LN5
Ligand Assay Cal

Ver/Lin
114
LN5S

Cal Ver/Lin
114
SALC
Salivary Cortisol
71
N/NX
Urine Chemistry,
Special
64
Toxicology
88
UT
Urine Toxicology
88
ING
Insulin, Gastrin,
C-Peptide, PTH
80
CRP, IL
Immunology
188
LN12,
LN12E
C-Reactive Protein Cal

Ver/Lin
116
HSCRP
High-Sensitivity
C-Reactive Protein
58
LN21
High-Sensitivity
Ver/Lin
119
Pg

CZ, CZ2X,
CZX
JATE1
Conductivity, sweat
Coproporphyrins
Description
ENR Code
Complexed PSA
Copper, urine
LAP Program
Creatinine
Chemistry and TDM

C1, C3,
C3X, C4, CZ,
CZ2X, CZX
50
52
CZQ

Chemistry and TDM
53
FLD
Body Fluid
67
IFS
125
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
LN24
Creatinine Accuracy
Cal Ver/Lin
120
SCO
Serum Carryover
126
ABU
103
BU
Bone and Mineral,

Urine
79
CD
Cadmium
94
DAI
Urine Drug Adulterant/

Integrity Testing
90
LN6
Urine Chemistry Cal

Ver/Lin
114
LN20
Urine Albumin Cal

Ver/Lin
119
Urine Chemistry,
General
63
UDC
Forensic Urine Drug

91
UMC
Urine Albumin/
Creatinine
144
VF
93
WBCR
61
Creatinine, urine
X
Creatinine, vitreous fluid
Creatinine, whole blood
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Crossmatching
Cryptococcal antigen
detection
EXM, EXM2
Electronic Crossmatch
203
J, JAT
200
MX1B,
MX1C, MXB,
MXC
214
215
MX2B,
HLA Analysis Class II
MX2C, MXB,
MXC
214
215
TMCA
Competency
Assessment
202
Mycology
171
F1
Yeast
171
GIP
184
Crystals
P, P3, P4, P5 Parasitology
Body Fluid Crystals
141
UAA
Automated Urinalysis
141
URC
Urine Crystals
141
Bacteriology
158
BMV5
Bone Markers and

Vitamin
79
BU
Bone and Mineral,

Urine
79
Cyclic citrullinated
peptide antibody
CCP
Anti-cyclic citrullinated
peptide antibody
192
Cyclobenzaprine
DFC
99
FTC
Criminalistics
96
Toxicology
88
UT
Urine Toxicology
88
CS
Immunosuppressive
Drugs
53
LN31
Immunosuppressive
Drugs Cal Ver/Lin
121
C-telopeptide (CTX)
Cyclosporine
CYP2C9
PGX
Pharmacogenetics
227
CYP2C19
PGX
Pharmacogenetics
227
CYP2D6
PGX
Pharmacogenetics
227
CYP3A4
PGX
Pharmacogenetics
227
CYP3A5
PGX
Pharmacogenetics
227
Cystatin C
Cystic fibrosis
Cytogenomic microarray
Cytology proficiency
testing
Cytomegalovirus (CMV)
ID1
Nucleic Acid Amp,

Viruses
183
LN38
CMV Viral Load Cal

Ver/Lin
122
180
VLS, VLS2
Viral Load
VM3
209
VR1
Virology Culture
178
VR2
Virology by DFA
178
VR3
Infectious Disease
Serology
186
PAPCE1
PAP Edu, Conventional
251
PAPJE1
PAP Edu, All

Technologies
251
PAPKE1
PAP Edu, SurePath
251
PAPME1
PAP Edu, ThinPrep
251
PAPCPT
PAP PT, Conventional
250
PAPJPT
PAP PT, Combination
250
PAPKPT
PAP PT, SurePath
250
PAPLPT
PAP PT, Combination
250
PAPMPT
PAP PT, ThinPrep
250
FNA/FNA1
Fine-Needle Aspiration- 255

online
FNAG/
FNAG1

glass
Cytopathology GYN
education
174
BFC
CSF antigen detection
Pg
CYS
Cystatin C
68
MGL2,
MGL5
Molecular Genetics
225
CYCGH
Cytogenomic
Microarray Analysis
221
Cytopathology GYN
proficiency testing
Cytopathology,
nongynecologic
NGC/NGC1 Nongynecologic
Cytopath Edu Prgm
254
Cytopreparation
differential
HFC
Hemocytometer Fluid
Count
142
Dabigatran
DBGN
Anticoagulant
152
D-dimer, qualitative
CGDF
Coagulation, D-dimer/
FDP
150
CGL
Coagulation, Ltd
150
WBDD
Whole Blood D-dimer
155
CGDF
FDP
150
D-dimer, quantitative
X
X
X
Delta-9-THC
See Cytopathology
GYN proficiency
testing
Delta-9-THC-COOH
CGL
Coagulation, Ltd
150
LN42
D-dimer Cal Ver/Lin
123
PCARM,
PCARMX
Plasma Cardiac
Markers
60
POC12
Competency Plasma
Cardiac Markers
43
FTC
Criminalistics
96
OFD

Abuse
92
Toxicology
88
UT
Urine Toxicology
88
DFC
99
800-323-4040 | 847-832-7000 Option 1 | cap.org
21
Cryptosporidium
immunoassay,
preserved specimen
Description
ENR Code
Cryptosporidium
LAP Program
275
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Delta-9-THC-COOH
(cont.)
Drug Monitoring for

Pain Management
98
FTC
Criminalistics
96
Toxicology
88
UDC
Forensic Urine Drug

91
UDS, UDS6
Urine Drug Screen
90
UT
Urine Toxicology
88
UTCO
Urine Toxicology
Carryover
126
Deoxypyridinoline (DPD)
BU
Bone and Mineral,

Urine
79
Dermatopathology
DPATH/
DPATH1
Online Digital Slide

Program
239
Mycology
171
Toxicology
88
UT
Urine Toxicology
88
DFC
99
FTC
Criminalistics
96
Toxicology
88
UT
Urine Toxicology
88
Dermatophyte
identification
Desalkylflurazepam
Desipramine
X
Desmethylclomipramine
Desmethylsertraline
Dextromethorphan
DHEA sulfate
DIA (Dimeric inhibin A)
Diazepam
Description
Pg
ENR Code
DMPM
21
LAP Program
ZT, ZZT
TDM, Special
54
Toxicology
88
UT
Urine Toxicology
88
FTC
Criminalistics
96
Toxicology
88
UT
Urine Toxicology
88
Toxicology
88
UT
Urine Toxicology
88
Differential, automated
Differential, manual
Digital slide program in

fine-needle aspiration,
online
Digoxin
Digoxin, free
Dihydrocodeine
Diltiazem

FH1-FH4,
FH6, FH9,
FH10, FH13,
FH1P-FH4P,
FH6P, FH9P,
FH10P,
FH13P
131
FH3Q,
FH4Q,
FH6Q,
FH9Q

132
Series
BMD
Bone Marrow Cell

Differential
134
HFC, HFCI
Hemocytometer Fluid
Count
142
143
FNA/FNA1

Program
255
CZ, CZ2X,
CZX, Z
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
LN3
TDM Cal Ver/Lin
113
CZ, CZ2X,
CZX, Z
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
Toxicology
88
UT
Urine Toxicology
88
Toxicology
88
UT
Urine Toxicology
88
Dilute prothrombin time
CGE/CGEX
150
Dilute Russells viper

venom time
CGE/CGEX
150
FP, FPX
Maternal Screen
80
DFC
99
FTC
Criminalistics
96
DFC
99
Toxicology
88
UT
Urine Toxicology
88
Y/YY
77
FP/FPX
Maternal Screen
80
Toxicology
88
DMPM
Drug Monitoring for

Pain Management
98
UT
Urine Toxicology
88
FTC
Criminalistics
96
OFD

Abuse
92
Toxicology
88
UT
Urine Toxicology
88
Dimeric inhibin A (DIA)
Diphenhydramine
Diphenylhydantoin
Direct antiglobulin
testing
Direct bilirubin
See Phenytoin
X
DAT
Direct Antiglobulin
Testing
207
TMCAD
Competency
Assessment
202
C1, C3,
C3X, CZ,
CZ2X, CZX
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Direct bilirubin (cont.)
X
Disease Association/
Drug Risk
Disopyramide
DMD/Becker
DNA analysis
Description
Pg
EGFR
Mutation testing
233
MTP
233
LN24
Creatinine Accuracy
CalVer/Lin
120
ENR Code
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
NB, NB2
Neonatal Bilirubin
59
DADR1,
DADR2
Disease Associate/
Drug Risk
217
CZ, CZ2X,
CZX, Z
Chemistry and TDM
CZQ
EGFR-Epidermal growth
factor receptor
eGFR
EXM, EXM2
203
HG
Hemoglobinopathy
134
LPE
70
50
52
Lipoprotein
Electrophoresis
M, OLI
68

Chemistry and TDM
53
CSF Chemistry and

Oligoclonal Bands
SPE
70
MGL2
Molecular Genetics
225
UBJP
70
DL, DML
HLA Molecular Typing
Urinary Bence Jones

Proteins
ELU
Eluate
207
TMCAE
Eluate Competency
Assessment
202
215
Electrophoresis
Elution, antibody
DNA, DNAF DNA Database
258
FID, FIDM
Forensic Identity
258
ML
HLA Molecular Typing
215
Embryology
EMB
Embryology
147
MHO
Molecular Oncology
234
GIP
184
ID1
Nucleic Acid Amp,

Viruses
183
IDR
Infectious Disease,
Respiratory Panel
184
PARF
Parentage/Relationship 212
Enterotoxigenic E. coli
(ETEC)
DNA content/cell cycle

analysis
FL, FL2
Flow Cytometry
Enterovirus
DNA database
258
DNA extraction and

amplification
MHO5
Molecular Oncology
Hematologic
231,
234
VR1
Virology Culture
178
DNA fingerprinting
IDN, IDO
Nucelic Acid Amp,

Organisms
182
Eosinophils, urine
SCM2
Special Clinical
Microscopy
144
DNA Mismatch Repair
MMR
DNA Mismatch Repair
245
Ephedrine
FTC
SEC, SEC1
DNA Sequencing
226
Criminalistics
96
DNA sequencing
N/NX
Urine Chemistry,
Special
64
Toxicology
88
UT
Urine Toxicology
88
DFC
99
EGFR
Mutation testing
233
FTC
Criminalistics
96
Epidermal growth factor

receptor (EGFR)
MTP
233
Toxicology
88
Epinephrine
N/NX
64
UT
Urine Toxicology
88
Urine Chemistry,
Special
DFC
99
Epithelial cells, urine
UAA1
141
88
Epstein-Barr virus (EBV)
ID1
Nucleic Acid Amp,

Viruses
183
Dopamine
Doxepin
Doxylamine
T
Duloxetine
E. coli O157
Toxicology
196
UT
Urine Toxicology
88
Toxicology
88
UT
Urine Toxicology
88
FTC
Criminalistics
96
Toxicology
88
UT
Urine Toxicology
88
FTC
Criminalistics
96
Toxicology
88
UT
Urine Toxicology
88
GIP
184
ISH
231
VLS, VLS2
Viral Load
180
VR3
Antibody DetectionInfectious Disease

Serology
186
PM2
ER, PgR by
247
Erythrocyte
sedimentation rate
ESR, ESR1,
ESR2, ESR3
Erythrocyte
Sedimentation Rate
131
Erythropoietin
EPO
Erythropoietin
79
Escherichia coli O157
GIP
184
ER, PgR by
800-323-4040 | 847-832-7000 Option 1 | cap.org
21
LAP Program
277
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Estradiol
ABS
21
X
Estriol, unconjugated
(uE3)
103
Reproductive
Endocrinology Cal
Ver/Lin
115
Y/YY
77
LN24
Creatinine Accuracy
Cal Ver/Lin
120
Maternal Screen
80
FP/FPX
Description
Pg
ENR Code
Accuracy-Based
Testosterone and
Estradiol
LN8
LAP Program
Factor VII
CGE/CGEX
150
CGE/CGEX
150
CGS3
151
Factor VIII Inhibitor
CGE/CGEX
150
Factor IX
CGE/CGEX
150
Factor X
CGE/CGEX
150
Factor XI
CGE/CGEX
150
Factor XII
CGE/CGEX
150
Factor XIII
CGE/CGEX
150
Factor VIII
Familial dysautonomia
MGL4
Molecular Genetics
225
Fanconi anemia
MGL4
Molecular Genetics
225
Fecal fat, qualitative
FCFS
Fecal Fat
69
Fecal lactoferrin
FLAC
Fecal Lactoferrin
166
Fentanyl
DFC
99
DMPM
Drug Monitoring for

Pain Management
98
FTC
Criminalistics
96
Toxicology
88
UDS, UDS6
Urine Drug Screen
90
UT
Urine Toxicology
88
Y/YY
77
Estrogen receptors by
PM2
ER, PgR by
247
Ethanol
AL1

Ethylene Glycol/
Volatiles
93
AL2
Serum Alcohol/
Ethylene Glycol/
Volatiles
93
LN11
Serum Ethanol Cal

Ver/Lin
116
LN14
Whole Blood Ethanol

Cal Ver/Lin
117
Fern test
CMMP,
CMP3
Clinical Microscopy,
Misc
139
Ethanol, urine
UDS, UDS6
Urine Drug Screen
90
Ferritin
VF
93
C3, C3X,
CZ, CZ2X,
CZX
Chemistry and TDM
Ethanol, vitreous fluid
50
52
ETEC (Enterotoxigenic
E. coli)
GIP
184
CZQ

Chemistry and TDM
53
CZ, CZ2X,
CZX, Z
Chemistry and TDM
50
52
K, KK, K2
76
LN5
114
CZQ

Chemistry and TDM
53
Ligand Assay Cal

Ver/Lin
LN5S

Ethylene Glycol/
Volatiles
93

Cal Ver/Lin
114
AL1
Serum Alcohol/
Ethylene Glycol/
Volatiles
93
Ethosuximide
Ethylene glycol
AL2
Fetal fibronectin
LM, LM1
Lung Maturity
70
ROM1
Rupture of Fetal
Membrane
143
94
Fetal lung maturity
94
Fetal membrane rupture
Ethylone
SCDD
Designer Drugs
97
Euglobulin Test
CGE/CGEX
150
Everolimus
EV
Everolimus
53
CGE/CGEX
150
TPM
Thrombophilia
Mutations
228
CGE/CGEX
150
MGL1
Molecular Genetics
225
TPM
Thrombophilia
Mutations
228
134
Ethanol Biomarkers
Ethanol Biomarkers
Factor V Leiden mutation
142
Hemoglobinopathy
ETB
Factor V
79
Fetal Hemoglobin
HG
ETB
Fetal Fibronectin
Ethyl sulfate (EtS)
Factor II mutation
FF
APT
Fetal hemoglobin
identification
Ethyl glucuronide (EtG)
Factor II
Fetal hemoglobin (gastric

fluid)
Fetal red cell quantitation
Fetal screen (Rosette

testing)
Fibrin monomer
HBF
Fetal Red Cell Detection 207
TMCAF
Competency
Assessment
HBF
Fetal Red Cell Detection 207
TMCAF
Competency
Assessment
202
CGE/CGEX
150
202
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Fibrinogen
LAP Program
Description
Pg
ENR Code
CGL
Coagulation, Ltd
LN44
Fibrinogen, Cal Ver/Lin 123
150
Fluoxetine (cont.)
FTC
Criminalistics
96
CGE/CGEX
150
Toxicology
88
Fibrinogen degradation
products, plasma
CGDF
FDP
150
UT
Urine Toxicology
88
FTC
96
CGL
Coagulation, Ltd
150
Criminalistics
CGDF
FDP
150
Toxicology
88
UT
Urine Toxicology
88
CGL
Coagulation, Ltd
150
Folate, RBC
FOL
RBC Folate
81
Fine-needle aspiration,
digital slide program
FNA/FNA1

Program
255
Folate, serum
K, KK, K2
76
LN5
FNAG/
FNAG1
Fine-Needle Aspiration
256
Ligand Assay Cal

Ver/Lin
114
Fine-needle aspiration,
glass slides
LN5S
Hybridization-Breast
Cancer
221

Cal Ver/Lin
114
CYH
LN8
Reproductive
Endocrinology Cal
Ver/Lin
115
Fibrinogen degradation
products, serum
FISH for breast

carcinoma hybridization
and interpretation
on site (HER2 gene
amplification)
Flurazepam
Follicle-stimulating
hormone (FSH)
FISH for brain/glioma
CYJ
Hybridization, Brain/
Glioma Tissue
221
Y/YY
77
Fondaparinux
FNPX
152
FISH for constitutional

and hematologic
disorders
CYF
Hybridization
220
Anticoagulant
Monitoring,
Fondaparinux
Forensic identity (DNA)
FID, FIDM
Forensic Identity
258
Forensic pathology
FR/FR1
Forensic Pathology
259
FISH for lymphoma
CYL
Forensic toxicology
FTC
Criminalistics
96
MGL1
Molecular Genetics
225
FP1B
First Trimester Maternal

Screening, Free Beta
80
FISH for paraffinembedded tissue
CYH
CYJ
CYK
CYL
FISH for sarcoma
FISH for urothelial

carcinoma hybridization
and interpretation on-site
Flunitrazepam
CYK
Fluorescence In
Situ Hybridization,
Lymphoma
221
Cancer
221
Glioma Tissue
221
Fragile X
221
Hybridization, Sarcoma
Tissue or Pediatric
Neoplasm
Fluorescence In
Situ Hybridization,
Lymphoma
Free Beta hCG

Free testosterone
DY
77
Friedreich ataxia
MGL2
Molecular Genetics
225
Fructosamine
FT
Fructosamine
69
Fungal culture
CBT
Cord Blood Testing
206
SCP
206
FSER
Fungal Serology
172
Mycology
171
F1
Yeast
171
F3
Candida culture
172
Gabapentin
ZE
Therapeutic Drug
54
Galactomannan
FGAL
Galactomannan
172
Gamma globulin
M, OL1
CSF Chemistry
68
SPE
Serum Electrophoresis
70
C3, C3X,
CZ, CZ2X,
CZX
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
IFS
125
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
Fungal serology
Fungus identification
221
221
Hybridization, Sarcoma
Tissue or Pediatric
Neoplasm
CYI
Fluorescence In
Situ Hybridization,
220
Toxicology
88
UT
Urine Toxicology
88
Fluorescent microscope
check
Instrumentation
124
Fluoxetine
DFC
99
Gamma glutamyl
transferase (GGT)
800-323-4040 | 847-832-7000 Option 1 | cap.org
21
Fibrinogen antigen
279
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
Gamma hydroxybutyrate
DFC
99
FTC
Criminalistics
96
VS
Vaginitis Screen
169
GOCB
Gastric Occult Blood
142
Gardnerella vaginalis,
DNA Probe
Gastric pH
Glucose, urine
Pg

CMP2,
CMP3
HCC2
Waived Combination
61
LN6
Urine Chemistry Cal

Ver/Lin
114
POC3
POC Urine Dipstick

Competency
42
Urine Chemistry,
General
63
VF
93
61
Gastric occult blood
Description
ENR Code
Gamma glutamyl
transferase (GGT) (cont.)
21
LAP Program
Glucose, vitreous fluid
139
GOCB
142
Gastrin
ING
Insulin, Gastrin,
C-Peptide, PTH
80
X
HCC
Waived Combination
Gaucher disease
MGL4
Molecular Genetics
225
HCC2
Waived Combination
61
CYCGH
Cytogenomic
Microarray Analysis
221
LCW
Ltd Chem, Waived
59
LN17
Chemistry and TDM
50
52
Whole Blood Glucose

Cal Ver/Lin
118
CZ, CZ2X,
CZX, Z
POC2

Chemistry and TDM
53
POC Glucose
Competency
42
CZQ
POC7
TDM Cal Ver/Lin
113
GIP
184
POC/Waived Glucose
and Hemoglobin
Competency
42
LN3
WB2
Whole Blood Glucose,

3 challenges
61
Genomic copy number

array
Gentamicin
Giardia
Glucose, whole blood
Giardia immunoassay,
preserved specimen
Giemsa stain
BP
Blood Parasite
175
Parasitology
174
CYJ
Glioma Tissue
221
AQ2, AQ4
Aqueous Blood Gas
84
AQ2Q,
AQ4Q

Blood Gas Series
85
Glioma by FISH
Glucose
Glucose, CSF
174
WBG
Whole Blood Glucose
61
Glucose-6-phosphate
dehydrogenase
G6PDS
Glucose-6 Phosphate
Dehydrogenase
69
Glutaraldehyde, urine
DAI

Integrity Testing
90
Glycated Serum albumin
GSA
Glycated Serum
Albumin
58
Glycogen storage
disease type 1A
MGL4
Molecular Genetics
225
Glycohemoglobin
GH2, GH5,
GH5I
Hemoglobin A1c
57
LN15
Hemoglobin A1c Cal

Ver/Lin
117
BGL
223
Chemistry and TDM

C1, C3,
C3X, C4, CZ,
CZ2X, CZX
50
52
CZQ

Chemistry and TDM
53
FLD
Body Fluid
67
Glycosaminoglycans
(mucopolysaccharides)
IFS
125
Gram stain
Bacteriology
158
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
D2, D3, D7
Throat, Urine, GC
Cultures
160
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
D4
Bacteriology, Ltd
160
D5
Gram Stain
162
MC1
Microbiology
Combination with GC
161
LN13C
117
MC2
CSF Chemistry and

Oligoclonal Bands
68
Microbiology
Combination
161
M, OLI
MC5
Strep
161
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Gram stain (cont.)
antigen detection
Description
Pg
ENR Code
HDL cholesterol (cont.)
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112

Gram stain
Heavy Chain/Light
Chain Analysis
HCA
Heavy Chain/Light
Chain Analysis
193
Bacteriology
Helicobacter pylori
HPS
H. pylori Antigen, Stool 166
S2, S4
H. pylori IgG Antibody
189
VGS1
Virtual Gram Stain

Basic
162
VGS2
Virtual Gram Stain

Advanced
162
VS2
D
158
D4
Bacteriology, Ltd
160
S5
189
D6
Rapid Group A Strep
162
VR3
186
D9

Waived
163
AQ, AQ2,
AQ3, AQ4
Aqueous Blood Gas
84
MC1
Microbiology
Combination with GC
161
MC2
Microbiology
Combination
161

Blood Gas Series
85
AQQ,
AQ2Q,
AQ3Q,
AQ4Q
MC4
Urine Colony Count

Combination
161
CBT
Cord Blood Testing
206
MC5
Strep
161
POC4
POC Strep Screen

Competency
42
Group B Streptococcus
D8
Group B Strep
163
Growth hormone
Y/YY
77
Gyn cytopathology
See Cytopathology
GYN proficiency testing
Gyn cytopathology
education
See Cytopathology
GYN education
X
IG/IGX
Immunology, General
188
S2/S4
Immunology, Special
189
HBeAg
VM2
209
HBsAg
VM1
209
HBV
X
HCV
X
HDL cholesterol
X
Hematocrit
HBVL, HBVL5 Hepatitis Viral Load
180
NAT
Nucleic Acid Testing
211
HCV2
Hepatitis Viral Load,

Genotyping and
Qualitative
180
NAT
211
ABL
Accuracy-Based Lipid
102
Chemistry and TDM

C1, C3,
C3X, C4, CZ,
CZ3X, CZX
50
52
CZQ

Chemistry and TDM
53
LCW
Ltd Chem, Waived
59
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112

FH1-FH4,
FH6, FH9,
FH10, FH13,
FH1P-FH4P,
FH6P, FH9P,
FH10P,
FH13P
131
FH3Q,
FH4Q,
FH6Q,
FH9Q

132
Series
FH15
Centrifugal Hematology 132
HCC2
Waived Combination
61
HE, HEP
Basic Hematology
130
POC10,
POC11

Gases
SCP
206
SO
Blood Oximetry
86
SOQ

Blood Oximetry
86
EHE1
Expanded Virtual
137
BMD
Bone Marrow Cell

Differential
134
VPBS
Virtual Periperal Blood

Smear
136
HPATH,
HPATH1
Hematopathology
Online Education
138
Hematology case studies
Hematopathology
Online Education
Hemochromatosis
MGL1
Molecular Genetics
225
Hemocytometer fluid
count
HFC, HFCI
Hemocytometer Fluid
Count
142
143
CBT
Cord Blood Testing
206
Hemoglobin
21
Haptoglobin
LAP Program
800-323-4040 | 847-832-7000 Option 1 | cap.org
281
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Hemoglobin (cont.)
21
131

132
Series
FH15
HCC
Waived Combination
HCC2
Waived Combination
61
HE, HEP
Basic Hematology
130
LN9
Hematology Cal
Ver/Lin
116
POC7
POC/Waived Glucose
and Hemoglobin
Competency
42
SCP
206
SO
Blood Oximetry
86
SOQ

Blood Oximetry
86
Description
Pg
ENR Code

FH1-FH4,
FH6, FH9,
FH10, FH13,
FH1P-FH4P,
FH6P, FH9P,
FH10P,
FH13P
FH3Q,
FH4Q,
FH6Q,
FH9Q
LAP Program
61
Hemolytic complement,
total
CH50
Total Hemolytic
Complement
194
Hemosiderin, urine
SCM1
Special Clinical
Microscopy
144
Heparin assay
CGS4
151
Heparin-induced
thrombocytopenia
CGE/CGEX
150
CGS5
Coag, Special, HIT
151
CGS6
Coagulation Special
151
Heparin, low molecular

weight
LN36
Heparin Cal Ver/Lin
122
LN36
Heparin Cal/Ver Lin
122
Heparin/platelet Factor
IV
CGS5
Coag, Special, HIT
151
CGS6
Coagulation Special
151
Hepatitis B virus
180
Hepatitis C virus
HCV2
Hepatitis Viral Load,

Genotyping and
Qualitative
180
HER2, gastric
GHER2
Gastric HER2
247

by ISH
ISH2
231
CYH
Cancer
221
Hemoglobin
electrophoresis
HG
Hemoglobinopathy
134

by FISH, hybridization
and interpretation on site
AQ, AQ2,
AQ3, AQ4
Aqueous Blood Gas
84
HER2 by
HER2
HER2 by
247
AQQ,
AQ2Q,
AQ3Q,
AQ4Q

Blood Gas Series
85
Herpes simplex virus

(HSV)
HC2
HSV by DFA
179
HC4
HSV Culture
179
ID1
183
POC10,
POC11

Gases
Nucleic Acid Amp,

Viruses
VR1
Virology Culture
178
PHG
Plasma Hemoglobin
70
VR2
178

CMP2,
CMP3
139
VR3

Serology
186
HCC2
Waived Combination
61
ID1
183
POC3
POC Urine Dipstick

Competency
42
Nucleic Acid Amp,

Viruses
Hemoglobin A1c
57
Hemoglobin, plasma
Hemoglobin, urine
Hemoglobin A1c
VLS2
Viral Load
180
HHV8
ID1
Nucleic Acid Amp,

Viruses
183
CGE/CGEX
150
HSCRP
hsCRP
58
LN21
High-Sensitivity
Ver/Lin
119
GH2
GH5, GH5I
Hemoglobin A1c
57
LN15
Hemoglobin A1c Cal

Ver/Lin
117
High molecular weight

kininogen
HG
Hemoglobinopathy
134
High-sensitivity
C-reactive protein
Hemoglobin A2
Hemoglobin F
Hemoglobin S/C
HHV6
HG
Hemoglobinopathy
134
SCS
Sickle Cell Screen
135
HGM
Hemoglobinopathies
Genotyping
224
MGL2
Molecular Genetics
225
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Histotechnology quality
improvement
HIV
X
HIV genotyping
HQIP,
HQIPBX,
HQBX1,
HQBX2,
HQBX3,
HQIHC
HistoQIP
HIV, HV2
HIV Viral Load
180
LN39
HIV Viral Load Cal

Ver/Lin
122
NAT
211
242
244
HIV Viral Genotyping
180
VM3
209
HIV-1 p24 antigen,

Anti HIV 1/2
VM6
210
HLA-A, -B, -C antibody

identification
MX1B,
MX1C,
MX1E, MXB,
MXC
214
215
MX2B,
MX2C,
MX2E, MXB,
MXC
214
215
MX1B,
MX1C,
MX1E, MXB,
MXC
214
215
MX2B,
MX2C,
MX2E, MXB,
MXC
214
215
HLA-(Class I/II) antibody

screen
HLA-B27 typing
DL, DML, ML HLA Molecular Typing
Homocysteine
HMS
Homocysteine
58
LN16
Homocysteine Cal
Ver/Lin
118
HLAS,
HLAS1
N/NX
Urine Chemistry,
Special
64
HPV (cytology), highrisk
CHPVD
Digene Specimen
Transport Medium
252
CHPVJ
Mixed Medium
252
CHPVK
SurePath Preservative
252
Fluid Transport Medium
CHPVM
ThinPrep PreservCyt
Transport Medium
252
HPV
Digene Hybrid Capture

Technology Only
182
ISH
231
HC2
HSV by DFA
179
HC4
HSV Culture
179
ID1
Nucleic Acid Amp,

Viruses
183
VR1
Virology Culture
178
VR2
178
VR3

Serology
186
Chemistry and TDM

C1, C3,
C3X, C4, CZ,
CZ2X, CZX
50
52
CZQ

Chemistry and TDM
53
FP/FPX,
FP1T
Maternal Screen
80
HCG, IL
Immunology
188
K/KK
76
LN5
Ligand Assay Cal

Ver/Lin
114
215
LN5S

Cal Ver/Lin
114
LN8
Reproductive
Endocrinology Cal
Ver/Lin
115
SCO
Serum Carryover
126
B27
HLA-B27 Typing
216
Pharmacogenetics
227
DADR1
Disease Association,
Drug Risk
217
HLA-B*57:01
DADR1
Drug Risk
217
HLA-B*58:01
DADR1
Drug Risk
217
HLA-DQA1*03/
DQB1*03:02
DADR2
Drug Risk
217
HLA-DQA1*05/
DQB1*02
DADR2
Drug Risk
217
HLAS
215
215
Homovanillic acid
HSV
PGX2
HLA-B*57:01
HLA-DR, -DQ typing

(serologic)
HLA molecular typing
Human chorionic
gonadotropin (hCG),
serum
MX1B,
HLA Analysis, Class I/II 214
MX1C,
215
MX1E,
MX2B,
MX2C,
MX2E, MXB,
MXC
HLA-A, -B, -C typing

(serologic)
Pg
Human chorionic
gonadotropin (hCG),
urine

CMP2,
CMP3
21
HIVG
X
HLA-(Class I/II)
crossmatching
Description
ENR Code
HIV-1 p24 antigen
LAP Program
139
HCC2
Waived Combination
61
POC1
POC hCG Competency
42
POC3
POC Urine Dipstick

Competency
42
UHCG
Urine HCG
144
800-323-4040 | 847-832-7000 Option 1 | cap.org
283
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Human herpesvirus 6
ID1
21
Human immunodeficiency virus (HIV)
Hydrocodone
Urine Toxicology
88
Toxicology
88
UT
Urine Toxicology
88
Toxicology
88
UT
Urine Toxicology
88
GLI
Glioma
233
183
Ibuprofen
HIV, HV2
HIV Viral Load
180
IDH1
HIVG
HIV Genotyping
180
LN39
HIV Viral Load Cal

Ver/Lin
122
ID2
Nucleic Acid Amp,

Respiratory
183
IDR
Infectious Disease,
Respiratory Panel
184
CHPVD
Digene Specimen
Transport Medium
252
CHPVJ
Mixed Medium
252
CHPVK
SurePath Preservative
252
Fluid Transport Medium
CHPVM
ThinPrep PreservCyt
Transport Medium
252
Digene Hybrid Capture

Technology Only
182
ISH
231
CHPVJ
Mixed Medium
252
CHPVM
ThinPrep PreservCyt
Transport Medium
252
MGL2
Molecular Genetics
225
DFC
99
DMPM
Drug Monitoring for

Pain Management
98
FTC
Criminalistics
96

Abuse
IDH2
IgA
X
IgA kappa and lambda
IgD
IgE
GLI
Glioma
233
IG/IGX
Immunology, General
188
LN7
Immunology Cal
Ver/Lin
115
SPE
70
HCA
Heavy Chain/Light
Chain Analysis
193
S2, S4
Immunology, Special
189
IG/IGX
Immunology, General
188
K/KK
76
SE
Diagnostic Allergy
193
SE
Diagnostic Allergy
193
IgE allergen-specific,
quantitative
IgE multi-allergen screen
SE
Diagnostic Allergy
193
BGS
Bone and Growth
78
Y/YY
77
IG/IGX
Immunology, General
188
LN7
Immunology Cal
Ver/Lin
115
IgG
IgG, CSF
S2, S4
Immunology, Special
189
SPE
70
M, OLI
CSF Chemistry and

Oligoclonal Bands
68
IgG subclass proteins

IgM
Immunology, Special
189
IG/IGX
Immunology, General
188
LN7
Immunology Cal
Ver/Lin
115
SPE
70
92
CTKN
Cytokines
192
IL-6
CTKN
Cytokines
192
88
IL-8
CTKN
Cytokines
192
Forensic Urine Drug

91
IL-10
CTKN
Cytokines
192
IL28B
PGX1
Pharmacogenetics
Urine Toxicology
88
81,
227
DFC
99
Imipramine
DFC
99
DMPM
Drug Monitoring for

Pain Management
98
FTC
Criminalistics
96
FTC
Criminalistics
96
Toxicology
88
UT
Urine Toxicology
88
OFD

Abuse
92
ZT, ZZT
TDM, Special
54
131
Toxicology
88
Immature granulocyte
parameter
FH9, FH9P
T
UDC
Forensic Urine Drug

91
GHER2
Gastric HER2
247
T
UDC
UT
Toxicology
S2, S4
IL-2
OFD
Hydromorphone
UT
Hydroxyzine
180
(cytology) high-risk
genotyping
Pg
Hydromorphone (cont.)
Viral Load
HPV
Huntington disease
183
Nucleic Acid Amp,

Viruses
Human
metapneumovirus
(cytology) high-risk
Nucleic Acid Amp,

Viruses
VLS2
Description
ENR Code
ID1
Human herpesvirus 8
LAP Program
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
(cont.)
India ink
Infectious mononucleosis
(IM)
HER2
LAP Program
Description
Pg
LN9
Hematology Cal
Ver/Lin
116
LN11
Serum Ethanol Cal

Ver/Lin
116
ENR Code
247
Instrument linearity
(cont.)
MK
245
MMR
DNA Mismatch Repair
245
PM1
CD117 by
245
LN12,
LN12E

Ver/Lin
116
PM2
ER, PR by
247
LN13
117
LN13C
117
PM3
CD20 by
245
LN14
Whole Blood Ethanol

Cal Ver/Lin
117
PM5
TMA
246
LN15
Hemoglobin A1c Cal

Ver/Lin
117
LN16
Homocysteine Cal
Ver/Lin
118
LN17
Whole Blood Glucose

Cal Ver/Lin
118
IND
India Ink
173
IL, IM
Immunology
188
IMW
Infectious
189
Mononucleosis, Waived
LN18, LN19
Reticulocyte Cal Ver/Lin 118
ID2
Nucleic Acid Amp,

Resp
183
LN20
Urine Albumin Cal

Ver/Lin
119
ID3
Influenza A, Influenza B, 183

RSV by NAA
LN21
119
IDR
Infectious Disease,
Respiratory Panel
184
High-Sensitivity
Ver/Lin
LN22
POC Influenza A/B Ag
42
Flow Cytometry Cal

Ver/Lin
119
POC8
X
VR1
Virology Culture
178
LN23
PSA Cal Ver/Lin
119
VR2

by DFA
178
LN24
Creatinine Accuracy
Cal Ver/Lin
120
VR4

by EIA and Latex
179
LN25
Troponin I Cal Ver/Lin
120
LN27
Troponin T Cal Ver/Lin
120
Influenza virus
ISH
231
LN30
BNP Cal Ver/Lin
120
ISH2
HER2
231
LN31
Immunosuppressive
Drugs Cal Ver/Lin
121
Instrument function
Instrumentation
124
LN32
Ammonia Cal Ver/Lin
121
Instrumentation
124
LN33
121
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
Serum Myoglobin Cal

Ver/Lin
LN34
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
Tumor Markers Cal

Ver/Lin
121
LN2BV
LN35
Thrombophilia Cal
Ver/Lin
122
LN36
Heparin Cal Ver/Lin
122
LN3
TDM Cal Ver/Lin
113
LN37
122
LN5
Ligand Assay Cal

Ver/Lin
114
von Willebrand Factor

Ag Cal Ver/Lin
LN38

Cal Ver/Lin
114
CMV viral load Cal

Ver/Lin
122
LN5S
LN39
Urine Chemistry Cal

Ver/Lin
114
HIV Viral Load Cal

Ver/Lin
122
LN6
LN40
122
LN7
Immunology Cal
Ver/Lin
115
LN41
Procalcitonin Cal
Ver/Lin
123
LN8
Reproductive
Endocrinology Cal
Ver/Lin
115
LN42
D-Dimer Cal Ver/Lin
123
In situ hybridization
800-323-4040 | 847-832-7000 Option 1 | cap.org
21
HER2 by
285
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
(cont.)
Insulin
21
Interferon (IFN) gamma

Interleukin (IL)-1 beta
International normalized
ratio (INR)
Ionized calcium
Iron
Isopropanol
Jo-1 (antihistidyl t-RNA

synthetase)
123
JWH-018 N-Pentanoic
Acid
SCDD
Designer Drugs
97
LN44
Fibrinogen Cal Ver/Lin
123
Kaolin-activated APTT
CGE/CGEX
Coagluation, Extended
150
ING
Insulin, Gastrin,
C-Peptide, PTH
80
Kaolin-activated CT
CGE/CGEX
Coagluation, Extended
150
ISH
231
CTKN
Cytokines
192
IG/IGX
Immunology, General
188
S2, S4
Immunology, Special
189
SFLC
Serum Free Light

Chains
195
Kappa/Lambda
192
Basic Coagulation
150
Free Kappa/Lambda
ratio
CGL
Coagulation, Ltd
150
Karyotype nomenclature
CGS1
151
Ketamine
CGS4
151
POC6
POC PT/INR,
CoaguChek XS Plus
42
WP3, WP4,
WP6, WP9
Whole Blood
Coagulation
154
WP10
Whole Blood
Coagulation
154
AQ, AQ2,
AQ3, AQ4
Aqueous Blood Gas
84
AQQ,
AQ2Q,
AQ3Q,
AQ4Q

Blood Gas Series
85
C3, CZ, CZX Chemistry and TDM
50
52
POC10,
POC11

Gases
117

CZ, CZ2X,
CZX
50
52
CZQ

Chemistry and TDM
53
IFS
125
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112

Ethylene Glycol/
Volatiles
93
Serum Alcohol/
Ethylene Glycol/
Volatiles
93
Nucleic Acid Amp, JC

and BK
183
Rheumatic Disease
Special
194
AL2
ID1T
RDS
Ketones, serum
Ketones, urine
99
FTC
Criminalistics
96
Toxicology
88
UT
Urine Toxicology
88
KET
Ketones
58
HCC2
Waived Combination
61
POC3
POC Urine Dipstick

Competency
42
KSA
Kidney Stone
Assessment
64
KIT
KIT/PDGFRA
233
CMMP,
CMP3
Misc
139
FSM
Fungal Smear
172
KRAS
Colorectal Cancer
Mutation
233
MTP
233
LPX
Laboratory
Preparedness Exercise
166
AQ, AQ2,
AQ3, AQ4
Aqueous Blood Gas
84
AQQ,
AQ2Q,
AQ3Q,
AQ4Q

Blood Gas Series
85
C3, C3X,
CZ, CZ2X,
CZX
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
FLD
Body Fluid
67
POC10,
POC11

Gases
LN13C
117
M, OLI
CSF Chemistry and

Oligoclonal Bands
68
Laboratory Preparedness
Exercise
X
Lactate, CSF
220
139
KRAS
Lactate
Cytogenetics

CMP2,
CMP3
KIT
KOH prep
CY, CYBK
DFC
Kidney stone assessment
LN13C
AL1
Kappa/Lambda ratio
Cytokines
JC virus
Lamellar Body Count

Cal Ver/Lin
CGB
Pg
LN43
CTKN
Description
ENR Code
LAP Program
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Lactate dehydrogenase
(LD)
Lamellar body count
Lamotrigine
Large unclassified cells

(LUC)
Description
Pg
ENR Code

CZ, CZ2X,
CZX
50
52
CZQ

Chemistry and TDM
53
FLD
Body Fluid
67
IFS
125
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
Toxicology
88
SCO
Serum Carryover
126
UT
Urine Toxicology
88
M, OLI
CSF Chemistry and

Oligclonal Bands
68
ZE
Therapeutic Drug
54
LBC
Lamellar Body Count
143
Lamellar Body Count

Cal Ver/Lin
123
CZ, CZ2X,
CZX, Z
Chemistry and TDM
LN43
50
52
CZQ
Toxicology
88

Chemistry and TDM
53
T
UT
Urine Toxicology
88
LN3
TDM Cal Ver/Lin
113
ZE
Therapeutic Drug
54
Toxicology
88
UT
Urine Toxicology
88
FH4, FH4P
131
Chemistry and TDM
50
52
53
Leukocyte esterase, urine

CMP2,
CMP3
139
HCC2
Waived Combination
61
POC3
POC Urine Dipstick

Competency
42
Leukocyte-reduced
platelets
TRC
Transfusion-Related Cell 208

Count
Leukocyte-reduced RBC
TRC

Count
CMMP,
CMP3
Misc
Leukocyte, stool, WrightGiemsa
Levetiracetam
Lidocaine
LD isoenzymes
CRTI
Cardiac Markers
57
LD1/LD2 ratio
CRTI
Cardiac Markers
57
CZQ
LDL cholesterol
ABL
102

Chemistry and TDM
LDL cholesterol,
calculated
C1, C3,
C3X, C4,
CZ, CZ2X,
CZX
Chemistry and TDM
50
52
FLD2
67
IFS
125
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
C1, C3,
C3X, C4,
CZ, CZ2X,
CZX
Chemistry and TDM
50
52
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
CZQ

Chemistry and TDM
53
ABL
102
Ltd Chem, Waived
59
139
C3, C3X,
CZ, CZ2X,
CZX
LDL cholesterol,
measured
Lipase
Lipids
BL
Blood Lead
94

CZ, CZ2X,
CZX
Lead, urine
TMU
Trace Metals, Urine
95
CZQ
LM, LM1
Lung Maturity
70

Chemistry and TDM
53
Lecithin:sphingomyelin
(L:S) ratio
LN2
IDN, IDO
Nucleic Acid Amp,

Organisms
182
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
Legionella pneumophila
LN2BV
LBAS
Legionella Ag
163
Leukemia/lymphoma
immunophenotype
FL3
Flow Cytometry
196
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
Legionella
Leukemia/lymphoma
interpretation only
FL5
Flow Cytometry
Interpretation Only
197
ABL
102
LDL cholesterol, waived
LCW
Lead (blood)
Lipoprotein (a)
21
50
52
800-323-4040 | 847-832-7000 Option 1 | cap.org
Lactate dehydrogenase
(LD), CSF
LAP Program
287
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Lipoprotein (a) (cont.)
21
Description
Pg
ENR Code
C1, C3,
C3X, CZ,
CZ2X, CZX
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
Lipoprotein-associated
phospholipase
PLA
Lp-PLA2
69
Lipoprotein
electrophoresis
LPE
Lipoprotein
Electrophoresis
70
Lithium
LAP Program
Magnesium (cont.)
CZQ

Chemistry and TDM
53
IFS
125
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
AQ, AQ2
Aqueous Blood Gas
84
AQQ,
AQ2Q

Blood Gas Series
85
LN13C
117
POC10,
POC11

Gases
Urine Chemistry,
General
63

CZ, CZ2X,
CZX, Z
50
52
CZQ

Chemistry and TDM
53
LN3
TDM Cal Ver/Lin
113
Liver-kidney microsomal
antibody
LKM
Liver-Kidney
Microsomal Antibody
194
Lorazepam
DFC
99
DMPM
Drug Monitoring for

Pain Management
98
Malaria
RMAL
Rapid Malaria
175
SCDD
Criminalistics
96
Designer Drugs
97
FTC
MAM 2201 pentanoic

acid metabolite
Manganese
Trace Metals
72
Toxicology
88
TMU
Trace Metals, Urine
95
UDC
Forensic Urine Drug

91
Toxicology
88
UT
Urine Toxicology
88
UT
Urine Toxicology
88
Lorazepam glucuronide
DMPM
Drug Monitoring for

Pain Management
98
MCAD
IMD2
MCAD
226
MCH
131
Lupus anticoagulant
(screen, conf)
CGE/CGEX
150
CGS1
151
LN8
Reproductive
Endocrinology Cal
Ver/Lin
115
FH1-FH4,
FH6, FH9,
FH10, FH13,
FH1P-FH4P,
FH6P, FH9P,
FH10P,
FH13P
Y/YY
77
TTD
Tick-Transmitted
Disease
186
FL, FL1
Flow Cytometry
196
Lymphoma by FISH
CYL
Fluorescence In
Situ Hybridization,
Lymphoma
221
Lysergic acid
diethylamide (LSD)
FTC
Criminalistics
96
Toxicology
88
UDS, UDS6
Urine Drug Screen
90
UT
Urine Toxicology
88
C1, C3,
C3X, CZ,
CZ2X, CZX
Chemistry and TDM
50
52
X
Lyme disease
Lymphocyte
immunophenotyping
Magnesium
Magnesium, ionized
Magnesium, urine
Maprotiline
FH3Q,
FH4Q,
FH6Q,
FH9Q
MCHC

132
Series
FH1-FH4,
FH6, FH9,
FH10, FH13,
FH1P-FH4P,
FH6P, FH9P,
FH10P,
FH13P
FH3Q,
FH4Q,
FH6Q,
FH9Q
131

132
Series
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
MCV
MECP2 genotyping
Mercury, urine
MEN2
Meperidine
Meprobamate
Metabolic disease testing

Metanephrine
Methadone
Methadone metabolite
(EDDP)
Pg
131
FH3Q,
FH4Q,
FH6Q,
FH9Q

132
Series
RETT
RETT Syndrome
Genotyping
227
TMU
Trace Metals, Urine
95
MGL3
Molecular Genetics
225
DFC
99
DMPM
Drug Monitoring for

Pain Management
98
FTC
Criminalistics
96
Toxicology
88
UT
Urine Toxicology
88
SCDD
Designer Drugs
97
Toxicology
88
UT
Urine Toxicology
88
DFC
99
DMPM
Drug Monitoring for

Pain Management
98
FTC
Criminalistics
96
Toxicology
88
UT
Urine Toxicology
88
BGL
223
N/NX
Urine Chemistry,
Special
64
DFC
99
DMPM
Drug Monitoring for

Pain Management
98
FTC
Criminalistics
96
OFD

Abuse
92
Toxicology
88
UDC
Forensic Urine Drug

91
UDS, UDS6
Urine Drug Screen
90
UT
Urine Toxicology
88
DFC
99
Methadone metabolite
(EDDP) (cont.)
Methamphetamine
Methanol
FTC
Criminalistics
96
Toxicology
88
UDC
Forensic Urine Drug

91
UDS, UDS6
Urine Drug Screen
90
UT
Urine Toxicology
88
DFC
99
DMPM
Drug Monitoring for

Pain Management
98
FTC
Criminalistics
96
OFD

Abuse
92
Toxicology
88
UDC
Forensic Urine Drug

91
Urine Drug Screen
90
Urine Toxicology
88
AL1

Ethylene Glycol/
Volatiles
93
AL2
Serum Alcohol/
Ethylene Glycol/
Volatiles
93
UDC
Forensic Urine Drug

91
UDS, UDS6
Urine Drug Screen
90
BCS1
Blood Culture
164
IDN, IDO
Nucleic Acid Amp,

Organisms
182
MRS, MRS5
S. aureus
167
SO
Blood Oximetry
86
SOQ

Blood Oximetry
86
CZ, CZ2X,
CZX, Z
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
DFC
99
DMPM
Drug Monitoring for

Pain Management
98
FTC
Criminalistics
96
98
UT
Methicillin-resistant
(MRSA)
Methotrexate
Drug Monitoring for

Pain Management
UDS, UDS6
Methaqualone
Methemoglobin
DMPM
800-323-4040 | 847-832-7000 Option 1 | cap.org
21
Mephedrone
Description
ENR Code
FH1-FH4,
FH6, FH9,
FH10, FH13,
FH1P-FH4P,
FH6P, FH9P,
FH10P,
FH13P
LAP Program
289
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
(cont.)
21
Methylenedioxyethylamphetamine (MDEA)
LAP Program
Description
Pg
MRD1
Minimal Residual
Disease, BCR/ABL1
p190
234
MRD2
Minimal Residual
Disease, PML/RARA
234
Toxicology
88
UT
Urine Toxicology
88
TMO

Arthropods
176
ENR Code
Minimal residual disease
(cont.)
OFD

Abuse
92
Toxicology
88
UDC
Forensic Urine Drug

91
UT
Urine Toxicology
88
OFD

Abuse
92
Mite identification
UDC
Forensic Urine Drug

91
Mitochondrial
cytopathies
IMD3
Mitochondrial
cytopathies
226
DFC
99
Mitochondrial DNA
Deletion Syndromes
IMD1
Mitochondrial DNA
Deletion Syndromes
226
DMPM
Drug Monitoring for

Pain Management
98
Mitochondrial DNA,
forensic
FTC
Criminalistics
96
OFD

Abuse
Mirtazapine
258
258
FIDM
Forensic Identity
Mixing studies, PT
CGE/CGEX
150
92
Mixing studies, APTT
CGE/CGEX
150
Toxicology
88
CGS1
151
UDC
Forensic Urine Drug

91
MLH1 promoter
methylation analysis
MSI
231
UDS, UDS6
Urine Drug Screen
90
UT
Urine Toxicology
88
SCDD
Designer Drugs
97
Defective DNA
Mismatch Repair/
Hereditary
Nonpolyposis
Colorectal Cancer
(HNPCC)
Modified acid-fast stain
Toxicology
88
Mold identification
Mycology
171
UT
Urine Toxicology
88
Molecular genetics
Molecular Genetics
225
MGL1
Molecular Genetics
225
Methylone
SCDD
Designer Drugs
97
MGL1,
MGL2,
MGL3,
MGL4,
MGL5
Molecular HLA typing
DL, DML, ML HLA Molecular Typing
Methylphenidate
Toxicology
88
Methylenetetrahydrofolate reductase
(MTHFR)
Metoprolol
UT
Urine Toxicology
88
Toxicology
88
UT
Urine Toxicology
88
MGMT
GLI
Glioma
233
Microalbumin, urine
LN20
Urine AlbuminCal
Ver/Lin
119
Urine Chemistry
63
UMC
Urine Albumin
(Microalbumin)/
Creatinine
144
MSI
Microsatellite Instability
231
Microtiter plate reader

linearity
Instrumentation
124
MRD
Minimal Residual
Disease, BCR/ABL1
p210
234
Minimal residual disease
215
Molecular hematologic
oncology
MHO,
MHO1,
MHO2,
MHO3,
MHO5
Molecular Hematologic 231,

Oncology
234
Molecular typing
IDN, IDO
Nucleic Acid Amp,

Organisms
ME
Monitoring Engraftment 216
Monitoring engraftment
Mononuclear cell count
Morphine
Microsatellite instability
174
182
CBT
Cord Blood Testing
206
SCP
206
DFC
99
DMPM
Drug Monitoring for

Pain Management
98
FTC
Criminalistics
96
OFD

Abuse
92
Toxicology
88
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Morphine (cont.)
UT
Urine Toxicology
88
SPE
70
FH1-FH4,
FH6, FH9,
FH10, FH13,
FH1P-FH4P,
FH6P, FH9P,
FH10P,
FH13P
131
BCS1
Blood Culture
164
IDN, IDO
Nucleic Acid Amp,

Organisms
182
MRS, MRS5
S. aureus
167
Mucolipidosis IV
MGL4
Molecular Genetics
225
Mucopolysaccharide
(Glycosaminoglycan)
BGL
223
Multiple endocrine
neoplasia type 2 (MEN2)
MGL3
Molecular Genetics
225
MPV
MRSA
Mumps-IgG
91
VR3M
Virology
186
Mycobacterial culture
E1
Mycobacteriology, Ltd
170
Mycobacterial
identification
Mycobacteriology
170
Mycobacterium
tuberculosis
IDO
Nucleic Acid Amp,

Organisms
182
Mycobacterium
tuberculosis antibody
detection
QF
M. tuberculosis Infection 194

Detection
Mycobacterium
tuberculosis identification
and resistance detection
MTBR
Molecular MTB
Identification and
Resistance Detection
Mycophenolic acid
Mycoplasma
pneumoniae
Myoglobin
Myoglobin, urine
Pg
N-acetylprocainamide
(NAPA) (cont.)
CZQ

Chemistry and TDM
53
LN3
TDM Cal Ver/Lin
113
DMPM
Drug Monitoring for

Pain Management
98
FTC
Criminalistics
96
Toxicology
88
UT
Urine Toxicology
88
Naphyrone
SCDD
Designer Drugs
97
Naproxen
Toxicology
88
UT
Urine Toxicology
88
139
N-desmethyltramadol
Nasal smears, eosinophil
CMMP,
CMP3
Misc.
Neisseria gonorrhoeae
D3
GC Cultures
160
D4
Bacteriology, Ltd
160
HC6/HC6X
Nucleic Acid Amp
181
HC7
C. trachomatis/GC
DNA by NAA
181
MC1
Microbiology
Combination with GC
161
Neoplastic cellularity
NEO
Neoplastic Cellularity
232
Neoplastic disorder by
FISH
CYF
Hybridization
220
Neuropathology
NP/NP1
Neuropathology
Program
249
Neutral fats
FCFS
Fecal Fat
69
Next-Generation
Sequencing
NGS
Next-Generation
Sequencing
229
NGSB1
NGS Bioinformatics for

Illumina Platforms
230
NGSB2
NGS Bioinformations
230
for Ion Torrent Platforms
NGSST
Next Generation
Sequencing, Solid
Tumor
229
NGSHM
Next Generation
Sequencing
Hematologic
Malignancies
229
170
MPA
Mycophenolic Acid
54
IDN, IDO
Nucleic Acid Amp,

Organisms
182
VR3

Serology
186
CRT, CRTI
Cardiac Markers
57
LN33
Serum Myoglobin Cal

Ver/Lin
121
PCARM,
PCARMX
Plasma Cardiac
Markers
60
POC12
Competency Plasma
Cardiac Markers
43
MYG
Myoglobin, Urine
64
Myotonic dystrophy
MGL2
Molecular Genetics
225
N-acetylprocainamide
(NAPA)
CZ, CZ2X,
CZX, Z
Chemistry and TDM
50
52
Nicotine
Toxicology
88
UT
Urine Toxicology
88
Niemann-Pick type A/B

disease
MGL4
Molecular Genetics
225
Nitrite, urine

CMP2,
CMP3
139
DAI
90

Integrity Testing
800-323-4040 | 847-832-7000 Option 1 | cap.org
21
Forensic Urine Drug

Description
ENR Code
UDC
M-protein (paraprotein)
identification
LAP Program
291
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Nitrite, urine (cont.)
21
Description
Pg
ENR Code
HCC2
Waived Combination
61
Norfluoxetine (cont.)
UT
Urine Toxicology
88
POC3
POC Urine Dipstick

Competency
42
Norketamine
DFC
99
FTC
Urine Chemistry,
General
63
Criminalistics
96
Nitrogen, total, urine
Toxicology
88
Nongynecologic
cytopathology
FNA/FNA1

Digital
UT
Urine Toxicology
88
DFC
99
DMPM
Drug Monitoring for

Pain Management
98
Toxicology
88
UT
Urine Toxicology
88
N/NX
Urine Chemistry Special
64
GIP
184
SP1
Stool Pathogens
168
Noroxycodone
DMPM
Drug Monitoring for

Pain Management
98
Noroxymorphone
DMPM
Drug Monitoring for

Pain Management
98
Norpropoxyphene
DFC
99
DMPM
Drug Monitoring for

Pain Management
98
FTC
Criminalistics
96
Toxicology
88
UDC
Forensic Urine Drug

91
FNAG/
FNAG1
Norbuprenorphine
LAP Program
Norchlordiazepoxide
Norcodeine

Glass
NGC/NGC1 Nongynecologic
Cytopathology
Education Program
254
DMPM
Drug Monitoring for

Pain Management
98
Toxicology
88
UDC
Forensic Urine Drug

91
UT
Urine Toxicology
88
Toxicology
88
UT
Urine Toxicology
88
Toxicology
88
UT
Urine Toxicology
88
Norcyclobenzaprine
Toxicology
88
UT
Urine Toxicology
88
Nordiazepam
DMPM
Drug Monitoring for

Pain Management
98
FTC
Criminalistics
96
OFD

Abuse
92
Toxicology
88
UDC
Forensic Urine Drug

91
Nordoxepin
Norepinephrine
Norfentanyl
Norfluoxetine
UT
Urine Toxicology
88
DFC
99
FTC
Criminalistics
96
Toxicology
88
UT
Urine Toxicology
88
N/NX
Urine Chemistry,
Special
64
DMPM
Drug Monitoring for

Pain Management
98
FTC
Criminalistics
96
Toxicology
88
UT
Urine Toxicology
88
DFC
99
FTC
Criminalistics
96
Toxicology
88
Normeperidine
Normetanephrine
Norovirus
UT
Urine Toxicology
88
DFC
99
FTC
Criminalistics
96
Toxicology
88
UT
Urine Toxicology
88
Toxicology
88
UT
Urine Toxicology
88
DFC
99
FTC
Criminalistics
96
Toxicology
88
UT
Urine Toxicology
88
ZT, ZZT
TDM, Special
54
Toxicology
88
UT
Urine Toxicology
88
NRAS
MTP
233
nRBC
FH3, FH3P,
FH9, FH9P
131
BNP
B-Type Natriuretic
Peptides, 2 Chall
55
BNP5
B-Type Natriuretic
Peptides, 5 Chall
55
Norsertraline
Nortrimipramine
Nortriptyline
X
Norverapamil
NT-pro B-type natriuretic

peptides
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
NT-pro B-type natriuretic
peptides (cont.)
BNPQ
N-telopeptide (NTX)
X
Nucleated cells, total
Nucleated red cells, total
LAP Program
Description
Pg
ENR Code
B-Type Natriuretic
Peptides
56
LN30
BNP Cal Ver/Lin
120
BMV6
Bone Markers and

Vitamin
79
BU
Bone and Mineral,

Urine
79
CBT
Cord Blood Testing
206
SCP
206
ABF3
Automated Body Fluid
140
CBT
Cord Blood Testing
206
Olanzapine
Oligoclonal bands
Opiate group
206
FH3, FH3P,
FH9, FH9P
131
Organic acids, urine

qualitative
Nucleic acid
amplification
BSTE
Bacterial Strain Typing

Enterococcus
182
Organic acids, urine

quantitative
BSTN

Gram-Negative
Organisms
182
BSTS

Staphylococcus
182
Osmolality, measured
Toxicology
UT
Urine Toxicology
88
88
OLI
Oligoclonal Bands
68
DMPM
Drug Monitoring for

Pain Management
98
OFD

Abuse
92
Toxicology
88
UDS, UDS6
Urine Drug Screen
90
UT
Urine Toxicology
88
UTCO
Urine Toxicology
Carryover
126
BGL
223
BGL
223
C3, C3X,
CZ, CZ2X,
CZX
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
IFS
125

HCV2
180
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
HC6/HC6X
Nucleic Acid Amp
181
LN2BV
112
HC7
C. trachomatis/GC
DNA by NAA
181
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
HIV, HV2
HIV Viral Load
180
73
IDN, IDO
Nucleic Acid Amp,

Organisms
182
ID1, ID1T
Nucleic Acid Amp,

Viruses
ID2
Osmolality, sweat
SW1, SW2,
SW3, SW4
Osmolality, urine

CMP2,
CMP3
139
183
Nucleic Acid Amp,

Respiratory
183
LN6
Urine Chemistry Cal

Ver/Lin
114
ID3
Influenza A, Influenza
B, RSV by NAA
183
POC3
POC Urine Dipstick

Competency
42
MRS, MRS5
S. aureus
167
Urine Chemistry,
General
63
124
SP, SPN, SP1 Stool Pathogens
168
Osmometer check
Instrumentation
VLS, VLS2
Viral Load
180
Osteocalcin
BGS
Bone and Growth
78
VRE
Vancomycin-Resistant
Enterococcus
169
Oxazepam
DFC
99
DMPM
211
Drug Monitoring for

Pain Management
98
NAT
T
Toxicology
88
FTC
Urine Toxicology
88
Criminalistics
96
UT
OCB
Occult Blood
143
Toxicology
88
POC9
POC Fecal Occult Blood
42
UDC
91
Occult blood, gastric
GOCB
142
Forensic Urine Drug

Ocular micrometer check
Instrumentation
124
UT
Urine Toxicology
88
ZE
Therapeutic Drug
54
Nucleic acid testing

O-desmethyltramadol
Occult blood
Oxcarbazepine
metabolite
800-323-4040 | 847-832-7000 Option 1 | cap.org
21
SCP
Nucleated red blood cell
count
293
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
DAI

Integrity Testing
90
Parentage/relationship
testing
Oxycodone
DFC
99
Paroxetine
DMPM
Drug Monitoring for

Pain Management
98
FTC
Criminalistics
96
OFD

Abuse
92
Toxicology
88
UDC
Forensic Urine Drug

91
UDS, UDS6
Urine Drug Screen
90
UT
Urine Toxicology
88
SO
Blood Oximetry
86
SOQ

Blood Oximetry
86
DFC
99
DMPM
Drug Monitoring for

Pain Management
FTC
OFD
Oxyhemoglobin
Oxymorphone
Parentage/Relationship 212
DFC
99
FTC
Criminalistics
96
Toxicology
88
UT
Urine Toxicology
88
Parvovirus B19
ID1
Nucleic Acid Amp,

Viruses
183
PB-22 3-carboxyindole
metabolite
SCDD
Designer Drugs
97
AQ, AQ2,
AQ3, AQ4
Aqueous Blood Gas
84
AQQ,
AQ2Q,
AQ3Q,
AQ4Q

Blood Gas Series
85
98
POC10,
POC11

Gases
117
96
LN13,
LN13C
Criminalistics
Abuse
92
Toxicology
88
UDC
Forensic Urine Drug

91
P CO2
KIT
KIT/PDGFRA
233
DFC
99
Pentylone
SCDD
Designer Drugs
97
Performance
Improvement Program in
Surgical Pathology
PIP/PIP1,
Performance
PIPW/PIPW1 Improvement Program
in Surgical Pathology
VPBS
Urine Toxicology
88
246
Peripheral blood smear,

virtual

CZ, CZ2X,
CZX
50
52
pH
CZQ

Chemistry and TDM
53
FP1B

Screening, Free Beta
80
FP1T

Screening, Total hCG
80
ID2
Nucleic Acid Amp,

Respiratory
183
IDR
Infectious Disease,
Respiratory Panel
184
VR1
Virology Culture
178
VR2

by DFA
178
Paraprotein identification
SPE
70
Parasite identification
BP
Blood Parasite
175
174
ING
80
PAPP-A
Parainfluenza virus
Parathyroid hormone
(PTH)
Insulin, Gastrin,
C-Peptide, PTH
PDGFRA
TMA
Pentobarbital
PM5
Pancreatic amylase
Pg
PARF
UT
p16
Description
ENR Code
Oxidants, urine
21
LAP Program
pH, urine
236
237

Smear
AFL
Amniotic Fluid Leakage
140
AQ, AQ2,
AQ3, AQ4
Aqueous Blood Gas
84
AQQ,
AQ2Q,
AQ3Q,
AQ4Q

Blood Gas Series
85
FLD
Body Fluid
67
GOCB
142
POC10,
POC11

Gases
LN13,
LN13C
117

CMP2,
CMP3
139
DAI

Integrity Testing
90
HCC2
Waived Combination
61
POC3
POC Urine Dipstick

Competency
42
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
LAP Program
Description
Pg
CZ, CZ2X,
CZX, Z
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
ENR Code
UDC
Forensic Urine Drug

91
pH meters
Instrumentation
124
Phencyclidine
DFC
99
FTC
Criminalistics
96
Phosphatidylglycerol
(PG)
LM, LM1
Lung Maturity
70
OFD

Abuse
92
Phosphorus
Chemistry and TDM
50
52
Toxicology
88
C3, C3X,
CZ, CZX,
CZ2X
UDC
Forensic Urine Drug

91
CZQ

Chemistry and TDM
53
UDS, UDS6
Urine Drug Screen
90
IFS
125
UT
Urine Toxicology
88
LN2
112
FTC
Criminalistics
96
Chemistry, Lipid,
Enzyme Cal Ver/Lin
LN2BV
Toxicology
88
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
LN6
Urine Chemistry Cal

Ver/Lin
114
Urine Chemistry,
General
63
MTP
233
CMMP,
CMP3
Misc
139
Pipette calibrationgravimetric
Instrumentation
124
Plasma hemogloblin
PHG
Plasma Hemoglobin
70
Plasminogen antigen
CGE/CGEX
150
Plasminogen activator
inhibitor
CGE/CGEX
150
Plasminogen activator
inhibitor (PAI)-1
MGL1
Molecular Genetics
225
PF
Platelet Function
153
PS
Platelet Serology
207
TRC

Count
Phenethylamine
Pheniramine
Phenobarbital
Phentermine
Phenylephrine
Phenylpropanolamine
Phenytoin
UT
Urine Toxicology
88
Toxicology
88
UT
Urine Toxicology
88
CZ, CZ2X,
CZX, Z
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
DFC
99
FTC
Criminalistics
96
LN3
TDM Cal Ver/Lin
113
Toxicology
88
UDC
Forensic Urine Drug

91
UT
Urine Toxicology
88
FTC
Criminalistics
96
Toxicology
88
UT
Urine Toxicology
88
Toxicology
88
UT
Urine Toxicology
88
Toxicology
88
UT
Urine Toxicology
88
CZ, CZ2X,
CZX, Z
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
DFC
99
FTC
Criminalistics
96
LN3
TDM Cal Ver/Lin
113
SCO
Serum Carryover
126
Toxicology
88
UT
Urine Toxicology
88
Phenytoin, free
Phosphorus, urine
X
PIK3CA
Pinworm prep
Platelet aggregation
Platelet antibody
detection
Platelet calculator
Platelet count

FH1-FH4,
FH6, FH9,
FH10, FH13,
FH1P-FH4P,
FH6P, FH9P,
FH10P,
FH13P
21
pH, urine (cont.)
131
FH3Q,
FH4Q,
FH6Q,
FH9Q

132
Series
FH15
HE, HEP
Basic Hematology
130
800-323-4040 | 847-832-7000 Option 1 | cap.org
295
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Platelet count (cont.)
21
50
52
CZQ

Chemistry and TDM
53
153
FLD2
67
155
IFS
125
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
LN13C
117
POC10,
POC11

Gases
LN6
Urine Chemistry Cal

Ver/Lin
114
Urine Chemistry,
General
63
Potassium, vitreous fluid
VF
93
PRA
MX1B,
MX1C,
MX1E, MXB,
MXC
214
215
MX2B,
MX2C,
MX2E, MXB,
MXC
214
215
MGL1
Molecular Genetics
225
C3, C3X,
CZ, CZX,
CZ2X
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
S2, S4
Immunology, Special
189
CGE/CGEX
150
HER2
HER2 by
247
GHER2
Gastric HER2
247
PM1
CD117 by
245
PM2
ER, PgR by
247
PM3
CD20 by
245
PM5
TMA
246
CZ, CZX,
CZ2X, Z
Chemistry and TDM
50
52
TRC

Count
Platelet crossmatch
PS
Platelet Serology
207
Platelet function
PF1
Platelet Function
Platelet induced
aggregation
PIA
Platelet Function
Platelet mapping
PLTM
Platelet Mapping
155
Platelet morphology
EHE1
Expanded Virtual
137
PML/RARA
MRD2
Minimal Residual
Disease
234
PNA FISH-Enterococcus
PNA3
PNA FISH for

Enterococcus
164
PNA FISH-GramNegative Rods
PNA4
PNA FISH for GramNegative Rods
164
PNA FISHStaphylococcus
PNA1
PNA FISH for

Staphylococcus
164
PNA FISH-Yeast
PNA2
PNA FISH for Yeast
164
Pneumocystis detection
PCP1
Pneumocystis jiroveci,
Calcofluor White Stain
173
PCP2
DFA Stain
173
PCP3
Giemsa Stain
173
PCP4
GMS Stain
173
PNH
Paroxysmal Nocturnal
Hemoglobinuria, RBC
197
AQ, AQ2,
AQ3, AQ4
Aqueous Blood Gas
84
Prader-Willi/Angelman
Syndrome
AQQ,
AQ2Q,
AQ3Q,
AQ4Q

Blood Gas Series
85
Prealbumin
(transthyretin)
LN13,
LN13C
117
POC10,
POC11

Gases
Porphobilinogen, Urine
UPBG
Porphobilinogen, Urine
Postanalytical DNA
sequencing
SEC
DNA Sequencing Count 226
PNH immunophenotype
P O2
65
Postvasectomy sperm
count
PV
Postvasectomy Sperm
Count
146
Potassium
AQ, AQ2,
AQ3, AQ4
Aqueous Blood Gas
84
AQQ,
AQ2Q,
AQ3Q,
AQ4Q

Blood Gas Series
85
Pg

C4, CZ, CZX,
CZ2X
116
Potassium (cont.)
Hematology Cal
Ver/Lin
Description
ENR Code
LN9
Platelet count (Plateletrich plasma)
LAP Program
Potassium, urine
X
X
Prekallikrein
Predictive markers by
Primidone
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Primidone (cont.)
Pro B-type natriuretic

peptides
Procainamide

Chemistry and TDM
53
Protein electrophoresis,
serum, interpretation
Protein C
TDM Cal Ver/Lin
113
BNP
B-Type Natriuretic
Peptides, 2 Chall
55
BNP5
B-Type Natriuretic
Peptides, 5 Chall
55

B-Type Natriuretic
Peptides
56
CZ, CZX,
CZ2X, Z
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
LN3
TDM Cal Ver/Lin
113
LN41
Procalcitonin Cal
Ver/Lin
123
PCT
Procalcitonin
71
LN8
Reproductive
Endocrinology Cal
Ver/Lin
115
Y/YY
77
PM2
ER, PgR by
247
LN8
Reproductive
Endocrinology Cal
Ver/Lin
115
Procalcitonin
X
Progesterone
Progesterone receptors
by immunohistochemistry
Prolactin
X
Propoxyphene
Propranolol
Pg
Protein S
Protein, total
SPE
70
CGE/CGEX
150
CGS2
151
LN35
Thrombophilia Cal
Ver/Lin
122
CGE/CGEX
150
CGS2
151

CZ, CZX,
CZ2X
50
52
CZQ

Chemistry and TDM
53
FLD
Body Fluid
67
IFS
125
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
SPE
Lipoprotein and Protein

Electrophoresis
70
Protein, CSF
M, OLI
CSF Chemistry and

Oligoclonal Bands
68
Protein, urine

CMP2,
CMP3
139
DSC
141
HCC2
Waived Combination
61
LN6
Urine Chemistry Cal

Ver/Lin
114
POC3
POC Urine Dipstick

Competency
42
Urine Chemistry,
General
63
Y/YY
77
DFC
99
DMPM
Drug Monitoring for

Pain Management
98
FTC
Criminalistics
96
Toxicology
88
UDC
Forensic Urine Drug

91
UDS, UDS6
Urine Drug Screen
90
UT
Urine Toxicology
88
UTCO
Urine Toxicology
Carryover
126
Toxicology
88
Prothrombin fragment
1.2
UT
Urine Toxicology
88
Prothrombin time
K, KK, K2
76
X
Prothrombin mutation
MGL1
Molecular Genetics
225
TPM
Thrombophilia
Mutations
228
CGE/CGEX
150
CGB
Basic Coagulation
150
CGL
Coagulation, Ltd
150
CGS1
151
151
Prostate-specific antigen
(PSA)
LN23
PSA Cal Ver/Lin
119
CGS4
complexed (cPSA)
K/KK
76
DBGN
Anticoagulant
152
free (PSA, free)
K/KK
76
FNPX
152
Prostatic acid
phosphatase (PAP)
K/KK
76
Anticoagulant
Monitoring,
Fondaparinux
POC6
POC PT/INR,
CoaguChek XS Plus
42
800-323-4040 | 847-832-7000 Option 1 | cap.org
21
LN3
X
Description
ENR Code
CZQ
BNPQ
LAP Program
297
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Prothrombin time (cont.)
21
Prothrombin time, dilute

Provider-performed
microscopy
Pseudoephedrine
Rapid Group A Strep
162
D9

Waived
163
MC1
Microbiology
Combination with GC
161
139
MC2
Microbiology
Combination
161
MC4
Urine Colony Count

Combination
161
MC5
Strep
161
152
WP3, WP4,
WP6, WP9
Whole Blood
Coagulation
154
CGE/CGEX
150
CMMP,
CMP3
Misc
C7
71
FTC
Criminalistics
96
Toxicology
88
Urine Toxicology
88
GLI
Glioma
233
Pyridinoline (PYD)
BU
Bone and Mineral,

Urine
79
Q-MONITORS
QM1
Quality Management
Tools
40
Q-PROBES
QP161
Quality Management
Tools
25
QP162
Quality Management
Tools
26
QP163
Quality Management
Tools
27
QP164
Quality Management
Tools
28
QT1-5
Quality Management
Tools
3132,
37
Quality Management
Tools
3334
QT15-17,
19
Quality Management
Tools
3536,
38
Toxicology
88
UT
Urine Toxicology
88
CZ, CZX,
CZ2X, Z
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
LN3
TDM Cal Ver/Lin
113
Toxicology
88
Quinidine
Quinine
Ranitidine
Rapid Group A Strep

(cont.)
D6
Anticoagulant
Monitoring
Rivaroxaban
UT
Quetiapine
Pg
RVBN
QT7, 8, 10
Description
ENR Code
PTEN
Q-TRACKS
LAP Program
UT
Urine Toxicology
88
Toxicology
88
UT
Urine Toxicology
88
Toxicology
88
UT
Urine Toxicology
88
RBC count
X

ABF3
140

FH1-FH4,
FH6, FH9,
FH10, FH13,
FH1P-FH4P,
FH6P, FH9P,
FH10P,
FH13P
131
FH3Q,
FH4Q,
FH6Q,
FH9Q

132
Series
HE, HEP
Basic Hematology
130
HFC, HFCI
Hemocytometer Fluid
Count
142
143
LN9
Hematology Cal
Ver/Lin
116
RBC count, urine
141
FOL
RBC Folate
81
RBC morphology
EHE1
Expanded Virtual
137
RDW
FH1-FH4,
FH6, FH9,
FH10, FH13,
FH1P-FH4P,
FH6P, FH9P,
FH10P,
FH13P
RBC folate
131
FH3Q,
FH4Q,
FH6Q,
FH9Q

132
Series
HE, HEP
Basic Hematology
130
Red blood cell antigen

detection
J, J1
200
Rapamycin (sirolimus)
CS
Immunosuppressive
Drugs
53

genotyping
RAG

genotyping
208
Rapid Group A Strep
Bacteriology
158
RBCAT
D4
Bacteriology, Ltd
160

typing
208

typing
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
Description
Pg
IDR
Infectious Disease,
Respiratory Panel
184
VR1
Virology Culture
178
VR2

by DFA
178
VR4

by EIA and Latex
179
Rubella antibody, IgG
IL, RUB/
RUBX
Immunology
188
Rubeola antibody
(English measles)
VR3

Serology
186
Rupture of Fetal
Membranes
ROM1
Rupture of Fetal
Membranes
143
Russells viper venom

time, dilute
CGE/CGEX
150
CZ, CZX,
CZ2X, Z
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
LN3
TDM Cal Ver/Lin
113
SDS
Serum Drug Screen
93
Toxicology
88
ENR Code
Reducing substance,
urine
Renin
ENR Code

CMP2,
CMP3
139
HCC2
Waived Combination
61
POC3
POC Urine Dipstick

Competency
42
Instrumentation
124
Refractometer check
X
Renin and Aldosterone
81
CGE/CGEX
150
Respiratory syncytial
virus (RSV)
ID2
Nucleic Acid Amp,

Respiratory
183
ID3
B, RSV by NAA
183
IDR
Infectious Disease,
Respiratory Panel
184
VR1
Virology Culture
178
VR2

by DFA
178
VR4
Virology Antigen
Detection by EIA and
Latex
179
LN18, LN19
Reticulocyte Cal Ver/Lin 118
RT, RT2, RT3, Reticulocyte

RT4
135
RSV (cont.)
Salicylate
UT
Urine Toxicology
88
Salmonella
GIP
184
Reticulocyte count,
absolute
RT, RT2, RT3, Reticulocyte

RT4
135
Sarcoma by FISH
CYK
Hybridization
221
RETT Syndrome
RETT
RETT Syndrome
Genotyping
227
Sarcoma translocation
SARC
Sarcoma Translocation
232
RDS
Rheumatic Disease
Special
194
RhD
MGL2
Molecular Genetics
225
Scl-70 (anti-DNA
topoisomerase)
RhD typing
J, J1
200
Scopolamine
DFC
99
JAT
Automated
200
Secobarbital
DFC
99
JATE1
200
FTC
Criminalistics
96
TMCA
Competency
Assessment
202
UDC
Forensic Urine Drug

91
Trace Metals
72
IL, RF/RFX
Immunology
188
TMU
Trace Metals, Urine
95
ID2
Nucleic Acid Amp,

Respiratory
183
ASA, SC,
SV, PV
Semen Analysis
146
IDR
Infectious Disease,
Respiratory Panel
184
SC1, SM
Semen Analysis
146
184
Semen Analysis, CDROM
146
GIP
SP, SPN
Stool Pathogens
168
SMCD,
SM1CD,
SM2CD
VR4

by EIA and Latex
179
AAT
Alpah-1 Antitrypsin
Genotyping
223
ID2
Nucleic Acid Amp,

Respiratory
183
DFC
99
FTC
96
ID3
B, RSV by NAA
183
Criminalistics
Toxicology
88
UT
Urine Toxicology
88
Rheumatoid factor
Rhinovirus
Rotavirus
X
RSV
Selenium
Selenium, urine
Semen analysis
SERPINA1 genotyping
Sertraline
800-323-4040 | 847-832-7000 Option 1 | cap.org
21
RAP
Reptilase time
Reticulocyte count,
percent
LAP Program
299
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
21
SFLC
Serum Free Light

Chains
195
Sex hormone-binding
globulin (SHBG)
ABS
Testosterone and
Estradiol Accuracy
103
DY
77
SP
Stool Pathogens-Rapid
and Molecular
168
ST
Shiga Toxin
168
GIP
184
Shiga toxin
Shiga-like toxin
producing E. coli (STEC)
Shigella
Sickle cell screen
Sirolimus (Rapamycin)
GIP
184
HG
Hemoglobinopathy
134
SCS
Sickle Cell Screen
135
CS
Immunosuppressive
Drugs
53
PGX
Pharmacogenetics
227
AQ, AQ2,
AQ3, AQ4
Aqueous Blood Gas
84
AQQ,
AQ2Q,
AQ3Q,
AQ4Q

Blood Gas Series
85
SLCO1B1
Sodium
Chemistry and TDM

C1, C3,
C3X, C4, CZ,
CZ2X, CZX
50
52
CZQ

Chemistry and TDM
53
Sodium, urine
X
FLD2
IFS
LN2
Spectrophotometer
linearity
Sperm count
Sperm count, automated

CMP2,
CMP3
139
DAI

Integrity Testing
90
HCC2
Waived Combination
61
POC3
POC Urine Dipstick

Competency
42
UDC
Forensic Urine Drug

91
Instrumentation
124
SMCD
Semen Analysis,
CD-ROM
146
SC1
Semen Analysis
146
SC
Semen Analysis
146
PV
Postvasectomy Sperm
Count
146
SM
Semen Analysis
146
SM1CD
Semen Analysis,
CD-ROM
146
Sperm motility
SMCD
Semen Analysis,
CD-ROM
146
Sperm viability
SM2CD
Semen Analysis,
CD-ROM
146
Sperm count, manual
Sperm morphology
SV
Semen Analysis
146
Bacteriology
158
67
125
Spinal muscular atrophy
MGL2
Molecular Genetics
225
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
Spinocerebellar ataxia
MGL2
Molecular Genetics
225
Split fats
FCFS
Fecal Fat
69
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
Staphylococcus aureusblood culture
BCS1
Blood Culture
164
GIP
184
LN13C
117
STEC (Shiga-like toxin

producing E. coli)
POC10,
POC11

Gases
Strep screen
POC4
POC/Waived Strep
Screen Competency
42
SW1, SW2,
SW3, SW4
73
LN6
Urine Chemistry Cal

Ver/Lin
114
Urine Chemistry,
General
63
93
Soluble transferrin
receptor
STFR
Soluble Transferrin
Receptor
73
VF
SOX10
Specific gravity
Sodium, vitreous fluid
Somatomedin C (IGF-1)
Pg
Spinal fluid meningitis

panel
LN2BV
Sodium, sweat
Description
ENR Code
Serum free light chains
LAP Program
Y, YY
77
PM5
TMA
246
Streptococcus agalactiae
D8
Group B Strep
163
SBAS
S. pneumoniae Ag
Detection
163
Bacteriology
158
D1, D7
160
D4
Bacteriology, Ltd
160
D6
Rapid Group A Strep
162
D9

Waived
163
MC1
Microbiology
Combination with GC
161
MC2
Microbiology
Combination
161
Streptococcus
pneumoniae
Streptococcus pyogenes
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Streptococcus pyogenes
(cont.)
MC4
Urine Colony Count

Combination
161

(cont.)
MC5
Strep
161
T4, total (thyroxine,

total)
Toxicology
88
UT
Urine Toxicology
88
Sulfosalicylic acid (SSA)
DSC
141
Surgical pathology
DPATH/
DPATH1

Program
239
Syphilis
T3, free
(triiodothyronine)
X
X
T3, total
(triiodothyronine)
X
T3 uptake & related

tests
X
X
Pg
PIP/PIP1,
Performance
PIPW/PIPW1 Improvement Program
in Surgical Pathology
236
237
PCSP, PCSP1 Practicum in Cancer

Surgical Pathology
241
VBP/VBP1
Online Virtual Biopsies

Program
238
SCDD
Designer Drugs
97
Syphilis Serology
194
Tay Sachs
tCO2
Tacrolimus
K/KK
76
ABTH
Harmonized Thyroid
104

CZ, CZX,
CZ2X
50
52
CZQ
53

Chemistry and TDM
K/KK
76
LN5
Ligand Assay Cal

Ver/Lin
114
LN5S

Cal Ver/Lin
114
CS
Immunosuppressive
Drugs
53
LN31
Immunosuppressive
Drugs Cal Ver/Lin
121
MGL4
Molecular Genetics
225
AQ, AQ2,
AQ3, AQ4
Aqueous Blood Gas
84
AQQ,
AQ2Q,
AQ3Q,
AQ4Q

Blood Gas Series
85
POC10,
POC11

Gases
DFC
99
DMPM
Drug Monitoring for

Pain Management
98
ABTH
Harmonized Thyroid
104
C1, C3,
C3X, CZ,
CZX, CZ2X
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
K/KK
76
ABTH
Harmonized Thyroid
104

CZ, CZX,
CZ2X
50
52
FTC
Criminalistics
96
CZQ

Chemistry and TDM
53
OFD

Abuse
92
K/KK
76
Toxicology
88
UDC
Forensic Urine Drug

91
LN5
Ligand Assay Cal

Ver/Lin
114
LN5S

Cal Ver/Lin
114

CZ, CZX,
CZ2X
50
52
CZQ

Chemistry and TDM
53
K/KK
76
ABTH
Harmonized Thyroid
104

CZ, CZX,
CZ2X
50
52
CZQ
53

Chemistry and TDM
Temazepam
UT
Urine Toxicology
88
Teriflunomide
ZE
Therapeutic Drug
54
Testosterone
ABS
Accuracy-Based
Testosterone and
Estradiol
103
LN8
Reproductive
Endocrinology Cal
Ver/Lin
115
X
Testosterone,
bioavailable
Y/YY
77
ABS
Testosterone and
Estradiol Accuracy
103
DY
77
800-323-4040 | 847-832-7000 Option 1 | cap.org
21
Designer Drugs
Description
ENR Code
Strychnine
LAP Program
301
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Testosterone, free
ABS
Pg
ENR Code
Testosterone and
Estradiol Accuracy
103
77
Thyroxine, total
ABTH
Harmonized Thyroid
104
50
52
53
Tetrahydrozoline
DFC
99
Thallium, urine
TMU
Trace Metals, Urine
95
CZQ
CZ, CZX,
CZ2X, Z
Chemistry and TDM
50
52

Chemistry and TDM
K/KK
76
CZQ

Chemistry and TDM
53
LN5
Ligand Assay Cal

Ver/Lin
114
LN3
TDM Cal Ver/Lin
113
LN5S
114
SCDD
Designer Drugs
97

Cal Ver/Lin
TMO
D1, D7
160

Arthropods
176
X
X
D4
Bacteriology, Ltd
160
BP
Blood Parasite
175
MC1
Microbiology
Combination with GC
161
MC2
Microbiology
Combination
161
Tissue plasminogen
activator
MC4
Urine Colony Count

Combination
161
Tobramycin
MC5
Strep
161
CGE/CGEX
150
CGS4
151
152
Theophylline
THJ-2201
Throat culture
Description

CZ, CZX,
CZ2X
21
LAP Program
Thrombin time
DY
DBGN
Dabigatran
Thrombin-antithrombin
CGE/CGEX
150
Thromboelastogram
TEG
Thromboelastogram
153
Thrombophilia Mutations
TPM
Thrombophilia
Mutations
228
Thyroglobulin
TM/TMX
Tumor Markers
82
ABS
Accuracy-Based
Testosterone and
Estradiol
103
Thyroid-stimulating
hormone (TSH)
ABTH
X
Thyroxine, free
Harmonized Thyroid
104

CZ, CZX,
CZ2X
50
52
CZQ
53
K/KK
76
LN5
Ligand Assay Cal

Ver/Lin
114
LN5S

Cal Ver/Lin
114
Harmonized Thyroid
104

CZ, CZX,
CZ2X
50
52
CZQ

Chemistry and TDM
53
K/KK
76
ABTH
X

Chemistry and TDM
Tick identification
Tissue parasite
identification
X
X
Total bile acids

Total bilirubin
Total bilirubin, urine
174
150
CZ, CZX,
CZ2X, Z
Chemistry and TDM
50
52
CZQ

Chemistry and TDM
53
LN3
TDM Cal Ver/Lin
113
TBLA
Total Bile Acid
72
50
52
CZQ

Chemistry and TDM
53
FLD2
67
IFS
125
LM1
Lung Maturity
70
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
NB, NB2
Neonatal Bilirubin

CMP2,
CMP3
139
DSC
141
FCFS
Fecal Fat
69
FP1T

Screening, Total hCG
80
CH50
Total Hemolytic
Complement
194
Total hemolytic
complement
Total iron binding
capacity, measured and
% saturation
Parasitology

CZ, CZX,
CZ2X
Total free fatty acids

Total hCG
P
CGE/CGEX
C3, C3X, CZ Chemistry and TDM

CZX, CZ2X
59
50
52
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
CZQ

Chemistry and TDM
53
Total nitrogen, urine
Urine Chemistry,
General
63
CBT
Cord Blood Testing
206
SCP
CBT
SCP
Total nucleated red cells

Total protein
Toxicology, urine,
qualitative
Toxicology, urine,
qualitative/quantitative
Toxoplasma gondii
Tramadol
96
Toxicology
88
UT
Urine Toxicology
88
Chemistry and TDM
50
52
206
C3, C3X,
CZ, CZX,
CZ2X
Cord Blood Testing
206
CZQ
206

Chemistry and TDM
53

CZ, CZX,
CZ2X
50
52
LN7
Immunology Cal
Ver/Lin
115
S2, S4
Immunology, Special
189
CZQ
53
ETME1
Medicine Exercises
201
Transferrin
FTC
X
Transfusion medicine
Body Fluid
67
EXM, EXM2
203
IFS
125
J, J1
200
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
JAT
Automated
200
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
JATE1
Automated
200
JE1
Education
201
SPE
70
TMCA
CSF Chemistry and

Oligoclonal Bands
68
Competency
Assessment
202
M, OLI
LN6
Urine Chemistry Cal

Ver/Lin
114
TMCAD
202
Urine Chemistry,
General
63
Competency
Assessment
TMCAE
SDS
Serum Drug Screen
93
ZT, ZZT
TDM, Special
54
Competency
Assessment
202
TICP, TICP1
Touch Imprint/Crush
Prep
253
TMCAF
202
SDS
Serum Drug Screen
93
Competency
Assessment
TRC
Toxicology
88

Count
DMPM
Drug Monitoring for

Pain Management
98
FTC
Criminalistics
96
Toxicology
88
Toxicology
88
UDS, UDS6
Urine Drug Screen
90
UT
Urine Toxicology
88
Syphilis Serology
194
TVAG
Trichomonas vaginalis,
Molecular
176
Touch imprint/Crush
prep
Toxicology, serum,
qualitative
Criminalistics

Chemistry and TDM
Tramadol (cont.)
FLD
Total protein, urine
Total tricyclics
Pg
UT
Urine Toxicology
88
DMPM
Drug Monitoring for

Pain Management
98
UDC
Forensic Urine Drug

91
VR3

Serology
186
DFC
99
DMPM
Drug Monitoring for

Pain Management
98
X
Trazodone
Treponema pallidum
X
Tricyclic group
Tricyclics, total
Triglycerides
VS, VS1
Vaginitis Screen
169
Toxicology
88
UDS, UDS6
Urine Drug Screen
90
UT
Urine Toxicology
88
SDS
Serum Drug Screen
93
ZT, ZZT
TDM, Special
54
ABL
102
800-323-4040 | 847-832-7000 Option 1 | cap.org
21
Total protein, CSF
Description
ENR Code
Total iron binding

capacity, measured and
% saturation (cont.)
Total nucleated cells
LAP Program
303
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Triglycerides (cont.)
21
X
Triiodothyronine (T3)
Triiodothyronine (T3),
Free
X
X
Trimipramine
Troponin I, plasma
Troponin I, serum
Troponin T, serum
X
Tumor necrosis factor
(TNF)-alpha
UGT1A1
Unsaturated iron binding
capacity, measured
Description
Pg
ENR Code

C4, CZ, CZX,
CZ2X
50
52
Unsaturated iron binding

capacity, measured
(cont.)
CZQ

Chemistry and TDM
53
CZQ

Chemistry and TDM
53
UR-144 N-pentanoic
acid metabolite
SCDD
Designer Stimulant
97
FCFS
Fecal Fat
69
Urea nitrogen
AQ2, AQ4
Aqueous Blood Gas
84
FLD
Body Fluid
67
Ltd Chem, Waived
59
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112

Blood Gas Series
85
LCW
AQ2Q,
AQ4Q
LN2BV
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
Harmonized Thyroid

C4, CZ, CZX,
CZ2X
50
52
CZQ

Chemistry and TDM
53
104
IFS
125

CZ, CZX,
CZ2X
50
52
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
LN2BV

Chemistry and TDM
53
K/KK
76
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
112
CZQ
LN5
Ligand Assay Cal

Ver/Lin
114
LN6
Urine Chemistry Cal

Ver/Lin
114
LN5S

Cal Ver/Lin
114
Urine Chemistry,
General
63
ABTH
Harmonized Thyroid
104
Urea nitrogen, vitreous

fluid
VF
93
C1, C3,
C3X, CZ,
CZX, CZ2X
Chemistry and TDM
50
52
Urease
RUR
Rapid Urease
167
Uric acid
50
52
CZQ

Chemistry and TDM
53

C4, CZ, CZX,
CZ2X
CZQ

Chemistry and TDM
53
FLD2
67
IFS
125
ABTH
X
LAP Program
Urea nitrogen, urine

X
K/KK
76
Toxicology
88
UT
Urine Toxicology
88
PCARM,
PCARMX
Plasma Cardiac
Markers
60
LN2
Chemistry, Lipid,
Enzyme Cal Ver/Lin
112
POC12
Competency Plasma
Cardiac Markers
43
LN2BV
112
CRT, CRTI
Cardiac Markers
57
LN25
Troponin I Cal Ver/Lin
120
Chemistry, Lipid,
Enzyme all Beckman
Ver/Lin
LN27
Troponin T Cal Ver/Lin
120
LN6
Urine Chemistry Cal

Ver/Lin
114
Urine Chemistry,
General
63
LN20
Urine albumin Cal

Ver/Lin
119
Urine Chemistry,
General
63
UMC
Urine Albumin
Creatinine
144
TNT
Troponin T
57
TNT5
Troponin T, 5 challenge
57
CTKN
Cytokines
192
PGX
Pharmacogenetics
227
C3, C3X,
CZ, CZX,
CZ2X
Chemistry and TDM
50
52
Uric acid, urine

X
Urine albumin
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Pg
ENR Code
ABU
103
Vaginitis screen (cont.)
Urine Chemistry,
General
63
Valproic acid
UMC
Urine Albumin
Creatinine
MC3
MC4
CZ, CZX,
CZ2X, Z
Chemistry and TDM
50
52
144
CZQ

Chemistry and TDM
53
Urine Colony Count
161
DFC
99
Urine Colony Count

Combination
161
LN3
TDM Cal Ver/Lin
113
Toxicology
88
UAA
141
UT
Urine Toxicology
88
URC
Crystals
141
Chemistry and TDM
D2, D7
160
CZ, CZX,
CZ2X, Z
50
52
D4
Bacteriology, Ltd
160
CZQ
MC1
Microbiology
Combination with GC
161

Chemistry and TDM
53
MC2
Microbiology
Combination
161
CZ, CZX,
CZ2X, Z
Chemistry and TDM
50
52
CZQ
Urine Colony Count
161

Chemistry and TDM
53
MC3
MC4
Urine Colony Count

Combination
161
LN3
TDM Cal Ver/Lin
113
IDN, IDO
182
Strep
161
Nucleic Acid Amp,

Organisms
VRE
Vancomycin-resistant
Enterococcus
169
N/NX
Urine Chemistry,
Special
64
ID1
Nucleic Acid
Amplification
183
Urine crystals
Valproic acid, free
Vancomycin
MC5
CMP, CMP1, Clinical MIcroscopy

CMP2,
CMP3
139
POC3
POC/Waived Urine
Dipstick Competency
42
Vancomycin-resistant
Enterococcus
Vanillylmandelic acid
Varicella-zoster virus
(VZV)
UDS, UDS6
Urine Drug Screen
90
VR1
Virology Culture
178
DMPM
Drug Monitoring for

Pain Management
98
VR2

by DFA
178
Urine sediment, color

photographs

CMP3,
CMMP
139
VR3

Serology
186
Urobilinogen

CMP2,
CMP3
139
Vascular endothelial
growth factor (VEGF)
CTKN
Cytokines
192
Venlafaxine
Toxicology
88
HCC2
Waived Combination
61
UT
Urine Toxicology
88
POC3
POC Urine Dipstick

Competency
42
Verapamil
Toxicology
88
UT
Urine Toxicology
88
CBT
Cord Blood Testing
206
Urine drug screen
Uroporphyrin
N/NX
Urine Chemistry,
Special
64
Viability
Urothelial carcinoma by
FISH, hybridization and
interpretation on-site
CYI
Fluorescence In
Situ Hybridization,
220
Viral antigen detection
Vaginal wet preparations
CMMP,
CMP3
Misc.
139
BV
Bacterial Vaginosis
168
VS
BD Affirm VP III Antigen 169

Detection
VS1
Genzyme OSOM
Trichomonas
Vaginitis screen
169
Viral isolation/
identification
SCP
206
HC2
HSV by DFA
179
POC8
POC Influenza A/B Ag
42
VR2

by DFA
178
VR4

by EIA and Latex
179
HC4
HSV Culture
179
ID3
B, RSV by NAA
183
800-323-4040 | 847-832-7000 Option 1 | cap.org
21

Gram Stain
Urine colony count
Urine dipstick
Description
VS2
Urine albumin:
creatinine ratio
Urine culture
LAP Program
305
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
Viral isolation/
identification (cont.)
Virology Culture
178
Virtual biopsy program,

online
VBP/VBP1
Online Virtual Biopsies

Program
238
Virtual Gram Stain
VGS1
Virtual Gram Stain

Basic
162
VGS2
Virtual Gram Stain

Advanced
162
Virtual peripheral blood

smear
VPBS

Smear
Viscosity
Viscosity
195
Vitamin A
BMV3
Bone Markers and

Vitamins
79
K, KK, K2
76
LN5
Ligand Assay Cal

Ver/Lin
114
LN5S

Cal Ver/Lin
114
ABVD
Accuracy-Based
Vitamin D
78
LN40
122
21
Vitamin B12
Vitamin D, 25-OH
Description
Pg
FH1-FH4,
FH6, FH9,
FH10, FH13
FH1P-FH4P,
FH6P, FH9P,
FH10P,
FH13P
131
FH3Q,
FH4Q,
FH6Q,
FH9Q

132
Series
FH15
ENR Code
VR1
LAP Program
WBC count (cont.)
FL4
HE, HEP
Basic Hematology
130
HFC, HFCI
Hemocytometer Fluid
Count
142
143
LN9
Hematology Cal
Ver/Lin
116
RWBC
Rapid Total White

Blood Cell Count
136
SCP
206
141
VITD
25-OH Vitamin D
78
Vitamin D, 1, 25
Dihydroxy
BMV1
Bone Markers and

Vitamins
79
WBC count (leukocytereduced platelets)
TRC

Count
Vitamin E
BMV4
Bone Markers and

Vitamins
79
WBC count (leukocytereduced RBCs)
TRC

Count
VKORC1
PGX
Pharmacogenetics
227
WBC differential
EHE1
AL1

Ethylene Glycol/
Volatiles
93
Expanded Virtual
137
VPBS

Smear
AL2
Serum Alcohol/
Ethylene Glycol/
Volatiles
93
Volatiles
von Willebrand factor
CGE/CGEX
150
CGS3
151
LN37
von Willebrand Factor

Ag Cal Ver/Lin
122
ID1
Nucleic Acid
Amplification
183
VR1
Virology Culture
178
VR2

by DFA
178
VR3

Serology
186
Instrumentation
124
VZV
Wavelength and
photometric calibration
WBC count

ABF3
140
CBT
206
Cord Blood Testing
WBC differental (2-part)
FH15
WBC differential,
automated
FH1-FH4,
FH6, FH9,
FH10, FH13
FH1P-FH4P,
FH6P, FH9P,
FH10P,
FH13P
FH3Q,
FH4Q,
FH6Q,
FH9Q

132
Series
WBC differential-body
fluid
VBF
Virtual Body Fluid
WBC morphology
EHE1
Expanded Virtual
137
West Nile virus
140
NAT
211
Worm identification
WID
Worm Identification
176
XLR-11 4-hydroxypentyl
metabolite
SCDD
Designer Drugs
97
Mycology
171
F1
Yeast
171
131
Analyte/Procedure
LAP Program
Description
Pg
Analyte/Procedure
ENR Code
(cont.)
F3
LAP Program
Description
Pg
ENR Code
Candida culture
172
Zolpidem
DFC
99
FTC
Criminalistics
96
Toxicology
88
UT
Urine Toxicology
88
Zaleplon
DFC
99
ZAP-70
ZAP70
ZAP-70 Analysis by
Flow Cytometry
198
Trace Metals
72
Zopiclone/Eszopiclone
DFC
99
Zinc, urine
TMU
Trace Metals, Urine
95
Zonisamide
ZE
54
Ziprasidone
DFC
99
Therapeutic Drug
Zinc
21
800-323-4040 | 847-832-7000 Option 1 | cap.org
307
Fast identification
of cells, fungi, and
parasites at your
fingertips
These laminated guides are
a quick, easy reference for
confident identification.
Portable5 x 6.5 or 6.5 x 7
Durableheavy duty to
withstand years of benchtop use
Praticalfull color images for
easy reference
See sample pages and order at

cap.org under the Shop tab.
Also available in ebook format at
ebooks.cap.org.
22 | Program Code Page Index
What we really like is the span of the programs

that the CAP offers. Within each of these areas we
can see how we can become more efficient.
22
Program Code Page Index

Program Code
22
Pg
Program Code
Pg
Program Code
Pg
Program Code
Pg
Program Code
Pg
AAT
223
AQ2Q
85
C1
5052
CTKN
192
EMB
ABF1
140
AQ3
84
C3
5052
CY
220
EPO
79
ABF2
140
AQ3Q
85
C3X
5052
CYBK
220
ESR
131
ABF3
140
AQ4
84
C4
5052
CYCGH
221
ESR1
131
ABL
102
AQ4Q
85
C7
71
CYF
220
ESR2
131
ABO
215
AQQ
85
CAMP
165
CYH
221
ESR3
131
ABOSG
203
ARP
191
CBT
206
CYI
220
ETB
94
ABRG
185
ASA
146
CCP
192
CYJ
221
ETME1
201
ABS
103
ASC
191
CD
94
CYK
221
EV
53
ABT
204
ASO
188
CDF2
165
CYL
221
EXM
203
ABT1
204
AUCD
248
CDF5
165
CYS
68
EXM2
203
ABT2
204
AUCD1
248
CES
192
CZ
50-52
171
ABT3
204
B27
216
CESX
192
CZ2X
50-52
F1
171
ABTH
104
BCP
130
CGB
150
CZQ
53
F3
172
ABU
103
BCP2
130
CGDF
150
CZVM
62
FCFS
69
ABVD
78
BCR
141
CGE
150
CZX
5052
FCN
190
ACA
190
BCS
163
CGEX
150
158
FF
79
ACE
66
BCS1
164
CGL
150
D1
160
FGAL
172
ACL
191
BDP
205
CGM
156
D2
160
FH1
131
ADL
66
BDP5
205
CGS1
151
D3
160
FH1P
131
AFA
248
BDPV
205
CGS2
151
D4
160
FH2
131
AFL
140
BDPV5
205
CGS3
151
D5
162
FH2P
131
AG
66
BFC
141
CGS4
151
D6
162
FH3
131
AHIV
210
BGL
223
CGS5
151
D7
160
FH3P
131
AHIVW
210
BGL1
223
CGS6
151
D8
163
FH3Q
132
AHT
190
BGS
78
CGS7
151
D9
163
FH4
131
AL1
93
BL
94
CH50
194
DADR1
217
FH4P
131
AL2
93
BLM
100
CHPVD
252
DADR2
217
FH4Q
132
AL2M
100
BMD
134
CHPVJ
252
DAI
90
FH5
131
AMH
78
BMV1
79
CHPVK
252
DAT
207
FH5P
131
ANA
188
BMV2
79
CHPVM
252
DBGN
152
FH6
131
APAPCE
251
BMV3
79
CMMP
139
DEX
159
FH6P
131
APAPCPT
250
BMV4
79
CMP
139
DFC
99
FH6Q
132
APAPJE
251
BMV5
79
CMP1
139
DL
215
FH7
131
APAPJPT
250
BMV6
79
CMP2
139
DML
215
FH7P
131
APAPKE
251
BNP
55
CMP3
139
DMPM
98
FH8
131
APAPKPT
250
BNP5
55
CPIP
14
DNA
258
FH8P
131
APAPLE
251
BNPQ
56
CPIP1
14
DNAF
258
FH9
131
APAPLPT
250
BOR
164
CRP
188
DPATH
239
FH9P
131
APAPME
251
BP
175
CRT
57
DPATH1
239
FH9Q
132
APAPMPT
250
BRAF
233
CRTI
57
DSC
141
FH10
131
APC
190
BRCA
224
CS
53
DY
77
FH10P
131
APOE
223
BSTE
182
CT
152
170
FH11
131
APS
191
BSTN
182
CT1
152
E1
170
FH11P
131
APT
142
BSTS
182
CT2
152
EGFR
233
FH12
131
AQ
84
BU
79
CT3
152
EHE1
137
FH12P
131
AQ2
84
BV
168
CT5
152
ELU
207
FH13
131
147
Program Code
Pg
Program Code
Pg
Program Code
Pg
Program Code
Pg
Program Code
Pg
131
HC6
181
ING
80
LN24
120
MTBR
170
FH15
132
HC6X
181
ISH
231
LN25
120
MTP
233
FID
258
HC7
181
ISH2
231
LN27
120
MVM
74
FIDM
258
HCA
193
200
LN30
120
MX1B
214
FL
196
HCC
61
J1
200
LN31
121
MX1C
214
FL1
196
HCC2
61
JAT
200
LN32
121
MX1E
214
FL2
196
HCG
188
JATE1
200
LN33
121
MX2B
214
FL3
196
HCV2
180
JE1
201
LN34
121
MX2C
214
FL4
196
HE
130
76
LN35
122
MX2E
214
FL5
197
HEP
130
K2
76
LN36
122
MXB
215
FLAC
166
HER2
247
KET
58
LN37
122
MXC
215
FLD
67
HFC
142
KIT
233
LN38
122
MYG
64
FLD2
67
HFCi
143
KK
76
LN39
122
64
FNA
255
HG
134
KRAS
233
LN40
122
NAT
211
FNA1
255
HGM
224
KSA
64
LN41
123
NB
59
FNAG
256
HIV
180
KVM
82
LN42
123
NB2
59
FNAG1
256
HIVG
180
LBAS
163
LN43
123
NEO
232
FNPX
152
HLAS
215
LBC
143
LN44
123
NGC
254
FOL
81
HLAS1
215
LCW
59
LPE
70
NGC1
254
FP
80
HMS
58
LDM
127
LPX
166
NGS
229
FP1B
80
HPATH
138
LKM
194
LUM
127
NGSB1
230
FP1T
80
HPATH1
138
LLM
127
68
NGSB2
230
FPX
80
HPS
166
LM
70
MBRG
173
NGSHM
229
FR
259
HPV
182
LM1
70
MBT
159
NGSST
229
FR1
259
HQBX1
244
LN2
112
MC1
161
NP
249
FSER
172
HQBX2
244
LN2BV
112
MC2
161
NP1
249
FSM
172
HQBX3
244
LN2VM
127
MC3
161
NVM
65
FT
69
HQIHC
243
LN2VM1
127
MC4
161
NX
64
FTC
96
HQIP
242
LN3
113
MC5
161
OCB
143
194
HQIPBX
243
LN5
114
ME
216
OFD
92
G6PDS
69
HSCRP
58
LN5S
114
MGL1
225
OLI
68
GH2
57
HV2
180
LN6
114
MGL2
225
174
GH5
57
124
LN7
115
MGL3
225
P3
174
GH5I
57
ID1
183
LN8
115
MGL4
225
P4
174
GHER2
247
ID1T
183
LN9
116
MGL5
225
P5
174
GIP
184
ID2
183
LN11
116
MHO
234
PAPCE
251
GLI
233
ID3
183
LN12
116
MHO1
234
PAPCPT
250
GNBC
185
IDN
182
LN12E
116
MHO2
234
PAPJE
251
GOCB
142
IDO
182
LN13
117
MHO3
234
PAPJPT
250
GPBC
185
IDR
184
LN13C
117
MHO5
PAPKE
251
GSA
58
IFS
125
LN14
117
231,
234
PAPKPT
250
190
IG
188
LN15
117
MK
245
PAPLE
251
HBF
207
IGX
188
LN16
118
ML
215
PAPLPT
250
HBRG
137,
222
IL
188
LN17
118
MMR
245
PAPME
251
IM
188
LN18
118
MPA
54
PAPMPT
250
HBVL
180
IMD1
226
LN19
118
MRD
234
PARF
212
HBVL5
180
IMD2
226
LN20
119
MRD1
234
PBRG
175
HC1
165
IMD3
226
LN21
119
MRD2
234
PCARM
60
HC2
179
IMW
189
LN22
119
MRS
167
PCARMX
60
HC3
165
IND
173
LN23
119
MRS5
167
PCP1
173
HC4
179
MSI
231
800-323-4040 | 847-832-7000 Option 1 | cap.org
22
FH13P
311
Program Code
22
Pg
Program Code
Pg
Program Code
Pg
Program Code
Pg
PCP2
173
QT1
31
SEC
226
UPBG
65
PCP3
173
QT2
31
SEC1
226
URC
141
PCP4
173
QT3
32
SFLC
195
UT
88
PCSP
241
QT4
32
SM
146
UTCO
126
PCSP1
241
QT5
37
SM1CD
146
UVM
65
PCT
71
QT7
33
SM2CD
146
195
PF
153
QT8
33
SMCD
146
VBF
140
PF1
153
QT10
34
SO
86
VBP
238
PGX
227
QT15
35
SOQ
86
VBP1
238
PGX1
227
QT16
35
SP
168
VF
93
PGX2
227
QT17
36
SP1
168
VGS1
162
PHG
70
QT19
38
SPE
70
VGS2
162
PIA
155
72
SPN
168
VITD
78
PIP
236
RAG
208
ST
168
VLS
180
PIP1
236
RAP
81
STFR
73
VLS2
180
PIPW
237
RBCAT
208
SV
146
VM1
209
PIPW1
237
RDS
194
SW1
73
VM2
209
PLA
69
RETT
227
SW2
73
VM3
209
PLTM
155
RF
188
SW3
73
VM4
210
PM1
245
RFAV1
198
SW4
73
VM5
210
PM2
247
RFAV2
198
88
VM6
210
PM3
245
RFX
188
TBLA
72
VPBS
136
PM5
246
RHCVW
211
TBX
155
VR1
178
PNA1
164
RMAL
175
TEG
153
VR2
178
PNA2
164
ROM1
143
TICP
253
VR3
186
PNA3
164
RT
135
TICP1
253
VR3M
186
PNA4
164
RT2
135
TM
82
VR4
179
PNH
197
RT3
135
TMCA
202
VRE
169
POC1
42
RT4
135
TMCAD
202
VS
169
POC2
42
RUB
188
TMCAE
202
VS1
169
POC3
42
RUBX
188
TMCAF
202
VS2
169
POC4
42
RUR
167
TMO
176
WB2
61
POC6
42
RVBN
152
TMU
95
WBCR
61
POC7
42
RWBC
136
TMX
82
WBDD
155
POC8
42
S2
189
TNT
57
WBG
61
POC9
42
S4
189
TNT5
57
WID
176
POC10
43
S5
189
TPM
228
WP3
154
POC11
43
SALC
71
TRC
208
WP4
154
POC12
43
SARC
232
TTD
186
WP6
154
POC14
43
SBAS
163
TVAG
176
WP9
154
POC15
43
SC
146
63
WP10
154
POC16
43
SC1
146
UAA
141
77
PS
207
SCDD
97
UAA1
141
YVM
82
PV
146
SCM1
144
UBJP
70
YY
77
QF
194
SCM2
144
UDC
91
5052
QM1
40
SCO
126
UDS
90
ZAP70
198
QP161
25
SCP
206
UDS6
90
ZE
54
QP162
26
SCS
135
UDSM
100
ZT
54
QP163
27
SDS
93
UHCG
144
ZZT
54
QP164
28
SE
193
UMC
144
Only this box takes your

proficiency testing to the
next level
Only the CAPs proficiency testing (PT)
programs offer more than just regulatory
exercises; they also serve as quality
management tools that support better
patient care.
Laboratory professionals like you are finding added value
from using the CAPs Participant Summary Reports:
To evaluate instrument and method performance for
optimal patient diagnostics
To compare results and methods against a robust peer
group for greater diagnostic confidence
To provide a quality check and to assist with
troubleshooting efforts for added staff efficiency
To obtain education on best practices while obtaining
valuable CE credit
To use as a training tool with valuable information
and images
The CAP proficiency testing program

is a resource that goes beyond the
objective of achieving an acceptable
score. We depend on the CAP critiques
because it is ultimately our patients
who benefit from our personal
commitment and the high standards
set forth by the CAP.
Eric R. Rosenbaum, MD, MPH, FCAP
University of Arkansas for
Medical Sciences
Ensuring the accuracy that todays environment demands

Maximize confidence in your test results with the most extensive selection of scientifically developed
programs available. The CAP can help your laboratory:

Deliver the highest quality standards that your laboratory and patients can depend on
Ensure performance through peer comparisons with programs used by more than
20,000 laboratories worldwide
Enhance staff skills through technical and professional guidance included in all
participant summaries
2016
Surveys
and Anatomic
Pathology
Education Programs
Choose from a comprehensive offering to cover your testing needs:

Histocompatibility
Anatomic Pathology
Coagulation
Microbiology
Endocrinology
Forensic Sciences
Toxicology
Transfusion Medicine, Viral Markers, and

Parentage Testing
325 Waukegan Road

Northfield, IL 60093-2750
800-323-4040
847-832-7000 (Country code: 001)
2015 College of American Pathologists. All rights reserved.

23873.0715.1937
cap.org
Together,
we move forward
to achieve better
patient care.

2016 Surveys Catalog PDF

Transféré par

Informations du document

Description originale:

Titre original

Copyright

Formats disponibles

Partager ce document

Partager ou intégrer le document

Options de partage

Avez-vous trouvé ce document utile ?

Ce contenu est-il inapproprié ?

Droits d'auteur :

Formats disponibles

2016 Surveys Catalog PDF

Transféré par

Droits d'auteur :

Formats disponibles

Ensuring the accuracy that todays environment demands

Choose from a comprehensive offering to cover your testing needs:

Immunology and Flow Cytometry

Blood Gas, Critical Care, and Oximetry

Instrumentation Validation Tools

Quality Management Tools

General Chemistry and Therapeutic Drug Monitoring

Genetics and Molecular Pathology

Transfusion Medicine, Viral Markers, and

Hematology and Clinical Microscopy

2016 Surveys and Anatomic Pathology Education Programs

325 Waukegan Road

2015 College of American Pathologists. All rights reserved.

Welcome to the 2016 Surveys Catalog

The CAPs decades-long partnership with laboratories in PT and accreditation,

R. Bruce Williams, MD, FCAP

2016 Surveys and Anatomic Pathology Education Programs

14 Microbiology ........................................... 157186

15 Immunology and Flow Cytometry ...... 187198

16 Transfusion Medicine, Viral Markers,

17 Histocompatibility .................................. 213218

19 Anatomic Pathology .............................. 235256

20 Forensic Sciences .................................. 257260

You get more

Its about building the trust of the clinical staff in the

the cutting edge of laboratory practices.

Quality Management Tools

Technical Staffing Ratios

Impact of Transit Times on Detection of

Hospital Nursing Satisfaction

Technical Competency Assessment on

General Chemistry and Therapeutic Drug Monitoring

General Chemistry and Therapeutic

General Chemistry and Therapeutic

General Chemistry and Therapeutic

Whole Blood Creatinine

Ligand Assay, Limited

4 College of American Pathologists

2016 Surveys & Anatomic Pathology Education Programs

Instrumentation Validation Tools

C-Reactive Protein, Extended Calibration

Lamellar Body Count Calibration Verification/Linearity

Fibrinogen Calibration Verification/Linearity

Hematology and Clinical Microscopy

Blood Cell Identification, Limited

Hematology Automated Differential Series

Urinalysis with Clinical Microscopy

800-323-4040 | 847-832-7000 Option 1 | cap.org

Microbiology Combination with GC

Urine Colony Count

Urine Colony Count Combination

Throat Culture/Rapid Strep

Bordetella pertussis/parapertussis, Molecular

C. difficile Detection, 2 challenges

C. difficile Detection, 5 challenges

Trichomonas vaginalis, Molecular

Influenza A, Influenza B, RSV by NAA

Immunology and Flow Cytometry

Celiac Serology, Additional Volume

Rare Flow Antigen Validation, CD103

Transfusion Medicine, Viral Markers, and Parentage Testing

ABO Subgroup Typing